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4Abstract
S. Typhiumrium is a ubiquitous zoonotic pathogen, which remains a recognised
human health risk factor in the food production chain. Following the withdrawal of
antimicrobial growth promoters in animal feeds in the European Union, the
enhancement of the host’s resistance to enteropathogens by alternative control
strategies has become essential. Probiotics are classified as live microbial feed
supplements; often members of the normal flora and have been shown to improve gut
health and further act as competitors against foodborne pathogens. Prebiotics are non-
digestable in the upper gut, however fermented in the large intestine carbohydrates
aimed to selectively stimulate beneficial bacteria and therefore selectively modulate
gut microbiota.
Probiotics, prebiotic have been reported as successful in conferring protection
against many pathogens. Therefore the aim of this project was the construction of an
effective synbiotic combination of pre and probiotic that can be employed to control
Salmonella colonisation in pigs.
The results demonstrated that lactulose promoted the growth of L. plantarum in
the pure culture and in fermentations with the complex porcine microflora, resulting in
an increase of short chain fatty acid (SCFA) concentrations. The presence of L.
plantarum cell-free supernatant (CFS) conferred a strong inhibitory activity against S.
Typhimurium growth. Moreover, L. plantarum together with the CFS reduced S.
Typhimurium adherence and invasion to porcine epithelial cells. Inclusion of L.
plantarum and lactulose in a batch culture system resulted in the overall gradual
decrease in Salmonella numbers as evaluated by fluorescent in situ hybridisation
(FISH), which was correlated with the increases in SCFA. Finally, an in vivo trial was
undertaken using a pig infection model. The results generated from this in vivo study
in pigs, confirmed the superior effect of the probiotic candidate L. plantarum in
combination with lactulose in comparison to probiotic or prebiotic alone. Together
with the higher lactobacilli counts in the synbiotic feed group, a reduced frequency of
Salmonella shedding was observed.
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Chapter 1
Introduction
1.1 Salmonella - global zoonotic problem
Salmonellae are one of the major causes of food-borne disease worldwide
(Adams and Moss, 2008). The global human health impact of non-typhoidal
Salmonella is significant with estimated 93.8 million illnesses, of which approximately
80.3 million are food-borne (Majowicz et al., 2010). In the European Union (EU),
salmonellosis is consistently the second most frequently reported zoonotic disease in
humans (EFSA, 2012). In 2010 the most commonly reported Salmonella serovars were
S. Enteritidis and S. Typhimurium accounting for around 80% of all confirmed human
salmonellosis cases. Nevertheless, other serovars including Infantis, Newport,
Virchow, Hadar, Mbandaka are prevalent (EFSA, 2012). Salmonella infections in
humans and animals may lead to high morbidity and in some instances high mortality.
Clinically, human salmonellosis is usually manifested by diarrhea, nausea, vomiting,
intestinal cramping and mild fever. The severity of the symptoms differs, in general
infections are self limited, but in very young and elderly salmonellosis can lead to
severe dehydration and become life-threatening (Adams and Moss, 2008; Santos et al.,
2001). Globally, is it estimated that 155,000 deaths occur due to non-typhoidal
salmonellosis each year (Majowicz et al., 2010).
In 2010 in the EU the number of human illnesses due to salmonellosis decreased
by 8.8% compared to the previous year with 99,020 in 2010 and 108,618 in 2009
(EFSA, 2012). It was concluded that the reduction of human salmonellosis is largely a
consequence of implemented Salmonella control programs in chicken populations
(Collard et al., 2008; EFSA, 2012). In the UK, the number of laboratory-confirmed
human salmonellosis cases has declined with a total of 10,071 confirmed cases in 2009
and 9,685 in 2010 (DEFRA, 2009, 2010; EFSA, 2012). However, S. Enteritidis serovar
remained the most commonly reported serovar whilst S. Typhimurium, the second
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most commonly reported serovar, increased by 4.6% (DEFRA, 2010).
Salmonella infections result in significant economic losses and it has been
reported that the total cost of all Salmonella infections in the EU, accounting also for
premature deaths, are equivalent to nearly €600 million (Anonymous, 2010). Santos et
al. (2011) reported that when the societal costs were estimated for S. Enteritidis and S.
Typhimurium, the latter seem to be more expensive to treat. It has been concluded that
cases of human salmonellosis caused by S. Enteritidis are associated with the
consumption of contaminated eggs and poultry meat, whereas contaminated pig,
poultry and bovine meat is linked to S. Typhimurium infections (EFSA, 2010, 2012).
Total costs of Salmonella infections associated with pork in EU are estimated to be
around €90 million (Anonymous, 2010). Considering the public health impact and
economic burden and the fact that pork and pork products have been recognised as
important source of human salmonellosis (Lo Fo Wong et al., 2002) it is important to
reduce Salmonella levels in pigs and pork, thus reduce the risk of human salmonellosis
due to pig origin.
1.2 Salmonella general characteristics
1.2.1 History and nomenclature
The genus Salmonella was named after the American veterinary pathologist; Dr
Daniel Salmon and his colleague Dr Theobald Smith who first isolated the “hog
cholera bacillus” from a pig in 1885 (Salmon and Smith, 1886) and which at the time
was considered to be a cause of swine plague. Interestingly, these rod-shaped, Gram-
negative bacteria were visualized beforehand by Eberth in 1880 in tissue sections from
spleen and mesenteric lymph nodes of patients with typhoid fever and then isolated by
Gaffky in 1884 (Grimont et al., 2000; Le Minor, 1994; Parry, 2006).
Historically, Salmonella species were classified on the basis of their
epidemiology, host range, clinical manifestation, biochemical reactions and surface
antigenic pattern. Since then, there have been many revisions and nomenclature
changes in the classification of Salmonella genus (Euzeby, 1999; Ezaki et al., 2000a;
Ezaki et al., 2000b; Le Minor and Popoff, 1987) and, as concluded by Brenner et al.
(2000), standardization was considered necessary. Thus, the current concept
distinguished two species which are S. enterica and S. bongori, the latter was formerly
known as subspecies V (Reeves et al., 1989). Within Salmonella enterica six known
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subspecies are listed; enterica, salamae, arizonae, diarizonae, houtenae, and indica
(Le Minor and Popoff, 1987; Reeves et al., 1989; Tindall et al., 2005).
Serological classification of Salmonella is based on the antibody interaction with
the salmonellae lipopolisaccharides (O antigen), flagellar proteins (H antigen) and
capsular polysaccharides (Vi antigen). To date all identified serovars and their
antigenic formulae are listed in the White-Kaufmann-Le Minor Scheme (Grimont and
Weill, 2007; Popoff et al., 2004; Switt et al., 2009). The Salmonella serotyping
scheme, formerly known as Kauffmann-White Scheme is revised by the Institut
Pasteur, WHO Collaborating Centre for Reference and Research (Popoff et al., 2001;
Popoff et al., 2004). More than 2500 Salmonella serotypes are known, with the
majority belonging to S. enterica subsp. enterica (Grimont and Weill, 2007) (Table
1.1). Some Salmonella serovars can be further subdivided into phage types (PT) and to
date phage typing, is a frequently used method for epidemiological characterisation of
pathogens (Baggesen et al., 2010).
Table 1.1 Number of serovars in each species and subspecies of Salmonella (Grimont
and Weill, 2007).
Species and subspecies Number of serovars
S. enterica 2557
subsp. enterica 1531
subsp. salamae 505
subsp. arizonae 99
subsp. diarizonae 336
subsp. houtenae 73
subsp. indica 13
S. bongori 22
Total 2579
1.2.2 Phenotypic characteristics
Salmonella are Gram-negative, catalase-positive, oxidase- negative, rod-shaped
bacteria belonging to the family Enterobacteriaceae and phylum Proteobacteria. The
majority of Salmonella strains are motile with peritrichous flagella, which can be
encoded by two different flagellin genes on the bacterial chromosome (fliC and fljB)
(Switt et al., 2009). Salmonellae are facultative anaerobes, ferment glucose and
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produce hydrogen sulfide from thiosulphate. In general Salmonella strains are
prototrophic and, as a result, they can grow easily in minimal medium with glucose as
a sole carbon source, ammonia as a nitrogen source and mineral salts (Grimont et al.,
2000). A small number of host-adapted Salmonella serovars are auxotrophs and
require additional growth factors as they are not able to synthesize some essential
vitamins and amino acids and therefore supplements including vitamins (thiamin,
nicotinic acid), purines (adenine and guanine) and the amino acids (cystine,
methionine, leucine, threonine, histidine, arginine, and aspartic acid) must be supplied
in the medium to support their growth (Stokes and Bayne, 1958). For example, S.
Gallinarum requires thiamine and S. Pullorum a presence of nicotinic acid, leucine,
aspartic acid and cysteine (Stokes and Bayne, 1958).
Some phenotypic characteristics are often used for identification of bacteria, e.g. the
production of hydrogen sulphide from thiosulphate or the ability to hydrolyse 4-
methylumbelliferyl caprylate (MUCAP) leading to release of fluorescent
umbelliferone (Olsson et al., 1991). Most Salmonella subspecies lack the ability to
produce β-D-galactosidase, which distinguishes them from other Enterobacteriaceae
members such as E. coli (Kuhn et al., 1994). Moreover, as lactose, sucrose, salicin
cannot be fermented by Salmonella, those are together with the pH indicators often
included in the selective isolation media (Grimont et al., 2000).
1.2.3 Salmonella host range
Salmonella serotypes can be divided into host-restricted, host-adapted and un-
restricted serotypes (Uzzau et al., 2000). The latter includes S. Enteritidis and S.
Typhimurium and, in general, clinically those are associated with gastroenteritis which
is most often self limiting (Rabsch et al., 2002; Uzzau et al., 2000). On the contrary,
human host-restricted serotypes such as S. Typhi and S. Paratyphi cause severe
systemic diseases (McClelland et al., 2004; Santander and Curtiss, 2010). Similarly,
Abortusequi, Gallinarum, Typhisuis, Abortusovis, are almost completely restricted to
equine, fowl, swine, ovines respectively (Alam et al., 2009; Pardon et al., 1988;
Shivaprasad, 2000; Uzzau et al., 2000). Furthermore, the host-adapted group includes
S. Dublin and S. Choleraesuis, which predominantly cause disease in cattle or pig with
disease in other species, including human, possible (Bolton et al., 1999; Chiu et al.,
2004; Uzzau et al., 2000). It is suggested that the development of the host adaptation
was driven through multiple horizontal transfer events which resulted in new gene
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combination, especially genes that belong to Salmonella pathogenicity islands,
virulence plasmid, fimbrial operons, pseudogenes and lysogenic phages (Eswarappa et
al., 2008; Kingsley and Baumler, 2000).
1.2.4 Transmission and persistence
Although the main transmission route is thought to be the faecal-oral route, it has
been observed that tonsils and lungs are important sites for Salmonella invasion with
intranasal transmission via dust and an aerosol is probable (Fedorka-Cray et al., 1995;
Gray et al., 1995).
The ability of Salmonella to survive long-term outside the host results in
environmental contamination and creates the possibility for the transmission of
infection (Baloda et al., 2001; Winfield and Groisman, 2003). It has been
demonstrated that Salmonella persist in the pigs, faecal samples, feed and the piggery
environment for over 2 years (Baloda et al., 2001). Similarly, genetically
indistinguishable serotypes of Salmonella in outdoor swine wallows were isolated for
over 5 months (Callaway et al., 2005). Factors including temperature, oxygen,
chemical and biological composition of the environment influence survival time
(Semenov et al., 2009). The ability of Salmonella to persist in the environment raises
the awareness of additional sources of contamination, which can be rodents, insects,
contaminated feed and feedstuff. Moreover, this highlights the importance of
environmental decontamination and focuses research on alternative control strategies.
1.2.5 Pathogenesis
1.2.5.1 Salmonella stress resistance and attachment
The clinical symptoms of gastroenteritis range from asymptomatic to severe
diarrhoea. In order to colonise a host, bacteria must survive unfavorable conditions
such as gastric acid, detergent effects of bile, decreasing oxygen supply, coexisting
bacteria and immune responses (Rychlik and Barrow, 2005). Salmonella resist low pH
by expressing an acid tolerance response (ATR) which can protect the cell down to
pH3 (Foster, 2001). In response to acidic conditions Salmonella synthesize sets of
proteins which confer a protective role and thus facilitate survival and replication
(Foster, 1991; Foster and Hall, 1990; Wilmes-Riesenberg et al., 1996). The ATR of S.
Typhimurium requires the synthesis of over 50 acid shock proteins (ASPs) and there
Chapter 1
24
are at least two known ATR systems, one in logarithmic growth phase and the second
in stationary phase (Wilmes-Riesenberg et al., 1996). Salmonella harbour numerous
regulons allowing the adaptation to low pH, and it was demonstrated that two distinct
tolerance systems for surviving the organic and inorganic acid stress exist (Bearson et
al., 1998). RpoS and Fur, global regulatory proteins, are essential for surviving the
organic acid stress, whereas partially redundant protection against inorganic acid stress
is afforded by two RpoS and PhoPQ dependent systems (Bearson et al., 1998). The
PhoP-PhoQ system has also been implicated in the regulation of Salmonella virulence
genes (Bearson et al., 1998). In addition to PhoP-PhoQ system Salmonella virulence is
regulated by the OmpR/EnvZ signal transduction system, associated with osmolarity-
dependant regulation of OmpC and OmpF porins (Rychlik and Barrow, 2005).
Salmonella spp. express a range of fimbrial and non-fimbrial adhesins which
facilitate site specific colonisation of host cells, therefore playing an important role in
the host infection (Edwards et al., 2000). Several types of fimbriae associated with
Salmonella may play a role in colonisation including type 1 fimbriae (Fim), plasmid
encoded fimbriae (Pef), long polar fimbriae (Lpf) and thin aggregative fimbriae (Curli)
(Darwin and Miller, 1999). Interestingly, Baumler et al. (1996b) demonstrated that S.
Typhimurium fimbriae bind specifically receptors that are expressed on the particular
cell type. This study supported the previously investigated concept that S.
Typhimurium adhesion to the murine small intestine villous is mediated via Pef,
whereas Lpf mediates adhesion to ileal Peyer’s patches (Baumler and Heffron, 1995;
Baumler et al., 1996a). Studies have shown that Fim are important in the site specific
attachment of Salmonella to various eukaryotic cells (Darwin and Miller, 1999;
Duguid et al., 1966). Ewen et al. (1997) demonstrated that these proteinaceous
appendages contain mannose sensitive lectin, and this binds to the epithelial cells
which express α-d-mannose receptors.
Salmonella also express flagella which confer motility and are thought to be a
significant factor for pathogen attachment and invasion (Dibb-Fuller et al., 1999; Jones
et al., 1992). Studies conducted by Allen-Vercoe and Woodward, 1999 demonstrated
that flagella mutants were less capable of attaching to chicken tissues in vitro and
proven to be less pathogenic in vivo. Flagella and especially chemotaxis enable
Salmonella to respond to the various attractants and repellent gradients and was
declared as essential for efficient induction in murine Salmonella – induced colitis
(Stecher et al., 2004).
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1.2.5.2 Salmonella invasion and diarrhoea
Once attached, the entry of Salmonella into a host cell requires synchronized
action of numerous bacterial effector proteins (Galan and Zhou, 2000). The pathogen
protein secretion systems are important for bacteria to induce disease and can be
encoded by particular regions of pathogenicity islands. Those are large genomic
regions (10-200kb) of DNA encoding virulence factors found in pathogenic strains and
acquired by via horizontal gene transfer (Hacker and Kaper, 2000; Morgan, 2007).
Salmonella spp. harbours five main Salmonella pathogenicity islands (SPIs),
namely, SPI-1, SPI-2, SPI-3, SPI-4 and SPI-5 although some 23 are now described
(Hayward personal communication) (Eswarappa et al., 2008). SPI-1 is essential for
Salmonella to invade the eukaryotic cell and induce the intestinal secretory and
inflammatory responses, whereas SPI2 plays a role in systemic infections and
intracellular accumulation of Salmonella and for its survival (Darwin and Miller, 1999;
Morgan, 2007; Wallis and Galyov, 2000). The SPI encoded type three secretion
system, TTSS, is one of the most complex protein secretion systems comprising over
20 proteins (Galan, 2001). The main function of this complex secretion system is
delivery of bacterial proteins to the host cells (Galan and Collmer, 1999). The TTSS
supramolecular structure named a “needle complex” consists of a numerous
substructures and architecturally resembles a flagellar hook-basal body (Kubori et al.,
1998; Kubori et al., 2000). The basal part of the “needle complex” consists of two
pairs of rings attached to the inner and outer membranes of the bacterial cell which are
connected with an inner rod. Several structural proteins of the “needle complex” have
been recognised, PrgK, InvG, PrgH are known to form the basal part, the PrgJ is the
putative inner rod protein and the needle portion is formed by a PrgI protein (Kubori et
al., 2000; Sukhan et al., 2003). In addition, the InvA, SpaP, SpaQ, SpaR and SpaS
proteins are a part of an export apparatus (Galan and Wolf-Watz, 2006).
The TTSS-1 system enables, through excellent synchronization between
translocators and translocated effector proteins, the continuous delivery of circa
thirteen effector proteins (Kubori et al., 2000; Main-Hester et al., 2008). Translocators,
such as SipB, SipC and SipD are a vital group of proteins for translocation of the
effector proteins into a host cells, nevertheless the full mechanism of this delivery has
yet to be fully elucidated (Galan and Wolf-Watz, 2006; Galan and Zhou, 2000).
Directly after the contact of Salmonella with the host cells, effectors including SopE,
SopE2 (with function similar to SopE) and SopB are involved in the reversible
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activation of the Rho family GTPases (Galyov et al., 1997; Hardt et al., 1998). The
latter being the key regulators of the host cellular architecture are under control of
guanine exchange factors (GEFs), which assist in GTP binding, and also the GTPase
activating proteins (GAPs) which promotes GTP hydrolysis (Moon and Zheng, 2003;
Patel and Galan, 2005). In Salmonella pathogenesis the exchange of inactive GDP for
GTP active state of Cdc42 and Rac-1 cytoskeleton regulatory proteins is directly
catalysed by SopE effector protein, functioning here as GEF (Hardt et al., 1998; Zhou
et al., 1999). Moreover, the alternative, indirect activation exist, Cdc42, but no Rac-1
is mediated through SopB effector protein by modification of phosphoinositide
phosphate (PIP) and inositol phosphate (IP) metabolism (Patel and Galan, 2005; Zhou
et al., 2001). The activation of Rho family GTPases by pathogen effectors leads to
actin cytoskeleton rearrangements and membrane ruffling through the involvement of
host Arp2/3 complex along with bacterial SipA and SipC effector proteins, triggering
Salmonella internalization (Hayward and Koronakis, 2002; McGhie et al., 2009).
Interestingly, studies by Hanisch et al. (2010) demonstrated that while complex
activator WAVE-2 of Arp2/3 is necessary for the formation of ruffles, the latter is not
required for Salmonella entry. Following bacterial internalization, SptP effector protein
is involved in reversing cytoskeletal changes by antagonizing GEF function and
switching Cdc42 and Rac-1 proteins to the GDP-bound inactive state (Fu and Galan,
1999).
Once inside the host cell Salmonella survives and replicates in the Salmonella-
containing vacuole (SCV). The early stage of SCV biogenesis is mediated via
numerous Salmonella effector proteins of SPI-1 with subsequent involvement of SPI-
2 TTSS (Steele-Mortimer, 2008). This second TTSS is activated under intracellular
conditions as mentioned above and is necessary for Salmonella survival and
proliferation (Brown et al., 2005; Hensel, 2000). SeeB, SseC and SseD proteins are
required for translocation of effector proteins across the membrane of the vacuole, but
in contrast to SPI-1 these do not posses effector functions (Waterman and Holden,
2003). Whereas proteins such as SipC, SseF, SseG, SifA, SspH1, SspH2, SseJ, SrfJ
and PipB are translocated (Waterman and Holden, 2003). These effectors assist in the
interference with endocytic trafficking, protection from reactive oxygen and reactive
nitrogen species, formation of tubular aggregates of endosomal compartments (Sifs),
cholesterol accumulation, induction of delayed macrophage apoptosis and assembly of
intracellular actin (Kuhle et al., 2004; Miao et al., 2003; Steele-Mortimer, 2008;
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Uchiya et al., 1999; Waterman and Holden, 2003).
The SCV migrates through the epithelial cell to the basolateral membrane and
subsequently interacts with associated with Peyer’s patches in the submucosal space
macrophages (Ohl and Miller, 2001). In response to pathogen recognition, chemokine
production generates neutrophil influx and transmigration into a lumen. It is suggested
that interleukin-8, potent neutrophil chemokine is important in recruiting neutrophils to
the submucosal space (Ohl and Miller, 2001). Loss of epithelial integrity is caused by
neutrophil inflammation and is linked with necrosis of the mucosa which, in turn, leads
to diarrhoea (Santos et al., 2003; Zhang et al., 2003).
1.3 Salmonella in pigs and pork
1.3.1 Clinical disease and pathology
Salmonella infections in pigs are associated with both broad-range and host
adapted serotypes and characterised by diverse clinical symptoms (Fedorka-Cray et al.,
2000). Host-adapted S. Choleraesuis causes a swine paratyphoid with clinical
manifestations of enterocolitis and septicemia and is correlated with high mortality in
young animals (Wilcock and Schwartz, 1992). Importantly, infection with this
serotype is not limited to pigs only, but also systemic infections in human (Chiu et al.,
2004).
Nevertheless, the main subject of this thesis is a ubiquitous serotype S.
Typhimurium, to which pigs undoubtedly are predisposed among other hosts. It must
be highlighted that although broad host range serotypes including S. Typhimurium
could cause a disease as discussed in this section, in general those infections remain
subclinical (Boyen et al., 2008a; Fedorka-Cray et al., 2000; Kranker et al., 2003).
Importantly, the carriage of Salmonella in tonsils, intestines and the gut-associated
lymphoid tissue (GALT) by asymptomatic carriers pose a risk to human health
(Fedorka-Cray et al., 2000). It is when an appropriate pathogen population is reached
that affects the virulence gene expression, the disease occurs (Lawley and Walker,
2013).
Clinical disease caused by S. Typhimurium, is linked with enterocolitis,
characterised by high morbidity rates and with yellow, watery diarrhea, pyrexia,
inappetence and lethargy (Fedorka-Cray et al., 2000; Wilcock and Schwartz, 1992).
The recovery is usually quick, leading to asymptomatic carriage and intermittent
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shedding of Salmonella in faeces (Nielsen et al., 1995; Verbrugghe et al., 2011;
Wilcock and Olander, 1977; Wilcock and Schwartz, 1992). In pigs infected with S.
Typhimurium macroscopic lesions found during necropsy are mainly located in the
spiral colon, they constitute of localized or diffuse catarrhal colitis with hemorrhages
and erosions, and can also form diffuse diptheresis (Wilcock, 1979; Wilcock et al.,
1976). Similar but less apparent lesions are observed in the descending colon and
rectum (Wilcock et al., 1976). Microscopically, in the colon the mild mucosal necrosis
and mononuclear infiltration into the lamina propria is observed (Wilcock, 1979;
Wilcock et al., 1976).
1.3.2 Diagnosis
As mentioned in the previous section, the non-typhoid Salmonella infections in
pigs often results in mild or no clinical signs. Consequently, a range of diagnostic
procedures is used to detect Salmonella in pigs and later during other stages of pork
production. The isolation Salmonella from animal faeces consist of several steps.
Those include pre-enrichment, selective enrichment and the use of selective plating
media, which is dictated by factors such as, sub-lethal bacterial injury, low number of
excreted bacteria and mixed sample population (Adams and Moss, 2008). The
detection result often depends on the sample size, type of medium and incubation
temperature (Davies et al., 2000; Funk et al., 2000). The EU approved method for the
detection of Salmonella in food and animal feedstuffs ISO 6579:2002 (Annex D)
consist of pre-enrichment of the sample in buffered peptone water (PBW), followed by
selective enrichment in modified version of Rappaport-Vassiliadis (RV) enrichment
medium (Vassiliadis, 1983) called Modified Semi-Solid Rappaport-Vassiliadis
(MSRV) (Aspinall et al., 1992; De Smedt and Bolderdijk, 1987) and further plating
onto a two selective agar plates (ISO, 2002). Agar media, used for plating out
following enrichment contain selective agents such as bile salts or deoxycholate and/or
brilliant green (Adams and Moss, 2008). Those include brilliant green agar (BGA)
(Kauffmann, 1935), xylose lysine deoxycholate (XLD) agar and Rambach agar
(Rambach, 1990), often used for isolation of Salmonella, particularly subspecies
enterica (Carrique-Mas and Davies, 2008; Kuhn et al., 1994). At the farm level
confirmation of Salmonella infection can sometimes be restricted due to duration and
intermittent shedding (Ivanek et al., 2012; Wilcock and Schwartz, 1992). Serological
testing of blood serum and meat juice using enzyme-linked immunosorbent assay
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(ELISA) is therefore used to detect Salmonella antibodies and to asses sero-
prevalence, particularly on farm when the whole herds are tested and at the abattoir
level (Hill et al., 2008; Nielsen et al., 1995; Nielsen et al., 1998; Vico and Mainar-
Jaime, 2011). The onset of the serological response following the infection could differ
from weeks to months (Kranker et al., 2003; Nielsen et al., 1995) with resultant low
serum IgG concentrations (Barrow, 2000), which could often be a limitation.
Various biochemical and serological methodology combined with further
phenotypic and genotypic characterisation is used to fully identify disease aetiological
agent, and it is particularly helpful during the common-source outbreaks studies
(Threlfall and Frost, 1990; Wilcock and Schwartz, 1992). Testing based on the
phenotypic characteristics such as serotyping, biotyping, phage typing, antibiotic
susceptibility testing is used for the subdivision of Salmonella serovar. Further, genetic
subdivision is granted with plasmid profiling, amplified fragment length polymorphism
(AFLP), pulsed field gel electrophoresis (PFGE), multilocus sequence typing (MLST),
variable number of tandem repeat (VNTR) analysis and multilocus variable number of
tandem repeats analysis (MLVA).
1.3.3 Risk factors associated with infection and transmission
Identification and re-evaluation of Salmonella associated risk factors in pork
production is essential for implementation of suitable control strategies. One of the
potential sources of Salmonella at the farm is animal feed that is now recognised as a
significant source of infection (Davies and Wray, 1997; Fedorka-Cray et al., 1997b; Lo
Fo Wong et al., 2002). Moreover, it should be regarded that risk of animal feed
contamination can arise at feed mills, during transport and storage (Davies et al., 2004;
Fedorka-Cray et al., 1997b; Linton et al., 1970). With regards to physical properties of
the feed, it has been reported that feeding non-pelleted, coarsely ground meal could
have a protective effect against infection and it is correlated with higher abundance in
anaerobic microflora and increases in organic acids concentrations in the porcine
gastrointestinal tract (Lo Fo Wong et al., 2002; Mikkelsen et al., 2004). Acidification
of feed with organic acids is a recognised effective control measure (Davies et al.,
2004). Transmission of Salmonella might also occur by way of mechanical vectors
including other farm or domestic animals, birds, flies and rodents, hence their control
is essential in order to prevent introduction of Salmonella (Davies and Wray, 1995;
Liebana et al., 2003; Lo Fo Wong et al., 2002; Wang et al., 2011). Other on farm risk
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factors are associated with the type of flooring and housing used and slatted floors
have been linked with reduced Salmonella prevalence (Davies et al., 1997b; Letellier
et al., 1999). Greater Salmonella shedding  could be attributed to housing pigs in barns
with open-flush gutters (Davies et al., 1997a). Oversized herds can create stressful
environments in which immunity may be compromised; therefore intensively reared
pigs may be more prone to infection. Salmonella express their virulence genes in
presence of norepinephrine (Bearson and Bearson, 2008; Bearson et al., 2008) which is
produced by stressed pigs (Rosochacki et al., 2000). Norepinephrine enhances
Salmonella pathogenesis and leads to increased pathogen shedding and environmental
contamination (Bearson and Bearson, 2008; Pullinger et al., 2010). The stress factor
would also play a role during pig transport to the abattoir as well as the contaminated
truck itself (Fedorka-Cray et al., 1994; Lo Fo Wong et al., 2002). Moreover, as
demonstrated by Swanenburg et al. (2001a) keeping pigs in the lairage introduces a
risk of Salmonella infection.
Salmonella has been identified at all levels of pork production, thus further
carcass and pork product contamination can occur at the slaughterhouse, packing plant,
processing and retail level (Lo Fo Wong et al., 2002). Multiple risk factors regarding
Salmonella contamination and cross-contamination at abattoir-level have been
identified (Swanenburg et al., 2001) and the need for adequate hygiene regimes
highlighted (Botteldoorn et al., 2003). At that level of pork production, the critical
control points (CCP) should be identified and regularly monitored in line with the
Hazard Analysis Critical Control Point (HACCP) system to avoid carcass
contamination (Lo Fo Wong et al., 2002).
1.3.4 Prevalence in pigs and pork
Contaminated with Salmonella pork is recognised as an important source of
human gastroenteritis (Swanenburg et al., 2001) that has a significant economic impact
linked to human health care and loss of work productivity (Fedorka-Cray et al.,
1997a). The prevalence of Salmonella in fattening pigs at the point of slaughter was
determined in a baseline survey carried out in 2006/2007 (Anonymous, 2010). In the
EU, the prevalence in slaughter pigs infected with Salmonella in ileo-caecal lymph
nodes was 10.3% and in the UK it was 21.2% with 13.8% attributable to S.
Typhimurium, the most frequently isolated serovar at EU and national level. In the
same survey in the UK, 13.5% of pig carcases were contaminated with Salmonella of
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which 7.2% was due to S. Typhimurium (EFSA, 2008a). In 2008 another baseline
survey on the prevalence of Salmonella in holdings with breeding pigs was carried out
across the EU (EFSA, 2009) because of their potential role in disseminating
Salmonella. The overall prevalence was 31.8% (S. Typhimurium 7.8% and S. Derby
8.9%). The prevalence of Salmonella-positive breeding holdings in the EU was 28.7%
and in the UK was 52.2% with 19.4% prevalence attributable to S. Typhimurium. The
results on prevalence of Salmonella-positive production holdings showed that in the
EU prevalence was 33.3% and in the UK 44% with 9.9% prevalence attributable to S.
Typhimurium (EFSA, 2009). Those baseline studies were aimed to provide important
information with regards to setting Salmonella reduction targets and for future
assessment of the impact that control programs might have.
1.3.5 The aim to reduce Salmonella
In response to emerging animal and zoonotic diseases and increasing
international trade higher interest in veterinary surveillance systems has been reported
(Stark et al., 2006). In June 2002 in response to the high incidence of Salmonella in
pigs, the British Pig Executive (BPEX) in partnership with Food Standards Agency
(FSA) and Defra introduced the Zoonoses Action Plan (ZAP) Salmonella monitoring
programme which was in operation until April 2008. Under this scheme, the
Salmonella sero-prevalence in finisher pig herds was measured using the Salmonella
meat-juice ELISA test (Hill et al., 2008). Based on the antibody levels, farms were
assigned to 3 categories and control measures were required at herds with highest sero-
positivity (level 2 and 3). In November 2003, Regulation (EC) No 2160/2003 on the
control of Salmonella and other specified food-borne agents came into force
(Anonymous, 2003) in order to protect; the principle of the regulation is for the whole
food chain to be controlled (Anonymous, 2003). As the requirement for all EU
Member States to have a National Control Plan for Salmonella in pigs ZAP Salmonella
scheme was replaced by a wider scheme – Zoonoses National Control Program for
Salmonella in pig meat (ZNCPig) in April 2008. The ZNCPig takes action at every
level in the chain from farm to fork in order to reduce the risk from Salmonella in pork
and pork products (Belsue et al., 2011; Clough et al., 2009).
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1.4 Controlling Salmonella – multiple strategies
1.4.1 Biosecurity and disinfection
Salmonella infections in animals are controlled by a number of means.
Appropriate grouping of animals and applying all-in, all-out production systems can
minimize spread of Salmonella infection (Beloeil et al., 2007). Reducing carriers such
as, rodents, birds, vehicles and visitors decreases the likelihood of cross-contamination
between houses or farms (Lo Fo Wong et al., 2002). The reduced sero-prevalence of
Salmonella was associated when holdings were equipped with staff showers and
changing room facilities (Lo Fo Wong et al., 2004). Importance of effective cleaning
and disinfection has been reported in various publications, however studies have also
shown that disinfectant exposure can create a selective pressure and decreased
susceptibility to antibiotic (Randall et al., 2007; Randall et al., 2004). The same
authors observed that the disinfectant-selected mutant could colonise the chicken
equally to the control strain, thus persisting in the host and environment (Randall et al.,
2007).
1.4.2 Antimicrobials
Intensive farm production, overfeeding, overpopulation and stress can predispose
to acute or chronic diseases and to changes in microbiological status of the gut flora. In
order to try and address the consequences of intensification antimicrobial growth
promoters were introduced in the 1940’s (Page, 2006). Beneficial effects of
antimicrobial growth promoters such as better weight-gain ratio and more uniform
growth resulted in their frequent use in the farming industry (Delsol et al., 2004; Page,
2006). Consequently, prolonged use of antimicrobials in veterinary medicine and
animal husbandry has resulted in the adaptation of pathogenic bacteria evolving
resistance mechanisms (Boerlin and Reid-Smith, 2008). Antimicrobial resistance
(AMR) can be acquired via horizontal gene transfer or mutations of genes already
present in bacteria. Several mechanisms are involved in the horizontal gene transfer
(HGT). Intracellular gene movement is via transposons which can move within the
genome and integrons. Integrons can encode mechanisms to gain and/or excise genes,
thus moving resistant gene cassette. Frequent transmission of resistance genes from
one bacterium to another is by plasmids and bacteriophages (Boerlin and Reid-Smith,
2008). The importance of genomic islands (SGI1) in the spread of penta-resistant S.
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Typhimuirum has been widely reported (Threlfall, 2000). The typical pattern of penta-
resistance is characterised by resistance to ampicillin, chloramphenicol, streptomycin,
sulphonamide and tetracycline (ACSSuT). A number of reports have demonstrated
acquired resistance to more antimicrobials in DT104 e.g. fluoroquinolones (Threlfall,
2000). The isolation of S. Typhimurium DT104 in the UK from humans dates back to
1980 (Threlfall et al., 1994) and currently constitutes an increasing public health
problem. Concerns about increased resistance and multidrug resistance in bacteria and
particularly those that are zoonotic resulted in the withdrawal of antimicrobial growth
promoters in an animal feeds in EU in 2006, thus the need of alternative in feed control
measures is evident.
1.4.3 Feed incorporated control strategies
Growing concern regarding antimicrobial resistance in bacterial pathogens led
first to restrictions and then a total ban of antibiotics as growth promoters in animal
feed in EU. Subsequently, a need for utilization of a various alternative intervention
strategies increased. One such alternative is use of probiotics, live microbial
supplements, which can be administered as defined mono-strain, multi-strain cultures,
multispecies or undefined mixed cultures (Bomba et al., 1998; Callaway et al., 2008b;
La Ragione et al., 2001; Stavric and d’Aoust, 1993; Timmerman et al., 2004).
Probiotics can be administered to the animal in the pelleted feed or as powder, granules
or encapsulated (Fuller, 1989). Microorganisms used are those belonging to
Lactobacillus, Bifidobacterium, Lactococcus, Enterococcus, Pediococcus,
Streptococcus genera, but also avirulent E. coli and yeasts belonging to the
Saccharomyces cerevisiae species (Anadon et al., 2006; Vondruskova et al., 2010) and
currently there are several commercially available veterinary products which have
been considered as safe to use in the EU (SCAN, 2003). There are multiple possible
mechanisms by which probiotics confer health benefits to the host. Those include
competition for nutrients and binding sites, production of a variety of antimicrobial
compounds, alteration of microbial metabolism and immunity stimulation (Delcenserie
et al., 2008; Fuller, 1989; Rowland et al., 2010), nevertheless the full array of
mechanisms has not yet been elucidated. The subject of probiotic use in livestock with
regards to their ability to control infections is continuously investigated. Numerous
studies have demonstrated that various probiotic strains reduce foodborne pathogens
in pigs and poultry (Casey et al., 2007; Higgins et al., 2010; Konstantinov et al., 2008;
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Nemcova et al., 2007; Stern et al., 2001). Despite, however, many scientific reports of
probiotic efficacy against pathogens and health benefits, some authors have not seen
such effects (Kreuzer et al., 2012; Szabo et al., 2009).
In addition to probiotics, a range of prebiotics are also administered alone to
enhance certain bacterial populations or in combination with the selected probiotic
(Macfarlane et al., 2008; Patterson and Burkholder, 2003). Other effects of prebiotics
might include host immunomodulation, inhibition of intestinal colonisation by
pathogens, also improve feed intake and animal weight gain (Collins et al., 2009) and
will be discussed in the subsequent sections.
Organic acids are regularly included in animal diets as a preservative and
alternative control strategy for pathogen reduction. It is reported that addition of
organic acids lowers pH, increases proteolysis and nutrient digestibility, also reduces
numbers of pathogenic bacteria and as a consequence improves animal health, diet
utilization and growth in pigs and poultry (Mroz, 2005; Van Immerseel et al., 2006). In
pigs both antimicrobial activity and growth performance improvement was reported
with the use of organic acids, especially during weaning and post-weaning period
(Partanen et al., 2006; Tsiloyiannis et al., 2001). The efficacy of this treatment differs
and is dependent on various factors, such as type of acid, concentration and pH and
encapsulation (Boyen et al., 2008b; Foegeding and Busta, 1991; Papatsiros et al.,
2012).
1.4.4 Bacteriophages
Another prospective intervention strategy to reduce pathogen carriage is thought
to be application of lytic bacteriophages, specific for foodborne pathogens (Doyle and
Erickson, 2012). Bacteriophages recognise specific bacterial outer membrane
receptors, then infect their DNA into a host bacterium, replicate within and then cause
bacterial cell lyses only releasing newly formed virions (Doyle and Erickson, 2006).
Several studies have confirmed their efficacy against E. coli and Salmonella spp. in
various animal species (Raya et al., 2011; Smith and Huggins, 1983; Wall et al., 2010)
and others report that therapeutic effect is dependent on the route of administration
(Huff et al., 2002a; Huff et al., 2002b). The specificity of bacteriophage and their
ability to self-replicate only in the target host bacterium is an attractive potential
control mechanism (Sulakvelidze et al., 2001). However, further research is needed as
several concerns regarding to their efficacy have been raised including development of
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phage-neutralizing antibodies, phage resistance or possibility of bacterial toxin genes
transfer by bacteriophages (Matsuzaki et al., 2005; Sulakvelidze et al., 2001).
1.4.5 Vaccination
The aim of the vaccination is to mimic the development of immunity by
inoculation of avirulent but still immunogenic whole cells or components of the
pathogen (Meeusen et al., 2007). The vaccine should in consequence prevent
colonisation, reduce shedding by infected pigs and increase threshold for infection of
susceptible pigs with S. Typhimurium (Haesebrouck et al., 2004).
Live attenuated vaccines seem to give better protection due to the stimulation of
the cellular and humoral immune systems. Of the live vaccines a number have been
gene knock-outs such as aroA, cya and crp, these vaccines have been tested for use as
live vaccines in mice, poultry and pigs (Barrow et al., 2001; Barrow and Wallis, 2000;
Curtiss and Kelly, 1987). A metabolic drift mutant of S. Typhimurium (gyrA-cpxA-
rpoB) has proven to be successful in reducing colonisation by wild type Salmonella
strains in poultry (Linde et al., 1996). The same mutant-based vaccine was used in
young piglets, followed by challenge with S. Typhimurium DT104 strain and as
previously, a significant reduction in colonisation and shedding was observed (Roesler
et al., 2004). In the further study, a reduction of Salmonella shedding in piglets after
inactivated herd-specific Salmonella vaccine was used in pregnant sows was
demonstrated (Roesler et al., 2006). However, an attenuated aroA S. Typhimurium
mutant failed to produce a protective response in gnotobiotic pigs against S.
Typhimurium LT2 challenge (Trebichavsky et al., 2006).
Efficient vaccination could be useful to control Salmonella on farm, however the
efficacy in reducing prevalence is not yet fully demonstrated (Denagamage et al.,
2007). Moreover, the inability to differentiate between vaccinated and infected animals
could be a problem, as the interpretation of serological test results might occur and
confound statutory testing. A negative-marker vaccine against Salmonella that enables
the separation of infected from vaccinated animals has been effective in reducing
clinical signs and colonisation in pigs challenged with S. Typhimurium (Selke et al.,
2007).
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1.5 The gut microbiota - probiotics, prebiotics and synbiotics
1.5.1 Importance of gastrointestinal microbiota
The gastrointestinal tract (GIT) is a complex ecosystem forming a border
between the outside world and extracellular host fluids; it is also the main gate of entry
for enteropathogens.
Humans and animals are born without gastrointestinal microflora, however,
colonisation by a microbiota derived from the mother and the environment begins
immediately after birth (Conway, 1997; Servin, 2004). The order in which colonisation
begins in human starts with aerobic and facultative bacteria e.g. coliforms and then
streptococci followed by the later appearance of bifidobacteria, lactobacilli and
clostridia spp. (Dibner et al., 2008; Mackie et al., 1999). Similarly, piglets become
rapidly colonised, firstly with aerobes and facultative anaerobes and the numbers
reach 109 – 1010 bacteria/g of colonic content after 12 hours after birth (Swords et al.,
1993). Those very early aerobic and facultative anaerobes colonisers constitute 80% of
the total microflora, however as soon as 48 hours after birth facultative anaerobes are
displaced by obligate anaerobes, which then account for 90% of the microflora
(Swords et al., 1993). From then on, this gastrointestinal ecosystem of suckling piglets
remains established until the weaning period. Weaning is a very stressful period and
results in significant changes in the intestinal microflora with most noticeably
decreases in the number of lactobacilli (Pieper et al., 2006; Pieper et al., 2008).
Establishment of a gastrointestinal microflora plays an important role in
development of intestinal functions, including maturation of the immune system
(Isolauri, 2001). It has been reported that the host-microbial relationship is mutual and
that gut-associated lymphoid tissue (GALT) can affect the gut bacterial composition
(Xu and Gordon, 2003). The presence of the balanced GIT microflora facilitates its
normal function in both human and animal health (Rakoff-Nahoum et al., 2004;
Servin, 2004; Xu and Gordon, 2003). The large intestine is occupied by various groups
of bacteria, which can both have positive and negative effects on the host health
(Figure 1.1). During homeostasis, both of these groups are involved in fermentation of
non-digestible for the host products (Gibson and Roberfroid, 1995). Interestingly, in
pig, LAB bacteria are associated with the non-secreting area of the stomach (pars
oesophega), of which cells are continuously desquamating (Fuller et al., 1978). As a
results LAB are being continuously released into the lumen, which as has been
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suggested could contribute to control of enteropathogenic bacteria (Fuller, 1992).
It has been suggested that early exposure to environmental bacteria is able to
affect the presence of certain groups of bacteria in the GIT, thus colonisation of the
host with fully developed bacterial GIT population  may be less effective (Mackie et
al., 1999). The need of host early exposure to numerous microorganisms, especially
the health-promoting ones, is important as mentioned already for development of
immune system and intestine architecture (Round and Mazmanian, 2009). Antibiotics
alter the gut flora and when used therapeutically this should be taken into account and
recovery strategies developed. Suitable, accurately designed feeding strategies
including probiotics, prebiotics and synbiotics could therefore facilitate the normal
physiological development of an animal but also guard the gut homeostasis thereafter
and contribute to disease prevention.
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Figure 1.1 The composition and health effects of predominant human faecal bacteria
and their possible effect on the host. Adapted from Gibson and Roberfroid (1995).
1.5.2 Defining probiotics, prebiotics and synbiotics
The term ‘probiotic’ was first used in 1965 by Lilly and Stillwell (Lilly and
Stillwell, 1965; Schrezenmeir and de Vrese, 2001) to describe substances produced by
various protozoan species that stimulated growth of other protozoan species. By 1974,
Parker defined probiotics as “organisms and substances which contribute to intestinal
microbial balance” (Fuller, 1989; Parker, 1974). This definition was further modified
by Fuller (1989) due to its imprecise form and to highlight the importance of live cells.
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Thereafter the definition was read as "live microbial feed supplement which
beneficially affects the host animal by improving its intestinal microbial balance". As
scientific knowledge about probiotics widened, the definition was also expanded by
others (Schrezenmeir and de Vrese, 2001), nevertheless the Fuller version has been
most widely used. Recently, it was again updated to “a preparation of viable
microorganisms, which is consumed by humans or other animals with the aim of
inducing beneficial effects by qualitatively or quantitatively influencing their gut
microbiota and/or modifying their immune status” (Cartman et al., 2008; Fuller, 2004).
In 1995, Gibson and Roberfroid introduced the concept of prebiotics and termed
them as “non-digestible food ingredients that beneficially affect the host by selectively
stimulating the growth and/ or activity of one or a limited number of bacteria in the
colon” (Gibson and Roberfroid, 1995).
The same authors encouraged further research and definition of a combination of
pro and prebiotics, namely synbiotics, as “a mixture of probiotics and prebiotics that
beneficially affects the host by improving the survival and implantation of live
microbial dietary supplements in the gastrointestinal tract, by selectively stimulating
the growth and/or by activating the metabolism of one or a limited number of health-
promoting bacteria, and thus improving host welfare” (Gibson and Roberfroid, 1995).
1.5.3 Probiotics
1.5.3.1 History of probiotic development and use in humans and livestock
The concept of probiotics as we understand it today was first introduced by a
Russian scientist Élie Metchnikoff, who suggested that enhanced health and longevity
of Bulgarian peasants was attributed to the consumption of fermented dairy products
containing lactobacilli (Metchnikoff, 1907). This however, was not the first reference
claiming health benefits due to consumption of live microorganisms in the food and
most probably the oldest dates back to a Persian version of the Old Testament (Genesis
18:8) (Bottazzi, 1983; Schrezenmeir and de Vrese, 2001). Those health benefits were
not only referred to lactobacilli. Henry Tissier, a French pediatrician isolated
Bifidobacterium species from the gut of breast-fed infants and suggested that those
when administered to infants suffering from diarrhoea could displace putrefactive
bacteria and restore healthy microflora (Tissier, 1906). Furthermore, German Professor
Alfred Nissle isolated and demonstrated the use non lactic acid bacterium E. coli
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(Nissle, 1916). To date E. coli Nissle 1917 is commonly used as a probiotic strain
(Altenhoefer et al., 2004; Schierack et al., 2011). Later on, in 1935 Lactobacillus
acidophilus was proposed by Rettger to be an appropriate species to treat human
disorders (Rettger et al., 1935).
Since those early days the concept of probiotics flourished, and in humans
probiotics are often been administered as a functional food showing a variety of
beneficial effects (Andersson et al., 2001; Kotowska et al., 2005; Ruszczyński M,
2008). Moreover, the concept of alternative strategies to control gastrointestinal
pathogens in livestock such as S. Typhimurium is a popular area of research. In order
to replace antimicrobials, probiotic, prebiotics, competitive exclusion cultures (CE)
and organic acids (Callaway et al., 2008a; Cho et al., 2011; Papatsiros et al., 2012) are
accepted as such alternatives. In pigs, probiotic bacteria have not only been used to
control microbial balance in disease control, but also as growth-promoters, improving
efficiency of digestion (Cho et al., 2011; Collins et al., 2009).
1.5.3.2 Design and selection of probiotics
With the continuing scientific interest and commercial use of probiotics both in
humans and animals the precise assessment with regards to a specific selection criteria
and safety is needed. It is often a part of scientific research providing the information
about the uniqueness of a particular probiotic isolate. According to Klaenhammer and
Kullen (1999) all criteria for the probiotic selection can be functionally collated into
four categories, namely appropriateness, technological suitability, competitiveness,
performance and functionality. Those criteria are the outcome of over 20 years of
recommendations and many comprehensive scientific publications are available.
A trustworthy probiotic requires thorough and correct identification using current
molecular methodology, should have generally regarded as safe (GRAS) status and be
of host origin (Gueimonde and Salminen, 2006; Klaenhammer and Kullen, 1999).
Within the European Union (EU) safety of probiotics as animal feed additives is
regulated by Regulation 18131/2003 EU and in accordance with guidelines of
scientific committees (von Wright, 2005). Currently, European Food Safety Authority
(EFSA), which overtook the functions of the scientific committees in the food and feed
areas, is providing independent scientific advice to the European Commission (EC)
(Anadon et al., 2006; von Wright, 2005). Previously, for animal feed additives the
advice and guidelines were of responsibility of Scientific Committee of Animal
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Nutrition (SCAN). Probiotic safety has to be assessed according to the guidelines
defined in Council Directive 87/153/EEC (von Wright, 2005). The directive states that
the probiotics must not produce toxins, virulence factors, antibiotic substances of
clinical importance or carry transmissible antibiotic resistance determinants. The
expression and transferability of antimicrobial resistance determinants from probiotics
to the commensal bacteria present in the gut is an important concern (Sanders et al.,
2010), and the assessment of antibiotic sensitivities and deduction of the genetic basis
of any resistance prior to its clinical use are vital components of the safety assessment.
Some genes responsible for the resistance of specific antimicrobials are identical
among pathogenic and commensal LAB (Teuber et al., 1999). In general LAB
antibiotic resistance is of intrinsic nature although infrequent plasmid-linked
resistances are observed (Salminen et al., 1998). The technical guidance prepared by
the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP),
which updated previously adopted SCAN opinion “on the criteria for assessing the
safety of micro-organisms resistant to antibiotics of human clinical and veterinary
importance” sets the minimum inhibitory concentrations (MICs) for the commonly
used antimicrobials (EFSA, 2008b).
The ability of a probiotic to withstand various in vivo stresses, including acid,
bile, and antimicrobial compounds produced by other gut bacteria plus the ability to
adhere to and colonise gut epithelium are all part of the competitiveness selection
criteria. Performance and functionality criteria concentrate mainly on probiotic
antagonistic effects towards pathogens, production of bioactive compounds and
immunodulation. Numerous scientific reports focusing on evaluating those criteria
have been published to date (Bielecka et al., 2002; Casey et al., 2007; Dunne et al.,
2001; Gueimonde and Salminen, 2006; Hyronimus et al., 2000; Ljungh and
Wadstrom, 2006). Nevertheless, as the mechanisms of the functional roles of
probiotics remain unclear, the importance of the competitiveness and performance
criteria mentioned above are questioned by others (Klaenhammer and Kullen, 1999).
1.5.3.3 Mechanism of probiotic action
The mechanism of probiotic action has not been fully elucidated. However, it is
clear that multiple physiological, antimicrobial and immunomodulatory mechanisms
are involved (Gill, 2003; Servin, 2004). Competition for nutrients, restriction of and
competition for receptor sites, immunomodulation and production of antimicrobial
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substances are all possible mechanisms by which effectiveness of CE cultures can be
explained (Doyle, 2001; Mead, 2000). Furthermore, the effect of the gut microbial
community as a whole on the host health is very important. The mammalian–microbial
symbiosis could affect the metabolism of endogenous and exogenous compounds and
be important in disease etiology (Dumas et al., 2006; Martin et al., 2007). In fact, in
vivo all those factors synergistically contribute to the effectiveness of probiotics.
The concept of “competitive exclusion” was introduced by Nurmi and Rantala
(1973) following observations that administration of intestinal contents from adult
birds to a chicks resulted of their increased resistance to Salmonella infection.
Interestingly, over 20 years prior to introduction of the CE term, the age related
reduction in susceptibility to experimental Salmonella was well known (Milner and
Shaffer, 1952). The form of CE is mucosal competitive exclusion (MCE), which
follows the idea that deeper tissue scraping could be more efficient against pathogen
colonisation and was first developed in order to control Campylobacter colonisation
(Stern et al., 2001). The same authors reported that in birds challenged with S.
Typhimurium CE cultures were less protective than used MSC cultures (Stern et al.,
2001). Moreover, Fedorka-Cray et al. (1999) developed a mucosal competitive
exclusion culture from swine (MCES) which was linked with reduction of S.
Choleraesuis in caecal contents and ileocolic junction compared with the un-treated
group. The prevention or reduction of pathogens by CE has been acknowledged in the
scientific community and studied continuously, particularly with regards to pathogen
control in poultry (Fedorka-Cray et al., 1999; Genovese et al., 2000; La Ragione et al.,
2001; La Ragione et al., 2004; La Ragione and Woodward, 2003; Zhang et al., 2007a,
b). In chicks it has been shown that CE treatment could be effective against pathogens
such as pathogenic E. coli, C. jejuni, Listeria monocytogenes and C. perfringens
(Hakkinen and Schneitz, 1996, 1999; Hume et al., 1998; La Ragione et al., 2004;
Nisbet, 2002; Schoeni and Wong, 1994). To date both undefined and defined CE
cultures have been used to evaluate efficacy against Salmonella in poultry and swine
and several commercial products are available (Schneitz, 2005; Stavric and d’Aoust,
1993).
Production of a wide range of antimicrobial compounds such as organic acids,
mainly lactate and acetate; inhibitory peptides and hydrogen peroxide has been
reported as an effective means against many pathogenic bacteria, fungi and viruses.
Carbohydrates fermentation by lactobacilli results in accumulation of fermentation
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products, mainly lactic, acetic acid but also ethanol, and formic acid, dependant on the
type of fermentation (Collins et al., 2009). The inhibition of growth of bacterial
pathogens in the presence of organic acids such as lactate or acetate has been
demonstrated (Adams and Hall, 1988; Makras et al., 2006; Servin, 2004). The
antibacterial mechanism of lactic acid has not only been attributed to lowering the pH
and diffusion of the un-dissociated molecule across the bacterial cell membrane, but
also it has been reported that lactate acts as an outer membrane permeabilizer enabling
effective penetration of the numerous other than organic acids antimicrobial
metabolites produced by the lactobacilli (Alakomi et al., 2000; De Keersmaecker et
al., 2006; Eklund, 1983). Studies of Makras et al. (2006) reported antibacterial activity
of L. johnsonii La1 and L. plantarum ACA-DC 287 against S. Typhimurium that was
due to unknown compounds that were effective in the presence of lactic acid.
Coconnier-Polter et al. (2005) reported S. Typhimurium SL1344 sensitization to lytic
compounds following exposure of to the cell free supernatant of L. acidophilus. It was
thereafter concluded that this antibacterial activity was due to the non-lactic-acid
molecule. In the dynamic environment of the gastrointestinal tract, the antagonistic
activity of probiotics is far more complex, due to modulation of both organic acids
concentration and members of microbial community. Moreover, the presence of other
bacterial genera would result in the presence of other than lactic and acetic acids, such
as butyrate, propionate, formate (Belenguer et al., 2006; Macfarlane and Macfarlane,
2007; Ushida et al., 2002) and those can modulate bacterial pathogenicity (Boyen et
al., 2008b; Gantois et al., 2006; Van Immerseel et al., 2006).
In addition to organic acids, lactic acid bacteria can produce several antimicrobial
metabolites that can be divided based on their molecular mass into bacteriocins and
low molecular mass compounds (Niku-Paavola et al., 1999).
Bacteriocins are a heterogeneous group of peptides and proteins with regards to
their size and function and their classification is continuously revised with several
different bacteriocin classes and subclasses (Beshkova and Frengova, 2012; Cotter et
al., 2005). Bacteriocins produced by LAB show promise as candidates for pathogen
control (Cotter et al., 2005). However, the activity of these heat-stable peptides is
mainly directed against Gram-positive bacteria, unless the integrity of the outer
membrane Gram-negative species has been compromised (Ouwehand and Vesterlund,
2004).
Low molecular antimicrobial substances produced by some L. reuteri strains in
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the presence of glycerol (Axelsson et al., 1989) has attracted intensive interest.
Reuterin that is water-soluble, active at a wide pH range, resistant to proteolytic and
lipolytic enzymes (Rodriguez et al., 2003), has been shown to have activity against
Gram-negative and Gram-positive bacteria and also  against yeast, fungi or protozoa
(Axelsson et al., 1989; Spinler et al., 2008). The presence of reuterin producing L.
reuteri in proximal regions of the swine gastrointestinal tract has been shown
(Axelsson et al., 1989). Another low molecular weight, antimicrobial compound
produced by some L. reuteri strains is reutericyclin, a tetramic acid derivative which is
structurally related to tenuazonic acid (Ganzle et al., 2000). It is bacteriostatic or
bactericidal to Gram-positive bacteria, whereas Gram-negative bacteria are resistant to
its activity (Ganzle, 2004).
The ability of certain Lactobacillus species to produce hydrogen peroxide with a
sufficient oxygen supply has been long-established (Antonio et al., 2005; Eschenbach
et al., 1989; Song et al., 1999). Numerous studies showed antimicrobial activity of
hydrogen peroxide producing lactobacilli on various pathogens (Dahiya and Speck,
1968; Klebanoff et al., 1991). The bactericidal effect of hydrogen peroxide has been
ascribed to its strong oxidizing effect on the bacterial cell (Ouwehand and Vesterlund,
2004). Pridmore et al. (2008) demonstrated in vitro killing activity of the hydrogen
peroxide produced by L. johnsonii strain NCC 553 towards S. Typhimurium SL1344.
However, the presence of hydrogen peroxide producing lactobacilli has been linked
with the displacement of pathogens and the maintenance of homeostasis of the normal
vaginal flora (Eschenbach et al., 1989; Felten et al., 1999; Martin et al., 2008). In the
human gut, the presence hydrogen peroxide of bacterial origin has been linked with
apoptosis of colonocytes (Strus et al., 2009).
Dysbiosis of the gut microflora can increase antigen transport across the gut
mucosa (Isolauri et al., 2001). It is postulated that probiotics can enhance the mucosal
epithelial cell barrier via release of bioactive compounds or indirectly through immune
cells activation, thus improving host defenses and preventing pathogens from attaching
to the epithelium (Deplancke and Gaskins, 2001; Saulnier et al., 2009a). Probiotics are
recognised by toll-like receptors (TLRs) in the gut epithelial cells and/or antigen-
presenting cells and they stimulate a cascade of immunological events including
production of cytokines by enterocytes such as IL-8, IL-6 (Delcenserie et al., 2008;
Rakoff-Nahoum et al., 2004; Walker, 2008). The microbiota present in the gut also
exerts effect through balanced control of both pro and anti-inflammatory responses,
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however, the exact mechanism and the contribution of probiotics to immune
modulation is not yet fully understood (Fleige et al., 2009; Isolauri et al., 2002; Round
and Mazmanian, 2009). The fact that probiotic immune modulation is very complex
with each specific strain altering the specific immune responses, highlights the need
for candidate probiotics to be described accurately as suggested by Delcenserie et al.
(2008) with regards to the cytokine profiles secreted by lymphocytes, enterocytes
and/or dendritic cells.
1.5.4 Prebiotics
1.5.4.1 Prebiotics concept in human and livestock
Bifidobacteria can utilize complex oligosaccharides, resulting in decreased faecal
pH and increased bifidobacteria numbers (Mitsuoka et al., 1987; Yazawa et al., 1978).
In 1995 Gibson and Roberfroid defined prebiotics as “non-digestible food ingredients
that beneficially affects the host by selectively stimulating the growth and/ or activity
of one or a limited number of bacteria in the colon” (Gibson and Roberfroid, 1995). As
this definition regarded only human colonic environment it was updated in 2004 by
Gibson et al. (2004). Restructured definition stated that “A prebiotic is a selectively
fermented ingredient that allows speciﬁc changes, both in the composition and/or
activity in the gastrointestinal microﬂora that confers beneﬁts upon host wellbeing and
health”. Numerous “colonic foods” can be used as a substrate for endogenous bacteria,
yet they cannot be classified as prebiotics (Gibson and Roberfroid, 1995). To be
defined as prebiotic, each food ingredient must demonstrate resistance to gastric
acidity, hydrolysis by mammalian enzymes and gastrointestinal absorption. Moreover,
it must be fermented by the intestinal microflora with selective stimulation of the
growth/or activity of intestinal bacteria that are associated with health and wellbeing
(Gibson et al., 2004). To asses if a prebiotic fulfills these criteria, especially its
resistance to low pH, hydrolysis and absorption both in vitro and in vivo methodology
are applied (Gibson et al., 2004). Moreover, to date several in vitro systems have been
applied to evaluate candidate prebiotic fermentation and selective stimulation
properties. Those include simple pure mono or mixed culture studies, batch culture
systems inoculated with the faecal slurry and continuous culture systems, mimicking
various parts of colon (Macfarlane and Macfarlane, 2007; Macfarlane et al., 1998;
Rycroft et al., 2001). Regardless of complexity of an in vitro method employed, a
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feeding trial should be included as a concluding demonstration of prebiotic efficacy
(Roberfroid, 2008). Fermentation of prebiotics by intestinal microbiota is linked with
increase in the numbers of selectively enhanced bacterial groups, mainly lactobacilli
and bifidobacteria (Collins and Gibson, 1999).
Prebiotics are considered as safe, as they can be found in existing foods range such
as bananas, onions, artichokes and human breast milk, nevertheless considerations
should be taken into account when the maximum dose is administered (Tuohy et al.,
2003). The most commonly studied nondigestable carbohydrates in both humans and
animals are inulin, fructooligosaccharides (FOS) (Nemcova et al., 2007; Roberfroid,
2000; Sabater-Molina et al., 2009; Tsukahara et al., 2003), galactooligosaccharides
(GOS) (Searle et al., 2009; Searle et al., 2010; Vulevic et al., 2008) and lactulose
(Bouhnik et al., 2004; Fleige et al., 2007, 2009; Martin-Pelaez et al., 2010).
Nevertheless, other such as lactitol, raffinose and mannanoligosaccharides (MOS)
(Castillo et al., 2008; Zentek et al., 2002) have also been evaluated. Commercially
available prebiotics of confirmed efficacy are FOSs and inulin, GOSs and lactulose
(Tuohy et al., 2003). Interestingly, although in humans lactulose is conventionally
used as a laxative to treat constipation, in small doses has proven to have beneficial
effects on the human colonic bifidobacteria (Tuohy et al., 2005). In animals several
studies aiming to evaluate the effect of prebiotic administration demonstrate their
beneficial effects associated with modulation of gut bacterial microbiota and the
enhancement of the increase in the SCFA concentrations (Smiricky-Tjardes et al.,
2003; Yusrizal and Chen, 2003), reduction of intestinal colonisation by pathogens
(Bovee-Oudenhoven and Van der Meer, 1997; Collins et al., 2009; Lowry et al., 2005;
Searle et al., 2009) and increase in animal performance (Pierce et al., 2005; Sims et al.,
2004; Verdonk et al., 2005).
1.5.4.2 Prebiotics fermentation by gut microbiota
Due to the greater availability of carbohydrate in the proximal colon, this is the
active site of carbohydrate fermentation whereas the subsequent parts of the large
intestine are proteolytic as the substrate availability diminishes (Macfarlane et al.,
1992). Fermentation of accessible carbohydrates in the colon results in production of
short chain fatty acids (SCFA), lactate and various other end metabolites such as
ethanol, succinate, hydrogen, carbon dioxide and hydrogen sulfide (Cummings, 1981;
Gibson et al., 1996).
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SCFA, mainly acetate, propionate, butyrate are the major end products of
microbial fermentation and are fundamental to many biological functions, not only
have a positive effect on digestion, but also on host immunity and metabolism
(Gibson, 1999; Macfarlane and Macfarlane, 2007; Saulnier et al., 2009b). The uptake
of the SCFA in the colon seems to be in a concentration-dependent manner and is
associated with increased water, calcium and magnesium absorption (Topping and
Clifton, 2001; Yanahira et al., 1997). Following absorption, SCFAs are metabolised in
the cecocolonic epithelium, muscle and liver cells (Gibson, 1999; Wong and Jenkins,
2007). The role of the active end-products of bacterial fermentation is illustrated in the
Table 1.2. In particular, butyrate was found to be very important as it acts as an energy
source, signaling metabolite, proliferation stimulus for colonic epithelial cells and an
anti-proliferative signal for neoplastic colonocytes (Topping and Clifton, 2001).
Interestingly, in a complex microbial environment production of butyrate is not only
determined by the ability of particular bacteria to utilise the prebiotic directly, but also
indirectly through a cross-feeding on metabolic products such as lactic acid by other
bacteria (Belenguer et al., 2006).
Table 1.2 Gut bacteria and their metabolic products of carbohydrate fermentation.
Adapted from Gibson (1999).
End product Bacterial group involved Metabolic designation
Acetate Bacteroides, bifidobacteria, eubacteria, lactobacilli,
clostridia, ruminococci, peptococci, veillonella,
peptostreptococci, propionibacteria, fusobacteria
Metabolised in muscle, kidney, heart
and brain
Propionate Bacteroides, propionibacteria, veillonella Cleared by the liver, possible
gluceogenic precursor, suppresses
cholesterol synthesis
Butyrate Clostridia, fusobacteria, butyrivibrio, eubacteria,
peptostreptococci
Metabolised by the colonic
epithelium, regulator of cell growth
and differentiation
Ethanol, succinate,
lactate, pyruvate
Bacteroides, bifidobacteria, lactobacilli, eubacteria,
peptostreptococci, clostridia, ruminococci,
actinomycetes, enterococci, fusobacteria
Absorbed, electron sink products,
further fermented to short-chain fatty
acids
Hydrogen Clostridia, ruminococci, fusobacteria Partially excreted in breath,
metabolised by hydrogenotrophic
bacteria
1.5.4.3 Therapeutic effects of prebiotics
There are numbers of proposed mechanisms by which prebiotics exert their
therapeutic effect, such as selective stimulation of favorable bacterial species,
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increased production of organic acids, direct pathogen reduction and stimulation of the
host immune system (Collins et al., 2009; Macfarlane et al., 2008). Growth stimulation
of intestinal microbiota, increased concentrations of organic acids and reduced pH in
the gut has been linked with inhibitory properties on pathogenic bacteria (Collins and
Gibson, 1999; Sako et al., 1999; Skrivanova and Marounek, 2007). It has been
reported that butyric and propionic acid can decrease intestinal colonisation by S.
Enteritidis in poultry (Van Immerseel et al., 2005; Van Immerseel et al., 2006).
Similarly, recent studies have shown that even low concentrations of especially butyric
and propionic acids decreased virulence gene expression of S. Typhimurium and
decreased faecal shedding and intestinal colonisation of pigs (Boyen et al., 2008b).
Some prebiotics can directly prevent pathogen adherence as they resemble or mimic
host oligosaccharide receptors (Shoaf-Sweeney and Hutkins, 2008), thus preventing
colonisation and infection. Prebiotics that act as receptor analogues for a pathogen
include human milk oligosaccharides (HMOs), galactooligosacharides (GOSs) and
mannanoligosaccharides (MOS) (Castillo et al., 2008; Kunz et al., 2000; Quintero et
al., 2011; Tzortzis et al., 2005). It has been demonstrated that GOS formulations have
the potential to reduce the adherence of enteropathogenic E. coli and S. Typhimurium
in vitro and in vivo (Searle et al., 2009; Searle et al., 2010; Tzortzis et al., 2005).
In addition, it has been suggested that prebiotics may affect the immune system
either directly or indirectly, through enhanced growth of specific intestinal bacterial
groups (Roberfroid et al., 2010; Vos et al., 2007). Increased caecal secretion of IgA
was reported in rats fed glucomannan and lactulose (Kudoh et al., 1999). In the study
of Agunos et al. (2007) increased S. Enteritidis specific secretory IgA (sIgA)
concentrations were observed in caecal and bile contents of chicks fed a diet
supplemented with β1–4 mannobiose or D-mannose, which was linked with a decline
in shedding and caecal carriage of the pathogen. Various human intervention and
animals studies indicate prebiotics ability to modulate immune system (Fleige et al.,
2009; Janardhana et al., 2009; Macfarlane et al., 2008; Nagura et al., 2002). The exact
mechanism of their action has not yet been fully elucidated, nevertheless few means
have been suggested and summarised by Seifert and Watzl (2008). Those include
interaction of prebiotics with carbohydrate receptors on leukocytes or their partial
absorption resulting in local and systemic contact with the immune system.
Furthermore, alteration in particulate bacterial group and in turn modulation in
production of cytokines and antibodies, increased SCFA production and their
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enhanced binding to G-protein on leucocytes has also been proposed as potential
mechanisms (Seifert and Watzl, 2008).
1.5.5 The use of probiotics, prebiotics and synbiotics in pigs
It has been demonstrated that the administration of probiotics (Fuller, 1989;
Ohashi et al., 2007; Scharek et al., 2007b; Takahashi et al., 2007; Vondruskova et al.,
2010) and prebiotics (Bauer et al., 2001; Houdijk et al., 2002; Konstantinov et al.,
2004; Martin-Pelaez et al., 2010; Smiricky-Tjardes et al., 2003; Tzortzis et al., 2005)
have stimulatory effect on the gut microbiota of pigs. Beneficial effects of probiotics
(Lessard et al., 2009; Scharek et al., 2007a; Schierack et al., 2007) and prebiotics
(Jung et al., 2004; Pie et al., 2007) related to their immunomodulatory properties have
also been reported. Moreover, it has been showed that the administration of probiotics
and prebiotics in pigs can improve digestion, pig growth performance and feed
efficiency (Davis et al., 2004; Estrada et al., 2001; Huang et al., 2004; Nousiainen et
al., 2004). Inclusion of LAB complexes comprising of E. faecium, P. pentosaceus, L.
plantarum and L. acidophilus resulted in significantly increased daily feed intake,
weight gain and feed conversion ratio during the first two weeks after weaning (Giang
et al., 2010). The concept of synbiotics is particularly interesting, as prebiotics confer
beneficial effects to the administered probiotic, other resident microflora and the host.
One such study reported that in weanling pigs, the effect of the administration of L.
paracasei together with oligofructose was better than using the probiotic alone and
resulted in a reduction in clostridia and enterobacteria but increased the beneficial
lactobacilli and bifidobacteria (Nemcova et al., 1999). Similarly, Bomba et al. (2002)
found that superior to L. paracasei alone, the use of L. paracasei and FOS synbiotic
combination had beneficial effects on bacterial population of weanling pigs, and
particularly lactobacilli and bifidobacteria. In addition to the beneficial effects of
probiotics, prebiotics and synbiotics on the physiology of pigs, the evidence of their
efficacy against intestinal pathogens such as E. coli (Genovese et al., 2000; Huang et
al., 2004; Konstantinov et al., 2008; Krause et al., 2010; Nemcova et al., 2007),
Campylobacter (Jensen et al., 2012), Brachyspira (Hansen et al., 2011; Hansen et al.,
2010; Thomsen et al., 2007) and Salmonella (Casey et al., 2007; Fedorka-Cray et al.,
1999; Genovese et al., 2003) has been promising.
Numerous studies have demonstrated probiotics, prebiotic and synbiotics
efficacy as briefly discussed above, however, some publications show conflicting
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results. For example with regards to pathogen colonisation and shedding (Kreuzer et
al., 2012; Martin-Pelaez et al., 2010; Szabo et al., 2009), whilst Taras et al. (2005)
reported that although administration of probiotic E. faecium decreased the percentage
of piglets with post weaning diarrhoea, no beneficial effect with regards to average
daily weight gain or feed intake was observed. This could be due to the fact that
multiple factors exist that might contribute to effectiveness of probiotics and prebiotic
in particular those including their survival in the gut, dose, frequency of
administration, specificity and the original health status of animals (Bomba et al.,
2002).
1.6 Aims and objectives
The aforementioned introduction discusses the still existing problem of S.
Typhimurium as an important zoonotic pathogen and that pigs and pork products
might contribute to Salmonella persistence in the food chain. It also highlights the need
for efficient pathogen control, including on farm alternative intervention strategies that
will fill the niche since the EU ban of antimicrobial growth promoters. Thus the
hypothesis to be tested in this PhD study is that the colonisation of the porcine gut by
S. Typhimurium may be controlled by the combined suppressive effects of pre and
probiotics.
Thus to fulfil this hypothesis, the specific aims and objectives of this project are:
 To screen and select prospective probiotic and prebiotic candidate to be used in
the further studies as a part of a synbiotic combination.
 To study the effect of L. plantarum and lactulose on S. Typhimurium growth,
and in mitigating against adhesion and invasion of this pathogen using porcine
in vitro models.
 To improve understanding of the L. plantarum and lactulose mechanism of
action by which the pathogen suppression is mediated.
 To investigate the effect of L. plantarum and lactulose on the porcine faecal
microbiota, their fermentative activity and S. Typhimurium survival in the
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porcine batch culture model.
 To investigate the ability of L. plantarum and lactulose to reduce pathogen
colonisation and shedding in pigs experimentally challenged with S.
Typhimurium – a pilot in vivo study.
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Chapter 2
Materials and Methods
2.1 Bacteriological methods
2.1.1 Bacterial strains and culture conditions
All bacterial isolates used in these studies were obtained from the culture
collection at the Animal Health and Veterinary Laboratories Agency (AHVLA,
Weybridge, UK). A total of 11 S. Typhimurium isolates were provisionally used,
however, following brief characterisation a nalidixic acid resistant derivative of S.
Typhimurium SL1344 was used throughout the studies. In addition, a total of 16
Lactobacillus isolates and the control strains including E. coli DH5α-K12, E. faecalis
ATCC 29212, E. faecium SF11770 and C. jejuni NCTC 11351 were used. L.
plantarum B2028 (JC1) and L. reuteri B2026 were previously isolated from pig faeces
(Collins et al., 2010).
Bacterial isolates were maintained in heart infusion broth (HIB) supplemented
with 30% (v/v) glycerol (Oxoid) at -80°C. For routine use Salmonella, E. coli and E.
faecalis ATCC 29212 isolates were cultured at 37°C for 16 hours, aerobically on 5%
sheep’s blood agar (SBA) or on lysogeny broth (also known as Luria-Bertani)
(Bertani, 1951, 2004) agar without glucose (LB-G), respectively. LB-G broth cultures
of both Salmonella and E. coli were incubated at 37°C for 16 hours, aerobically with
gentle agitation (225 rpm). For studies where the S. Typhimurium SL1344 nalr
recovery was required from a microbially abundant samples brilliant green agar (BGA)
(Kauffmann, 1935) containing 15 µg/ml nalidixic acid was used.
Lactobacilli were cultured on de Man, Rogosa, Sharpe (MRS) agar and broth (De
Man et al., 1960) at 37°C for 24 hours, microaerophilically in GasPak jars using a
GasPak™ plus system (BBL™) (94% H2, 6% CO2). Lactobacilli broth cultures (MRS
broth) were incubated statically at 37°C for 24 hours. C. jejuni NCTC 11351 was
cultured on 5% SBA, microaerophilically at 42°C.
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2.1.2 Gram stain
Salmonella and lactobacilli isolates were cultured as described in section 2.1.1. A
single colony was picked from the plate and smeared onto a glass slide. The smear was
then heat fixed and 1% crystal violet (Sigma-Aldrich) applied to the smear for 60
seconds. The slide was washed with water after which Lugol’s iodine (Sigma-Aldrich)
was applied for 60 seconds and subsequently washed off with water. The excess of the
crystal violet was removed using ethanol de-colouriser and the slide was once again
washed using water. The counter stain safranin was applied for 60 seconds and again
washed with water. Slides were allowed to air dry and then examined under oil
immersion using light microscopy (Olympus CX21, × 1000). Gram stain results were
recorded accordingly.
2.1.3 Catalase and oxidase test
Salmonella and lactobacilli isolates were cultured as described previously (section
2.1.1). For catalase testing, a representative colony of each isolate was picked and
placed onto a Petri-dish and then a drop of 3% (v/v) hydrogen peroxide (H2O2) was
mixed in with it. Production of gas (bubbles) was recorded as a catalase positive result.
For oxidase testing, a representative colony of each isolate was picked from a plate
with a sterile plastic inoculation loop and smeared onto an oxidase strip (Sigma-
Aldrich). The result was read after 1 minute and development of a dark blue spot at the
position of placed colony was recorded as a positive result. C. jejuni NCTC 11351was
used as a positive control, whereas E. faecium SF11770 as a negative control.
2.1.4 API identification system
BioMerieux API 20E and API 50CH kit (BioMérieux) was used to determine
bacterial species. Assays were conducted according to the manufacturer’s instructions.
Salmonella and E. coli isolates were tested using API 20E whereas lactobacilli were
tested using API 50CH with specific API 50CHL medium.
For the API 20E kit, a saline suspension of a pure culture of E. coli and
Salmonella strains was dispensed into mini cupules, rehydrating the medium present in
each of the tubes. In addition, a number of tubes were overlaid with few drops of
mineral oil to create anaerobic atmosphere (ADH, LDC, ODC, H2S, URE). Strips were
incubated at 37°C, aerobically for 18-24 hours and visual readings were taken and
cross referenced with apiweb™ software (BioMérieux).
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For API 50 CHL, lactobacilli were cultured on MRS agar as described previously
in section 2.1.1 and subsequently colonies were removed from the plate and inoculated
into API 50 CHL medium to obtain turbidity equal to McFarland 2.0. Tubes of the API
strip were inoculated with prepared suspension, covered with few drops of mineral oil
to create anaerobic conditions and incubated at 37°C for 48 hours. Visual readings
were taken at 24 and 48 hours, subsequently cross referenced with apiweb™ software
(BioMérieux).
2.1.5 Slide agglutination test
The identity of Salmonella was also confirmed using standard laboratory slide
agglutinations. Agglutination tests were performed using Salmonella antisera (Pro-
Lab Diagnostics) as per the manufacturer’s instructions. Briefly, approximately 15
μl of anti-sera were placed upon a glass slide and then mixed with a small amount
of bacterial suspension. The slide was gently tilted side to side and agglutination of
the bacteria within one minute was considered a positive result. Irrelevant anti-sera
acted as a negative control.
2.1.6 Hydrogen peroxide production
Production of H2O2 by lactobacilli isolates was assessed using the method
described previously (Pascual et al., 2006). Briefly, a modified MRS was prepared
supplemented with 0.01mg/ml horseradish peroxidase (Sigma-Aldrich) and 0.25
mg/ml 3,3’,5,5’-tetramethylbenzidine dihydrochloride (TMB) (Sigma-Aldrich).
Isolates were sub-cultured on MRS medium containing TMB and incubated at 37°C
for 72 hours in an anaerobic chamber. Following incubation plates were exposed to air
for 30 minutes and the presence of blue colonies recorded as a positive result. Assays
were performed on two separate occasions.
2.1.7 Colony overlay assay
A colony overlay assay was used according to Barbosa et al. (2005) to investigate
antimicrobial activity of lactobacilli isolates against S. Typhimurium SL1344 nalr
growth. Briefly, three 5 µl volumes of an overnight culture (section 2.1.1) of each
Lactobacillus isolate were inoculated onto MRS agar and incubated
microaerophilically at 37°C for 24 hours. To kill the bacterial cells, plates were
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exposed to chloroform (Sigma-Aldrich) vapours for 30 minutes followed by 20
minutes aeration. Subsequently, plates were overlaid with 0.7% (v/w) LB-G agar
containing 105 cfu/ml of an overnight culture of the S. Typhimurium SL1344 nalr.
Plates were incubated aerobically at 37°C and zones of inhibition around the three
spots were measured at 24 and 48 hours. MRS plates overlaid with the LB-G agar with
or without indicator strain and without a probiotic were used as controls. Assays were
performed on three separate occasions.
2.1.8 Conditioned medium assay
S. Typhimurium SL1344 nalr and lactobacilli were cultured as described in section
2.1.1. To obtain lactobacilli cell free supernatants (CFSs) probiotic broth cultures were
centrifuged (2447 × g) for 10 minutes at room temperature and supernatants were filter
sterilized using 0.22 µm filter (Satorius Stedim Biotech).
For preliminary selection studies described in Chapter 3, an un-buffered CFS of
sixteen lactobacilli was added (as 10% (v/v) dilution factor) to a 96-well micro-titre
plate (Iwaki, SLS) inoculated with S. Typhimurium SL1344 nalr culture (105 cfu/ml) in
LB-G. Plates were incubated at 37°C and an optical density (OD) of 600nm was read
every 15 minutes for 24 hours using FLUOstar OPTIMA (BMG LABTECH). S.
Typhimurium SL1344 nalr culture containing 10% (v/v) of MRS broth (pH 5.8) was
used as a control. In addition LB-G broth with 10% (v/v) MRS and lactobacilli CFSs
but without the indicator strain was included to standardise the OD readings.
For further studies described in Chapter 5, to identify mechanism of L. plantarum
B2028 cell free supernatant inhibitory activity against S. Typhimurium SL1344 nalr
growth, CFS at pH 3.8 (un-buffered), adjusted to pH 4.5 and separately to pH 7.2 was
tested as described above. The control broths were prepared accordingly; MRS broth
adjusted to pH 3.8, 4.5 and 7.2 was used as a pH control, whereas MRS broth
containing L-lactic acid (Sigma-Aldrich) and adjusted to pH 3.8, 4.5 and 7.2 was used
as a lactic acid control (-LA) (Table 2.1). LB-G broth with 10% (v/v) of relevant MRS
broth and L. plantarum B2028 CFS but without the indicator strain was included to
standardise the OD readings.
In addition, for this assay and in subsequent studies where cell-free supernatant of
L. plantarum B2028 was used as a part of synbiotic, for which the L. plantarum B2028
was cultured in modified MRS broth devoid of glucose but containing 1% (w/v)
prebiotic lactulose, and hereinafter abbreviated as MRSL broth. Consequently, L.
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plantarum B2028 cell free supernatant obtained from culture in MRSL broth was
named CFSL. Growth inhibition assays of S. Typhimurium SL1344 nalr were carried
out subsequently as described above (Table 2.1).
Table 2.1 Experimental conditions used in conditioned medium assays.
Medium/Condition Experimental strategy
LB-G S. Typhimurium SL1344 nalr culture medium
MRS Standard lactobacilli growth medium containing 2% (w/v) glucose
MRSL Modified lactobacilli growth medium devoid of glucose, containing 1% (w/v)
lactulose
CFS L. plantarum B2028 cell free supernatant obtained by centrifugation and filter
sterilization of 24 h culture in MRS broth
CFSL L. plantarum B2028 cell free supernatant obtained by centrifugation and filter
sterilization of 24 h culture in MRSL broth
SL S. Typhimurium SL1344 nalr culture in LB-G (105 cfu/ml)
MRS pH 3.8/
MRSL pH 3.8
S. Typhimurium SL1344 nalr culture in LB-G (105 cfu/ml) with 10% (v/v) MRS
or MRSL broth, adjusted to pH 3.8
MRS pH 4.5/
MRSL pH 4.5
S. Typhimurium SL1344 nalr culture in LB-G (105 cfu/ml) with 10% (v/v) MRS
or MRSL broth, adjusted to pH 4.5
MRS pH 7.2/
MRSL pH 7.2
S. Typhimurium SL1344 nalr culture in LB-G (105 cfu/ml) with 10% (v/v) MRS
or MRSL broth, adjusted to pH 7.2
MRS-LA pH 3.8/
MRSL-LA pH 3.8
S. Typhimurium SL1344 nalr culture in LB-G (105 cfu/ml) with 10% (v/v) MRS
or MRSL broth containing lactic acid, adjusted to pH 3.8
MRS-LA pH 4.5/
MRSL-LA pH 4.5
S. Typhimurium SL1344 nalr culture in LB-G (105 cfu/ml) with 10% (v/v) MRS
or MRSL broth containing lactic acid, adjusted to pH 4.5
MRS-LA pH 7.2/
MRSL-LA pH 7.2
S. Typhimurium SL1344 nalr culture in LB-G (105 cfu/ml) with 10% (v/v) MRS
or MRSL broth containing lactic acid, adjusted to pH 7.2
CFS pH 3.8/
CFSL pH 3.8
S. Typhimurium SL1344 nalr culture in LB-G (105 cfu/ml) with 10% (v/v)
L. plantarum CSF or CFSL, at pH 3.8
CFS pH 4.5/
CFSL pH 4.5
S. Typhimurium SL1344 nalr culture in LB-G (105 cfu/ml) with 10% (v/v)
L. plantarum CSF or CFSL, adjusted to pH 4.5
CFS pH 7.2/
CFSL pH 7.2
S. Typhimurium SL1344 nalr culture in LB-G (105 cfu/ml) with 10% (v/v)
L. plantarum CSF or CFSL, adjusted to pH 7.2
2.1.9 Carbohydrate growth assay
Evaluation of S. Typhimurium SL1344 nalr growth was monitored in minimal
medium (MM) and standard LB-G medium supplemented accordingly with 1% (w/v)
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of lactulose ((LAC, 4-O-β-D-galactopyranosyl- D-fructose) (Sigma-Aldrich)), FOS
(Raftilose® P95, Tienen, Belgium) and GOS mixture (Bimuno®, Clasado). Control
medium was included containing 1% (w/v) glucose. MM or LB-G medium containing
respective carbohydrates was added to standardise the OD readings. For the assay S.
Typhimurium SL1344 nalr was cultured as described in section 2.1.1 in LB-G,
centrifuged for 10 minutes and supernatant decanted. The pellet was washed in 0.1M
PBS (pH 7.2) and resuspended at 1:1000 dilution in the respective test medium. For
each condition, 200 µl of the re-suspended culture was dispensed into a 96-well micro-
titre plate (Iwaki, SLS) and respective un-inoculated test medium was included as a
blank standard for each condition. Plates were incubated at 37°C an optical density
(OD) of 600nm was read every 15 minutes for 24 hours using FLUOstar OPTIMA
(BMG LABTECH). Assays were conducted in triplicate on three separate occasions.
For analysis the mean OD values were used and area under the curve (AUC) calculated
using GraphPad Prism® version 5 program (GraphPad Software, LaJolla, CA, USA).
In addition the growth response on each prebiotic was calculated as described below.
Lactobacillus isolates ability to utilise prebiotics was tested subsequently as
described above in carbohydrate-free basal MRS medium (Saarela et al., 2003)
consisting of the following components (g/l): peptone from casein (10.0), yeast extract
(5.0), K2HPO4×3H2O (2.0), Na-acetate×3H2O (5.0), (NH4)3C6H5O7×2H2O (2.0),
MgSO4×7H2O (0.2), MnSO4×3H2O (0.05) and Tween 80 (1ml).
For analysis, in addition to AUC calculations the growth of particular Lactobacillus
isolate on each prebiotic relative to its growth on glucose was calculated over 24 hours
using method given below, according to Kneifel et al. (2000):
Growth response = (mean values on tested prebiotic calculated from all OD
readings / mean OD values of the same isolate grown in the basal medium containing
glucose) × 100%
Additionally, the specific growth rate for lactobacilli on each prebiotic was calculated
using formula according to Saminathan et al. (2011):
Growth rate (µ) = (ln x – ln x0) / (t – t0)
where:
x and x0 are absorbances measured within exponential phase of growth
t and t0 respective to the absorbance times
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2.1.10 Acid tolerance
The acid tolerance test was conducted as described previously (Hyronimus et al.,
2000) with slight modifications. L. plantarum B2028 was cultured in MRS broth,
centrifuged at 2447 x g for 10 minutes and supernatant decanted. The pellet was
washed in 0.1M PBS (pH 7.2) and the culture subsequently diluted (1:1000) in 0.1M
PBS adjusted to pH 2.0, 2.5, 3.0 and non-adjusted PBS (pH 7.2) as a control. Samples
were incubated microaerophilically at 37°C for 3 and 6 hours. Viable counts of
bacteria were determined using Miles and Misra method (Miles et al., 1983), serially
diluted culture was plated onto MRS agar. Plates were incubated for 48 hours and
counted. The log reduction was calculated as shown below:
Log reduction = log10 N0 – log10 Nt
where:
N0 – number of viable cells at time point 0
Nt – number of viable cells at respective time after treatment
2.1.11 Bile tolerance
The ability of the probiotic candidate L. plantarum B2028 to survive in the
presence of bile was assessed using Oxgall bile salt (Sigma-Aldrich) and freshly
collected native porcine bile, using method adapted from Gilliland et al. (1984) with
slight modifications. Porcine bile was collected from the gall bladder of a healthy pig,
filter sterilized and used in concentrations as described further. Briefly, for the bile
tolerance assay L. plantarum B2028 was cultured in MRS broth as described
previously in section 2.1.1. Subsequently, MRS broth containing 0.3% or 0.6% (w/v)
oxgall and 0.3%, 0.6% and 0.9% (v/v) porcine bile was inoculated with 106 cfu/ml of
test isolate. MRS inoculated with L. plantarum B2028 culture but without addition of
bile was used as positive growth control. For each condition, 200 µl of the re-
suspended culture was transferred into a 96-well micro-titre plate (Iwaki, SLS) and
respective un-inoculated MRS broth was included as a blank standard for each
condition. Plates were incubated at 37°C an optical density (OD) of 600nm was read
every 15 minutes for 24 hours using FLUOstar OPTIMA (BMG LABTECH). Assays
were conducted in triplicate on three separate occasions.
Growth curves were plotted and analysis followed the principles described by
Chateau et al. (1994) and based on the time necessary for each condition to reach an
0.3 unit at 600nm, and the difference (delay of growth) (d) between the growth control
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and test conditions. This delay of growth (minutes) was used as a measure of the
inhibitory effect of bile on tested isolate and to classify the isolates onto four following
groups: resistant (d ≤ 15 min), tolerant (15 < d ≤ 40 min), weakly tolerant (40 < d < 60
min) and sensitive (d ≥ 60 min).
2.1.12 Bile Salt Hydrolase (BSH) activity
BSH activity of the L. plantarum B2028 was evaluated using the method
described by du Toit et al. (1998). Modified MRS plates were prepared by adding
0.5% (w/v) of taurodeoxycholic acid (TCDA), (Sigma-Aldrich) and 0.37g/l CaCl2 to
MRS agar. To perform the assays sterile filter disks were impregnated in an overnight
culture of L. plantarum and placed onto the MRS plates. An MRS agar plate without
TCDA supplementation was used as a control. The plates were incubated anaerobically
at 37°C for 72 hours. Positive result for BSH activity was recorded when the
taurodeoxycholic acid precipitated in the agar medium below and around the disc. The
test was performed in triplicate on three separate occasions.
2.1.13 Antimicrobial susceptibility testing
For determining the minimum inhibitory concentration (MIC) of various
antimicrobials for L. plantarum B2028 the broth microdilution method was used as
recommended by EFSA (2008). For MICs LAB susceptibility test medium (LSM)
consisting of a mixture of 90% Iso-Sensitest (ITS) broth and 10% MRS broth (pH 6.7)
was used, as it fully supports lactobacilli growth and has no interaction with the
antimicrobials tested (Klare et al., 2005; Klare et al., 2007). The following
antimicrobials were obtained from Sigma-Aldrich and tested in the concentration
ranges (ng/ µl): ampicillin, gentamicin, erythromycin and clindamycin (0.06-128) and
streptomycin, kanamycin, chloramphenicol, tetracycline and vancomycin (1-256).
Stock solutions of the antibiotics were prepared at twice the final concentration and
filtered through 0.22 µm filter. Double strength concentration of the antibiotic was
added to the first well and then the solution was double diluted into LSM medium. The
control strain used for this assay was E. faecalis ATCC 29212 and for this strain the
MIC’s breakpoints were recommended by British Society for Antimicrobial
Chemotherapy (BSAC). Antibiotic suspensions without the cell suspension were
included as a negative control.
Briefly, L. plantarum B2028 was grown on MRS agar, whereas E. faecalis ATCC
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29212 was grown on LB-G agar. Subsequently, fresh bacterial cells were taken off a
plate using a sterile cotton swab and transferred to approximately 3 ml of 0.1M PBS
(pH 7.2) to obtain turbidity equal to McFarland 1.0. A further 10 µl of the cell
suspension was added to a volume of 1 ml in 24-well plate (Nunc) containing the test
antibiotic dilutions. Plates were incubated at 37°C for 24 hours and MICs were
recorded as the lowest antibiotic concentration to inhibit growth of the test organism.
The assay was performed in duplicate on two separate occasions.
2.1.14 Porcine batch culture fermentation system
Batch culture fermentation system was set up according to previously published
methodology (Sarbini et al., 2011; Saulnier et al., 2008) with slight modifications to
mimic the conditions of a porcine distal colon (Martin-Pelaez et al., 2008). Two
experiments were carried out, firstly for studies described in Chapter 3, system was
inoculated with each of the following the substrates: lactulose (LAC) (Sigma-Aldrich)
and FOS (Raftilose® P95, Tienen, Belgium). Where synbiotic was included, L.
plantarum B2028 was used in addition to each prebiotic. In subsequent studies
described in Chapter 5, batch culture system was inoculated with S. Typhimurium
SL1344nalr in addition to L. plantarum B2028 and LAC. To prepare porcine faecal
slurry, porcine faecal samples were collected from Salmonella-free pigs (confirmed by
bacteriology) (AHVLA) and immediately placed in an anaerobic jar and the samples
were transported to the lab and used within maximum of 1-2 hours. Faecal samples
were diluted with 0.1M PBS (pH 7.2) and homogenized in a stomacher (Stomacher
400, Seward) to yield 10 % (w/v) faecal slurry. Porcine faecal samples were confirmed
to be Salmonella-free by direct plating out of serial dilutions onto BGA and further
enrichment (see section 2.6.5).
Briefly, sterile stirred batch culture fermentation vessels were assembled and
aseptically filled with sterile basal nutrient medium (135 ml each). The basal medium
consisted of the following components (g/l): peptone water (2.0), yeast extract (2.0),
NaCl (0.1), K2HPO4 (0.04), MgSO47H20 (0.04), CaCl26H20 (0.01), Tween 80 (1 ml),
NaHC03 (2.0), hemin (0.05), vitamin K (10 µl), cysteine HCl (0.5), bile salts (0.5). The
medium was gassed overnight with oxygen-free nitrogen (15 ml/min). Subsequently,
glass vessels were inoculated with 15 ml of freshly prepared porcine faecal slurry (see
above) and for preliminary studies appropriately labeled vessels were consequently
inoculated with 1% (w/v) of respective prebiotic (LAC and FOS) and in vessels with
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the synbiotic combination, an overnight culture (approx. 109 cfu/ml) of L. plantarum
B2028 was added 1% (v/v). Vessel containing no pre or synbiotic was included as a
control. The temperature in the vessels was maintained at the 37°C using a circulating
water bath and to mimic conditions of a pig’s large intestine, the pH was maintained
between the ranges 6.4 - 6.6 using 0.5M NaOH and HCl.
Samples (3 ml from each vessel) were collected at time points: 0, 5, 10 and 24
hours post inoculation and stored accordingly for further analysis, namely for
fluorescent in situ hybridisation (FISH) and for lactic acid and short chain fatty acids
(SCFA) analysis. For FISH analysis, samples (375 µl) were fixed in (1125 µl) of ice-
cold 4% (w/v) paraformaldehyde for 4-6 hours (4°C). Subsequently, samples were
centrifuged at 10 000 × g for 5 minutes, washed twice with 0.1M PBS (pH 7.2) and the
pellet was resuspended in 300 µl PBS/ethanol (50:50). Samples were thoroughly
mixed by vortexing and stored at -20°C until required. For SCFA collected from each
time point, samples (1 ml) were centrifuged at 10 000 × g for 10 minutes, supernatants
were filter sterilized using 0.22 µm filter (Satorius Stedim Biotech) and stored at -20°C
until required. The pellets were resuspended in PBS/glycerol (50:50) and stored at -
20°C until required. All samples were prepared in duplicates.
During the subsequent study, an appropriately prepared system (see above) was
inoculated with 1% (v/v) of an overnight culture (approx. 109 cfu/ml) of S.
Typhimurium SL1344nalr and in addition each vessel was inoculated with LAC, L.
plantarum B2028, L. plantarum B2028 and LAC as described above. Assays were
performed in duplicate on two separate occasions.
2.2 Molecular biology methods
2.2.1 DNA extraction
2.2.1.1 CTAB method
The cetyltrimethylammonium bromide (CTAB) method was used to obtain
genomic DNA from pure cultures of lactobacilli and Salmonella. All reagents unless
indicated otherwise were purchased from Sigma-Aldrich. Salmonella and lactobacilli
culture was grown in LB-G and MRS broth respectively. Bacterial pellets were
prepared by growth in broth culture followed by centrifugation at 4000 × g for 10
minutes, washing in 0.1M PBS (pH 7.2) and resuspension in 400 µl 1x Tris-ethylene-
diamine tetra-acetic acid (EDTA) (TE) buffer (pH 8.0). In circumstances when DNA
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was isolated from bacterial growth on agar plates, a bacterial suspension was prepared
in 0.1M PBS (pH 7.2) and the bacterial pellet prepared as described above. An
additional step was included for DNA isolation from lactobacilli with lysozyme, 20
mg/ml, added to TE buffer and incubated at 37°C for 60 minutes. Subsequently, the
cells were lysed by the addition of 70 µl 10% (w/v) sodium dodecyl sulphate (SDS)
and 70 µl of 20 mg/ml proteinase K and incubation at 55°C for 60 minutes. RNase (10
mg/ml) was added to remove RNA and samples were incubated at 37°C for 30
minutes. Subsequently, 100 µl 5 M NaCl and 80 µl of pre-warmed CTAB in 0.7 M
NaCl were added and samples were incubated at 55°C for further 10 minutes.
Following incubation, 750 µl chloroform/isoamyl alcohol (24:1) was added and
samples were centrifuged at (16 000 × g) for 5 minutes. The aqueous phase was gently
removed and transferred to clean phase lock tube (Eppendorf) and the wash step was
repeated twice. Finally, the upper aqueous phase was transferred to a sterile
microcentrifuge tube and 400 µl isopropanol was added to precipitate the DNA.
Samples were left at -20°C for a minimum of 30 minutes and then centrifuged for 10
minutes (1600 × g) and the DNA pellet was washed with 500 µl 70% cold ethanol.
Samples were subsequently centrifuged and supernatant discarded. The DNA pellet
was air-dried and resuspended in 50 µl nuclease-free water (Ambion). DNA quantity
and purity was determined using a NanoDrop™ spectrophotometer (Thermo
Scientific) and 5 µl of the sample was run on 1% agarose gel for visualisation after
EtBr staining. Aliquots were stored at - 20°C.
2.2.1.2 Bacterial DNA extraction from porcine batch culture samples
Bacterial DNA from porcine batch culture samples was extracted using a method
provided by Dr Adele Costabile, University of Reading (personal communication). All
reagents unless indicated otherwise were purchased from Sigma-Aldrich. Following
collection, batch culture samples were centrifuged (16 000 × g) for 10 minutes and
obtained pellet was stored in 50% (v/v) glycerol/0.1M PBS (pH 7.2) suspension at -
20°C until DNA extraction was performed. Cells were harvested from the suspension
at 16 000 × g for 5 minutes, washed once with 0.1M PBS (pH 7.2) and centrifuged
again. Subsequently, the pellet was resuspended in 500 µl of TES buffer (pH 8.0)
containing 8 µl 10 mg/ml lysozyme and 2 µl 1mg/ml mutanolysin and incubated at
37°C for 30 minutes. A 10 µl proteinase K (20 mg/ml) and 10 µl RNase (10 mg/ml)
was added and the suspension was incubated at 65°C for 60 minutes. Then, 100 µl
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10% (w/v) SDS was added to the samples and incubated for further 15 minutes after
which samples were placed on ice for a minimum of 30 minutes. Subsequently, 620 µl
phenol/chloroform/water (Applied Biosciences) was added to each sample, contents
were mixed by inversion for at least 2 minutes and centrifuged at 4000 × g for 10
minutes. The upper aqueous layer was transferred to a sterile microcentrifuge tube and
1 ml of ice-cold ethanol was added. The suspension was mixed by inversion and left at
-20°C overnight. Samples were subsequently centrifuged and the supernatant
discarded. The DNA pellet was air-dried and resuspended in 50 µl nuclease-free water
(Ambion). DNA quantity and purity was determined as described above.
2.2.1.3 Bacterial DNA extraction from porcine faecal samples
Freshly collected porcine faecal samples were stored at -20°C until further
analysis. After thawing at room temperature, bacterial DNA was extracted using the
QIamp DNA Stool Mini Kit (Qiagen, UK) according to the manufacturer’s
instructions. All reagents unless indicated otherwise were included in the extraction
kit. Briefly, for the extraction 180-220 mg faecal sample was used, immediately mixed
with ASL buffer and incubated at 90°C for 5 minutes. Following the lysis step,
samples were incubated with the addition of lysozyme (20 mg/ml) (Sigma-Aldrich) at
37°C for 60 minutes. Subsequently, samples were centrifuged at 16 000 × g for 60
seconds and supernatant was transferred to a new microcentrifuge tube. To remove
PCR inhibitors present within the sample, an InhibitiEX tablet was added to each of
the samples and treated according to the manufactures instructions. The supernatant
was transferred to a new microcentrifuge tube containing proteinase K, subsequently
lysis buffer AL was added, vortexed and incubated at 70°C for 10 minutes. Ethanol
(100 % (v/v)) was added to the lysate, applied to Qiamp spin column and centrifuged
(16 000 × g) for 60 seconds after which the spin column was placed in a new
collection tube. Following a series of washes using buffer AW1 and AW2 the spin
column was transferred to a new microcentrifuge tube and the bound DNA was eluted
using 50 µl of an elution buffer AE. DNA quantity and purity was determined as
described above.
2.2.2 Polymerase Chain Reaction (PCR)
2.2.2.1 Standard PCR
Amplification of a target DNA sequence was performed by PCR (Saiki et al.,
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1988) with a final reaction volume of 50 µl. The PCR reaction consisted of 25 µl
HotStarTaq® DNA polymerase Master Mix (Qiagen), 1 µl of each forward and reverse
primer (20 pmol/µl) (Sigma-Aldrich), 1 µl of genomic DNA (20-50 ng/µl) and made
up to 50 µl using distilled water. PCR amplifications were performed using
GeneAmp® PCR system 9700 thermal cycler (Applied Biosystems) and as follows: 1
cycle at 95°C for 15 minutes (initial denaturation), then 30 cycles consisting of
denaturation at 95°C for 60 seconds, annealing (50-65°C) for 60 seconds, extension at
72°C for 60 seconds and final extension at 72°C for 10 minutes.
2.2.2.2 Multiplex PCR
Multiplex PCR was used for Lactobacillus species identification according to
Kwon et al. (2004). Briefly, the PCR reaction with the final volume of 50 µl consisted
of 25 µl HotStarTaq® DNA polymerase Master Mix (Qiagen), primers as outlined in a
Table 2.2 (20 pmol each), genomic DNA template (20-50 ng/µl) and distilled water up
to the final volume. PCR amplifications were performed on a thermal cycler (see
above) and as follows: 1 cycle at 95°C for 15 minutes (initial denaturation), then 35
cycles consisting of denaturation at 95°C for 30 seconds, annealing at 56°C for 30
seconds, extension at 72°C for 30 seconds and final extension at 72°C for 7 minutes.
2.2.3 PCR product purification
PCR products were purified using QIAquick® purification kit (Qiagen) according
to the manufacturer’s instructions. All reagents unless indicated otherwise were
included in the extraction kit. Briefly, five volumes of the binding buffer PB were
added to one volume of the PCR product and transferred to a QIAquick spin column.
The column was centrifuged (16 000 × g) for 60 seconds and the flow-through was
discarded. Following a wash step using the PE buffer to remove salts, column was
placed in a clean microcentrifuge tube and DNA eluted with 30 µl EB buffer (elution
buffer). If necessary, the PCR products were stored at -20°C until further use.
2.2.4 Gel electrophoresis
Agarose gel (1% or 2% (w/v)) was prepared in Tris-Acetate-EDTA buffer (TAE)
(pH 8.0) (Sigma-Aldrich) and placed in Sub-Cell tank (Bio-Rad), sunken in TAE
buffer. To each gel well, 5 µl sample and 1 µl DNA loading buffer (6×) (Promega) was
loaded. A 1 Kb or 100 bp DNA molecular marker ladder (Promega) was run each time.
Chapter 2
64
Running conditions were 75 volts for approximately 60 minutes. The gel was stained
in 1µg/ml ethidium bromide solution (Sigma-Aldrich) for approximately 30 minutes
and de-stained in distilled water. DNA was visualized under ultra-violet light using the
GeneGenius gel imaging system.
Table 2.2 Multiplex PCR primes used in this studies (Kwon et al., 2004).
Target species Primer Sequence (5' to 3') Target
sitea
Product
(bp)b
Lactobacillusc IDL03R CCACCTTCCTCCGGTTTGTCA 1178-1198 -
Lactobacillusc IDL04F AGGGTGAAGTCGTAACAAGTAGCC 1499-1522 -
L.casei groupd IDL11F TGGTCGGCAGAGTAACTGTTGTCG 427-495 727
L. acidophilus IDL22R AACTATCGCTTACGCTACCACTTTGC 2079-2104 606
L. delbrueckii IDL31F CTGTGCTACACCTAGAGATAGGTGG 1015-1039 184
L. gasseri IDL42R ATTTCAAGTTGAGTCTCTCTCTC 1748-1770 272
L. reuteri IDL52R ACCTGATTGACGATGGATCACCAGT 94-118 1105
L. plantarum IDL62R CTAGTGGTAACAGTTGATTAAAACTGC 1900-1926 428
L. rhamnosus IDL73R GCCAACAAGCTATGTGTTCGCTTGC 1922-1946 448
a All Lactobacillus - target site indicates the start and end point of the complimentary sequences
annealing the forward and reverse primer, respectively.
b Approximated length of each PCR product derived from primer pair composed of species-specific
primer and bacterial conserved primer (IDLC3R or IDLC4F).
c All Lactobacillus spp.
d L. casei group includes all of L. casei-related Lactobacillus species such as L. casei and L. rhamnosus.
Table adapted from Kwon et al. (2004).
2.2.5 16S rRNA gene sequencing
Lactobacillus DNA was extracted as described previously in section 2.2.1.1 and
the 16S rRNA gene was amplified using PCR primers 63F and 1387R (Marchesi et al.,
1998) (Table 2.3). The resulting PCR product (1324 bp) was visualized as described
above and subsequently was sent to Central Sequencing Unit (CSU) (AHVLA,
Weybridge, UK), where the sequencing was performed. The BigDye® Terminator v3.1
Cycle Sequencing kit (Applied Biosystems) was used according to the manufacturer’s
instructions and the sequencing was carried out on 3130xl Genetic Analyzer (Applied
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Biosystems) with a 50 cm capillary length. The PCR parameters were as follows: 25
cycles of 96°C for 10 seconds, 50°C for 5 seconds and 60°C for 2 minutes.
Obtained from CSU sequence traces were analysed and edited in SeqMan
(DNAstar, Lasergene) and the consensus sequences were saved in EditSeq (DNAstar,
Lasergene). Subsequently, Basic Local Alignment Search Tool (BLAST) was used to
carry out homology searches (Altschul et al., 1990) against National Centre for
Biotechnology Information (NCBI) website.
Table 2.3 PCR primers used to amplify 1342 bp product of 16S rRNA gene (Marchesi
et al., 1998).
Primer Sequence (5' to 3')
63F CAGGCCTA ACACATGCAAGTC
1387R GGGCGGWGTGTACAAGGC
2.2.6 Gram-positive antimicrobial resistance array
To determine the presence antimicrobial resistance genes in the potential probiotic
strain, the Indentibac AMR+ve™ microarray was employed (Perreten et al., 2005) and
used according to the manufacturer’s instructions. L. plantarum B2028 genomic DNA
was isolated using the CTAB method. E. faecium SF11770 was used as the control for
the Gram positive AMR. Genomic DNA was labeled using a randomly primed
polymerization reaction (Bohlander et al., 1992; Perreten et al., 2005). PCR consisted
of two rounds (A and B) and primers are showed in Table 2.4. Briefly, in round A the
DNA (10-100 ng) was denatured, with Sequenase (5×) buffer and primer A (40 pmol)
for 2 minutes at 94°C. Subsequently, during a cooling step at 10°C (5 minutes) mixture
consisting of: (Sequenase buffer (5×), deoxyribonucleotide triphosphates dNTPs,
dithiothreitol (DTT), bovine serum albumin (BSA), Sequenase and water was added to
each sample. Samples were subjected to temperature ramping from 10°C to 37°C, at
37°C for 8 minutes, at 94°C for 2 minutes, at 10°C for 5 minutes. During this last step
a Sequenase buffer (1:4 diluted) was added to the sample and again subjected to
temperature ramping from 10°C to37°C and at 37°C for 8 minutes. The product from
round A was mixed with sterile water and 7.5 µl was added to master mix (Quiagen
buffer (10×), dNTPs, biotin-16-deoxyuridine triphosphate (dUTP), MgCl2, primer B
(100 pmol), Taq polymerase and water). Samples were amplified in thermal cycler
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with the following conditions: 35 cycles of 94°C for 30 seconds, 40°C for 30 seconds,
50°C for 30 seconds, 72°C for 2 minutes, 4°C hold).
Table 2.4 Primers used in AMR+ve™ Gram positive microarray.
Primer Sequence (5' to 3')
Primer A GTTTCCCAGTCAGCATCNNNNNNNNN
Primer B GTTTCCCAGTCACGATC
PCR product from round B was run on a 1% agarose gel to ensure successful
amplification and 10 µl volume was used for the array. Briefly, before sample
application the microarray tubes were washed with hybridization buffer and incubated
at 30°C with shaking at 550 rpm for 5 minutes. A mix of PCR product and
hybridization buffer was incubated at 95°C for 5 minutes, cooled down and transferred
to the microarray tube. Tubes were incubated at 60°C with shaking at 550 rpm for 60
minutes and afterwards were washed three times with appropriate washing buffer. First
wash was carried out at 30°C with shaking at 550 rpm for 5 minutes, and subsequent
two washes at 20°C. Subsequently, microarray tubes were blocked with freshly
prepared blocking solution (containing 2% (w/v) milk powder) at 30°C with shaking at
550 rpm for 15 minutes and diluted streptavidin-conjugated horseradish peroxidase
(Poly-HRP Streptavidin) was added to the sample and incubated at 30°C for 15
minutes. This was then followed by a series of three washes at 30°C with shaking at
and 550 rpm for 5 minutes. Subsequently, a 3',5,5'-tetramethylbenzidine (TMB) analog
(SeramunGrün®, Seramun Diagnostica) was added to each array tube, incubated at the
room temperature 10-15 minutes and the array was imaged using a tube reader
(Clondiag). Data were analysed using Iconoclust software (Clondiag), which measures
the signal intensity and the background for each spot on the array. AMR analyses were
performed in duplicate.
2.2.7 Fluorescent in situ Hybridization
Fluorescent in situ Hybridization (FISH) using 16S rRNA oligonucleotide probes
was performed accordingly to the previously described method (Daims et al., 2005).
Specific probes (Table 2.5) for bifidobacteria, lactobacilli/enterococci and Salmonella
were used to enumerate bacteria of interest. Total bacterial counts were obtained with
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nucleic acid stain 4′6-diamidino-2-phenylindole (DAPI). Briefly, faecal slurry samples
were collected from batch culture at 0, 5, 10 and 24 hours post inoculation and fixed in
ice-cold 4% (w/v) paraformaldehyde for 4-6 hours at 4°C. Subsequently, samples were
centrifuged at (16 000 × g) for 5 minutes, washed twice with 0.1M PBS (pH 7.2) and
pellet was resuspended in 300 µl PBS/ethanol (50:50). Samples were mixed by
vortexing and stored at -20°C until required. For hybridization, samples were diluted in
PBS/SDS and a 20 µl aliquot of the diluted sample was pipetted onto Teflon- and poly-
L-lysine- coated, six well slides (Tekdon Inc.). Samples were dried at 46°C for 15
minutes and then dehydrated in ethanol using 50%, 80% and 96% (v/v) concentrations
(3 minutes in each). Following dehydration samples were again dried at 46°C to allow
evaporation of alcohol. For the detection of lactobacilli/enterococci (probe Lab158), a
5 µl of lysozyme was applied to each well and left for 15 minutes at 37°C; washed
briefly in water and dehydrated in a alcohol series as described above. A 50 µl mixture
containing 5 µl of the probe and 45 µl of the hybridization buffer (HB) was applied
onto each well and hybridization was performed for 4 hours using ISO20 oven (Grant
Boekel). Following hybridization, slides were transferred into 50 ml wash buffer
containing 20 µl DAPI and incubated in a water bath for 15 minutes. Slides were then
washed in ice-cold water, dried under compressed air and 5 µl of anti-fade reagent was
added to each well. The coverslips were applied and the slides were stored at 4°C until
required. Slides were examined under an epifluoresce microscope (Eclipse 400; Nikon,
Surrey, United Kingdom).
Bacteria were enumerated according to the following equation:
DF × ACC × 6732.42 × 50 × DF sample
where:
DF is the dilution factor, ACC is the average cells count of 15 fields of view, 6732.42
number is the area of the well divided by the area of the field of view, 50 is the factor
that reverts the cell count to per milliliter of sample, DF sample is the dilution of
sample according to the used probe or stain.
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Table 2.5 16S rRNA oligonucleotide probes used for bacterial enumeration.
Probe name Sequence (5' to 3')
Short Full name
Bif164a S-G-Bif-0164-a-A-18 CATCCGGCATTACCACCC
Lab158b† S-G-Lab-0158-a-A-20 GGTATTAGCAYCTGTTTCCA
Sal303c L-S-Sal-1713-a-A-18 AATCACTTCACCTACGTG
a Target species: Most Bifidobacterium spp. and Parascardovia dendicolens (Langendijk et al., 1995)
b Target species: Most Lactobacillus, Leuconostoc and Weissella spp.; Lactococcus lactis; all
Vagococcus, Enterococcus, Melisococcus, Tetragenococcus, Catellicoccus, Pediococcus and
Paralactobacillus spp. (Harmsen et al., 1999).
c Target species: Different serovars of Salmonella spp. (Nordentoft et al., 1997).
† Requires lysozyme treatment.
Table adapted from Martin-Pealez et al. (2008).
2.3 Mass spectrometry methods
2.3.1 Matrix-assisted laser desorption ionization time-of-flight mass spectrometry
(MALDI-ToF)
Lactobacillus strains were grown on MRS agar as described in section 2.1.1 and
fresh overnight culture was used for preparation of samples for MALDI ToF analysis.
Method of Mellmann et al. (2008) was followed for sample preparation. Briefly,
approximately 1 inoculation loop of fresh bacterial culture was resuspended in 300 µl
water and 900 µl of ethanol. Samples were centrifuged at 13 000 × g and supernatant
was decanted. To extract the cells, 50 μl of 70% formic acid (in water) was added to
the bacterial pellet, sample was mixed thoroughly after which 50 μl of acetonitrile was
added. Samples were again centrifuged at 13 000 × g for 2 minutes and 1 μl of
obtained supernatant was transferred onto wells on a steel MALDI target plate.
Supernatants were allowed to dry at room temperature and subsequently overlaid with
1.5 μl saturated solution of α-cyano-4-hydroxy-cinnamic acid in 50% acetonitrile-2.5%
trifluoroacetic acid mixture (MALDI matrix) and samples were left to dry. Samples
were analysed using Bruker Autoflex 2 MALDI-ToF machine (Bruker, Daltonics). The
main spectral projection (MSP) spectra were processed with BioTyper software
(Bruker, Daltonics) based on a comparison with the BioTyper reference library of
MALDI-TOF mass spectra. Sample identification was based on two technical repeats.
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2.4 Chromatography methods
2.4.1 High-performance liquid chromatography (HPLC)
SCFA analysis of lactobacilli CFS’s and of batch culture samples were
performed using an HPLC system and as described previously (Sarbini et al., 2011).
Briefly, lactobacilli cultures and batch culture samples (section 2.1.14) were
centrifuged for 10 minutes at (13 000 × g), supernatants were filter sterilized using
0.22 µm polycarbonate syringe filter and analysed using a HPLC system (LaChrom
Merck Hitachi, Poole, Dorset, UK). System was equipped with a pump (L-7100), a
refractive index detector (L-7490), and an autosampler (L-7200). For the separation of
organic acids the ion-exclusion REZEX ROA-Organic acid column was used
(Phenomenex Inc.). During the separation of organic acids the temperature was
maintained at 85°C. The eluent used in the system was degassed sulphuric acid diluted
in the HPLC-grade H2O (0.0025 mmol/L); the flow rate was maintained at 0.5 ml/min.
Standards for lactic, acetic, propionic, butyric, isobutyric, valeric and isovaleric acids
were used at the following concentrations 12.5 mM, 25 mM, 50 mM, 75 mM, and 100
mM. Quantification of the samples was gained through calibration of the standards
curves and results were the average from three replicates.
2.5 In vitro methods
2.5.1 Porcine intestinal epithelial cell line (IPEC-J2)
2.5.1.1 IPEC-J2 monolayers
IPEC-J2 cell line (derived from jejunum of an un-suckled 1-day old piglet) when
used as monolayers were maintained according to Schierack et al. (2006). All reagents
unless indicated otherwise were purchased from Sigma-Aldrich. Briefly, cells were
cultured in a mixture of DMEM/Ham’s F12 (1:1) medium supplemented with 5% (v/v)
foetal calf serum (FCS), ITS media supplement (5 µg/ml insulin, 5 µg/ml transferrin, 5
ng/ml sodium selenite), 5 ng/ml epidermal growth factor, 1% (v/v) non-essential
amino acids, 1% (v/v) L-glutamine and gentamycin (50 µg/ml), hereafter referred as
IPEC-J2 medium. Cells were maintained in a 5% CO2 atmosphere.
For experiments cells were seeded in 24-well plates (Nunc) at a density of 2 × 105 cells
per well and grown to confluent monolayers. During the assays cells were maintained
in IPEC-J2 depleted of antibiotics.
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2.5.1.2 Three-dimensional IPEC-J2 model
The porcine jejunal 3D cell culture model was based upon the previous methods,
(Nickerson et al., 2001; Searle et al., 2010) and Dr J. W. Collins personal
communication. For the 3D cell model standard IPEC-J2 medium was additionally
supplemented with glucose, galactose and fructose (1 g/l, 0.25 g/l, 0.13 g/l) (Goodwin
et al., 1993). IPEC-J2 monolayers were cultured as described above, in tissue culture
flask. Cells were washed with Hank’s balanced salt solution (HBSS) and detached
using 0.25% trypsin for 5 minutes. Subsequently, fresh medium was added to remove
trypsin, cells were centrifuged and then resuspended in a complete fresh IPEC-J2-3D
medium to yield 2 × 105 cells/ml. Cell suspensions were mixed with 5mg/ml
Cytodex™ microcarrier beads (Cytodex-3, size 133-225 µm) in a 50 ml Corning®
centrifuge tube. Before use microcarrier beads were hydrated in 0.1M PBS (pH 7.2)
and autoclaved according to supplier instructions. In order to facilitate the initial cell-
bead attachment, suspensions were incubated at 37°C, 5% CO2 for approximately 30
minutes. Subsequently, cell suspensions were introduced to the 50 ml rotating wall
vessel (RWV) (Synthecon), air bubbles removed and cultured at a rotation starting at
13.7 rpm to maintain the cell-bead aggregates in the suspension. Cells were incubated
for two days without media change to allow further attachment of cells. Circa 80% of
the medium was replenished every second day and rotation was gradually increased
over time as necessary. Cells were cultured in RWV (37°C, 5% CO2) for 20-22 days.
Following this time (day of the assay) cells were removed from the RWV, resuspended
in IPEC-J medium (without antibiotics) to yield 5 × 105 cells/ml of suspension. To
obtain the cell number in 1 ml, the cell aggregate suspensions were trypsinized and
passed through a 70 µm sieve in order to separate them from the microcarrier beads.
Following separation from the microcarrier bead fresh IPEC-J2 medium was added
and cells were counted using a haemocytometer. For experiments cell aggregates were
seeded into 1.5 ml centrifuge tubes.
2.5.2 L. plantarum B2028 and lactulose adherence assay.
Adhesion assay was performed as previously described (Dibb-Fuller et al., 1999)
with slight modifications. Briefly, L. plantarum B2028 inocula were prepared by
centrifugation (2447 × g) for 10 minutes, the supernatant was decanted, the pellet
washed in 0.1M PBS (pH 7.2) and resuspended in IPEC-J2 medium to yield 5 × 107
cfu/ml. Cell-free supernatants were prepared by filter sterilization as described in
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section 2.1.8. Cells were washed twice with Hank’s balanced salt solution (HBSS) and
1 ml of the bacterial inoculum containing accordingly: L. plantarum B2028, L.
plantarum B2028 + 1% (w/v) LAC, both cultured in standard MRS and L. plantarum
B2028 cultured in MRSL (with 1% (w/v) LAC) was added to a 24-well plate. Wells
containing IPEC-J2 medium only were included as a control conditions. Plates were
incubated at 37°C and in the presence of 5% CO2 for up to 2 hours. Subsequently, cells
were washed three times with HBSS, disrupted with 1% Triton X-100 (Sigma-Aldrich)
and mechanical stirring. Serially diluted cell suspensions (100 – 106) were plated onto
MRS agar and incubated microaerophilically at 37°C for 24 hours.
2.5.3 S. Typhimurium viability and inhibition of invasion assay
To evaluate the effect of pre-treatment with L. plantarum B2028 supernatant on S.
Typhimurium SL1344nalr viability and invasion, a previously described method was
followed (Coconnier et al., 1997; Makras et al., 2006). Briefly, S. Typhimurium
SL1344nalr cells (108 cfu/ml) were co-incubated with IPEC-J2 medium containing
10% (v/v) of L. plantarum B2028 cell-free CFS’s (CFS/CFSL), pH control medium
(MRS/MRSL) and lactic acid control medium (MRS-LA/MRSL-LA) at pH 3.8 and
prepared as described previously in section 2.1.8. S. Typhimurium SL1344nalr cells
incubated in IPEC-J2 medium only and medium without bacterial inoculum added
were included as controls. Following 1 hour incubation at 37°C serially diluted cell
suspensions (100 – 107) were plated onto LB-G agar for enumeration. Subsequently, S.
Typhimurium SL1344nalr cells were washed in 0.1M PBS (pH 7.2) and resuspended in
IPEC-J2 medium to yield 5 × 107 cfu/ml and the invasion assay was conducted as
described below for competition assays (section 2.5.4).
2.5.4 Competition assays using IPEC-J2 monolayers and 3D model
Competition assays were performed as previously described (Dibb-Fuller et al.,
1999; Dibb-Fuller et al., 2001; Mappley et al., 2011; Searle et al., 2009; Searle et al.,
2010). Briefly, L. plantarum B2028 and S. Typhimurium SL1344nalr culture (section
2.1.1) was centrifuged (2447 × g) for 10 minutes and the supernatant was decanted.
Bacterial pellet was washed in 0.1M PBS (pH 7.2) and subsequently resuspended in
IPEC-J2 medium to yield 108 cfu/ml. Subsequently, bacterial inocula (Table 2.6) were
added to 24-well plates (Nunc) (for monolayers) or 1.5 ml centrifuge tubes (for 3D cell
aggregates) to a final concentration of 5 × 107 cfu in a well/tube in a 1 ml volume.
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Wells/ centrifuge tubes containing IPEC-J2 medium only were included as a control
conditions. Inoculated plates, one for adhesion and one for invasion and centrifuge
tubes were incubated at 37°C (in the presence of 5% CO2) for 60 minutes.
Following incubation, to count the S. Typhimurium SL1344nalr associated, the
cells were washed three times with HBSS and disrupted with 1% Triton X-100
(Sigma-Aldrich) using magnetic stirrer. To distinguish the number of S. Typhimurium
SL1344nalr invaded, the cells were washed twice with HBSS and inoculated with 1 ml
of media containing 100 µg/ml gentamycin solution (Sigma-Aldrich) and incubated for
additional 2 hours. Subsequently, cells were washed three times with HBSS and
disrupted as described above. To determine the number of associated and invaded S.
Typhimurium SL1344nalr, 10-fold serial dilutions (100 – 10-4) were plated onto LB-G
agar (Oxoid). The number of adhered S. Typhimurium SL1344nalr was obtained by
subtracting the number of invaded bacteria from the number of associated bacteria. All
assays were conducted in duplicate on three separate occasions.
Table 2.6 Experimental conditions used in the competition assays using IPEC-J2 cell
line (monolayers and 3D cells) and porcine in vitro organ culture (IVOC) model.
Condition Experimental strategy
SL S. Typhimurium SL1344nalr
MRSL pH 3.8 S. Typhimurium SL1344nalr + 10% (v/v) MRSLa pH 3.8
LAC S. Typhimurium SL1344nalr + 1% (w/v) LAC
Lp S. Typhimurium SL1344nalr + L. plantarum B2028
Lp + LAC S. Typhimurium SL1344nalr + L. plantarum B2028 + 1% (w/v) LAC
Lp + CFSL S. Typhimurium SL1344nalr + L. plantarum B2028+ 10% (v/v) CFSLb
CFSL S. Typhimurium SL1344nalr + 10% (v/v) CFSLb
a MRS broth with 1% (w/v) lactulose as a main carbon source.
b Cell free supernatant of L. plantarum B2028 cultured in MRSL broth.
2.5.5 Giemsa assay
IPEC-J2 monolayers were used and maintained as described in section 2.5.1.1
with a slight modification as cells were grown in 24-well plates on 13 mm cover slips.
Each well was inoculated with inocula containing L. plantarum B2028 cells, cells with
10% (v/v) CFS, or with 1% (w/v) LAC. Media only and media containing 10% (v/v)
CFS and 1% (w/v) LAC were also added but depleted of bacterial cells. Plates were
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incubated for 60 min as described for adhesion assays. Cells were stained with 10%
Giemsa stain (Sigma-Aldrich) for 60 minutes and subsequently washed three times
with distilled water and differentiated with 1% (v/v) acetic acid for 2 minutes followed
by a wash with sterile distilled water. Cover slips containing cells were then removed
from the 24-well plate and mounted on glass slides using DPX mountant (mixture of
distyrene, a plasticizer and xylene) (Sigma-Aldrich). Slides were examined under oil
immersion using light microscope (Olympus CX21, × 1000). Assays were performed
in duplicate on two separate occasions.
2.5.6 Porcine in vitro organ culture
In vitro organ culture association assays were performed as previously described
(Collins et al., 2010). Briefly, four 6-week old male commercial pigs were housed and
fed a commercial un-medicated diet and water ad libitum for 7 days prior to the study.
Pigs were euthanased by stunning and exanguination and subsequently placed on their
dorsal recumbency and a mid-line incision was made. At post-mortem the whole
intestinal tract was exteriorized and the jejunum and spiral colon located and sampled
aseptically. Tissue samples were immediately placed in pre-cooled IVOC medium and
transported to the laboratory on ice. The IVOC medium consisted of: complete RPMI
1640 medium containing 10% (v/v) fetal calf serum (FCS), 0.25% lactalbumin
hydrosylate, 75 mM mercaptoethanol, 0.2 µg/ml hydrocortisone (1:1
chloroform/ethanol), 0.1 µg/ml insulin, 2 mM L-glutamine and L-aspartate (Collins et
al., 2010; Girard et al., 2005). All reagents unless indicated otherwise were purchased
from Sigma-Aldrich. Tissues were washed in IVOC medium, aseptically trimmed into
circa 2cm x 2cm squares and immobilized in CellCrowns™ (Scaffdex) to obtain fixed
mucosal surface of the tissue explants. Subsequently, immobilized intestinal explants
from jejunum and colon were placed into pre-filled with IVOC medium (500 µl) 24-
well plates (Nunc) with the mucosal surface facing upwards.
For association assays, L. plantarum B2028 and S. Typhimurium SL1344nalr
bacterial inocula were prepared and administered essentially as described for the
competition assays (Table 2.6) with the exception that the final bacterial concentration
in a well (1ml volume) was 108 cfu. Plates were incubated at 37°C (in the presence of
5% CO2) for 30 minutes with gentle agitation. Following the incubation tissue samples
were washed in and placed in 9 ml 0.1M PBS (pH 7.2) and homogenized for
bacteriological analysis. Serial dilutions (100 – 10-6) were plated out onto BGA
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supplemented with 15 µg/ml nalidixic acid. Uninfected tissues were incubated with
media only as controls. Assays were conducted in quadruplicate on two separate
occasions.
2.6 In vivo methods
2.6.1 Animals and management
A total of twenty four, cross breed, mixed sex pig with a mean initial weight of
7.98 ± 0.7 kg were used for the study. Animals were weaned at 4 weeks of age, faecal
samples were collected from sows (n = 3) and piglets and tested for the presence of
Salmonella before the trial commencement. Pigs were randomly divided into four
equal groups of six on the basis of their mean body weight and housed in a bio-
containment facility (CLII). Each pen was equipped with a feeder and water supply
from a water tray and from a nipple. Pens, feeders and water trays were cleaned on a
daily basis. Pigs were fed commercial un-medicated pelleted feed (Lillico Attlee, Wm.
Lillico & Son Ltd), according to their daily requirements (ASU Unit, AHVLA) and
water was provided ad libitum. The left over feed was weighed every morning.
Biosecurity measures were implemented in order to avoid cross contamination. These
studies were performed in accordance with the UK Animals (Scientific Procedures)
Act 1986 and were approved by the AHVLA ethics committee. All procedures were
carried out at the AHVLA Coomblands Farm.
2.6.2 Bacterial strains preparation
S. Typhimurium SL1344 nalr and L. plantarum B2028 were cultured as previously
described in LB-G and MRS broth respectively, centrifuged (2447 × g) for 10 minutes
and the supernatant was decanted. For S. Typhimurium SL1344 nalr the pellet was and
resuspended in 0.1M PBS (pH 7.2) to yield 109 cfu/ml bacteria and further diluted in
sterile water to yield 5 × 107 cfu/ml. L. plantrarum B2028 was resuspended in sterile
water and mixed with the small portion of feed for each pig to receive 1010 cfu/pig/day.
2.6.3 Experimental design and diets
Once distributed into four separate pens, the animals were allowed 7 days of
acclimatisation after which the experimental diets were provided. The experimental
treatment consisted of pelleted control diet without additives (Control), diet containing
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1% (w/w) (15 ml/kg) lactulose given as a Duphalac syrup (LAC), diet containing 1010
cfu of L. plantarum B2028/animal/day (Lp) and diet containing 1010 cfu of L.
plantarum B2028/animal/day together with 1% (w/v) (15 ml/kg) lactulose (Lp +
LAC). Once stabilised on the above diets (6 days), each piglet in the all four groups
was challenged with S. Typhimurium SL1344nalr (5 × 108 cfu in 10 ml sterile water)
administered by oral gavage (day 0). Approximately 30 minutes before the challenge
animals were orally dosed with 10% (w/v) sodium bicarbonate solution to neutralise
stomach acid (20 ml). Clinical performance was monitored throughout the entire study
and samples were collected as detailed in section 2.6.4. At the end of the study, 10
days after Salmonella challenge all animals were humanely sacrificed for post-mortem
examination.
2.6.4 Experimental monitoring and animals handling
All animals were examined clinically and scored as per Table 2.7 throughout the
duration of the study. Feed consumption was recorded daily and body weights were
taken weekly. Rectal temperature and faecal samples were collected from each piglet
by rectal digital insertion on three separate occasions before Salmonella challenge,
while animals were fed the experimental diet.
Table 2.7 Clinical score evaluation.
Clinical
score
Diarrhoea Feed consumption Behaviour Temperature
0 None Normal Active Normal
(38.5 – 40°C)
1+ Slight Slightly off food Active if stimulated Raised
(40.5 – 41°C)
2+ Watery
(yellow, watery,
+/- blood)
Off food Inactive, when
stimulated
Fever
(above 41°C)
Following S. Typhimurium SL1344nalr challenge, sampling was performed on a daily
basis. Faecal samples (approx. 5 g) from each pen were collected from the floor daily
and pooled for Salmonella testing.
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2.6.5 Bacterial isolation and enumeration
Direct isolation and enumeration of S. Typhimurium SL1344nalr from faeces
were obtained by resuspending 10% (w/v) freshly collected samples in a buffered
peptone water (BPW) (Edel and Kampelmacher, 1973), plating out serially diluted
samples (100-10-5) onto BGA supplemented with nalidixic acid 15 µg/ml and
incubating at 37°C for 16 hours (Searle et al., 2009). For initial enrichment,
resuspended in BPW samples were incubated at 37°C for 18 ± 2 hours. Subsequently,
100 µl of the overnight incubated broth was inoculated onto modified semisolid
Rappaport-Vassiliadis medium (MSRV) (Aspinall et al., 1992; De Smedt et al., 1986)
as a three equal drops. MSRV plates were incubated at 41.5°C for 24 hours. Plates
which were negative for growth were allowed further 24 hours incubation and
examined for growth. Subsequently, a 1 µl loop was used to pick the material from the
edge of the definite growth, which was streaked onto Rambach agar and BGA agar
supplemented with 15µg/ ml of nalidixic acid and colonies were allowed to develop
for 24 hours at 37°C.
Tissues collected at post-mortem, were weighed (1 g where possible),
homogenised in BPW (10% w/v) and serially diluted samples (100-10-5) were plated
onto BGA supplemented with 15µg/ ml of nalidixic acid. Samples were enriched as
described above and a 100 µl aliquot was taken from the samples that were negative
upon direct plating.
Lactobacilli numbers were determined by diluting fresh faecal samples 10% (w/v)
in BPW and 10-fold serial dilutions in 0.1M PBS (pH 7.2) (10-1-10-8) were prepared
and plated out on MRS agar (De Man et al., 1960). Plates were incubated at 37°C
microaerophilically in GasPak jars using a GasPak™ plus system (BBL™) and
colonies were allowed to develop for 48 hours. At four distinct time points during the
study, feacal samples were subjected to PCR analysis to test for L. plantarum spp.
presence (Kwon et al., 2004).
For E. coli and coliform enumeration of faeces, samples were prepared as above
and plated onto a Chromagar ™ ECC (Randall et al., 2009). Plates were incubated at
37°C for 24 hours and all blue E. coli and mauve coliforms were counted.
2.6.6 Post-mortem examination
Ten days following pathogen challenge all pigs were euthanased by stunning and
exanguination and subsequently placed in dorsal recumbency for a mid-line incision to
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be made. Faecal samples were collected from rectum from all experimental animals.
Tissues (jejunum, ileum, colon, caecum, rectum and mesenteric lymph nodes) from
three pigs from each experimental group were sampled at post-mortem for bacteriology
and histopathology.
2.7 Statistical analysis
Statistical analysis of the data presented within this thesis was performed using
GraphPad Prism® version 5 program (GraphPad Software, LaJolla, CA, USA). Unless
otherwise indicated the evaluation of statistically significant differences between
results from the treatment groups and the treatment groups and the control were
determined by repeated-measures One-way analysis of variance (ANOVA) and
Bonferroni post test. For the studies where two factors (time and treatment) were taken
into account, the repeated-measures Two-way ANOVA was used followed by the
Bonferroni post test. The area under the curve (AUC) was calculated by the trapezoidal
method with GraphPad Prism® version 5 program. The mean AUC values were
compared using One-way ANOVA and Bonferroni post test. For analysis of
Salmonella counts from the in vivo trial, the scoring system was applied and data
between treated and control group compared.
Statistical significance was accepted at P<0.05 and differences among means with
0.05<P<0.10 were accepted as tendencies to differences. All data within this thesis are
presented as the mean with the standard error of the mean (SEM). The significance (P
value) was visualized on graphs using an asterisk scale system (Table 2.8).
Table 2.8 P value summary.
P value Symbol
≤ 0.001 ***
> 0.001 to ≤ 0.01 **
> 0.01 to ≤ 0.05 *
> 0.05 ns
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Materials and Methods
2.1 Bacteriological methods
2.1.1 Bacterial strains and culture conditions
All bacterial isolates used in these studies were obtained from the culture
collection at the Animal Health and Veterinary Laboratories Agency (AHVLA,
Weybridge, UK). A total of 11 S. Typhimurium isolates were provisionally used,
however, following brief characterisation a nalidixic acid resistant derivative of S.
Typhimurium SL1344 was used throughout the studies. In addition, a total of 16
Lactobacillus isolates and the control strains including E. coli DH5α-K12, E. faecalis
ATCC 29212, E. faecium SF11770 and C. jejuni NCTC 11351 were used. L.
plantarum B2028 (JC1) and L. reuteri B2026 were previously isolated from pig faeces
(Collins et al., 2010).
Bacterial isolates were maintained in heart infusion broth (HIB) supplemented
with 30% (v/v) glycerol (Oxoid) at -80°C. For routine use Salmonella, E. coli and E.
faecalis ATCC 29212 isolates were cultured at 37°C for 16 hours, aerobically on 5%
sheep’s blood agar (SBA) or on lysogeny broth (also known as Luria-Bertani)
(Bertani, 1951, 2004) agar without glucose (LB-G), respectively. LB-G broth cultures
of both Salmonella and E. coli were incubated at 37°C for 16 hours, aerobically with
gentle agitation (225 rpm). For studies where the S. Typhimurium SL1344 nalr
recovery was required from a microbially abundant samples brilliant green agar (BGA)
(Kauffmann, 1935) containing 15 µg/ml nalidixic acid was used.
Lactobacilli were cultured on de Man, Rogosa, Sharpe (MRS) agar and broth (De
Man et al., 1960) at 37°C for 24 hours, microaerophilically in GasPak jars using a
GasPak™ plus system (BBL™) (94% H2, 6% CO2). Lactobacilli broth cultures (MRS
broth) were incubated statically at 37°C for 24 hours. C. jejuni NCTC 11351 was
cultured on 5% SBA, microaerophilically at 42°C.
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2.1.2 Gram stain
Salmonella and lactobacilli isolates were cultured as described in section 2.1.1. A
single colony was picked from the plate and smeared onto a glass slide. The smear was
then heat fixed and 1% crystal violet (Sigma-Aldrich) applied to the smear for 60
seconds. The slide was washed with water after which Lugol’s iodine (Sigma-Aldrich)
was applied for 60 seconds and subsequently washed off with water. The excess of the
crystal violet was removed using ethanol de-colouriser and the slide was once again
washed using water. The counter stain safranin was applied for 60 seconds and again
washed with water. Slides were allowed to air dry and then examined under oil
immersion using light microscopy (Olympus CX21, × 1000). Gram stain results were
recorded accordingly.
2.1.3 Catalase and oxidase test
Salmonella and lactobacilli isolates were cultured as described previously (section
2.1.1). For catalase testing, a representative colony of each isolate was picked and
placed onto a Petri-dish and then a drop of 3% (v/v) hydrogen peroxide (H2O2) was
mixed in with it. Production of gas (bubbles) was recorded as a catalase positive result.
For oxidase testing, a representative colony of each isolate was picked from a plate
with a sterile plastic inoculation loop and smeared onto an oxidase strip (Sigma-
Aldrich). The result was read after 1 minute and development of a dark blue spot at the
position of placed colony was recorded as a positive result. C. jejuni NCTC 11351was
used as a positive control, whereas E. faecium SF11770 as a negative control.
2.1.4 API identification system
BioMerieux API 20E and API 50CH kit (BioMérieux) was used to determine
bacterial species. Assays were conducted according to the manufacturer’s instructions.
Salmonella and E. coli isolates were tested using API 20E whereas lactobacilli were
tested using API 50CH with specific API 50CHL medium.
For the API 20E kit, a saline suspension of a pure culture of E. coli and
Salmonella strains was dispensed into mini cupules, rehydrating the medium present in
each of the tubes. In addition, a number of tubes were overlaid with few drops of
mineral oil to create anaerobic atmosphere (ADH, LDC, ODC, H2S, URE). Strips were
incubated at 37°C, aerobically for 18-24 hours and visual readings were taken and
cross referenced with apiweb™ software (BioMérieux).
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For API 50 CHL, lactobacilli were cultured on MRS agar as described previously
in section 2.1.1 and subsequently colonies were removed from the plate and inoculated
into API 50 CHL medium to obtain turbidity equal to McFarland 2.0. Tubes of the API
strip were inoculated with prepared suspension, covered with few drops of mineral oil
to create anaerobic conditions and incubated at 37°C for 48 hours. Visual readings
were taken at 24 and 48 hours, subsequently cross referenced with apiweb™ software
(BioMérieux).
2.1.5 Slide agglutination test
The identity of Salmonella was also confirmed using standard laboratory slide
agglutinations. Agglutination tests were performed using Salmonella antisera (Pro-
Lab Diagnostics) as per the manufacturer’s instructions. Briefly, approximately 15
μl of anti-sera were placed upon a glass slide and then mixed with a small amount
of bacterial suspension. The slide was gently tilted side to side and agglutination of
the bacteria within one minute was considered a positive result. Irrelevant anti-sera
acted as a negative control.
2.1.6 Hydrogen peroxide production
Production of H2O2 by lactobacilli isolates was assessed using the method
described previously (Pascual et al., 2006). Briefly, a modified MRS was prepared
supplemented with 0.01mg/ml horseradish peroxidase (Sigma-Aldrich) and 0.25
mg/ml 3,3’,5,5’-tetramethylbenzidine dihydrochloride (TMB) (Sigma-Aldrich).
Isolates were sub-cultured on MRS medium containing TMB and incubated at 37°C
for 72 hours in an anaerobic chamber. Following incubation plates were exposed to air
for 30 minutes and the presence of blue colonies recorded as a positive result. Assays
were performed on two separate occasions.
2.1.7 Colony overlay assay
A colony overlay assay was used according to Barbosa et al. (2005) to investigate
antimicrobial activity of lactobacilli isolates against S. Typhimurium SL1344 nalr
growth. Briefly, three 5 µl volumes of an overnight culture (section 2.1.1) of each
Lactobacillus isolate were inoculated onto MRS agar and incubated
microaerophilically at 37°C for 24 hours. To kill the bacterial cells, plates were
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exposed to chloroform (Sigma-Aldrich) vapours for 30 minutes followed by 20
minutes aeration. Subsequently, plates were overlaid with 0.7% (v/w) LB-G agar
containing 105 cfu/ml of an overnight culture of the S. Typhimurium SL1344 nalr.
Plates were incubated aerobically at 37°C and zones of inhibition around the three
spots were measured at 24 and 48 hours. MRS plates overlaid with the LB-G agar with
or without indicator strain and without a probiotic were used as controls. Assays were
performed on three separate occasions.
2.1.8 Conditioned medium assay
S. Typhimurium SL1344 nalr and lactobacilli were cultured as described in section
2.1.1. To obtain lactobacilli cell free supernatants (CFSs) probiotic broth cultures were
centrifuged (2447 × g) for 10 minutes at room temperature and supernatants were filter
sterilized using 0.22 µm filter (Satorius Stedim Biotech).
For preliminary selection studies described in Chapter 3, an un-buffered CFS of
sixteen lactobacilli was added (as 10% (v/v) dilution factor) to a 96-well micro-titre
plate (Iwaki, SLS) inoculated with S. Typhimurium SL1344 nalr culture (105 cfu/ml) in
LB-G. Plates were incubated at 37°C and an optical density (OD) of 600nm was read
every 15 minutes for 24 hours using FLUOstar OPTIMA (BMG LABTECH). S.
Typhimurium SL1344 nalr culture containing 10% (v/v) of MRS broth (pH 5.8) was
used as a control. In addition LB-G broth with 10% (v/v) MRS and lactobacilli CFSs
but without the indicator strain was included to standardise the OD readings.
For further studies described in Chapter 5, to identify mechanism of L. plantarum
B2028 cell free supernatant inhibitory activity against S. Typhimurium SL1344 nalr
growth, CFS at pH 3.8 (un-buffered), adjusted to pH 4.5 and separately to pH 7.2 was
tested as described above. The control broths were prepared accordingly; MRS broth
adjusted to pH 3.8, 4.5 and 7.2 was used as a pH control, whereas MRS broth
containing L-lactic acid (Sigma-Aldrich) and adjusted to pH 3.8, 4.5 and 7.2 was used
as a lactic acid control (-LA) (Table 2.1). LB-G broth with 10% (v/v) of relevant MRS
broth and L. plantarum B2028 CFS but without the indicator strain was included to
standardise the OD readings.
In addition, for this assay and in subsequent studies where cell-free supernatant of
L. plantarum B2028 was used as a part of synbiotic, for which the L. plantarum B2028
was cultured in modified MRS broth devoid of glucose but containing 1% (w/v)
prebiotic lactulose, and hereinafter abbreviated as MRSL broth. Consequently, L.
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plantarum B2028 cell free supernatant obtained from culture in MRSL broth was
named CFSL. Growth inhibition assays of S. Typhimurium SL1344 nalr were carried
out subsequently as described above (Table 2.1).
Table 2.1 Experimental conditions used in conditioned medium assays.
Medium/Condition Experimental strategy
LB-G S. Typhimurium SL1344 nalr culture medium
MRS Standard lactobacilli growth medium containing 2% (w/v) glucose
MRSL Modified lactobacilli growth medium devoid of glucose, containing 1% (w/v)
lactulose
CFS L. plantarum B2028 cell free supernatant obtained by centrifugation and filter
sterilization of 24 h culture in MRS broth
CFSL L. plantarum B2028 cell free supernatant obtained by centrifugation and filter
sterilization of 24 h culture in MRSL broth
SL S. Typhimurium SL1344 nalr culture in LB-G (105 cfu/ml)
MRS pH 3.8/
MRSL pH 3.8
S. Typhimurium SL1344 nalr culture in LB-G (105 cfu/ml) with 10% (v/v) MRS
or MRSL broth, adjusted to pH 3.8
MRS pH 4.5/
MRSL pH 4.5
S. Typhimurium SL1344 nalr culture in LB-G (105 cfu/ml) with 10% (v/v) MRS
or MRSL broth, adjusted to pH 4.5
MRS pH 7.2/
MRSL pH 7.2
S. Typhimurium SL1344 nalr culture in LB-G (105 cfu/ml) with 10% (v/v) MRS
or MRSL broth, adjusted to pH 7.2
MRS-LA pH 3.8/
MRSL-LA pH 3.8
S. Typhimurium SL1344 nalr culture in LB-G (105 cfu/ml) with 10% (v/v) MRS
or MRSL broth containing lactic acid, adjusted to pH 3.8
MRS-LA pH 4.5/
MRSL-LA pH 4.5
S. Typhimurium SL1344 nalr culture in LB-G (105 cfu/ml) with 10% (v/v) MRS
or MRSL broth containing lactic acid, adjusted to pH 4.5
MRS-LA pH 7.2/
MRSL-LA pH 7.2
S. Typhimurium SL1344 nalr culture in LB-G (105 cfu/ml) with 10% (v/v) MRS
or MRSL broth containing lactic acid, adjusted to pH 7.2
CFS pH 3.8/
CFSL pH 3.8
S. Typhimurium SL1344 nalr culture in LB-G (105 cfu/ml) with 10% (v/v)
L. plantarum CSF or CFSL, at pH 3.8
CFS pH 4.5/
CFSL pH 4.5
S. Typhimurium SL1344 nalr culture in LB-G (105 cfu/ml) with 10% (v/v)
L. plantarum CSF or CFSL, adjusted to pH 4.5
CFS pH 7.2/
CFSL pH 7.2
S. Typhimurium SL1344 nalr culture in LB-G (105 cfu/ml) with 10% (v/v)
L. plantarum CSF or CFSL, adjusted to pH 7.2
2.1.9 Carbohydrate growth assay
Evaluation of S. Typhimurium SL1344 nalr growth was monitored in minimal
medium (MM) and standard LB-G medium supplemented accordingly with 1% (w/v)
Chapter 2
56
of lactulose ((LAC, 4-O-β-D-galactopyranosyl- D-fructose) (Sigma-Aldrich)), FOS
(Raftilose® P95, Tienen, Belgium) and GOS mixture (Bimuno®, Clasado). Control
medium was included containing 1% (w/v) glucose. MM or LB-G medium containing
respective carbohydrates was added to standardise the OD readings. For the assay S.
Typhimurium SL1344 nalr was cultured as described in section 2.1.1 in LB-G,
centrifuged for 10 minutes and supernatant decanted. The pellet was washed in 0.1M
PBS (pH 7.2) and resuspended at 1:1000 dilution in the respective test medium. For
each condition, 200 µl of the re-suspended culture was dispensed into a 96-well micro-
titre plate (Iwaki, SLS) and respective un-inoculated test medium was included as a
blank standard for each condition. Plates were incubated at 37°C an optical density
(OD) of 600nm was read every 15 minutes for 24 hours using FLUOstar OPTIMA
(BMG LABTECH). Assays were conducted in triplicate on three separate occasions.
For analysis the mean OD values were used and area under the curve (AUC) calculated
using GraphPad Prism® version 5 program (GraphPad Software, LaJolla, CA, USA).
In addition the growth response on each prebiotic was calculated as described below.
Lactobacillus isolates ability to utilise prebiotics was tested subsequently as
described above in carbohydrate-free basal MRS medium (Saarela et al., 2003)
consisting of the following components (g/l): peptone from casein (10.0), yeast extract
(5.0), K2HPO4×3H2O (2.0), Na-acetate×3H2O (5.0), (NH4)3C6H5O7×2H2O (2.0),
MgSO4×7H2O (0.2), MnSO4×3H2O (0.05) and Tween 80 (1ml).
For analysis, in addition to AUC calculations the growth of particular Lactobacillus
isolate on each prebiotic relative to its growth on glucose was calculated over 24 hours
using method given below, according to Kneifel et al. (2000):
Growth response = (mean values on tested prebiotic calculated from all OD
readings / mean OD values of the same isolate grown in the basal medium containing
glucose) × 100%
Additionally, the specific growth rate for lactobacilli on each prebiotic was calculated
using formula according to Saminathan et al. (2011):
Growth rate (µ) = (ln x – ln x0) / (t – t0)
where:
x and x0 are absorbances measured within exponential phase of growth
t and t0 respective to the absorbance times
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2.1.10 Acid tolerance
The acid tolerance test was conducted as described previously (Hyronimus et al.,
2000) with slight modifications. L. plantarum B2028 was cultured in MRS broth,
centrifuged at 2447 x g for 10 minutes and supernatant decanted. The pellet was
washed in 0.1M PBS (pH 7.2) and the culture subsequently diluted (1:1000) in 0.1M
PBS adjusted to pH 2.0, 2.5, 3.0 and non-adjusted PBS (pH 7.2) as a control. Samples
were incubated microaerophilically at 37°C for 3 and 6 hours. Viable counts of
bacteria were determined using Miles and Misra method (Miles et al., 1983), serially
diluted culture was plated onto MRS agar. Plates were incubated for 48 hours and
counted. The log reduction was calculated as shown below:
Log reduction = log10 N0 – log10 Nt
where:
N0 – number of viable cells at time point 0
Nt – number of viable cells at respective time after treatment
2.1.11 Bile tolerance
The ability of the probiotic candidate L. plantarum B2028 to survive in the
presence of bile was assessed using Oxgall bile salt (Sigma-Aldrich) and freshly
collected native porcine bile, using method adapted from Gilliland et al. (1984) with
slight modifications. Porcine bile was collected from the gall bladder of a healthy pig,
filter sterilized and used in concentrations as described further. Briefly, for the bile
tolerance assay L. plantarum B2028 was cultured in MRS broth as described
previously in section 2.1.1. Subsequently, MRS broth containing 0.3% or 0.6% (w/v)
oxgall and 0.3%, 0.6% and 0.9% (v/v) porcine bile was inoculated with 106 cfu/ml of
test isolate. MRS inoculated with L. plantarum B2028 culture but without addition of
bile was used as positive growth control. For each condition, 200 µl of the re-
suspended culture was transferred into a 96-well micro-titre plate (Iwaki, SLS) and
respective un-inoculated MRS broth was included as a blank standard for each
condition. Plates were incubated at 37°C an optical density (OD) of 600nm was read
every 15 minutes for 24 hours using FLUOstar OPTIMA (BMG LABTECH). Assays
were conducted in triplicate on three separate occasions.
Growth curves were plotted and analysis followed the principles described by
Chateau et al. (1994) and based on the time necessary for each condition to reach an
0.3 unit at 600nm, and the difference (delay of growth) (d) between the growth control
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and test conditions. This delay of growth (minutes) was used as a measure of the
inhibitory effect of bile on tested isolate and to classify the isolates onto four following
groups: resistant (d ≤ 15 min), tolerant (15 < d ≤ 40 min), weakly tolerant (40 < d < 60
min) and sensitive (d ≥ 60 min).
2.1.12 Bile Salt Hydrolase (BSH) activity
BSH activity of the L. plantarum B2028 was evaluated using the method
described by du Toit et al. (1998). Modified MRS plates were prepared by adding
0.5% (w/v) of taurodeoxycholic acid (TCDA), (Sigma-Aldrich) and 0.37g/l CaCl2 to
MRS agar. To perform the assays sterile filter disks were impregnated in an overnight
culture of L. plantarum and placed onto the MRS plates. An MRS agar plate without
TCDA supplementation was used as a control. The plates were incubated anaerobically
at 37°C for 72 hours. Positive result for BSH activity was recorded when the
taurodeoxycholic acid precipitated in the agar medium below and around the disc. The
test was performed in triplicate on three separate occasions.
2.1.13 Antimicrobial susceptibility testing
For determining the minimum inhibitory concentration (MIC) of various
antimicrobials for L. plantarum B2028 the broth microdilution method was used as
recommended by EFSA (2008). For MICs LAB susceptibility test medium (LSM)
consisting of a mixture of 90% Iso-Sensitest (ITS) broth and 10% MRS broth (pH 6.7)
was used, as it fully supports lactobacilli growth and has no interaction with the
antimicrobials tested (Klare et al., 2005; Klare et al., 2007). The following
antimicrobials were obtained from Sigma-Aldrich and tested in the concentration
ranges (ng/ µl): ampicillin, gentamicin, erythromycin and clindamycin (0.06-128) and
streptomycin, kanamycin, chloramphenicol, tetracycline and vancomycin (1-256).
Stock solutions of the antibiotics were prepared at twice the final concentration and
filtered through 0.22 µm filter. Double strength concentration of the antibiotic was
added to the first well and then the solution was double diluted into LSM medium. The
control strain used for this assay was E. faecalis ATCC 29212 and for this strain the
MIC’s breakpoints were recommended by British Society for Antimicrobial
Chemotherapy (BSAC). Antibiotic suspensions without the cell suspension were
included as a negative control.
Briefly, L. plantarum B2028 was grown on MRS agar, whereas E. faecalis ATCC
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29212 was grown on LB-G agar. Subsequently, fresh bacterial cells were taken off a
plate using a sterile cotton swab and transferred to approximately 3 ml of 0.1M PBS
(pH 7.2) to obtain turbidity equal to McFarland 1.0. A further 10 µl of the cell
suspension was added to a volume of 1 ml in 24-well plate (Nunc) containing the test
antibiotic dilutions. Plates were incubated at 37°C for 24 hours and MICs were
recorded as the lowest antibiotic concentration to inhibit growth of the test organism.
The assay was performed in duplicate on two separate occasions.
2.1.14 Porcine batch culture fermentation system
Batch culture fermentation system was set up according to previously published
methodology (Sarbini et al., 2011; Saulnier et al., 2008) with slight modifications to
mimic the conditions of a porcine distal colon (Martin-Pelaez et al., 2008). Two
experiments were carried out, firstly for studies described in Chapter 3, system was
inoculated with each of the following the substrates: lactulose (LAC) (Sigma-Aldrich)
and FOS (Raftilose® P95, Tienen, Belgium). Where synbiotic was included, L.
plantarum B2028 was used in addition to each prebiotic. In subsequent studies
described in Chapter 5, batch culture system was inoculated with S. Typhimurium
SL1344nalr in addition to L. plantarum B2028 and LAC. To prepare porcine faecal
slurry, porcine faecal samples were collected from Salmonella-free pigs (confirmed by
bacteriology) (AHVLA) and immediately placed in an anaerobic jar and the samples
were transported to the lab and used within maximum of 1-2 hours. Faecal samples
were diluted with 0.1M PBS (pH 7.2) and homogenized in a stomacher (Stomacher
400, Seward) to yield 10 % (w/v) faecal slurry. Porcine faecal samples were confirmed
to be Salmonella-free by direct plating out of serial dilutions onto BGA and further
enrichment (see section 2.6.5).
Briefly, sterile stirred batch culture fermentation vessels were assembled and
aseptically filled with sterile basal nutrient medium (135 ml each). The basal medium
consisted of the following components (g/l): peptone water (2.0), yeast extract (2.0),
NaCl (0.1), K2HPO4 (0.04), MgSO47H20 (0.04), CaCl26H20 (0.01), Tween 80 (1 ml),
NaHC03 (2.0), hemin (0.05), vitamin K (10 µl), cysteine HCl (0.5), bile salts (0.5). The
medium was gassed overnight with oxygen-free nitrogen (15 ml/min). Subsequently,
glass vessels were inoculated with 15 ml of freshly prepared porcine faecal slurry (see
above) and for preliminary studies appropriately labeled vessels were consequently
inoculated with 1% (w/v) of respective prebiotic (LAC and FOS) and in vessels with
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the synbiotic combination, an overnight culture (approx. 109 cfu/ml) of L. plantarum
B2028 was added 1% (v/v). Vessel containing no pre or synbiotic was included as a
control. The temperature in the vessels was maintained at the 37°C using a circulating
water bath and to mimic conditions of a pig’s large intestine, the pH was maintained
between the ranges 6.4 - 6.6 using 0.5M NaOH and HCl.
Samples (3 ml from each vessel) were collected at time points: 0, 5, 10 and 24
hours post inoculation and stored accordingly for further analysis, namely for
fluorescent in situ hybridisation (FISH) and for lactic acid and short chain fatty acids
(SCFA) analysis. For FISH analysis, samples (375 µl) were fixed in (1125 µl) of ice-
cold 4% (w/v) paraformaldehyde for 4-6 hours (4°C). Subsequently, samples were
centrifuged at 10 000 × g for 5 minutes, washed twice with 0.1M PBS (pH 7.2) and the
pellet was resuspended in 300 µl PBS/ethanol (50:50). Samples were thoroughly
mixed by vortexing and stored at -20°C until required. For SCFA collected from each
time point, samples (1 ml) were centrifuged at 10 000 × g for 10 minutes, supernatants
were filter sterilized using 0.22 µm filter (Satorius Stedim Biotech) and stored at -20°C
until required. The pellets were resuspended in PBS/glycerol (50:50) and stored at -
20°C until required. All samples were prepared in duplicates.
During the subsequent study, an appropriately prepared system (see above) was
inoculated with 1% (v/v) of an overnight culture (approx. 109 cfu/ml) of S.
Typhimurium SL1344nalr and in addition each vessel was inoculated with LAC, L.
plantarum B2028, L. plantarum B2028 and LAC as described above. Assays were
performed in duplicate on two separate occasions.
2.2 Molecular biology methods
2.2.1 DNA extraction
2.2.1.1 CTAB method
The cetyltrimethylammonium bromide (CTAB) method was used to obtain
genomic DNA from pure cultures of lactobacilli and Salmonella. All reagents unless
indicated otherwise were purchased from Sigma-Aldrich. Salmonella and lactobacilli
culture was grown in LB-G and MRS broth respectively. Bacterial pellets were
prepared by growth in broth culture followed by centrifugation at 4000 × g for 10
minutes, washing in 0.1M PBS (pH 7.2) and resuspension in 400 µl 1x Tris-ethylene-
diamine tetra-acetic acid (EDTA) (TE) buffer (pH 8.0). In circumstances when DNA
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was isolated from bacterial growth on agar plates, a bacterial suspension was prepared
in 0.1M PBS (pH 7.2) and the bacterial pellet prepared as described above. An
additional step was included for DNA isolation from lactobacilli with lysozyme, 20
mg/ml, added to TE buffer and incubated at 37°C for 60 minutes. Subsequently, the
cells were lysed by the addition of 70 µl 10% (w/v) sodium dodecyl sulphate (SDS)
and 70 µl of 20 mg/ml proteinase K and incubation at 55°C for 60 minutes. RNase (10
mg/ml) was added to remove RNA and samples were incubated at 37°C for 30
minutes. Subsequently, 100 µl 5 M NaCl and 80 µl of pre-warmed CTAB in 0.7 M
NaCl were added and samples were incubated at 55°C for further 10 minutes.
Following incubation, 750 µl chloroform/isoamyl alcohol (24:1) was added and
samples were centrifuged at (16 000 × g) for 5 minutes. The aqueous phase was gently
removed and transferred to clean phase lock tube (Eppendorf) and the wash step was
repeated twice. Finally, the upper aqueous phase was transferred to a sterile
microcentrifuge tube and 400 µl isopropanol was added to precipitate the DNA.
Samples were left at -20°C for a minimum of 30 minutes and then centrifuged for 10
minutes (1600 × g) and the DNA pellet was washed with 500 µl 70% cold ethanol.
Samples were subsequently centrifuged and supernatant discarded. The DNA pellet
was air-dried and resuspended in 50 µl nuclease-free water (Ambion). DNA quantity
and purity was determined using a NanoDrop™ spectrophotometer (Thermo
Scientific) and 5 µl of the sample was run on 1% agarose gel for visualisation after
EtBr staining. Aliquots were stored at - 20°C.
2.2.1.2 Bacterial DNA extraction from porcine batch culture samples
Bacterial DNA from porcine batch culture samples was extracted using a method
provided by Dr Adele Costabile, University of Reading (personal communication). All
reagents unless indicated otherwise were purchased from Sigma-Aldrich. Following
collection, batch culture samples were centrifuged (16 000 × g) for 10 minutes and
obtained pellet was stored in 50% (v/v) glycerol/0.1M PBS (pH 7.2) suspension at -
20°C until DNA extraction was performed. Cells were harvested from the suspension
at 16 000 × g for 5 minutes, washed once with 0.1M PBS (pH 7.2) and centrifuged
again. Subsequently, the pellet was resuspended in 500 µl of TES buffer (pH 8.0)
containing 8 µl 10 mg/ml lysozyme and 2 µl 1mg/ml mutanolysin and incubated at
37°C for 30 minutes. A 10 µl proteinase K (20 mg/ml) and 10 µl RNase (10 mg/ml)
was added and the suspension was incubated at 65°C for 60 minutes. Then, 100 µl
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10% (w/v) SDS was added to the samples and incubated for further 15 minutes after
which samples were placed on ice for a minimum of 30 minutes. Subsequently, 620 µl
phenol/chloroform/water (Applied Biosciences) was added to each sample, contents
were mixed by inversion for at least 2 minutes and centrifuged at 4000 × g for 10
minutes. The upper aqueous layer was transferred to a sterile microcentrifuge tube and
1 ml of ice-cold ethanol was added. The suspension was mixed by inversion and left at
-20°C overnight. Samples were subsequently centrifuged and the supernatant
discarded. The DNA pellet was air-dried and resuspended in 50 µl nuclease-free water
(Ambion). DNA quantity and purity was determined as described above.
2.2.1.3 Bacterial DNA extraction from porcine faecal samples
Freshly collected porcine faecal samples were stored at -20°C until further
analysis. After thawing at room temperature, bacterial DNA was extracted using the
QIamp DNA Stool Mini Kit (Qiagen, UK) according to the manufacturer’s
instructions. All reagents unless indicated otherwise were included in the extraction
kit. Briefly, for the extraction 180-220 mg faecal sample was used, immediately mixed
with ASL buffer and incubated at 90°C for 5 minutes. Following the lysis step,
samples were incubated with the addition of lysozyme (20 mg/ml) (Sigma-Aldrich) at
37°C for 60 minutes. Subsequently, samples were centrifuged at 16 000 × g for 60
seconds and supernatant was transferred to a new microcentrifuge tube. To remove
PCR inhibitors present within the sample, an InhibitiEX tablet was added to each of
the samples and treated according to the manufactures instructions. The supernatant
was transferred to a new microcentrifuge tube containing proteinase K, subsequently
lysis buffer AL was added, vortexed and incubated at 70°C for 10 minutes. Ethanol
(100 % (v/v)) was added to the lysate, applied to Qiamp spin column and centrifuged
(16 000 × g) for 60 seconds after which the spin column was placed in a new
collection tube. Following a series of washes using buffer AW1 and AW2 the spin
column was transferred to a new microcentrifuge tube and the bound DNA was eluted
using 50 µl of an elution buffer AE. DNA quantity and purity was determined as
described above.
2.2.2 Polymerase Chain Reaction (PCR)
2.2.2.1 Standard PCR
Amplification of a target DNA sequence was performed by PCR (Saiki et al.,
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1988) with a final reaction volume of 50 µl. The PCR reaction consisted of 25 µl
HotStarTaq® DNA polymerase Master Mix (Qiagen), 1 µl of each forward and reverse
primer (20 pmol/µl) (Sigma-Aldrich), 1 µl of genomic DNA (20-50 ng/µl) and made
up to 50 µl using distilled water. PCR amplifications were performed using
GeneAmp® PCR system 9700 thermal cycler (Applied Biosystems) and as follows: 1
cycle at 95°C for 15 minutes (initial denaturation), then 30 cycles consisting of
denaturation at 95°C for 60 seconds, annealing (50-65°C) for 60 seconds, extension at
72°C for 60 seconds and final extension at 72°C for 10 minutes.
2.2.2.2 Multiplex PCR
Multiplex PCR was used for Lactobacillus species identification according to
Kwon et al. (2004). Briefly, the PCR reaction with the final volume of 50 µl consisted
of 25 µl HotStarTaq® DNA polymerase Master Mix (Qiagen), primers as outlined in a
Table 2.2 (20 pmol each), genomic DNA template (20-50 ng/µl) and distilled water up
to the final volume. PCR amplifications were performed on a thermal cycler (see
above) and as follows: 1 cycle at 95°C for 15 minutes (initial denaturation), then 35
cycles consisting of denaturation at 95°C for 30 seconds, annealing at 56°C for 30
seconds, extension at 72°C for 30 seconds and final extension at 72°C for 7 minutes.
2.2.3 PCR product purification
PCR products were purified using QIAquick® purification kit (Qiagen) according
to the manufacturer’s instructions. All reagents unless indicated otherwise were
included in the extraction kit. Briefly, five volumes of the binding buffer PB were
added to one volume of the PCR product and transferred to a QIAquick spin column.
The column was centrifuged (16 000 × g) for 60 seconds and the flow-through was
discarded. Following a wash step using the PE buffer to remove salts, column was
placed in a clean microcentrifuge tube and DNA eluted with 30 µl EB buffer (elution
buffer). If necessary, the PCR products were stored at -20°C until further use.
2.2.4 Gel electrophoresis
Agarose gel (1% or 2% (w/v)) was prepared in Tris-Acetate-EDTA buffer (TAE)
(pH 8.0) (Sigma-Aldrich) and placed in Sub-Cell tank (Bio-Rad), sunken in TAE
buffer. To each gel well, 5 µl sample and 1 µl DNA loading buffer (6×) (Promega) was
loaded. A 1 Kb or 100 bp DNA molecular marker ladder (Promega) was run each time.
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Running conditions were 75 volts for approximately 60 minutes. The gel was stained
in 1µg/ml ethidium bromide solution (Sigma-Aldrich) for approximately 30 minutes
and de-stained in distilled water. DNA was visualized under ultra-violet light using the
GeneGenius gel imaging system.
Table 2.2 Multiplex PCR primes used in this studies (Kwon et al., 2004).
Target species Primer Sequence (5' to 3') Target
sitea
Product
(bp)b
Lactobacillusc IDL03R CCACCTTCCTCCGGTTTGTCA 1178-1198 -
Lactobacillusc IDL04F AGGGTGAAGTCGTAACAAGTAGCC 1499-1522 -
L.casei groupd IDL11F TGGTCGGCAGAGTAACTGTTGTCG 427-495 727
L. acidophilus IDL22R AACTATCGCTTACGCTACCACTTTGC 2079-2104 606
L. delbrueckii IDL31F CTGTGCTACACCTAGAGATAGGTGG 1015-1039 184
L. gasseri IDL42R ATTTCAAGTTGAGTCTCTCTCTC 1748-1770 272
L. reuteri IDL52R ACCTGATTGACGATGGATCACCAGT 94-118 1105
L. plantarum IDL62R CTAGTGGTAACAGTTGATTAAAACTGC 1900-1926 428
L. rhamnosus IDL73R GCCAACAAGCTATGTGTTCGCTTGC 1922-1946 448
a All Lactobacillus - target site indicates the start and end point of the complimentary sequences
annealing the forward and reverse primer, respectively.
b Approximated length of each PCR product derived from primer pair composed of species-specific
primer and bacterial conserved primer (IDLC3R or IDLC4F).
c All Lactobacillus spp.
d L. casei group includes all of L. casei-related Lactobacillus species such as L. casei and L. rhamnosus.
Table adapted from Kwon et al. (2004).
2.2.5 16S rRNA gene sequencing
Lactobacillus DNA was extracted as described previously in section 2.2.1.1 and
the 16S rRNA gene was amplified using PCR primers 63F and 1387R (Marchesi et al.,
1998) (Table 2.3). The resulting PCR product (1324 bp) was visualized as described
above and subsequently was sent to Central Sequencing Unit (CSU) (AHVLA,
Weybridge, UK), where the sequencing was performed. The BigDye® Terminator v3.1
Cycle Sequencing kit (Applied Biosystems) was used according to the manufacturer’s
instructions and the sequencing was carried out on 3130xl Genetic Analyzer (Applied
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Biosystems) with a 50 cm capillary length. The PCR parameters were as follows: 25
cycles of 96°C for 10 seconds, 50°C for 5 seconds and 60°C for 2 minutes.
Obtained from CSU sequence traces were analysed and edited in SeqMan
(DNAstar, Lasergene) and the consensus sequences were saved in EditSeq (DNAstar,
Lasergene). Subsequently, Basic Local Alignment Search Tool (BLAST) was used to
carry out homology searches (Altschul et al., 1990) against National Centre for
Biotechnology Information (NCBI) website.
Table 2.3 PCR primers used to amplify 1342 bp product of 16S rRNA gene (Marchesi
et al., 1998).
Primer Sequence (5' to 3')
63F CAGGCCTA ACACATGCAAGTC
1387R GGGCGGWGTGTACAAGGC
2.2.6 Gram-positive antimicrobial resistance array
To determine the presence antimicrobial resistance genes in the potential probiotic
strain, the Indentibac AMR+ve™ microarray was employed (Perreten et al., 2005) and
used according to the manufacturer’s instructions. L. plantarum B2028 genomic DNA
was isolated using the CTAB method. E. faecium SF11770 was used as the control for
the Gram positive AMR. Genomic DNA was labeled using a randomly primed
polymerization reaction (Bohlander et al., 1992; Perreten et al., 2005). PCR consisted
of two rounds (A and B) and primers are showed in Table 2.4. Briefly, in round A the
DNA (10-100 ng) was denatured, with Sequenase (5×) buffer and primer A (40 pmol)
for 2 minutes at 94°C. Subsequently, during a cooling step at 10°C (5 minutes) mixture
consisting of: (Sequenase buffer (5×), deoxyribonucleotide triphosphates dNTPs,
dithiothreitol (DTT), bovine serum albumin (BSA), Sequenase and water was added to
each sample. Samples were subjected to temperature ramping from 10°C to 37°C, at
37°C for 8 minutes, at 94°C for 2 minutes, at 10°C for 5 minutes. During this last step
a Sequenase buffer (1:4 diluted) was added to the sample and again subjected to
temperature ramping from 10°C to37°C and at 37°C for 8 minutes. The product from
round A was mixed with sterile water and 7.5 µl was added to master mix (Quiagen
buffer (10×), dNTPs, biotin-16-deoxyuridine triphosphate (dUTP), MgCl2, primer B
(100 pmol), Taq polymerase and water). Samples were amplified in thermal cycler
Chapter 2
66
with the following conditions: 35 cycles of 94°C for 30 seconds, 40°C for 30 seconds,
50°C for 30 seconds, 72°C for 2 minutes, 4°C hold).
Table 2.4 Primers used in AMR+ve™ Gram positive microarray.
Primer Sequence (5' to 3')
Primer A GTTTCCCAGTCAGCATCNNNNNNNNN
Primer B GTTTCCCAGTCACGATC
PCR product from round B was run on a 1% agarose gel to ensure successful
amplification and 10 µl volume was used for the array. Briefly, before sample
application the microarray tubes were washed with hybridization buffer and incubated
at 30°C with shaking at 550 rpm for 5 minutes. A mix of PCR product and
hybridization buffer was incubated at 95°C for 5 minutes, cooled down and transferred
to the microarray tube. Tubes were incubated at 60°C with shaking at 550 rpm for 60
minutes and afterwards were washed three times with appropriate washing buffer. First
wash was carried out at 30°C with shaking at 550 rpm for 5 minutes, and subsequent
two washes at 20°C. Subsequently, microarray tubes were blocked with freshly
prepared blocking solution (containing 2% (w/v) milk powder) at 30°C with shaking at
550 rpm for 15 minutes and diluted streptavidin-conjugated horseradish peroxidase
(Poly-HRP Streptavidin) was added to the sample and incubated at 30°C for 15
minutes. This was then followed by a series of three washes at 30°C with shaking at
and 550 rpm for 5 minutes. Subsequently, a 3',5,5'-tetramethylbenzidine (TMB) analog
(SeramunGrün®, Seramun Diagnostica) was added to each array tube, incubated at the
room temperature 10-15 minutes and the array was imaged using a tube reader
(Clondiag). Data were analysed using Iconoclust software (Clondiag), which measures
the signal intensity and the background for each spot on the array. AMR analyses were
performed in duplicate.
2.2.7 Fluorescent in situ Hybridization
Fluorescent in situ Hybridization (FISH) using 16S rRNA oligonucleotide probes
was performed accordingly to the previously described method (Daims et al., 2005).
Specific probes (Table 2.5) for bifidobacteria, lactobacilli/enterococci and Salmonella
were used to enumerate bacteria of interest. Total bacterial counts were obtained with
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nucleic acid stain 4′6-diamidino-2-phenylindole (DAPI). Briefly, faecal slurry samples
were collected from batch culture at 0, 5, 10 and 24 hours post inoculation and fixed in
ice-cold 4% (w/v) paraformaldehyde for 4-6 hours at 4°C. Subsequently, samples were
centrifuged at (16 000 × g) for 5 minutes, washed twice with 0.1M PBS (pH 7.2) and
pellet was resuspended in 300 µl PBS/ethanol (50:50). Samples were mixed by
vortexing and stored at -20°C until required. For hybridization, samples were diluted in
PBS/SDS and a 20 µl aliquot of the diluted sample was pipetted onto Teflon- and poly-
L-lysine- coated, six well slides (Tekdon Inc.). Samples were dried at 46°C for 15
minutes and then dehydrated in ethanol using 50%, 80% and 96% (v/v) concentrations
(3 minutes in each). Following dehydration samples were again dried at 46°C to allow
evaporation of alcohol. For the detection of lactobacilli/enterococci (probe Lab158), a
5 µl of lysozyme was applied to each well and left for 15 minutes at 37°C; washed
briefly in water and dehydrated in a alcohol series as described above. A 50 µl mixture
containing 5 µl of the probe and 45 µl of the hybridization buffer (HB) was applied
onto each well and hybridization was performed for 4 hours using ISO20 oven (Grant
Boekel). Following hybridization, slides were transferred into 50 ml wash buffer
containing 20 µl DAPI and incubated in a water bath for 15 minutes. Slides were then
washed in ice-cold water, dried under compressed air and 5 µl of anti-fade reagent was
added to each well. The coverslips were applied and the slides were stored at 4°C until
required. Slides were examined under an epifluoresce microscope (Eclipse 400; Nikon,
Surrey, United Kingdom).
Bacteria were enumerated according to the following equation:
DF × ACC × 6732.42 × 50 × DF sample
where:
DF is the dilution factor, ACC is the average cells count of 15 fields of view, 6732.42
number is the area of the well divided by the area of the field of view, 50 is the factor
that reverts the cell count to per milliliter of sample, DF sample is the dilution of
sample according to the used probe or stain.
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Table 2.5 16S rRNA oligonucleotide probes used for bacterial enumeration.
Probe name Sequence (5' to 3')
Short Full name
Bif164a S-G-Bif-0164-a-A-18 CATCCGGCATTACCACCC
Lab158b† S-G-Lab-0158-a-A-20 GGTATTAGCAYCTGTTTCCA
Sal303c L-S-Sal-1713-a-A-18 AATCACTTCACCTACGTG
a Target species: Most Bifidobacterium spp. and Parascardovia dendicolens (Langendijk et al., 1995)
b Target species: Most Lactobacillus, Leuconostoc and Weissella spp.; Lactococcus lactis; all
Vagococcus, Enterococcus, Melisococcus, Tetragenococcus, Catellicoccus, Pediococcus and
Paralactobacillus spp. (Harmsen et al., 1999).
c Target species: Different serovars of Salmonella spp. (Nordentoft et al., 1997).
† Requires lysozyme treatment.
Table adapted from Martin-Pealez et al. (2008).
2.3 Mass spectrometry methods
2.3.1 Matrix-assisted laser desorption ionization time-of-flight mass spectrometry
(MALDI-ToF)
Lactobacillus strains were grown on MRS agar as described in section 2.1.1 and
fresh overnight culture was used for preparation of samples for MALDI ToF analysis.
Method of Mellmann et al. (2008) was followed for sample preparation. Briefly,
approximately 1 inoculation loop of fresh bacterial culture was resuspended in 300 µl
water and 900 µl of ethanol. Samples were centrifuged at 13 000 × g and supernatant
was decanted. To extract the cells, 50 μl of 70% formic acid (in water) was added to
the bacterial pellet, sample was mixed thoroughly after which 50 μl of acetonitrile was
added. Samples were again centrifuged at 13 000 × g for 2 minutes and 1 μl of
obtained supernatant was transferred onto wells on a steel MALDI target plate.
Supernatants were allowed to dry at room temperature and subsequently overlaid with
1.5 μl saturated solution of α-cyano-4-hydroxy-cinnamic acid in 50% acetonitrile-2.5%
trifluoroacetic acid mixture (MALDI matrix) and samples were left to dry. Samples
were analysed using Bruker Autoflex 2 MALDI-ToF machine (Bruker, Daltonics). The
main spectral projection (MSP) spectra were processed with BioTyper software
(Bruker, Daltonics) based on a comparison with the BioTyper reference library of
MALDI-TOF mass spectra. Sample identification was based on two technical repeats.
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2.4 Chromatography methods
2.4.1 High-performance liquid chromatography (HPLC)
SCFA analysis of lactobacilli CFS’s and of batch culture samples were
performed using an HPLC system and as described previously (Sarbini et al., 2011).
Briefly, lactobacilli cultures and batch culture samples (section 2.1.14) were
centrifuged for 10 minutes at (13 000 × g), supernatants were filter sterilized using
0.22 µm polycarbonate syringe filter and analysed using a HPLC system (LaChrom
Merck Hitachi, Poole, Dorset, UK). System was equipped with a pump (L-7100), a
refractive index detector (L-7490), and an autosampler (L-7200). For the separation of
organic acids the ion-exclusion REZEX ROA-Organic acid column was used
(Phenomenex Inc.). During the separation of organic acids the temperature was
maintained at 85°C. The eluent used in the system was degassed sulphuric acid diluted
in the HPLC-grade H2O (0.0025 mmol/L); the flow rate was maintained at 0.5 ml/min.
Standards for lactic, acetic, propionic, butyric, isobutyric, valeric and isovaleric acids
were used at the following concentrations 12.5 mM, 25 mM, 50 mM, 75 mM, and 100
mM. Quantification of the samples was gained through calibration of the standards
curves and results were the average from three replicates.
2.5 In vitro methods
2.5.1 Porcine intestinal epithelial cell line (IPEC-J2)
2.5.1.1 IPEC-J2 monolayers
IPEC-J2 cell line (derived from jejunum of an un-suckled 1-day old piglet) when
used as monolayers were maintained according to Schierack et al. (2006). All reagents
unless indicated otherwise were purchased from Sigma-Aldrich. Briefly, cells were
cultured in a mixture of DMEM/Ham’s F12 (1:1) medium supplemented with 5% (v/v)
foetal calf serum (FCS), ITS media supplement (5 µg/ml insulin, 5 µg/ml transferrin, 5
ng/ml sodium selenite), 5 ng/ml epidermal growth factor, 1% (v/v) non-essential
amino acids, 1% (v/v) L-glutamine and gentamycin (50 µg/ml), hereafter referred as
IPEC-J2 medium. Cells were maintained in a 5% CO2 atmosphere.
For experiments cells were seeded in 24-well plates (Nunc) at a density of 2 × 105 cells
per well and grown to confluent monolayers. During the assays cells were maintained
in IPEC-J2 depleted of antibiotics.
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2.5.1.2 Three-dimensional IPEC-J2 model
The porcine jejunal 3D cell culture model was based upon the previous methods,
(Nickerson et al., 2001; Searle et al., 2010) and Dr J. W. Collins personal
communication. For the 3D cell model standard IPEC-J2 medium was additionally
supplemented with glucose, galactose and fructose (1 g/l, 0.25 g/l, 0.13 g/l) (Goodwin
et al., 1993). IPEC-J2 monolayers were cultured as described above, in tissue culture
flask. Cells were washed with Hank’s balanced salt solution (HBSS) and detached
using 0.25% trypsin for 5 minutes. Subsequently, fresh medium was added to remove
trypsin, cells were centrifuged and then resuspended in a complete fresh IPEC-J2-3D
medium to yield 2 × 105 cells/ml. Cell suspensions were mixed with 5mg/ml
Cytodex™ microcarrier beads (Cytodex-3, size 133-225 µm) in a 50 ml Corning®
centrifuge tube. Before use microcarrier beads were hydrated in 0.1M PBS (pH 7.2)
and autoclaved according to supplier instructions. In order to facilitate the initial cell-
bead attachment, suspensions were incubated at 37°C, 5% CO2 for approximately 30
minutes. Subsequently, cell suspensions were introduced to the 50 ml rotating wall
vessel (RWV) (Synthecon), air bubbles removed and cultured at a rotation starting at
13.7 rpm to maintain the cell-bead aggregates in the suspension. Cells were incubated
for two days without media change to allow further attachment of cells. Circa 80% of
the medium was replenished every second day and rotation was gradually increased
over time as necessary. Cells were cultured in RWV (37°C, 5% CO2) for 20-22 days.
Following this time (day of the assay) cells were removed from the RWV, resuspended
in IPEC-J medium (without antibiotics) to yield 5 × 105 cells/ml of suspension. To
obtain the cell number in 1 ml, the cell aggregate suspensions were trypsinized and
passed through a 70 µm sieve in order to separate them from the microcarrier beads.
Following separation from the microcarrier bead fresh IPEC-J2 medium was added
and cells were counted using a haemocytometer. For experiments cell aggregates were
seeded into 1.5 ml centrifuge tubes.
2.5.2 L. plantarum B2028 and lactulose adherence assay.
Adhesion assay was performed as previously described (Dibb-Fuller et al., 1999)
with slight modifications. Briefly, L. plantarum B2028 inocula were prepared by
centrifugation (2447 × g) for 10 minutes, the supernatant was decanted, the pellet
washed in 0.1M PBS (pH 7.2) and resuspended in IPEC-J2 medium to yield 5 × 107
cfu/ml. Cell-free supernatants were prepared by filter sterilization as described in
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section 2.1.8. Cells were washed twice with Hank’s balanced salt solution (HBSS) and
1 ml of the bacterial inoculum containing accordingly: L. plantarum B2028, L.
plantarum B2028 + 1% (w/v) LAC, both cultured in standard MRS and L. plantarum
B2028 cultured in MRSL (with 1% (w/v) LAC) was added to a 24-well plate. Wells
containing IPEC-J2 medium only were included as a control conditions. Plates were
incubated at 37°C and in the presence of 5% CO2 for up to 2 hours. Subsequently, cells
were washed three times with HBSS, disrupted with 1% Triton X-100 (Sigma-Aldrich)
and mechanical stirring. Serially diluted cell suspensions (100 – 106) were plated onto
MRS agar and incubated microaerophilically at 37°C for 24 hours.
2.5.3 S. Typhimurium viability and inhibition of invasion assay
To evaluate the effect of pre-treatment with L. plantarum B2028 supernatant on S.
Typhimurium SL1344nalr viability and invasion, a previously described method was
followed (Coconnier et al., 1997; Makras et al., 2006). Briefly, S. Typhimurium
SL1344nalr cells (108 cfu/ml) were co-incubated with IPEC-J2 medium containing
10% (v/v) of L. plantarum B2028 cell-free CFS’s (CFS/CFSL), pH control medium
(MRS/MRSL) and lactic acid control medium (MRS-LA/MRSL-LA) at pH 3.8 and
prepared as described previously in section 2.1.8. S. Typhimurium SL1344nalr cells
incubated in IPEC-J2 medium only and medium without bacterial inoculum added
were included as controls. Following 1 hour incubation at 37°C serially diluted cell
suspensions (100 – 107) were plated onto LB-G agar for enumeration. Subsequently, S.
Typhimurium SL1344nalr cells were washed in 0.1M PBS (pH 7.2) and resuspended in
IPEC-J2 medium to yield 5 × 107 cfu/ml and the invasion assay was conducted as
described below for competition assays (section 2.5.4).
2.5.4 Competition assays using IPEC-J2 monolayers and 3D model
Competition assays were performed as previously described (Dibb-Fuller et al.,
1999; Dibb-Fuller et al., 2001; Mappley et al., 2011; Searle et al., 2009; Searle et al.,
2010). Briefly, L. plantarum B2028 and S. Typhimurium SL1344nalr culture (section
2.1.1) was centrifuged (2447 × g) for 10 minutes and the supernatant was decanted.
Bacterial pellet was washed in 0.1M PBS (pH 7.2) and subsequently resuspended in
IPEC-J2 medium to yield 108 cfu/ml. Subsequently, bacterial inocula (Table 2.6) were
added to 24-well plates (Nunc) (for monolayers) or 1.5 ml centrifuge tubes (for 3D cell
aggregates) to a final concentration of 5 × 107 cfu in a well/tube in a 1 ml volume.
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Wells/ centrifuge tubes containing IPEC-J2 medium only were included as a control
conditions. Inoculated plates, one for adhesion and one for invasion and centrifuge
tubes were incubated at 37°C (in the presence of 5% CO2) for 60 minutes.
Following incubation, to count the S. Typhimurium SL1344nalr associated, the
cells were washed three times with HBSS and disrupted with 1% Triton X-100
(Sigma-Aldrich) using magnetic stirrer. To distinguish the number of S. Typhimurium
SL1344nalr invaded, the cells were washed twice with HBSS and inoculated with 1 ml
of media containing 100 µg/ml gentamycin solution (Sigma-Aldrich) and incubated for
additional 2 hours. Subsequently, cells were washed three times with HBSS and
disrupted as described above. To determine the number of associated and invaded S.
Typhimurium SL1344nalr, 10-fold serial dilutions (100 – 10-4) were plated onto LB-G
agar (Oxoid). The number of adhered S. Typhimurium SL1344nalr was obtained by
subtracting the number of invaded bacteria from the number of associated bacteria. All
assays were conducted in duplicate on three separate occasions.
Table 2.6 Experimental conditions used in the competition assays using IPEC-J2 cell
line (monolayers and 3D cells) and porcine in vitro organ culture (IVOC) model.
Condition Experimental strategy
SL S. Typhimurium SL1344nalr
MRSL pH 3.8 S. Typhimurium SL1344nalr + 10% (v/v) MRSLa pH 3.8
LAC S. Typhimurium SL1344nalr + 1% (w/v) LAC
Lp S. Typhimurium SL1344nalr + L. plantarum B2028
Lp + LAC S. Typhimurium SL1344nalr + L. plantarum B2028 + 1% (w/v) LAC
Lp + CFSL S. Typhimurium SL1344nalr + L. plantarum B2028+ 10% (v/v) CFSLb
CFSL S. Typhimurium SL1344nalr + 10% (v/v) CFSLb
a MRS broth with 1% (w/v) lactulose as a main carbon source.
b Cell free supernatant of L. plantarum B2028 cultured in MRSL broth.
2.5.5 Giemsa assay
IPEC-J2 monolayers were used and maintained as described in section 2.5.1.1
with a slight modification as cells were grown in 24-well plates on 13 mm cover slips.
Each well was inoculated with inocula containing L. plantarum B2028 cells, cells with
10% (v/v) CFS, or with 1% (w/v) LAC. Media only and media containing 10% (v/v)
CFS and 1% (w/v) LAC were also added but depleted of bacterial cells. Plates were
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incubated for 60 min as described for adhesion assays. Cells were stained with 10%
Giemsa stain (Sigma-Aldrich) for 60 minutes and subsequently washed three times
with distilled water and differentiated with 1% (v/v) acetic acid for 2 minutes followed
by a wash with sterile distilled water. Cover slips containing cells were then removed
from the 24-well plate and mounted on glass slides using DPX mountant (mixture of
distyrene, a plasticizer and xylene) (Sigma-Aldrich). Slides were examined under oil
immersion using light microscope (Olympus CX21, × 1000). Assays were performed
in duplicate on two separate occasions.
2.5.6 Porcine in vitro organ culture
In vitro organ culture association assays were performed as previously described
(Collins et al., 2010). Briefly, four 6-week old male commercial pigs were housed and
fed a commercial un-medicated diet and water ad libitum for 7 days prior to the study.
Pigs were euthanased by stunning and exanguination and subsequently placed on their
dorsal recumbency and a mid-line incision was made. At post-mortem the whole
intestinal tract was exteriorized and the jejunum and spiral colon located and sampled
aseptically. Tissue samples were immediately placed in pre-cooled IVOC medium and
transported to the laboratory on ice. The IVOC medium consisted of: complete RPMI
1640 medium containing 10% (v/v) fetal calf serum (FCS), 0.25% lactalbumin
hydrosylate, 75 mM mercaptoethanol, 0.2 µg/ml hydrocortisone (1:1
chloroform/ethanol), 0.1 µg/ml insulin, 2 mM L-glutamine and L-aspartate (Collins et
al., 2010; Girard et al., 2005). All reagents unless indicated otherwise were purchased
from Sigma-Aldrich. Tissues were washed in IVOC medium, aseptically trimmed into
circa 2cm x 2cm squares and immobilized in CellCrowns™ (Scaffdex) to obtain fixed
mucosal surface of the tissue explants. Subsequently, immobilized intestinal explants
from jejunum and colon were placed into pre-filled with IVOC medium (500 µl) 24-
well plates (Nunc) with the mucosal surface facing upwards.
For association assays, L. plantarum B2028 and S. Typhimurium SL1344nalr
bacterial inocula were prepared and administered essentially as described for the
competition assays (Table 2.6) with the exception that the final bacterial concentration
in a well (1ml volume) was 108 cfu. Plates were incubated at 37°C (in the presence of
5% CO2) for 30 minutes with gentle agitation. Following the incubation tissue samples
were washed in and placed in 9 ml 0.1M PBS (pH 7.2) and homogenized for
bacteriological analysis. Serial dilutions (100 – 10-6) were plated out onto BGA
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supplemented with 15 µg/ml nalidixic acid. Uninfected tissues were incubated with
media only as controls. Assays were conducted in quadruplicate on two separate
occasions.
2.6 In vivo methods
2.6.1 Animals and management
A total of twenty four, cross breed, mixed sex pig with a mean initial weight of
7.98 ± 0.7 kg were used for the study. Animals were weaned at 4 weeks of age, faecal
samples were collected from sows (n = 3) and piglets and tested for the presence of
Salmonella before the trial commencement. Pigs were randomly divided into four
equal groups of six on the basis of their mean body weight and housed in a bio-
containment facility (CLII). Each pen was equipped with a feeder and water supply
from a water tray and from a nipple. Pens, feeders and water trays were cleaned on a
daily basis. Pigs were fed commercial un-medicated pelleted feed (Lillico Attlee, Wm.
Lillico & Son Ltd), according to their daily requirements (ASU Unit, AHVLA) and
water was provided ad libitum. The left over feed was weighed every morning.
Biosecurity measures were implemented in order to avoid cross contamination. These
studies were performed in accordance with the UK Animals (Scientific Procedures)
Act 1986 and were approved by the AHVLA ethics committee. All procedures were
carried out at the AHVLA Coomblands Farm.
2.6.2 Bacterial strains preparation
S. Typhimurium SL1344 nalr and L. plantarum B2028 were cultured as previously
described in LB-G and MRS broth respectively, centrifuged (2447 × g) for 10 minutes
and the supernatant was decanted. For S. Typhimurium SL1344 nalr the pellet was and
resuspended in 0.1M PBS (pH 7.2) to yield 109 cfu/ml bacteria and further diluted in
sterile water to yield 5 × 107 cfu/ml. L. plantrarum B2028 was resuspended in sterile
water and mixed with the small portion of feed for each pig to receive 1010 cfu/pig/day.
2.6.3 Experimental design and diets
Once distributed into four separate pens, the animals were allowed 7 days of
acclimatisation after which the experimental diets were provided. The experimental
treatment consisted of pelleted control diet without additives (Control), diet containing
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1% (w/w) (15 ml/kg) lactulose given as a Duphalac syrup (LAC), diet containing 1010
cfu of L. plantarum B2028/animal/day (Lp) and diet containing 1010 cfu of L.
plantarum B2028/animal/day together with 1% (w/v) (15 ml/kg) lactulose (Lp +
LAC). Once stabilised on the above diets (6 days), each piglet in the all four groups
was challenged with S. Typhimurium SL1344nalr (5 × 108 cfu in 10 ml sterile water)
administered by oral gavage (day 0). Approximately 30 minutes before the challenge
animals were orally dosed with 10% (w/v) sodium bicarbonate solution to neutralise
stomach acid (20 ml). Clinical performance was monitored throughout the entire study
and samples were collected as detailed in section 2.6.4. At the end of the study, 10
days after Salmonella challenge all animals were humanely sacrificed for post-mortem
examination.
2.6.4 Experimental monitoring and animals handling
All animals were examined clinically and scored as per Table 2.7 throughout the
duration of the study. Feed consumption was recorded daily and body weights were
taken weekly. Rectal temperature and faecal samples were collected from each piglet
by rectal digital insertion on three separate occasions before Salmonella challenge,
while animals were fed the experimental diet.
Table 2.7 Clinical score evaluation.
Clinical
score
Diarrhoea Feed consumption Behaviour Temperature
0 None Normal Active Normal
(38.5 – 40°C)
1+ Slight Slightly off food Active if stimulated Raised
(40.5 – 41°C)
2+ Watery
(yellow, watery,
+/- blood)
Off food Inactive, when
stimulated
Fever
(above 41°C)
Following S. Typhimurium SL1344nalr challenge, sampling was performed on a daily
basis. Faecal samples (approx. 5 g) from each pen were collected from the floor daily
and pooled for Salmonella testing.
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2.6.5 Bacterial isolation and enumeration
Direct isolation and enumeration of S. Typhimurium SL1344nalr from faeces
were obtained by resuspending 10% (w/v) freshly collected samples in a buffered
peptone water (BPW) (Edel and Kampelmacher, 1973), plating out serially diluted
samples (100-10-5) onto BGA supplemented with nalidixic acid 15 µg/ml and
incubating at 37°C for 16 hours (Searle et al., 2009). For initial enrichment,
resuspended in BPW samples were incubated at 37°C for 18 ± 2 hours. Subsequently,
100 µl of the overnight incubated broth was inoculated onto modified semisolid
Rappaport-Vassiliadis medium (MSRV) (Aspinall et al., 1992; De Smedt et al., 1986)
as a three equal drops. MSRV plates were incubated at 41.5°C for 24 hours. Plates
which were negative for growth were allowed further 24 hours incubation and
examined for growth. Subsequently, a 1 µl loop was used to pick the material from the
edge of the definite growth, which was streaked onto Rambach agar and BGA agar
supplemented with 15µg/ ml of nalidixic acid and colonies were allowed to develop
for 24 hours at 37°C.
Tissues collected at post-mortem, were weighed (1 g where possible),
homogenised in BPW (10% w/v) and serially diluted samples (100-10-5) were plated
onto BGA supplemented with 15µg/ ml of nalidixic acid. Samples were enriched as
described above and a 100 µl aliquot was taken from the samples that were negative
upon direct plating.
Lactobacilli numbers were determined by diluting fresh faecal samples 10% (w/v)
in BPW and 10-fold serial dilutions in 0.1M PBS (pH 7.2) (10-1-10-8) were prepared
and plated out on MRS agar (De Man et al., 1960). Plates were incubated at 37°C
microaerophilically in GasPak jars using a GasPak™ plus system (BBL™) and
colonies were allowed to develop for 48 hours. At four distinct time points during the
study, feacal samples were subjected to PCR analysis to test for L. plantarum spp.
presence (Kwon et al., 2004).
For E. coli and coliform enumeration of faeces, samples were prepared as above
and plated onto a Chromagar ™ ECC (Randall et al., 2009). Plates were incubated at
37°C for 24 hours and all blue E. coli and mauve coliforms were counted.
2.6.6 Post-mortem examination
Ten days following pathogen challenge all pigs were euthanased by stunning and
exanguination and subsequently placed in dorsal recumbency for a mid-line incision to
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be made. Faecal samples were collected from rectum from all experimental animals.
Tissues (jejunum, ileum, colon, caecum, rectum and mesenteric lymph nodes) from
three pigs from each experimental group were sampled at post-mortem for bacteriology
and histopathology.
2.7 Statistical analysis
Statistical analysis of the data presented within this thesis was performed using
GraphPad Prism® version 5 program (GraphPad Software, LaJolla, CA, USA). Unless
otherwise indicated the evaluation of statistically significant differences between
results from the treatment groups and the treatment groups and the control were
determined by repeated-measures One-way analysis of variance (ANOVA) and
Bonferroni post test. For the studies where two factors (time and treatment) were taken
into account, the repeated-measures Two-way ANOVA was used followed by the
Bonferroni post test. The area under the curve (AUC) was calculated by the trapezoidal
method with GraphPad Prism® version 5 program. The mean AUC values were
compared using One-way ANOVA and Bonferroni post test. For analysis of
Salmonella counts from the in vivo trial, the scoring system was applied and data
between treated and control group compared.
Statistical significance was accepted at P<0.05 and differences among means with
0.05<P<0.10 were accepted as tendencies to differences. All data within this thesis are
presented as the mean with the standard error of the mean (SEM). The significance (P
value) was visualized on graphs using an asterisk scale system (Table 2.8).
Table 2.8 P value summary.
P value Symbol
≤ 0.001 ***
> 0.001 to ≤ 0.01 **
> 0.01 to ≤ 0.05 *
> 0.05 ns
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Chapter 3
Salmonella and Lactobacillus isolate characterisation towards
selection of an effective synbiotic that reduces S.
Typhimurium colonisation
3.1 Introduction
The control of Salmonella colonisation in animals is of primary importance in
attempts to reduce the incidence of human salmonellosis. As a consequence of
increasing antibiotic resistance in zoonotic pathogens, the use of antimicrobial growth
promoters that were associated with pathogen control and improvement in
zootechnical parameters was banned in EU in 2006 (Cogliani et al., 2011).
A number of studies have indicated that probiotics may be used as a control
strategy against common intestinal pathogens in livestock (Brashears et al., 2003;
Casey et al., 2007) and genera including lactobacilli and bifidobacteria are commonly
used (Saarela et al., 2000). Nevertheless, there remains a continual challenge to find
suitable probiotic candidates that replace and/or supplement antibiotic use (Verstegen
and Williams, 2002). The concept of using one organism to exclude another is not
recent, the protective role of native gut microbiota in limiting the colonisation of
Salmonella in chicks was demonstrated nearly 40 years ago (Nurmi and Rantala,
1973). In addition to probiotics another widely used approach is to employ prebiotics
in animal nutrition, or the combination of prebiotics and probiotics, termed synbiotics.
Prebiotics are non-digestible, complex and variable chained length carbohydrates that
are often both synthesised and catabolised by probiotic strains. Therefore, a diet
supplemented by these compounds (FOS, GOS, MOS, XOS etc.) will see these
carbohydrates arrive in the distal part of the alimentary tract where they are catabolised
by organisms that have the capability to do so. Given synthesis of prebiotics is by
probiotic strains, these will be selectively enriched as they possess the relevant
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enzymic capabilities. Consequently beneficial microbiota will be enhanced and
increased resistance to enteric pathogens is provided (Patterson and Burkholder, 2003).
The importance of accurate probiotic strain identification and characterisation for
its selection and industrial suitability is evident and has been pointed out by numerous
researchers (Klaenhammer and Kullen, 1999; Saarela et al., 2000; Temmerman, 2004).
Therefore, within the first section of this chapter it was deemed prudent to characterise
and confirm the identity of the organisms to be used in this study; Salmonella as the
target pathogen for control and the lactobacilli strains as potential probiotics. The
ultimate goal of this work however will be to construct an effective synbiotic
combination that reduces colonisation of S. Typhimurium in pigs. Although, the
mechanism of probiotic action has not yet been fully elucidated, it has been
documented that probiotic strains are able to produce different antimicrobial
substances e.g. organic acids, hydrogen peroxide, carbon dioxide and bacteriocins
(Castillo et al., 2011; Fayol-Messaoudi et al., 2005; Servin, 2004). It has been
suggested that the major fermentation product of lactic acid bacteria, lactic acid, is a
significant component of their antimicrobial activity in vitro (Makras et al., 2006). In
addition to the pH lowering effect of lactic acid Alakomi et al. (2000) demonstrated its
role as an outer membrane disrupting agent of Gram-negative bacteria such as S.
Typhimurium, E. coli and P. aeruginosa.
The phenotypic and molecular characterisation of Lactobacillus isolated used in
this study is demonstrated in this chapter. Furthermore, in order to aid in the selection
of prospective probiotics, initial screening to evaluate the antimicrobial activity
towards S. Typhimurium SL1344nalr by lactobacilli is demonstrated. This chapter also
discusses the evaluation of a candidate prebiotic inclusion on the fermentative activity
of porcine microbiota including the candidate probiotic.
Chapter 3
80
3.2 Results
3.2.1 General characterisation of Salmonella isolates
To reconfirm S. Typhimurium isolates identity standard bacteriological testing
was performed as described in sections 2.1.2 and 2.1.3. Gram staining confirmed the
isolates to be Gram negative (red-pink) rod shaped bacteria. All isolates were catalase
positive and oxidase negative. The isolates were tested for their biochemical profiles
using API20E strips as described in section 2.1.4 and the results were analysed using
Apiweb™. The biochemical profiles were representative for Salmonella spp. for all
isolates with the high identification profiles (99.9%). All isolates were able to ferment
D-glucose, D-mannitol, inositol, D-sorbitol, L-rhamnose, D-melibiose, L- arabionose.
All isolates produced hydrogen sulphide (H2S) gas. Finally, having confirmed that all
isolates were Salmonella, their serovar designation was also confirmed by slide
agglutination test with each isolate was confirmed to be Typhimurium.
For all future studies however, a nalidixic acid resistant derivative of S.
Typhimurium SL1344 was selected in order to ease the recovery from the complex
experimental environments. The resistance to nalidixic acid was confirmed by plating
out on BGA containing 15 µg/ml nalidixic acid and this medium was used for the
pathogen recovery.
3.2.2 Phenotypic and molecular characterisation of lactobacilli isolates
For presumptive lactobacilli, obtained from the AHVLA culture collection, the
Gram staining confirmed the isolates to be Gram positive (purple) rod shaped bacilli
that lacked spores. All isolates were catalase and oxidase negative. Lactobacillus
strains characterised using API50 CHL strips allowed differentiation between species
on the basis of their typical fermentation profiles as described in section 2.1.4. The
API identification for each isolate gave a range of probability as follows (given from
the highest): L. plantarum B2028, B2989, B2994 and B2996 99.90%; L. rhamnosus
B2988, B2998, B2987 99.70-96.50%; L. bulgaricus B2999 (L. delbrueckii subspecies)
was identified as L. delbrueckii 88.60%; L. acidophilus B2993, B2990 76.40 & 47%;
L. fermentum B2992 59.80%; L. bulgaricus B2991, B2997 57.80% & 45.5%.
Moreover, L. reuteri B2026 was identified by API kit as L. fermentum 99.30%; L.
casei B2986 & B2995 was identified as L. paracasei 80% (Table 3.1).
In addition, isolates were identified at the species level using multiplex PCR,
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sequencing of the 16S rDNA gene and matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry (MALDI-TOF MS) profiling as described in section
2.3.1. The multiplex PCR was performed using the primers derived from the integrated
sequences of 16S rRNA and 23S rRNA genes that allow identification of seven
Lactobacillus species (Kwon et al., 2004). All isolates with the exception of L.
fermentum B2992 and L. buchneri B2997 were identified accordingly to a species
level (Table 3.1). In addition, the established PCR (Marchesi et al., 1998) using
universal primers 63f and 1387r has been used to amplify 16S rRNA gene of each
isolate and the amplicons were sequenced (see section 2.2.5). Forward and reverse
sequences were aligned and compared on the GenBank database. Species matches and
the accession number are shown in a Table 3.1. Finally, MALDI-TOF MS profiles
compared with database profile gave accurate ID to L. plantarum, L. fermentum, L.
buchneri, L. acidophilus (one isolate). Again, L. bulgaricus was identified as L.
delbrueckii. Moreover, L. casei was identified as L. paracasei and one of L. rhamnosus
strains was identified in the first repeat as L. casei and when profiling was repeated as
L. zeae. Similarly, in the instance of one of L. acidophilus strains it was recognised to
be L. ultunensis or L. helveticus. These data are summarized in Table 3.1.
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Table 3.1 The origin of the Lactobacillus strains and their phenotypic and molecular identification. Species identification match using API
50CH, MALDI-TOF MS, Multiplex PCR and 16S rRNA sequencing.
Strain bead
number
Species as
defined by
original source
definition
Origin API 50CH ID MALDI-TOF MS Multiplex PCRa 16S rRNA sequencing
Species ID % Species Species Match
species
Match accession ID %
B2028 (JC1) L. plantarum Swine L. plantarum 99.90% L. plantarum L. plantarum L. plantarum JQ278711.1 100%
B2026 L. reuteri Swine L. fermentum 99.30% L. reuteri L. reuteri L. reuteri JN981867.1 98%
B2986 L casei Human L. paracasei 80.00 % L. paracasei L. casei L. casei JN560879.1 99%
B2987 L. rhamnosus Human L. rhamnosus 96.50% L. rhamnosus L. rhamnosus L. rhamnosus HQ293051.1 97%
B2988 L. rhamnosus Human L. rhamnosus 99.70% - L. rhamnosus L. rhamnosus JQ621982.1 98%
B2989 L. plantarum Vegetable L. plantarum 99.90% L. plantarum L. plantarum L. plantarum GU451062.1 98%
B2990 L. acidophilus Human L. acidophilus 47.00% L. ultunensis/helveticus L. acidophilus L. acidophilus EU878007.1 99%
B2991 L. bulgaricus Dairy L. bulgaricus 57.80% L. delbrueckii L. delbrueckii L. bulgaricus FJ878007.1 98%
B2992 L. fermentum Vegetable L. fermentum 59.80% L. fermentum - L. fermentum EU626018.1 99%
B2993 L. acidophilus Human L. acidophilus 76.40% L. acidophilus L. acidophilus L. acidophilus JQ350808.1 100%
B2994 L. plantarum Vegetable L. plantarum 99.90% L. plantarum L. plantarum L. plantarum GU451062.1 98%
B2995 L. casei Dairy L. paracasei 80.00% L. paracasei L. casei L. casei JN560917.1 100%
B2996 L. plantarum Vegetable L. plantarum 99.90% L. plantarum L. plantarum L. plantarum AM279764.2 100%
B2997 L. buchneri Vegetable L. buchneri 45.50% L. buchneri - L. buchneri AB425940.1 100%
B2998 L. rhamnosus Dairy L. rhamnosus 99.60% L. casei/zeae L. rhamnosus L. rhamnosus HQ293051.1 100%
B2999 L. bulgaricus Dairy L. delbrueckii 88.60% L. delbrueckii L. delbrueckii L. bulgaricus EU547306.1 100%
a Multiplex PCR according to Kwon et al. (2004) detects L. acidophilus, L. casei, L. delbrueckii, L. gasseri, L. plantarum, L. reuteri, L. rhamnosus; -, result inconclusive;
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3.2.3 Antibacterial activity of lactobacilli against S. Typhimurium
3.2.3.1 Colony overlay assay
Antimicrobial activity of 16 lactobacilli isolates (Table 3.1) against S.
Typhimurium SL1344nalr was investigated using a colony overlay assay following the
method of Barbosa et al. (2005) and as described in section 2.1.7. All Lactobacillus
isolates generated a zone of inhibition against S. Typhimurium SL1344nalr (hereinafter
referred to as STm SL1344nalr) (Table 3.2). The strongest inhibition was demonstrated
by L. plantarum B2028, L. plantarum B2989 and L. acidophilus B2990 with the mean
inhibition zones measuring 19.66 ± 1.01 mm, 17.53 ± 1.08 mm and 17.15 ± 0.68 mm
in diameter respectively. The least potent with the inhibition zones measuring 7.85 ±
0.75 mm, 9.69 ± 2.44 mm, 5.11 ± 1.05 mm, 8.64 ± 1.29 mm in diameter were L.
reuteri B2026, L. fermentum B2992, L. buchneri B2997, L. bulgaricus B2999. These
data suggest diffusible substrates produced by each Lactobacillus isolate tested are
likely to be causing inhibition of STm SL1344nalr.
3.2.3.2 Characterisation of cell free supernatants from lactobacilli: pH and
organic acid production
A conditioned medium assay where lactobacilli cell free supernatants (CFSs) were
included at 10% dilution factor into LB-G broth inoculated with STm SL1344nalr was
performed as described in section 2.1.8.
Twelve of the 16 CFSs tested inhibited the growth of STm SL1344nalr
significantly as defined by AUC calculations (Table 3.2). CFS from isolates B2026,
B2993, B2997 and B2999 failed to reduce growth, whilst twelve gave a significant
reduction of Salmonella growth. Isolates B2989 (L. plantarum), B2028 (L. plantarum)
and B2990 (L. acidophilus) exerted greatest inhibition of growth with AUC values of
1.35 ± 0.69, 1.83 ± 0.63 and 2.74 ± 0.28 respectively (P<0.001). Interestingly, when
CFS of L. fermentum B2992 was used the growth of STm SL1344nalr was slower, but
over time the final OD was similar to a final OD of control used. At the final reading
point (24 hours) STm SL1344nalr OD was significantly different from the control in
the presence of 11 CSFs tested (Figure 3.1). These findings were comparable with the
results obtained previously from the colony overlay assay.
Lactic acid bacteria (LAB) whether hetero- or homo-fermentative are known to
produce organic acids, notably lactic acid, as metabolic end products and low pH is
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known to inhibit the growth of many Enterobacteriaceae including S. Typhimurium.
Thus, the CFS from each isolate was examined. The pH of the supernatants ranged
from pH = 3.75 ± 0.01 for L. plantarum B2028 and B2989 to pH = 5.35 ± 0.10 for L.
bulgaricus B2991 (Table 3.2). HPLC analyses were performed to quantify the
production of organic acids in CFS. The amount of lactic acid ranged from 47.8 mM
for L. bulgaricus B2999 to 145 mM for L. plantarum B2028. In general, it was
observed that the greater the inhibition of STm SL1344nalr the lower the pH of the
supernatant and the higher concentration of lactic acid (above 100 mM) (Table 3.2).
3.2.3.3 Hydrogen peroxide production
The ability of lactobacilli strains to produce H2O2 was evaluated as described
previously in section 2.1.6. Of the sixteen Lactobacillus isolates only L. acidophilus
B2990, L. acidophilus B2993, L. bulgaricus B991 and L. bulgaricus B2999 were H2O2
producers.
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Figure 3.1 Growth of STm
SL1344nalr in LB-G broth
supplemented with 10% (v/v)
non pH adjusted cell-free
supernatants of Lactobacillus
isolates. The CFSs are denoted
by their AHVLA reference
number. MRS broth (pH 5.8)
was added to Salmonella culture
as a control. Cultures were
incubated at 37°C for 24 hours
and the OD was measured at
600nm (OD600nm). The assay was
performed in triplicate on three
separate occasions and the SEM
is shown. Significantly different
from the control OD values at the
final reading point are indicated
by * P<0.05 and *** P<0.001.
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Table 3.2 The inhibitory effect of lactobacilli supernatants on STm SL1344nalr, production of hydrogen peroxide and organic acids by
lactobacilli. MRS broth (pH 5.8) was included as a control. Assays were conducted in triplicate and SEM is shown.
Isolate Hydrogen
peroxidea
Colony overlay
assay inhibition
zone (mm)b
10% CFS growth
assay (Mean AUC)c
CFSd pH CFSd lactic and SCFA concentration (mM)
Lactic Acetic Butyric Propionic
L. plantarum (B2028) - 19.66 ± 1.01(+++) 1.83 ± 0.63 *** 3.75 ± 0.01 145 ± 8.95 97.6 ± 0.20 35.3 ± 4.37 6.7 ± 1.14
L. reuteri (B2026) - 7.85 ± 0.75(+) 10.67 ± 0.93 NS 4.43 ± 0.17 50.8 ± 3.65 105 ± 15.1 18.8 ± 0.58 2.7 ± 2.19
L. casei (B2986) - 15.46 ± 0.63(++) 3.95 ± 0.52 *** 3.84 ± 0.03 129 ± 7.04 106 ± 3.44 20.2 ± 0.02 3.0 ± 1.19
L. rhamnosus (B2987) - 15.54 ± 1.19(++) 5.54 ± 0.75 *** 3.82 ± 0.01 116 ± 9.91 103 ± 12.8 24.7 ± 0.35 6.4 ± 1.22
L. rhamnosus (B2988) - 15.01 ± 0.46(++) 5.74 ± 0.61 *** 3.82 ± 0.02 115 ± 2.67 97.7 ± 4.02 20.8 ± 0 2.9 ± 2.14
L. plantarum (B2989) - 17.53 ± 1.08(+++) 1.35 ± 0.69 *** 3.75 ± 0.01 139 ± 9.09 98.7 ± 1.45 30.3 ± 0.68 2.9 ± 0.69
L. acidophilus (B2990) + 17.15 ± 0.68(+++) 2.74 ± 0.28 *** 3.81 ± 0.05 133 ± 4.21 92.6 ± 5.51 19.9 ± 0.65 7.7 ± 1.52
L. bulgaricus (B2991) + 12.97 ± 0.30(++) 8.88 ± 0.69 * 5.35 ± 0.10 95.7 ± 10.2 116 ± 14.1 21.4 ± 0.40 3.7 ± 2.08
L. fermentum (B2992) - 9.69 ± 2.44(+) 8.69 ± 0.66 * 4.13 ± 0.01 103 ± 3.29 116 ± 0.79 24.3 ± 1.76 4.4 ± 0.08
L. acidophilus (B2993) + 13.50 ± 0.76(++) 9.79 ± 0.05 NS 4.07 ± 0.18 76.4 ±11.2 116 ± 4.81 23.0 ± 3.08 13.8 ± 3.30
L. plantarum (B2994) - 15.58 ± 0.74(++) 4.16 ± 0.04 *** 3.83 ± 0.01 133 ± 6.90 104 ± 8.77 29.6 ± 0.82 4.2 ± 2.76
L. casei (B2995) - 12.18 ± 0.52(++) 8.36 ± 0.08 ** 4.13 ± 0.08 96.5 ± 0.86 106 ± 3.33 21.5 ± 0.97 3.7 ± 2.17
L. plantarum (B2996) - 16.05 ± 0.91(+++) 4.52 ± 0.58 *** 3.79 ± 0.04 128 ± 7.28 101 ± 3.35 24.7 ± 1.84 3.5 ± 0.11
L. buchneri (B2997) - 5.11 ± 1.05(+) 11.74 ± 0.09 NS 5.13 ± 0.13 55.7 ± 5.63 116 ± 4.94 23.3 ± 4.08 9.5 ± 1.90
L. rhamnosus (B2998) - 14.06 ± 1.06(++) 5.99 ± 0.39 *** 3.80 ± 0.01 144 ± 0.78 110 ± 6.52 24.3 ± 1.89 1.8 ± 0.56
L. bulgaricus (B2999) + 8.64 ± 1.29(+) 11.84 ± 0.24 NS 4.82 ± 0.25 47.8 ± 1.58 120 ± 4.79 23.6 ± 2.59 9.7 ± 1.01
MRS (pH 5.8)† - - 11.44 ± 0.07 5.82 ± 0.17 0.52 ± 0.08 110 ± 0.42 22.2 ± 1.19 11.5 ± 0.14
a (-) negative, (+) positive; b (+++) inhibition zone >16 mm, (++) inhibition zone between 16-11 mm, (+) inhibition zone < 10mm; c * P<0.05, ** P<0.01, *** P<0.001, NS not
significant; d Cell free supernatant; † control.
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3.2.4 Selection and evaluation of probiotic and prebiotic candidates for synbiotic
combination
3.2.4.1 Growth of S. Typhimurium in the presence of various prebiotics
The growth of STm SL1344nalr in minimal medium (MM) supplemented with 1%
of various prebiotics (LAC, FOS and GOS) was evaluated as described previously in
section 2.1.9. The growth of STm SL1344nalr with prebiotics as compared with that in
MM supplemented with glucose showed that STm SL1344nalr utilised the GOS
mixture and FOS but not LAC (Figure 3.2). Area under the curve values for each
substrate were 5.92 ± 0.082 (GOS), 2.46 ± 0.019 (FOS) and 0.33 ± 0.039 (LAC) and
growth response compared against the glucose control was 254% (GOS), 60% (FOS)
and 0% (LAC). The final OD readings at 24 hours were significantly lower (P<0.001)
for LAC (OD 0.01 ± 0.001) and significantly higher (P<0.001) for GOS’s (0.43 ±
0.005) compared to the glucose control (OD 0.21 ± 0.001), which was similar to the
OD obtained with FOS (OD 0.20 ± 0.002).
A question arose regarding the response of STm SL1344nalr to LAC in minimal
medium. Was this ‘no-growth’ an inability to grow because the carbon and energy was
not bioavailable due to the lack of the appropriate enzymic machinery to catabolise
LAC, or, alternatively, was LAC inhibitory?
To test this, the experiments were repeated in a complex medium using standard
lysogeny broth (LB) (Bertani, 2004) without glucose (LB-G) as the basal medium. The
growth studies showed that STm SL1344nalr grew in the presence of all prebiotics.
Interestingly the AUC of 8.77 ± 0.059 obtained with LAC was the poorest in this test
compared with the LB control with AUC of 9.71 ± 0.078 (Figure 3.3). The relative
growth in LB medium containing test prebiotics was weakest for LAC at 90%,
whereas utilisation of FOS and GOS resulted in growth response of 105% and 143%,
respectively. The final OD readings at 24 hours were significantly lower (P<0.001) for
LAC (OD 0.53 ± 0.002) and significantly higher (P<0.001) for GOS (0.86 ± 0.010)
compared to the LB control containing glucose (OD 0.65 ± 0.002). There was no
difference observed for the medium containing FOS (OD 0.66 ± 0.007). GOS used
here significantly stimulated the growth of STm SL1344nalr.
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Figure 3.2 Growth of STm SL1344nalr in minimal medium (MM) in the presence of
1% (w/v) LAC (hatched bar), FOS (white bar) and GOS (black bar). MM (grey bar)
containing 1% (w/v) glucose was included as a control. Dotted line indicates S.
Typhimurium SL1344nalr growth in the presence of LAC. Cultures were incubated at
37°C for 24 hours and the OD was measured at 600nm (OD600nm). The assay was
performed in triplicate on three separate occasions and the SEM is shown. The OD
values significantly different from the control at the final reading point are indicated by
*** P<0.001.
Figure 3.3 Growth of STm SL1344nalr in LB-G the presence of 1% (w/v) LAC
(hatched bar), FOS (white bar) and GOS (black bar). LB medium containing 1% (w/v)
glucose (grey bar) was included as a control. Dotted line indicates S. Typhimurium
SL1344nalr growth in the presence of LAC. Cultures were incubated at 37°C for 24
hours and the OD was measured at 600nm (OD600nm). The assay was performed in
triplicate on three separate occasions and the SEM is shown. The OD values
significantly different from the control at the final reading point are indicated by ***
P<0.001.
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3.2.4.2 Growth of lactobacilli in the presence of various prebiotics
Three out of sixteen Lactobacillus isolates (L. plantarum B2028, L. plantarum
B2989 and L. acidophilus B2990) with the significant (P<0.001) antimicrobial activity
against STm SL1344nalr were assessed for their growth with prebiotics LAC, FOS and
GOS (section 2.1.9). The growth as measured by AUC of each L. plantarum B2028,
B2989, L. acidophilus B2990 on each prebiotic was calculated to its growth response
on glucose which was set as 100%. The calculations were performed according to
(Kneifel et al., 2000) and as detailed in section 2.1.9.
Using glucose as the growth standard (i.e./ 100%) the three lactobacilli showed
similar growth on that LAC and GOS of 60%-80% and approximately 20% for FOS.
The specific growth rates for all isolates were calculated as previously described
(Saminathan et al., 2011) and demonstrated very similar results with no significant
differences between strains on glucose and LAC (Table 3.3). Growth on FOS was
relatively poor, but demonstrated higher growth rate for L. plantarum B2989 in
comparison to L. plantarum B2028 and L. acidophilus B2990 (P<0.05; P<0.001,
respectively). L. acidophilus B2990 demonstrated higher growth rates on GOS
compared to L. plantarum B2028 and B2989 (P<0.01; P<0.001 respectively). For all
three lactobacilli, the growth rate on LAC was slower in comparison to glucose (L.
plantarum B2028 and B2989 P<0.01, L. acidophilus B2990 P<0.05).
The final OD600 values on this prebiotic for B2028, B2989 and B2990 were 1.03,
1.02, 1.13 respectively, showing that L. acidophilus reached a higher cell density at the
final stage in comparison to both L. plantarum strains (P<0.05). L. acidophilus B2990
growth pattern was however characterised by longer lag phase comparing to L.
plantarum strains. FOS was utilised poorly by all three lactobacilli with the final OD600
value following 24 hour incubation not extending above 0.20 and low growth rate
values compared to glucose (P<0.001). The growth rate on GOS in contrast to glucose
was significantly slower for L. plantarum B2028 and B2989 strains (P<0.001) and
comparable for L. acidophilus B2990. The OD600 value reached following 24 hour
incubation for those isolates were 0.84, 0.82 and 1.01 respectively.
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Table 3.3 Growth parameters of L. plantarum B2028 and B2989, L. acidophilus
B2990 in the presence of various prebiotics. Cultures were incubated at 37°C for 24
hours and the OD was measured at 600nm (OD600nm). The assay was performed in
triplicate on three separate occasions and the SEM is shown.
Substratea Mean AUC GR (%)b GR (µ)c OD600nm at 24 h
L. plantarum B2028
GLU† 14.75 ± 0.28 - 0.144 1.17 ± 0.04
LAC 11.29 ± 0.23 76.54 0.126 1.03 ± 0.01
FOS 3.17 ± 0.16 21.44 0.041 0.17 ± 0.01
GOS 11.07 ± 0.45 74.98 0.100 0.84 ± 0.02
L. plantarum B2989
GLU† 15.05 ± 0.03 - 0.143 1.19 ± 0.03
LAC 10.96 ± 0.24 72.93 0.119 1.02 ± 0.01
FOS 3.61 ± 0.08 18.76 0.051 0.20 ± 0.01
GOS 10.77 ± 0.19 71.46 0.095 0.82 ± 0.04
L. acidophilus B2990
GLU† 13.21 ± 0.32 - 0.146 1.11 ± 0.01
LAC 8.70 ± 0.38 67.09 0.132 1.13 ± 0.02
FOS 2.48 ± 0.21 18.76 0.032 0.14 ± 0.02
GOS 11.52 ± 0.17 87.30 0.153 1.01 ± 0.02
a GLU, LAC, FOS and GOS added as 1% (w/v) into basal modified MRS.
b Lactobacilli growth response (%) calculated as growth measured by AUC on each prebiotic to its
growth on glucose (Kneifel et al., 2000).
c Specific growth rates on each prebiotic were calculated as previously proposed (Saminathan et al.,
2011).
†Positive control set as 100%.
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3.2.5 The effect of inclusion of the candidate prebiotics and L. plantarum B2028 in
a porcine batch culture system upon bacterial numbers and SCFA concentrations
The porcine batch culture model employed to evaluate the inclusion of the
synbiotic combination on the porcine faecal microbiota, mainly lactobacilli and
bifidobacteria and the short chain fatty acid (SCFA) concentrations was set up as
described in section 2.1.14 and as previously established (Martin-Pelaez et al., 2008;
Sarbini et al., 2011; Saulnier et al., 2008). For these studies two synbiotic
combinations were selected and comprised L. plantarum B2028 with either LAC or
FOS. All batch fermenters containing basal medium (section 2.1.14) were inoculated
with 10% (v/v) prepared faecal slurry and a control vessel (CTR) was left without the
inclusion of a pre or synbiotic.
The results demonstrated that the number of bacteria detected with the Bif164
fluorescent in situ hybridisation (FISH) probe were not affected by the fermentation of
LAC or FOS with or without the addition of L. plantarum (P=0.842). Furthermore, no
changes were observed in total numbers of bacteria present which were detected with
DAPI stain with all treatments (P=0.744). However, significantly increased numbers
of bacteria in comparison to control were detected with the Lab158 probe with the
mean values calculated from all collected time points for LAC, FOS, Lp + LAC, Lp +
FOS and CTR (8.18 ± 0.29 (P<0.05), 8.19 ± 0.18 (P<0.05), 8.52 ± 0.17 (P<0.01),
8.05 ± 0.19 7.25 ± 0.06 log10 cells/ml respectively). A significant increase after 5, 10
and 24 hours compared with 0 hour was observed for all treatment groups with
exception for Lp + FOS at 5 hours (Figure 3.4). In fermentation with CTR the number
of bacteria remained similar after 5 hours and had decreased significantly at 24 hours.
Taking into account different prebiotics and synbiotics at the specific time points,
significantly higher numbers of bacteria were detected with the Lab158 probe was
observed for LAC with regards to FOS at 10 hours of fermentation (P<0.01). Inclusion
of FOS resulted in higher numbers of bacteria detected with the Lab158 probe than
inclusion of synbiotic containing FOS at 10 hours. Moreover, at 5 hours, LAC and Lp
+ LAC showed higher count of Lactobacillus-Enterococcus in comparison to synbiotic
(Lp + FOS) (P<0.001). For Lp + LAC significantly higher counts were also observed
when compared to FOS and Lp + FOS (P<0.001) at 10 and to Lp + FOS at 24 hours
(P<0.01).
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Figure 3.4 Bacterial numbers (Log10 cells/ml) enumerated using the Lab158 FISH
probe over 24 hours incubation period within porcine batch culture system inoculated
with LAC, FOS, L. plantarum B2028 + LAC (Lp + LAC), L. plantarum B2028 + FOS
(Lp + FOS) and CTR. CTR was included inoculated only with 10% (v/v) faecal slurry.
Bacterial numbers are showed at specific time points: 0 hour (hatched bar), 5 hours
(white bar), 10 hours (black bar) and 24 hours (grey bar). The assay was performed in
duplicate on two separate occasions and the SEM is shown. Values significantly
different from the CTR at the 24 hours are indicated by *** P<0.001; values
significantly different from the 0 hour at 24 hours are indicated by aP<0.001, bP<0.05
and cP<0.05.
With the increased number of bacteria detected with the Lab158 probe, indicating
increased numbers of lactic acid bacteria, it might be anticipated that there would be a
concomitant increase in the production of their end product metabolites, and
specifically lactic acid. To test this, samples were taken from each batch culture and
subjected to HPLC analysis. Results showed that a significant and rapid increase in the
lactic acid concentrations was observed between 0 and 5 hours and this was associated
with the fermentation of FOS and inclusion of Lp + FOS (P<0.01; P<0.05,
respectively). In comparison to CTR, concentrations of lactate for FOS and Lp + FOS
also differed significantly at the 5 hours time point (P<0.05; P<0.01, respectively).
Further incubation resulted in the decrease in lactic acid concentrations by 24 hours to
a values not exceeding 1.5 mM for all conditions and showing no significant difference
to CTR. The concentrations (mM) of lactic acid during the 24 hours incubation time
with prebiotics and synbiotics are shown in Figure 3.5.
Inclusion of both prebiotics and synbiotics resulted in the gradual and significant
increase in SCFA (sum of acetic, propionic and butyric acids) concentrations from 0 to
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24 hours time point. Significant increase in SCFA was observed at 10 hours in
comparison to CTR for FOS and Lp + FOS (P<0.01; P<0.001, respectively). At 24
hours the increase in SCFA concentrations in comparison to CTR was shown for all
conditions (P<0.001) (Figure 3.6). Interestingly, the SCFA concentrations for Lp +
FOS were significantly higher at 10 and 24 hours in comparison to Lp + LAC
(P<0.05).
At time point 0 hour the two main detectable end product metabolites in the
porcine batch culture system were lactic and acetic acids and those were found at
concentrations below 2 mM for all the conditions. Following 5 hours incubation a
gradual but slow increase in acetic acid concentration was observed for all conditions.
A pronounced rise in lactate concentrations was observed, mainly for FOS and Lp +
FOS, which were significantly higher in comparison to acetate (P<0.05; P<0.01
respectively). Further, a significant increase in acetate concentrations for Lp + FOS at
10 hours (P<0.05) was observed in comparison to CTR. Interestingly, the increase of
acetate was correlated with decreases in lactate concentrations (P<0.01). Following the
24 hours incubation significant increase in SCFA was visible for all conditions (Figure
3.7).
For all conditions except Lp + LAC, acetate concentrations were significantly
higher in comparison to CTR (P<0.001) after 24 hours. At the same time point
propionate concentrations were significantly higher for all conditions in comparison to
CTR (P<0.001; P<0.05 for Lp + LAC). Similarly for butyrate, higher concentrations
were detected in comparison to CTR. After 24 hours fermentation, the acetic acid
concentrations were significantly higher versus those of propionate for LAC and FOS
(P<0.05) and significantly higher to butyrate for all conditions except the Lp + LAC
synbiotic. Interestingly for LAC the concentrations of butyrate after 24 hours were
significantly higher when compared with FOS or Lp + FOS (P<0.05; P<0.01).
Moreover, the butyrate concentrations generated in Lp + LAC condition were
significantly greater to those in Lp + FOS (P<0.05).
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Figure 3.5 Concentrations (mM) of lactic acid at 0, 5, 10 and 24 hours of fermentation
period, in a porcine batch culture system inoculated with LAC (hatched bar), FOS
(white bar), L. plantarum B2028 + LAC (grey bar), L. plantarum B2028 + FOS (black
bar). CTR (dotted bar) was inoculated only with 10% (v/v) faecal slurry. Prebiotics
were included at 1% (w/v). The assay was performed in duplicate on two separate
occasions and the SEM is shown. Values significantly different from CTR at the
specific time point are indicated by * P<0.05 and ** P<0.01.
Figure 3.6 Concentrations (mM) of total SCFA (sum of acetic, propionic and butyric
acid) at 0, 5, 10 and 24 hours of fermentation period, in a porcine batch culture system
inoculated with LAC (hatched bar), FOS (white bar), L. plantarum B2028 + LAC
(grey bar), L. plantarum B2028 + FOS (black bar). CTR vessel (dotted bar) was
inoculated only with 10% (v/v) faecal slurry. Prebiotics were included at 1% (w/v).
The assay was performed in duplicate on two separate occasions and the SEM is
shown. Values significantly different from CTR at the specific time point are indicated
by ** P<0.01 and *** P<0.001.
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Figure 3.7 Concentrations (mM) of lactic (hatched bar) acetic (white bar), propionic (black bar) and butyric acid (grey bar) at times 0 hour (A), 5
hours (B), 10 hours (C) and 24 hours (D) hours in porcine batch cultures inoculated with prebiotics (LAC, FOS) and synbiotic combinations (L.
plantarum B2028 + LAC, L. plantarum B2028 + FOS). CTR vessel was inoculated only with 10% (v/v) faecal slurry. Prebiotics were included at
1% (w/v). The assay was performed in duplicate on two separate occasions and the SEM is shown. Values significantly different from the CTR
at 24 hours are indicated by * P<0.05, ** P<0.01 and *** P<0.001.
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3.3 Discussion
Lactobacilli have been widely used as a feed supplements due to their health-
promoting benefits both in human and animals. Therefore, the aim of this study was to
assess combinations of probiotic and prebiotic, namely synbiotic combinations, for
their potential to suppress the growth of a test pathogen, STm SL1344nalr, in a
surrogate pig intestinal model. However, to undertake in vitro studies to select the
components of the synbiotic, a panel of representative pig S. Typhimurium isolates and
other experimentally well defined experimental strains were to be used. Firstly, it was
essential to confirm the identity of the bacterial isolates to be used in these studies.
Salmonella isolates were obtained from the AHVLA national veterinary Salmonella
reference library. The isolates were reconfirmed by Gram stain and biochemical tests
to be Salmonella spp. and as serovar Typhimurium by standard laboratory slide
agglutination test. From the panel of Salmonella strains, a nalidixic acid resistant
derivative of S. Typhimurium SL1344 was used throughout this study to allow
selective recovery for bacterial enumeration from complex experimental environments
during in vitro and in vivo studies.
A panel of lactic acid bacteria isolates was available from the AHVLA culture
collection and each came with a presumptive identification that was to be confirmed.
The lactobacilli are notoriously difficult to speciate and this is why a battery of tests
was used to give definitive descriptions of the isolates. All isolates were identified
initially as lactobacilli based on their morphology, staining characteristics and catalase
and oxidase reactions being coccal/rods, Gram+ve microorganisms. The identification
of lactic acid bacteria has been based traditionally on their carbohydrate fermentation
pattern. Using the API system to assess this, only moderate correlation of between
47% to 99.9% with presumptive identification was achieved, but in some instances
there was no apparent correlation. This system failed to differentiate between closely
related species (L. casei as L. paracasei). Other authors (Kwon et al., 2004; Yin and
Zheng, 2005) have shown similar discrepancies when using carbohydrate fermentation
profiles for identification purposes. For many lactic acid bacteria, mass spectral
identification has proven to be a useful additional tool for a rapid identification at the
species level (Angelakis et al., 2011; Tanigawa et al., 2010; Teramoto et al., 2007).
However, correct identification of closely related species often fails. For example in
this study, L. casei was identified as L. paracasei, one of the L. rhamnosus as L.
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casei/L. zeae and L. acidophilus as L. ultunensis/L. helveticus. Similar discrepancies in
speciation of closely related bacteria have been previously reported (Angelakis et al.,
2011), when MALDI-TOF MS was used for the identification of lactobacilli from
probiotic food and yoghurts. It has been suggested that both phenotypic and molecular
characterisation should be employed to allow accurate identification of lactobacilli,
particularly as discussed in closely related species (Holzapfel et al., 2001; Klein et al.,
1998). Therefore, to assure a reliable identification both multiplex PCR and
sequencing were used in this study. With the use of multiplex PCR (Kwon et al., 2004)
it was possible to accurately identify six probiotic species, as it was designed for. The
analysis of the 16S rRNA gene sequences showed match similarity 97-100% with the
GenBank sequences, which together with other speciation methods used allowed
confirmation of identity of each tested isolate at the species level. In conclusion, it was
evident that no one method was universally capable of yielding accurate speciation.
Thus, a combination of results was used. Where the majority of methods corroborated
the original source description, this was taken as the species designation. Based on this
approach, it was clear that using this battery of tests was essential for the identity of
each isolate to be confirmed.
A number of studies have reported the antagonistic properties of lactic acid
bacteria against various gastrointestinal pathogens (Collins et al., 2009). Some aspects
of Lactobacillus spp. anti-pathogen activity are associated with the production of lactic
acid, bacteriocin-like molecules, hydrogen peroxide and other unknown molecules
(Servin, 2004). In order to select appropriate candidates for future research, the panel
of lactobacilli strains was examined for their anti-Salmonella activity. Results
generated from conditioned medium experiments in which the growth medium for
STm SL1344 nalr was supplemented with un-buffered CFS showed that L. plantarum
B2028, L. plantarum B2989 and L. acidophilus B2990 exhibited the strongest
inhibitory effect (P<0.001). There was a clear correlation between the extent of
inhibition of the growth of STm SL1344nalr on the one hand and the concentration of
the lactic acid present and the pH of the cell free supernatant on the other. The
production of lactic acid varied between species but also in between strains, which has
been reported previously (Koll et al., 2008). All L. plantarum, L. rhamnosus and L.
casei produced high concentrations of lactic acid, whereas only one of two L.
acidophilus spp. showed strong antimicrobial activity and high lactic acid
concentrations. Another mechanism by which lactic acid bacteria confer their
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antimicrobial activity is the production of hydrogen peroxide and its inhibitory effect
on S. Typhimurium has been demonstrated previously (Pridmore et al., 2008; Watson
and Schubert, 1969; Yap and Gilliland, 2000). In this study the ability of lactobacilli to
produce hydrogen peroxide was also examined and only L. bulgaricus B2991, L.
acidophilus B2090, L. acidophilus B2993 and L. delbruckei B2999 were able to do so.
The construction of the appropriate synbiotic combination is an important and
complex process which requires the selection of the prebiotic that would benefit the
probiotic (Saarela et al., 2000). One of the key characteristics of an effective prebiotic
is it’s fermentability by the microflora colonising the gastrointestinal system (GIT) and
selectivity towards the growth/activity of beneficial/probiotic bacteria present in the
GIT (Kolida and Gibson, 2007). Therefore the subsequent studies showed to be an
important part of the characterisation aiming to select the prebiotic which would
selectively stimulate only bacteria of interest, namely potential probiotic bacteria,
whilst not being metabolised and used for growth and respiration by STm SL1344nalr.
Of many prebiotics, lactulose (LAC), fructooligosacharides (FOS) and
galalactooligosacharides (GOS) have been widely studied in human and pig nutrition
in order to expand the knowledge of their beneficial properties (Collins and Gibson,
1999; Kaplan and Hutkins, 2003; Kolida et al., 2002; Laerke et al., 2000; Tzortzis et
al., 2005). Studies conducted by Martin-Pelaez et al. (2008) indicated beneficial
effects on the porcine microbiota following the administration of 1% of various
prebiotics with LAC among them. Taking into consideration this previously published
data on LAC as a prebiotic, in the present studies 1% (w/v) of each tested prebiotic
was used. The results demonstrated that in pure cultures where competition for
bioavailability in mono-culture with either STm SL1344 nalr or the lactic acid bacteria
there was no issue as STm SL1344 nalr was unable to utilise lactulose as a sole carbon
source. This is understandable since the ebg operon required for lactulose utilisation is
absent in Salmonella (AbuOun et al., 2009). Unlike LAC, the prebiotics FOS and GOS
both stimulated the growth of Salmonella although growth on FOS was less than GOS
and in comparison to the glucose control. These data generated here indicate that both
commercial GOS and FOS contain carbohydrates that are available to STm
SL1344nalr as metabolites even though it lacks the relevant enzymes to cleave the
complex GOS and FOS oligosaccharides. Indeed, the work of Searle et al. (2010)
eloquently demonstrated that GOS is comprised of various fractions of increasing
complexity with the least complex fraction containing monomeric galactose that is a
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known substrate for catabolism by Salmonella. Given the aim of the synbiotic mixture
is to prevent and even suppress the growth of Salmonella, it was deemed sensible to
consider LAC as a potential prebiotic as this substance does not stimulate the growth
of Salmonella. It would of course be interesting to evaluate the bioavailability of the
minor fractions of GOS and FOS in the pig gut. It is likely that monomeric
carbohydrates would be readily catabolised by many bacterial species and, due to the
competition for this available substrate, may not stimulate Salmonella to grow in that
environment. The growth of Salmonella in LB broth, a complex medium used
commonly for the growth of Enterobacteriaceae, was affected by the various prebiotics
but to the lesser extent than when grown in supplemented minimal media. In LB
medium the main carbon source for Salmonella are recovered from oligopeptides and
amino acids, hence the growth of the pathogen was not limited to the utilisation of
prebiotic supplementation. Consequently, the LAC had no obvious impact on the
growth of Salmonella in either LB or minimal medium; it certainly did not have an
inhibitory effect on STm SL1344 nalr.
As probiotics are often capable of both synthesising as well as catabolising
complex chain carbohydrates, it might be anticipated that many of the panel of lactic
acid bacteria used in this study would be able to utilise LAC, GOS and FOS as carbon
and energy sources. In the tests described in this chapter, the lactobacilli utilised LAC,
FOS and GOS showing the highest growth stimulation with LAC and GOS. The
growth response of lactobacilli on LAC and GOS, calculated in comparison with the
glucose as a control (100%), was in value of over 60%, whilst growth on FOS was not
higher than 21.4%. The species and strain specific utilisation of FOS was previously
reported (Kaplan and Hutkins, 2003). In our study the growth of all lactobacilli on
FOS as determined by OD extinction value showed no values beyond OD 0.2. This is
in agreement with previously cited studies and suggests that those isolates were not
able to utilise FOS and the modest growth that was observed was most likely due to
the presence of simple sugar traces in the commercial FOS used in this study.
Moreover, the highest growth rates for L. plantarum isolates B2028 and B2989 were
observed on LAC and for L. acidophilus B2990 on GOS (Table 3.3). In this study
GOS was suitable for the growth of all lactobacilli tested. The efficacy of a prebiotic
depends on its selective fermentation and growth stimulation of particular bacterial
groups, mainly lactobacilli and bifidobacteria. Considering these data, it was
postulated that LAC supports the growth of the three Lactobacillus isolates and is
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likely to be a most suitable carbohydrate from those tested for synbiotic co-
administration. While the growth of probiotic was well supported by both LAC and
GOS, the later also supported the growth of STm SL1344nalr and the latter was
precluded from consideration for development as a component of this particulate
synbiotic. The results of this study accord with previous finding of Martin-Pelaez et al.
(2008) and therefore, what further justify the use of LAC in future studies. Moreover,
as LAC was indeed fermented by all three probiotic candidates.
With regard to the probiotic for use with LAC in pig studies it seemed appropriate
to select a porcine isolate L. plantarum B2028 for future research. The ability to
ferment LAC and the porcine origin of this strain may imply its better survival in and
colonisation of porcine gut. The studies by Collins et al. (2010) propose this to be the
case and so a synbiotic comprising LAC and L. plantarum B2028 was selected for
further investigation.
In addition to pure culture studies and to assess microbial changes and SCFA
production relating to the synbiotic inclusion, a static porcine simulated gut
fermentation system was used. Although more complex culture systems are available
for studying bacterial population shifts (Macfarlane and Macfarlane, 2007), the static
batch culture was chosen because it is economic, rapid, efficient and an ideal first
screen model system. The system was inoculated with the prebiotic (LAC or FOS) on
its own and the synbiotic combination with L. plantarum B2028. FOS was included in
this study despite being poorly metabolized by L. plantarum B2028 in the pure culture
because it could possibly be favored by other members of porcine faecal microflora
considered beneficial for the host (Bifidobacterium spp.) as it has been  previously
reported (Bouhnik et al., 2004; Saulnier et al., 2008). Assessments were made in the
concentration of SCFA produced by GC methods and in the number of generic LAB
by FISH. Lactobacilli and bifidobacteria genera are part of the normal intestinal
microflora and are commonly used as probiotics (Roberfroid, 2000). Enhancement of
these beneficial bacteria and modulation of the microbiota population are postulated to
not only have a positive effect on the host, but also the creation of an unfavorable
niche for pathogens. Although as shown in this study FOS was not fermented
specifically by the prospective probiotic strain in the pure cultures, it was included in
the batch cultures as a positive control, because numerous in vitro studies have
demonstrated enhancement of Lactobacillus and Bifidobaterium spp. by this prebiotic
(Kaplan and Hutkins, 2003; McBain and Macfarlane, 1997; Wang and Gibson, 1993).
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However, in contrast to these studies, we have not observed significant changes in the
Bifidobacterium population with either of the experimental conditions and no
differences were seen in total bacterial numbers detected with DAPI. Similarly,
Mountzouris et al. (2006) did not seen beneficial effect on the bacterial populations of
pig’s large intestinal segments fed prebiotics, including FOS.
Porcine batch culture model contains a complex microbial environment into which
the prebiotics and synbiotic pairs were introduced and in these studies an increase in
Lactobacillus-Enterococcus numbers after 24 hours in comparison to 0 hour was
observed for both prebiotics and synbiotics. Moreover, at 24 hours for all conditions
the Lactobacillus-Enterococcus count was significantly higher compared to the
untreated control. Interestingly, throughout the fermentation where LAC and L.
plantarum + LAC were included, the numbers of bacteria detected with the Lab158
probe were significantly higher in comparison to FOS or its synbiotic pair. In fact, the
synbiotic containing LAC was better able to stimulate the Lactobacillus-Enterococcus
group across the entire incubation time. The mean counts calculated along the 24
hours, for L. plantarum + LAC were significantly higher to control (P<0.001), whereas
for L. plantarum + FOS no difference in the mean values was observed. As previously
demonstrated, FOS failed to stimulate Lactobacillus-Enterococcus bacteria but
increased the count of Salmonella when included in the batch culture system (Martin-
Pelaez et al., 2008). Significantly higher counts of bacteria detected with the Lab158
probe with LAC containing synbiotics suggesting that when FOS and L. plantarum
was added, FOS (in agreement with the pure culture studies) was not utilised by our
probiotic but by other members of porcine faecal inocula, whereas LAC was in
addition selectively fermented by L. plantarum.
An increase in the numbers of lactic acid bacteria, following the administration of
prebiotics has been shown to be directly correlated with increased concentrations of
fermentation products, mainly acetate, propionate butyrate and lactate (Pan et al.,
2009). In our study, significant increases in lactate production were detected after 5
hours of incubation and especially associated with the fermentations with FOS and L.
plantarum + FOS (P<0.01; P<0.05, respectively). This was also linked with a
significant increase in Lactobacillus-Enterococcus group for FOS treatment group
only. Perhaps, as suggested by Sakata et al. (2003), indigestible oligosaccharides could
to some extent be providing the energy for the bacterial ecosystem to increase SCFA
production but may not promote the growth of specific probiotic species. Interestingly,
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the same significant increase in Lactobacillus-Enterococcus with LAC and LAC
containing synbiotic was not associated with an increase of lactic acid concentration at
the same time point. In this simple assessment we have only evaluated counts of
Lactobacillus-Enterococcus, Bifidobacterium and total bacteria. Nevertheless, it is
known that in pure cultures lactic acid is the major metabolic product of not only
lactobacilli, bifidobacteria and enterococci, but also streptococci, eubacteria,
fusobacteria and clostridia (Duncan et al., 2004). Further assessment targeting other
bacterial populations is warranted.
The concentrations of lactic acid decreased to values not above 1.5 mM for all
conditions after 24 hours. In the gut, lactic acid often plays a role of an intermediate
metabolite and it is utilised by other bacterial species such as Selenomonas, Veillonella
and Megasphaera and converted to acetate, propionate and butyrate (Duncan et al.,
2004; Hashizume et al., 2003; Ushida et al., 2002). In our study a gradual increase in
SCFA concentrations was observed during the first 5 hours and further significant
increase in SCFA concentrations for FOS and L. plantarum + FOS at 10 hours
(P<0.01, P<0.001) was observed in comparison to control. This SCFA increase was
correlated with lactate concentrations decrease (P<0.01). Fermentation of both
prebiotics resulted in significant increase in SCFA concentrations at 24 hours in
comparison to the un-supplemented control. Interestingly, fermentation of LAC
resulted in concentrations of butyrate after 24 hours that were significantly higher
when compared with FOS or FOS containing synbiotic (P<0.05; P<0.01). Moreover,
the butyrate concentrations generated in L. plantarum + LAC were significantly
greater to those in L. plantarum + FOS (P<0.05). It has been shown that various
butyrate producing genera such as Clostridium, Eubacterium, Fusobacterium can
either convert lactic acid or even degrade prebiotics to butyrate as an end product
(Belenguer et al., 2006; Bourriaud et al., 2005; Macfarlane and Macfarlane, 2007).
Furthermore, the important role of Megasphaera elsdenii in lactate conversion to
butyrate in the pig and cow has been pointed out (Counotte and Prins, 1981; Counotte
et al., 1981; Ushida et al., 2002). In the studies by Tsukahara et al. (2006) inclusion of
lactate-utilising Megasphera elsdenii in combination with lactic acid bacteria
significantly stimulated the production of butyrate in the pig cecal in vitro model. A
weakness of the current study was the lack of probing for these other relevant species.
However, it should be remembered that this model system was a static fermentation
rather than continuous flow and, as might be anticipated, the observations of SCFA
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profiles is dynamic reflecting the evolution of the existing population at the start of the
experiments and not, therefore, a reflection of the quasi steady state in the in vivo
model. The stimulation of different bacterial populations by the specific prebiotics and
lactate metabolism may be a partial explanation as to why in the present studies we did
not observe a significant increase in lactic acid production with the lactulose
fermentation. As the system is a static fermentation chamber, it is probable that other
organisms utilise the SCFA acid and convert it to alternative end products. It would
have been useful to use other probes for other genera such as Clostridium,
Eubacterium, Fusobacterium and Megasphaera to assess this hypothesis. Bergman
(1990) has stated that the beneficial role of SCFA to the health of the host, is due to
supporting epithelial cell growth, blood flow and secretory and absorptive function of
the large intestine.
Furthermore, recent studies have shown that even low concentrations of butyric and
propionic acid decreased virulence gene expression of S. Typhimurium and
subsequently decreased intestinal colonisation of pigs (Boyen et al., 2008).
Fermentation of LAC with or without L. plantarum enhanced butyrate concentrations
and generated lower concentrations of acetic acid in comparison to other conditions,
and the latter has been known to upregulate virulence gene expression of Salmonella
(Van Immerseel et al., 2004). Observations in this study of enhanced Lactobacillus-
Enterococcus spp. and concentrations of butyric acid upon LAC fermentation was in
agreement with the previously referenced study (Martin-Pelaez et al., 2008). In the
same study, fermentation of FOS by porcine faecal microbiota was correlated with
higher S. Typhimurium counts. Thus results generated in this section suggested that L.
plantarum B2028 and LAC might be a more ideal synbiotic for further investigation as
an intervention for S. Typhimurium infection in pigs.
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Chapter 4
Evaluation of L. plantarum B2028 resistance to
environmental stresses and its safety assessment as a part of
further in vitro screening for a prospective probiotic
4.1 Introduction
Currently, the concept of alternative treatment strategies to control gastrointestinal
pathogens such as S. Typhimurium in livestock is a popular area of research. In order
to replace antimicrobials, probiotics, prebiotics, CE cultures and organic acids are well
accepted as alternatives (Callaway et al., 2008; Cho et al., 2011; Papatsiros et al.,
2012). In pigs, probiotic bacteria have not only been used to control microbial balance
in disease control, but also as growth-promoters, improving efficiency of digestion
(Cho et al., 2011; Collins et al., 2009). It has been postulated that probiotics improve
intestinal balance resulting in better animal health, better growth and feed utilisation
(Alexopoulos et al., 2004; Suo et al., 2012). It was also demonstrated that
administration of lactobacilli strains lead to facecal microbial composition changes in
young piglets which could be beneficial for the animal (Pieper et al., 2009; Simpson et
al., 2000). Yet, in practice confirmation and identification of the specific health
benefits of probiotics is not an easy task and has been interfered by various factors
(Klaenhammer and Kullen, 1999).
The mechanism by which probiotics exert their anti-pathogenic effect is
multifactorial including for example production of organic acids, bacteriocins,
hydrogen peroxide, via competition for nutrients (Coconnier et al., 1997; Collins et al.,
2009; Corcionivoschi et al., 2010) but these are not yet fully identified. However,
firstly, in order to colonise the GI tract and exert their functional properties, probiotics
must survive passage through the gastric environment of the stomach, withstand the
antibacterial properties of bile and preferentially adhere to intestinal epithelium
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(Jankowska et al., 2008; Klaenhammer and Kullen, 1999; Pan et al., 2008) and
selection of strains which display these traits is highlighted (Fuller, 1989).
As for any feed additive, probiotics are tightly regulated, and currently within the
EU the approval and risk management of a probiotic product is the obligation of the
European Commission (EC) and its constituent member states (von Wright, 2005).
Subsequently, feed additives including probiotics must adhere to guidelines covered in
Council Directive 87/153/EEC (Anadon et al., 2006). The requirements for a microbial
feed additive cover its clear identification, characterisation to the species level,
evidence of probiotic efficacy and tolerance by the animal. Furthermore, it must be
safe for the operator and it must not pose a risk to the safety of the end-consumer
(SCAN, 2001). Council Directive 87/153/EEC states that “viable micro-organisms
used as an active agent(s) in fed additives should not add to the pool transferable
antibiotic resistance genes already present in the gut” (EFSA, 2005; SCAN, 2001; von
Wright, 2005). Thus in addition, it is mandatory to assess antibiotic sensitivities and
deduce the genetic basis of any resistance prior to its clinical use. The possibility of the
resistance genes to exchange is not the only concern which encourages evaluation of
lactobacilli resistance profile, but also the need of antibiotic therapy when
Lactobacillus associated infections occurs (Cannon et al., 2005; Salvana and Frank,
2006) although exceedingly rare.
The data presented in the previous chapter enabled the selection of a prospective
synbiotic combination which is to be tested as a control strategy for S. Typhimurium
colonisation in pigs. As briefly mentioned above, in order to be able to exert its
beneficial effects, a successful potential probiotic strain is expected to have a
numerous of desirable properties and many reports list the selection criteria that should
be applied (Klaenhammer and Kullen, 1999; Saarela et al., 2000). It was demonstrated
in the previous chapter that L. plantarum B2028 exerts strong antimicrobial effect
against S. Typhimurium growth. Therefore, in an attempt to address other selection
criteria before the animal study and to conform with the EU legislative framework, the
tolerance of L. plantarum B2028 to acid and bile, its adherence to epithelial cells and
the antimicrobial susceptibility is discussed in this chapter.
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4.2 Results
4.2.1 Evaluation of L. plantarum B2028 ability to resist environmental stress
4.2.1.1 Acid tolerance
The acid tolerance assay was performed according to previously described method
by Hyronimus et al. (2000) (section 2.1.10). While L. plantarum B2028 was grown in
MRS medium, it was washed in and subsequently inoculated into pH adjusted
phosphate buffered saline (PBS). Results showed that the viability of L. plantarum
B2028 decreased most rapidly at pH 2.0 with 3.22 ± 0.24 log10 reduction in bacterial
numbers after 3 hours and with no viable cells recovered after 6 hours incubation.
Similar decrease in the number L. plantarum cells was observed at pH 2.5 with the
significant loss of viability observed within first 3 hours of incubation (P<0.001)
(Table 4.1). However, only 0.03 ± 0.01 log10 reduction in the number of viable bacteria
was observed during 3 hours of incubation at pH 3.0. Further incubation at pH 3.0
resulted in a 0.51 ± 0 log10 reduction, that was significantly different (P<0.01). A
decrease in the number of viable cells was also observed when L. plantarum was tested
in the non-adjusted 0.1M PBS (pH 7.2) with 0.11 ± 0.02 and 1.05 ± 0.12 log10
reduction at 3 and 6 hours respectively.
Table 4.1 The effect of acidic conditions on L. plantarum B2028 survival. L.
plantarum numbers (Log10 cfu/ml) determined after 3 and 6 hours incubation at 37°C
in 0.1M PBS at various pH values. The assay was performed in triplicate on three
separate occasions and the SEM is shown. Values significantly different from 0 hour
are indicated by **P<0.01 and *** P<0.001.
Condition L. plantarum B2028 (log10 cfu/ml) Log10 reduction
0 h 3 h 6 h 3 h 6 h
pH 2.0 6.07 ± 0.01 2.85 ± 0.22*** < 1 3.22 ± 0.24 < 6
pH 2.5 6.06 ± 0.02 3.28 ± 0.18*** < 1 2.78 ± 0.20 < 6
pH 3.0 6.10 ± 0.01 6.06 ± 0.01 5.58 ± 0.01** 0.03 ± 0.01 0.51 ± 0
pH 7.2 6.10 ± 0.01 5.99 ± 0.01 5.04 ± 0.10*** 0.11 ± 0.02 1.05 ± 0.12
Chapter 4
107
4.2.1.2 Tolerance to bile
The tolerance of L. plantarum B2028 to bile was tested according to the
previously established method (Gilliland et al., 1984) and as previously described in
section 2.1.11.
Following the principles of Chateau et al. (1994), L. plantarum B2028 was
sensitive to 0.3%, 0.6% (w/v) Oxgall salts and 0.9% (v/v) native porcine bile, with the
delay of growth (d) greater than 60 minutes compared with MRS control (d > 60
minutes). The lower concentrations of native porcine bile demonstrated weaker
inhibitory effect towards L. plantarum B2028 growth. The L. plantarum B2028 was
weakly tolerant to 0.6% porcine bile and resistant to 0.3% porcine bile (d = 45, d = 15
respectively) (Table 4.2).
Table 4.2 Tolerance to 0.3%, 0.6% (w/v) Oxgall bile salts and 0.3%, 0.6% and 0.9%
(v/v) native porcine bile of L. plantarum B2028. Cultures were incubated at 37˚C for
24 hours and the absorbance was read at OD600nm. The assay was performed in
triplicate on three separate occasions and the SEM is shown.
Bile type and
concentration
Time to reach an OD of
0.3 at 600nm (hrs)
Delay of growtha
(min)
Toleranceb 24h OD
MRS† 11.30 ± 0.04 - + 1.11 ± 0.03
0.3% Oxgall 12.45 ± 0.03 > 60 - 0.90 ± 0.01
0.6% Oxgall 17.15 ± 0.04 > 60 - 0.36 ± 0.06
0.3% Porcine bile 11.45 ± 0.06 15 + 1.11 ± 0.02
0.6% Porcine bile 12.15 ± 0.04 45 ± 0.97 ± 0.01
0.9% Porcine bile 13.25 ± 0.04 > 60 - 0.74 ± 0.03
a Delay of growth (min) measured using optical density (OD600nm) to increase by 0.3 units between MRS
control and MRS containing bile.
b (+) resistant, (±) weakly resistant, (-) sensitive (Chateau et al., 1994).
† MRS control without bile.
The bactericidal effect of the Oxgall bile salts and porcine bile on the growth of L.
plantarum B2028 was monitored for up to 24 hours. The growth of prospective
probiotic showed to be significantly different with Oxgall or higher porcine bile
concentrations when compared with MRS control (P<0.001) (Figure 4.1).
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A.
B.
Figure 4.1 Growth of L. plantarum B2028 in MRS medium (closed circles) and MRS
containing 0.3% (open triangle), 0.6% (open circle) and 0.9% (open squares) of bile (A
– Oxgall bile salts (w/v), B – native porcine bile (PB) (v/v)). MRS without bile was
included as a control. Cultures were incubated at 37°C for 24 hours and the absorbance
was read at 600nm (OD600nm). Dotted line indicates OD = 0.3. The assay was
performed in triplicate on three separate occasions and the SEM is shown. Values
significantly different from MRS control growth over 24 hours is indicated by ***
P<0.001.
Screening for bile salt hydrolase (BSH) activity of L. plantarum B2028 was
undertaken, however, these preliminary results were inconclusive and further
investigation would be required.
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4.2.2 Adherence of L. plantarum B2028 to porcine epithelial cell line
The ability to adhere to the host epithelial cells was suggested to be an important
property of many probiotic strains (Morelli, 2000). The assay was performed as
described previously in section 2.5.2 and the number of L. plantarum B2028 adhered
cells to IPEC-J2 monolayers with or without lactulose was determined after one and
two hour’s incubation period. The presence of 1% (w/v) LAC in the growth medium or
tissue culture medium had no effect on the adherence of L. plantarum B2028 to IPEC-
J2 monolayers. As anticipated, the number of probiotic bacterial cells adhering
increased with time and after 2 hours was significantly different as compared with 1
hour incubation (P<0.001) (Figure 4.2).
Figure 4.2 Adherence of L. plantarum B2028 to IPEC-J2 cells in the presence or
absence of LAC, following 1 hour (closed, grey bar) and 2 hours incubation period
(closed, black bar). The assay was performed in triplicate on three separate occasions
and the SEM is shown. Values significantly different from the values of 1 hour
incubation time point are indicated by *** P<0.001.
4.2.3 Evaluation of the candidate pre and probiotic cellular toxicity
Giemsa staining was carried out as previously described in section 2.5.5 and slides
were assessed for vacuolisation, nuclear condensation and cellular detachment using a
light microscope and compared to uninfected cells. The results showed that L.
plantarum B2028, L. plantarum B2028 and LAC induced minor vacuolization, also
observed when CFS was included. However, for all conditions used no significant
cellular pathology was recorded.
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4.2.4 Further L. plantarum B2028 safety assessment - antimicrobial susceptibility
testing
Minimum inhibitory concentrations (MICs) were determined as previously
described in section 2.1.13. L. plantarum B2808 was tested for resistance to
ampicillin, chloramphenicol, clindamycin, erythromycin, gentamycin, kanamycin,
streptomycin, tetracycline and vancomycin with the exception of
quinupristin/dalfopristin. According to the FEEDAP Panel microbiological
breakpoints (EFSA, 2008), L. plantarum B2028 was susceptible to ampicillin,
chloramphenicol, clindamycin, erythromycin, gentamycin, kanamycin, streptomycin
and tetracycline. The MIC value for vancomycin for facultative heterofermentative
lactobacilli was not specified. However, the breakpoint for homofermentative
lactobacilli is 2ng/µl, demonstrating the resistance of L. plantarum B2808 to this
antibiotic (MIC >256). Table 4.3 shows MIC breakpoints for L. plantarum B2808.
In addition to MIC determination, a previously developed Gram positive
microarray (Perreten et al., 2005) was used as described in section 2.2.6. The control
for the microarray consisted of biotin-labelled oligonucleotides which were positive.
The microarray confirmed the presence of aminoglycoside resistance genes (aac(6’)-li,
aac(6’)-lm, ant(4’)-la, aph(2”)-lb, aph(3’)-III), streptothricin resistant gene (sat4),
MLSB resistance gene (erm(B)), tetracycline resistance genes (tet(L)-1, tet(M), tet(U))
and vancomycin and teicoplanim resistance genes (van(A), van(Z)) for E. faecium
SF11770. Furthermore, the E. faecium was also positive for internal positive control.
This preliminary result of the microarray for L. plantarum B2808 indicated an absence
of resistance genes. However, for L. plantarum B2028 the array internal controls were
negative which may indicate a failure to detect resistance genes. Future analysis using
specific primers for PCR would be desirable to complete molecular screening for
antimicrobial resistance in L. plantarum B2028.
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Table 4.3 Minimum inhibitory concentration (MIC) results for L. plantarum B2028.
MIC’s were determined for all, except quinupristin/dalfopristin recommended
antimicrobials (EFSA, 2008). The assay was performed in duplicate.
MIC breakpoints (ng/µl)
L. plantarum B2028 E. faecalis ATCC 29212 a
Antibiotic tested Actual MIC breakpoint b Actual Expected
Ampicillin 1 2 2 1
Chloramphenicol 8 8 8 4
Clindamycin <0.06 1 16 8
Erythromycin 0.5 1 4 4
Gentamicin 1 16 16 8
Kanamycin 32 64 128 -
Streptomycin 16 n.r. 256 -
Tetracycline 16 32 16 16
Vancomycin >256 c n.r. 4 2
a MIC control
b Microbiological breakpoints defined by FEEDAP. Strains with higher that MICs breakpoint are
considered resistant (EFSA, 2008).
c Intrinsic resistance to vancomycin reported as a general feature (Danielsen and Wind, 2003).
n.r.- not required for L. plantarum spp.
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4.3 Discussion
The findings presented in the previous chapter aided the selection of the
prospective synbiotic combination, which was ultimately subjected to further in vitro
studies prior to its inclusion in an in vivo model. Nevertheless, the concern of
‘suitability’ of L. plantarum B2028 for animal model use and the ethical responsibility
to assess risks prior to any animal studies, lead to the studies described in this chapter.
Klaenhammer and Kullen (1999) functionally collated ‘appropriate probiotics’ into
four general categories, (appropriateness, technological suitability, competitiveness,
performance and functionality) listing the ability to resist the environmental stresses of
gastric pH and bile and adherence within the GIT as a part of the competitiveness
category. Efficacy of the probiotic will need to be validated ultimately within the in
vivo model. However, the use of an array of in vitro tests is recommended, especially
with regards to the safety of the probiotic.
Surviving passage through the stomach is important for the probiotic efficacy and
resistance to low pH is considered as candidate desirable property. The viability of the
isolate will depend on numerous factors such as present pH, the time of exposure
(Bezkorovainy, 2001), the form and the strain type (Marteau et al., 1993). In general
the pH of the porcine stomach is considered similar to that of humans with the pH
ranging from as low as 1.15 to 4.0 (Hossain et al., 1990; Kass et al., 1980). However,
the pH values of contents of the stomach are known to differ between anterior portion
and the posterior portion (in the pig pH 4.3 and pH 2.2 respectively) (Kararli, 1995;
Smith, 1965). Consideration needs also to be given to the matrix, such as food or
protective formulation, in which the probiotic is presented to the gastric environment
and the time of exposure to that environment. The transit time appears to be
proportional to the size of the substance, but also the presence or absence of the food in
the stomach (Hossain et al., 1990). It was demonstrated that gastric emptying in the
pig consists of two phases, first a rapid phase occurring at the feeding stage and the
second extended phase characterised by regular but slower emptying (Gregory et al.,
1990). This process takes considerably less time in young pigs compared to adult
(Kararli, 1995). Laboratory based screening showed the ability of L. plantarum B2028
to survive the 3 hours exposure to all tested pH ranges.  However, with the lowest pH
range (pH 2 and pH 2.5) over 2-log reduction in viable counts was observed. Further
exposure, up to 6 hours to those pH values resulted in complete loss of viability.
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Interestingly, L. plantarum B2028 was resistant to pH 3.0 and only after 6 hours of
exposure 0.51-log reduction in viable counts was observed. Given the variable pH of
the porcine stomach and relatively rapid gastric emptying rate (Gregory et al., 1990), it
may be reasonably argued that a proportion of viable probiotic cells will reach the
small intestine within the first 3 hours. Moreover, Corcoran et al. (2005) demonstrated
that survival of L. rhamnosus GG in simulated gastric juice at pH 2.0 was improved in
the presence of carbohydrates that could be metabolised by this strain. It might also be
anticipated that administration of L. plantarum B2028 together with lactulose may
enhance the probiotic candidate survival.
Prospective probiotics capable of surviving harsh acidic environment will further
encounter the membrane damaging effect of bile during the passage through the small
intestine (Bron et al., 2004). Bile consists of bile salts, cholesterol and phospholipids
(Kararli, 1995). Cholic acid and chenodeoxycholic acid are the primary bile salts
present in the human gut and a range of animal species (Coleman et al., 1979). The
proportion of these primary bile acids in mammals and therefore toxicity depends on
the species, as it is recognized that dihydroxy bile salt are more effective at membrane
disruption than trihydroxy bile salts (Coleman et al., 1979; Vyvoda et al., 1977).
Secondary bile acids like deoxycholic and hyodeoxycholic are by-products of former
bile salts, produced by bacterial metabolism (Ridlon et al., 2006). In pigs, the primary
bile acids are glycine and taurine conjugates of dihydroxy bile salts, with smaller
quantities of trihydroxy bile salts (Coleman et al., 1979) and the most abundant
secondary bile acid is hyodeoxycholic acid (Coleman et al., 1979; Haslewood, 1971).
Considering the species specific composition of bile, in addition to the routinely used
Oxgall bile salts, the tolerance of L. plantarum B2028 to fresh porcine bile collected
from a gall bladder was evaluated here. This model was thought to be more
representative of the porcine in vivo environment. According to the classification
proposed by Chateau et al. (1994), L. plantarum B2028 would be considered sensitive
to 0.3% bovine bile salts, but fully resistant to 0.3 - 0.6% of the porcine bile. Only
0.9% of the freshly collected porcine bile significantly reduced the growth of the
isolate (P<0.001). As demonstrated, the resistance of L. plantarum B2028 towards
Oxgall bile salts is low which could be due to differences in the bile composition. The
resistance to (0.3-0.6%) porcine bile and the host origin indicates that L. plantarum
may be able to resist the antimicrobial properties of bile. However, care should be
taken with this argument as the concentration of bioavailable and bioactive bile acids
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in Oxgall and the fresh porcine sample may not be the same.
In the intestine conjugated bile acids can be hydrolyzed by a range of bacteria
present in the gut and among the various genera Lactobacillus is also found to express
conjugated bile salt hydrolases (BSHs). These enzymes have been speculated to
decrease the harmful effect of bile salts and, therefore, may be important for
colonisation (Moser and Savage, 2001). Attempts were made to screen for BSH
activity (data not presented) expressed by L. plantarum B2028 but the results were
inconclusive. In hindsight, screening for the presence of the bile salt hydrolase (bsh)
gene may have been an appropriate first step before undertaking detailed biochemical
analyses to establish the phenotype. In conclusion, the survival studies presented here
demonstrated the potential of L. plantarum B2028 to resist the stresses it might
encounter in the upper alimentary tract of pigs and, therefore, this organism is likely to
reach the colon assuming a sufficient inoculum is delivered orally to the pig. Only in
vivo feeding trials will test this hypothesis.
The adherence of Lactobacillus isolates has been thought to enhance the
likelihood of intestinal colonisation (Adlerberth et al., 1996; Klaenhammer and
Kullen, 1999; Morelli, 2000). Moreover, the ability of probiotics to attach to intestinal
cells is correlated with their capacity to interfere with the adherence of pathogens in
vitro (Bezkorovainy, 2001). The results in this chapter demonstrated that L. plantarum
B2028 was competent at adhering to porcine epithelial cells regardless of the presence
or absence of LAC. It can be concluded that LAC did not influence the adherence of L.
plantarum B2808 and the question remains whether LAC may inhibit the adherence of
pathogens as shown for GOS by Searle et al. (2010). This issue will be tackled in the
next chapter.
Much of the selection criteria for commercial probiotics are based on assessing
safety. Probiotic organisms are generally defined as non pathogenic and beneficial to
the host physiology (Ouwehand et al., 2002). However, in order to be used as a feed
additive, probiotics must be classified as generally regarded as safe (GRAS) and
therefore not cause any harmful effects on human or animal health (Tannock, 2003).
Firstly, we evaluated the cellular toxicity towards a porcine epithelial cell line of
L. plantarum B2808, lactulose and CFS. Giemsa stain results showed the presence of
only minor vacuolization following incubation with the bacteria, CFS and lactulose.
Although severe and long term vacuolization can lead to the cell death, the process of
vacuolization has been associated with the adaptive physiological response to a
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stressor and it is thought to be fully reversible (Henics and Wheatley, 1999). The
causes of vacuolization are multifactorial and it is difficult to give any clear reason
why the minor vacuolization in the cell line was generated. Technically, monolayers
by default are highly stressed cells and any further stress may induce the minor
vacuolization that was observed. Nevertheless, healthy epithelial cells in their natural
environment and with the presence of the mucus lining in the pig gut might suggest
that our observations will not be translated in vivo.
Further stringent safety assessment is particularly important when taking into
consideration the antibiotic resistance in these bacteria (Gueimonde and Salminen,
2006; Salminen et al., 1998). The extensive use of antimicrobials in both human and
animal medicine resulted in the selection of antibiotic resistance (Davies, 1997;
Mathur and Singh, 2005). Antibiotic resistance in bacteria can be either intrinsic or
acquired. The intrinsic resistance is not generally horizontally transferable, therefore,
creates less risk in non-pathogenic bacteria (Mathur and Singh, 2005). On the contrary,
specifically acquired resistance (via plasmids, transposons or integrons carrying
antibiotic resistance genes) is of significant interest as there are fewer obstacles for
transfer between pathogenic, potentially pathogenic and commensal LAB what could
lead to the exchange of the resistance genes (Teuber, 1999; Teuber et al., 1999). It is
therefore obligatory that prior to clinical use probiotic strains need to be fully
characterised in order to differentiate the antimicrobial resistant and sensitive strain.
As pointed out previously, FEDDAP guidelines for determination of MIC’s against a
range of widely used antimicrobials are essential for the safety screening of probiotics.
L. plantarum B2028 isolate was found to be susceptible to ampicillin,
chloramphenicol, clindamycin, erythromycin, gentamycin, kanamycin, streptomycin
and tetracycline and resistant to vancomycin. Resistance to vancomycin has been seen
in variety of lactobacilli, however the resistance pattern is not related to the type found
in enterococci (Salminen et al., 1998; Tynkkynen et al., 1998). Elisha and Courvalin
(1995) demonstrated that intrinsic resistance mediated by D-alanine: D-alanine ligase-
related enzymes towards vancomycin in Lactobacillus spp. are not closely related to
the Ddl-related enzymes, VanA and VanB associated with the acquired and therefore
mobile resistance in enterococci. Moreover intrinsic resistance to vancomycin has been
reported as a general feature for lactobacilli (Danielsen and Wind, 2003). In
conclusion, the results obtained in this chapter would indicate that L. plantarum B2028
be considered susceptible to a range of commonly used antimicrobials. However, to
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complete that screening the MIC for quinupristin/dalfopristin need to be carried out in
future studies. The phenotypic data were in agreement with the molecular screening
although some doubt must be cast over the array as the internal controls may have
failed. In addition prior to commercial application of this strain screening for the
presence of virulence factors should also be considered as an important aspect of safety
evaluation.
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Chapter 5
An in vitro evaluation of L. plantarum B2028 and lactulose
antagonistic activity against S. Typhimurium
5.1 Introduction
Salmonella infections in animals, including pigs result in health, productivity and
economic loses; in the EU anticipated cost associated with pork is around €90 million
(Anonymous, 2010). Moreover, it has been recognised that pork and pork products are
an important source of Salmonella infections in humans (Lo Fo Wong et al., 2002).
Antimicrobial growth promoters have been used in animals since 1940’s due to
numerous health benefits including disease control (Page, 2006). However, increasing
antibiotic resistance became recognised as a major problem that has implications for
both human and animal health (McEwen and Fedorka-Cray, 2002; Threlfall, 2000) and
this has led to their removal as feed additives in the EU in 2006 as regulated by the
Regulation (EC) No 2160/2003 (Anonymous, 2003).
The concept of including prebiotics and probiotics in the animal diet is an area of
current active research (Callaway et al., 2008) driven largely by the need to reduce
dependency on the use of antimicrobials. Among various alternative control strategies
applied in human and animals is the consumption of probiotics as this has been
associated with health benefits in both (Fuller, 1989). The beneficial effects for the
host are considered due to improved intestinal homeostasis and the inhibitory action of
probiotics against pathogens that could be mediated via immunomodulation, enhancing
epithelial barrier function, competition for the receptor sites on the host epithelium and
competition for nutrients in the gut (Chichlowski et al., 2007; Cho et al., 2011; Makras
et al., 2006; Oelschlaeger, 2010; Servin, 2004). Prebiotics, such as the complex
oligosaccharides that are not metabolized by the host but are by bacteria such as the
bifidobacteria, stimulate beneficial bacteria in the gut thereby enhancing probiotic
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effects (Macfarlane and Macfarlane, 2007; Macfarlane et al., 2008; Tzortzis et al.,
2005). Both probiotics and prebiotics and combinations, called synbiotics, have been
advocated as potent intervention measures that reduce adhesion and invasion of
pathogenic bacteria in vitro and in vivo (Coconnier et al., 1997; Hudault et al., 1997;
Lin et al., 2008; Searle et al., 2009; Searle et al., 2010). Moreover, the production of
short chain fatty acids (SCFA) such as lactate and acetate plus other antimicrobial
substances by probiotic bacteria has been reported to be inhibitory to a wide range of
pathogenic bacteria (Coconnier et al., 1997; De Keersmaecker et al., 2006; Makras et
al., 2006; Vandenbergh, 1993). SCFA have not only been implicated to have an
antagonistic effect towards Salmonella and other enteropathogens in vitro and in vivo
(McHan and Shotts, 1993) but also play a role in colonic health specifically in
colonocytes differentiation and proliferation, especially butyrate (Macfarlane et al.,
2008).
One of the testable hypotheses of the work presented in this thesis is that a
synbiotic combination containing L. plantarum B2028 and LAC would effectively
reduce S. Typhimurium colonisation in the pig. Before aforementioned feeding control
strategy is investigated using an animal model, adequate experimental models that
adhere to the three R’s principles need to be employed (Boyen et al., 2009; Russell and
Burch, 1992). To do this, the interactions of STm SL1344 nalr with the ‘host’ and in
the presence of pre, pro and synbiotic, extensive in vitro porcine models have been
utilised. To investigate the in vitro efficacy of L. plantarum B2028 and LAC against
STm SL1344 nalr the studies described in this chapter employed growth, viability,
adhesion and invasion assays. In addition to porcine faecal batch culture studies
described in Chapter 3, here the effect of L. plantarum B2028 and LAC inclusion into
the system on STm SL1344 nalr survival is described.
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5.2 Results
5.2.1 Antimicrobial activity of L. plantarum B2028 cell-free supernatant against S.
Typhimurium
5.2.1.1 Inhibition of S. Typhimurium growth, a role of low pH and lactic acid
The effect of cell-free supernatants from L. plantarum B2028 grown in MRS
(CFS) and MRS containing LAC (MRSL) (CFSL) on the growth of STm SL1344nalr
was investigated using the conditioned medium assay described previously (section
2.1.8). The pH adjusted MRS and MRSL broth were included as pH controls, whereas
MRS/MRSL lactic acid controls contained L- lactic acid (-LA) (Table 5.1 and Table
3.1 of Chapter 3). The growth of STm SL1344nalr was measured at OD 600nm (Figure
5.1 and Figure 5.2 A&B) and the reduction of growth was determined by the area
under the curve (AUC) over 24 hours (Table 5.2).
Inclusion of L. plantarum B2028 CFS and CFSL at pH 3.8 inhibited the growth of
STm SL1344nalr for approximately 10 hours, after which time growth occurred but at
a reduced rate compared with LB-G, a significant growth reduction (P<0.001) (Figure
5.1). Furthermore, the growth of STm SL1344nalr was also significantly reduced with
MRS-LA/MRSL-LA (P<0.001) and MRS pH control given at pH 3.8 when compared
with LB-G. Interestingly, it was also observed that STm SL1344nalr growth in the
presence of L. plantarum B2028 supernatants (CFS/CFSL) and lactic acid control
media (MRS-LA/MRSL-LA) (pH 3.8) was significantly reduced compared with
relevant MRS/MRSL pH controls (P<0.001).
When L. plantarum B2028 supernatants and control media were included at pH
4.5, the growth of STm SL1344nalr was significantly reduced only in the presence of
L. plantarum B2028 CFS, CFSL and one of the lactic acid controls (MRS-LA) when
compared with the LB-G control (P<0.001, P<0.001, P<0.01 respectively). Moreover,
lactic acid controls (MRS-LA/MRSL-LA) at pH 4.5 had no effect on the growth of
STm SL1344nalr when compared with respective pH controls (MRS/MRSL), while
with L. plantarum B2028 supernatants (CFS/CFSL) the reduction of the growth of
STm SL1344nalr was still observed (P<0.01, P<0.001) (Figure 5.2 A&B).
At pH 7.2, none of the conditions tested influenced STm SL1344nalr growth when
compared to its growth in non-conditioned LB-G medium; in fact, modest increases in
the growth of STm SL1344nalr were observed with pH and lactic acid controls (P<
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0.001). Very small, nevertheless significant reductions of growth of STm SL1344nalr
were observed with both L. plantarum B2028 supernatants (CFS/CFSL) and one of the
lactic acid control media (MRSL-LA) (P<0.001, P<0.01 respectively).
Table 5.1 Concentrations (mM) of organic acids in the L. plantarum B2028 CFSL and
MRSL broth. The assay was conducted in triplicate and the SEM is shown.
Condition pH Lactic and SCFA concentrations (mM)
Lactic acid Acetic acid Butyric acid Propionic acid
MRSLa 5.81± 0.10 1.40 ± 0.29 88.0 ±4.13 10.9 ± 0.06 11.5± 1.48
CFSLb 3.89± 0.08 123± 9.25 80.4 ± 7.65 19.8 ± 2.82 6.5 ± 0.53
a MRS broth with 1% (w/v) lactulose.
b Cell free supernatant of L. plantarum B2028 when grown in MRSL broth.
Figure 5.1 Growth of STm SL1344nalr in LB-G broth (closed, grey bar) and with
inclusion of 10% (v/v) L. plantarum B2028 CFS (closed, black bar) and CFSL (white
bar). Cultures were incubated at 37°C for 24 hours and the OD was measured at
600nm (OD600nm). The assay was performed in triplicate on three separate occasions
and the SEM is shown. Values significantly different from the non-conditioned control
(LB-G) at the final reading point are indicated by *** P<0.001.
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Figure 5.2 Growth of STm SL1344nalr in LB-
G broth supplemented with 10% (v/v) L.
plantarum B2028 CFS (A) and CFSL (B) at
pH 3.8 (red triangles), pH 4.5 (red squares)
and pH 7.2 (red circles). Lactic acid controls
(MRS-LA (A) and MRSL-LA (B)) adjusted to
pH 3.8 (blue triangles), pH 4.5 (blue squares)
and pH 7.2 (blue circles) and pH controls
(MRS (A) and MRSL (B)) adjusted to pH 3.8
(green triangles), pH 4.5 (green squares) and
pH 7.2 (green circles) were also included at
10% (v/v) dilution factor. OD at 600nm
(OD600nm) was measured as a growth reporter.
The assay was performed in triplicate on three
separate occasions and the SEM is shown.
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Table 5.2 The growth of STm SL1344nalr in the conditioned and pH controlled media.
Experimental condition Mean AUC Significance to LB-G
control
Significance to pH
control
S. Typhimurium SL1344 nalr culture in LB-G (SL)‡ 10.79 ± 0.16 - -
SL + 10% (v/v) MRSa broth at pH 3.8 (MRS pH 3.8)† 7.09 ± 0.19 P< 0.001 -
SL + 10% (v/v) MRSLb broth at pH 3.8 (MRSL pH 3.8)† 10.11 ± 0.11 NS -
SL + 10% (v/v) MRS broth containing lactate at pH 3.8 (MRS-LA pH 3.8)†† 5.34 ± 0.26 P< 0.001 P< 0.001
SL + 10% (v/v) MRSL broth containing lactate at  pH 3.8 (MRSL-LA pH 3.8)†† 5.45 ± 0.62 P< 0.001 P< 0.001
SL + 10% (v/v) L. plantarum B2028 CFSc at pH 3.8 (CFS pH 3.8) 1.44 ± 0.31 P< 0.001 P< 0.001
SL + 10% (v/v) L. plantarum B2028 CFSLd at pH 3.8 (CFSL pH 3.8) 1.92 ± 0.23 P< 0.001 P< 0.001
SL + 10% (v/v) MRS broth at pH 4.5 (MRS pH 4.5) 9.59 ± 0.18 NS -
SL + 10% (v/v) MRSL broth at pH 4.5 (MRSL pH 4.5) 11.55 ± 0.08 NS -
SL + 10% (v/v) MRS broth containing lactate at pH 4.5 (MRS-LA pH 4.5) 9.20 ± 0.34 P< 0.01 NS
SL + 10% (v/v) MRSL broth containing lactate at pH 4.5 (MRSL-LA pH 4.5) 11.10 ± 0.17 NS NS
SL + 10% (v/v) L. plantarum B2028 CFS at pH 4.5 (CFS pH 4.5) 8.11 ± 0.24 P< 0.001 P< 0.01
SL + 10% (v/v) L. plantarum B2028 CFSL at pH 4.5 (CFSL pH 4.5) 9.00 ± 0.17 P< 0.001 P< 0.001
SL + 10% (v/v) MRS broth at pH 7.2 (MRS pH 7.2) 13.70 ± 0.16 ( P< 0.001) -
SL + 10% (v/v) MRSL broth at pH 7.2 (MRSL pH 7.2) 11.87 ± 0.20 ( P< 0.001) -
SL + 10% (v/v) MRS broth containing lactate at pH 7.2 (MRS-LA pH 7.2) 13.26 ± 0.26 ( P< 0.001) NS
SL + 10% (v/v) MRSL broth containing lactate at pH 7.2 (MRSL-LA pH 7.2) 11.11 ± 0.12 ( P< 0.001) P< 0.01
123
Ch
apter
 5
Table 5.2 (cont’d).
Experimental condition Mean AUC Significance to LB-G
control
Significance to pH
control
SL + 10% (v/v) L. plantarum B2028 CFS at pH 7.2 (CFS pH 7.2) 11.65 ± 0.29 NS P< 0.001
SL + 10% (v/v) L. plantarum B2028 CFSL at pH 7.2 (CFSL pH 7.2) 10.83 ± 0.08 NS P< 0.001
a MRS broth containing 2% (w/v) glucose.
b MRS broth containing 1% (w/v) lactulose.
c L. plantarum B2028 cell free supernatant when grown in MRS broth.
d L. plantarum B2028 cell free supernatant when grown in MRSL broth.
† MRS /MRSL broth adjusted to relevant pH (3.8, 4.5, 7.2) used as pH control.
†† MRS /MRSL broth containing 145 mM and 123 mM L-lactic acid respectively and adjusted to relevant pH (3.8, 4.5, 7.2) used as lactic acid control.
‡ SL (S. Typhimurium SL1344 nalr) grown in LB-G - non-conditioned medium control.
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5.1.1.2 The effect of L. plantarum B2028 cell-free supernatant on viability and
invasive phenotype of S. Typhimurium
Viability assays were performed following previously established procedures
(Coconnier et al., 1997; Makras et al., 2006) with the slight modifications as described
in section 2.5.3. No significant reduction of STm SL1344nalr viability was observed
after 1 hour of incubation with 10 % (v/v) MRS, MRSL, MRS-LA, MRSL-LA, L.
plantarum B2028 CFS, CFSL at pH 3.8 (Figure 5.3).
Figure 5.3 Numbers of viable STm SL1344nalr cells before (0 hour, white bar) and
after pre-incubation (1 hour, grey bar) in IPEC-J2 medium with L. plantarum B2028
supernatants (CFS, CFSL), lactic acid controls (MRS-LA, MRSL-LA) and pH controls
(MRS, MRSL) (pH 3.8) at 10% (v/v) dilution factor. Non-buffered control (SL) was
included and incubated only in IPEC-J2 medium. The assay was performed in
duplicate on three separate occasions and the SEM is shown.
For the invasion assays the porcine jejunal epithelial cells (IPEC-J2) were used
(Schierack et al., 2006) and assays were performed as previously described (Coconnier
et al., 1997; Dibb-Fuller et al., 1999; Makras et al., 2006) (section 2.5.4) using the
bacterial cells that were pre-incubated for 1 hour in the media preparations used for
viability tests. The invasion of STm SL1344nalr into IPEC-J2 monolayers (expressed
as a % of the initial inoculum invaded) was significantly reduced after pre-incubation
with L. plantarum B2028 supernatants (CFS, CFSL), lactic acid controls (MRS-LA,
MRSL-LA) (P<0.001) and to a lesser extent by pH controls (MRS, MRSL) (P<0.05)
(Figure 5.4). The impact of pH alone (MRS/MRSL) was not as extensive as either pH
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and lactic acid (MRS-LA/MRSL-LA) and even lower to that of pH and additional
components of the spent medium CFS/CFSL (P<0.01).
Figure 5.4 Invasion of STm SL1344nalr to IPEC-J2 cells following pre-incubation
with 10% (v/v) of L. plantarum B2028 supernatants CFS (black bar) and CFSL (white
bar), lactic acid controls MRS-LA (hatched, black bar) and MRSL-LA (hatched, white
bar) and pH controls MRS (horizontal lines, black bar) and MRSL (horizontal lines,
white bar). Non-buffered control was included (SL, grey bar) and incubated only in
IPEC-J2 medium. The assay was performed in duplicate on three separate occasions
and the SEM is shown. Values significantly different from SL control are indicated by
* P<0.05, *** P<0.001; values significantly different from the MRS and MRSL
controls are indicated by the letter a P<0.01.
5.2.2 Reduction of S. Typhimurium adherence and invasion to IPEC-J2 cells
using monolayer and three-dimensional model
Adhesion and invasion assays were performed as previously described (Dibb-
Fuller et al., 1999; Dibb-Fuller et al., 2001; Searle et al., 2009; Searle et al., 2010)
using different experimental conditions in a competition assay as listed in section
2.5.4. Both traditional IPEC-J2 monolayer and novel 3D cell models were utilised and
the latter was based upon previous methods (Collins, 2010; Nickerson et al., 2001;
Searle et al., 2010) (section 2.5.1.2). L. plantarum B2028 supernatants and MRS
control (pH 3.8) were obtained as described in section 2.1.8 and used at a 10% (v/v)
dilution factor.
A significant reduction in the number of STm SL1344 nalr that had invaded was
observed when monolayers were simultaneously incubated with L. plantarum B2028
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and its CFSL or with CFSL on its own (P<0.001) as compared with the untreated STm
SL1344 nalr control (Figure 5.5). The reductions of invasion of STm SL1344 nalr in
monolayers were 20.6-fold and 10.0-fold respectively. Moreover, the adhesion of STm
SL1344 nalr to IPEC-J2 cells was also reduced when co-incubated with L. plantarum
B2028 and its CFSL and CFSL devoid of bacterial cells (P<0.05). Interestingly, the
probiotic without its supernatant or the prebiotic alone had no effect upon the
adherence or invasion of STm SL1344 nalr into porcine epithelial cells under the
laboratory conditions used.
The results obtained using the 3D IPEC-J2 model were comparable to those
acquired using the monolayer model (Figure 5.5), showing significant reduction in
STm SL1344 nalr adherence (P<0.05) to and invasion (P<0.001) into 3D IPEC-J2
cells when co-incubated with both cells and CFSL of L. plantarum B2028 or CFSL
alone. L. plantarum B2028 and its supernatant reduced invasion of STm SL1344 nalr
30.2-fold, whereas 13.0-fold reduction was observed when the cell free supernatant
was administered solely.
Figure 5.5 Adherence (white bars) and invasion (grey bars) of STm SL1344nalr to
IPEC-J2 monolayers in the presence of L. plantarum B2028 and LAC. All treatments
containing L. plantarum B2028 CFSL and control MRSL (pH 3.8) were delivered at
10% (v/v) dilution factor, whereas LAC at 1% (w/v). The assay was performed in
duplicate on three separate occasions and the SEM is shown. Values significantly
different from the control (SL) are indicated by * P<0.05, *** P<0.001.
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Figure 5.6 Adherence (white bars) and invasion (grey bars) of STm SL1344nalr to
IPEC-J2 3D cells in the presence of L. plantarum B2028 and LAC. All treatments
containing L. plantarum B2028 CFSL  and control MRSL (pH 3.8) were delivered at
10% (v/v) dilution factor, whereas LAC at 1% (w/v). The assay was performed in
duplicate on three separate occasions and the SEM is shown. Values significantly
different from the control (SL) are indicated by * P<0.05, *** P<0.001.
5.2.3 Porcine in vitro organ culture, the effect of L. plantarum B2028 and lactulose
on S. Typhimurium association
A polarized in vitro organ culture (IVOC) model using CellCrown™ technology
was employed as previously established by Collins et al. (2010) (section 2.5.6).
Porcine intestinal explants from jejunum and colon were immobilized in
CellCrowns™ (Scaffdex) with the mucosal side positioned upwards, placed into 24
well plates and submerged in a complete RPMI-1640 medium as previously described
in section 2.5.6. Subsequently, the immobilised tissues were inoculated under the same
experimental conditions that were used for adhesion and invasion assays (section
2.5.3) and incubated at 37°C in the presence of 5% CO2.
Conversely to the results obtained from adhesion and invasion assays using
monolayer and 3D cells, here the simultaneous co-incubation of STm SL1344nalr with
L. plantarum B2028 and CFSL (10% v/v) or CFSL (10% v/v) alone had no effect upon
the association STm SL1344nalr to porcine jejunal or colonic tissues.
Interestingly, a numerically small but statistically significant reduction in the
number of STm SL1344nalr associated with colonic tissue explants was observed when
L. plantarum B2028 cells and LAC (1% w/v) were added simultaneously with STm
SL1344nalr (P<0.05) (Figure 5.7).
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Figure 5.7 Association of STm SL1344nalr to porcine jejunal (white bar) and colonic
tissue explants (grey bar) in the presence of L. plantarum B2028 and LAC. All
treatments containing L. plantarum B2028 CFSL and control MRSL (pH 3.8) were
delivered at 10% (v/v) dilution factor, whereas LAC at 1% (w/v). The assay was
performed in quadruplicate on two separate occasions and the SEM is shown. Values
significantly different from the control (SL) are indicated by * P<0.05.
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5.2.4 The effect of L. plantarum B2028 and lactulose on bacterial and organic acid
changes in a porcine batch culture system infected with S. Typhimurium
5.2.4.1 Bacterial numbers changes
The experiment was set up and conducted as described in detail in section 2.1.14.
Porcine faecal samples were checked for and showed the absence of Salmonella as
described previously in section 2.6.5. The detection of the test organisms was by
fluorescent in situ hybridization (FISH) (section 2.2.7). A total of four porcine batch
culture fermentation systems were set up (section 2.1.14) and each was inoculated with
an overnight culture of STm SL1344nalr.
The numbers of Salmonella, detected using Sal303 FISH probe, were calculated
over the 24 hour period of incubation in the CTR (STm SL1344nalr only) porcine
batch culture fermentation system and showed a marginal decline that was not
statistically significant. The trend for all treatment groups was similar, but there were a
few noticeable differences in LAC and L. plantarum B2028 and LAC (Lp + LAC)
treatment groups. In the LAC treated porcine fermentation systems, Salmonella
numbers increased significantly (P<0.05) in the 24 hour sample compared with the
CTR 24 hour sample. In the Lp + LAC treated porcine fermentation systems, however,
the numbers of Salmonella detected was significantly lower (P=0.05) in both the 10
and 24 hour samples compared with the 0 hour sample. Nevertheless, no significant
differences were observed for Lp + LAC compared with CTR (Figure 5.8). No
significant differences were observed for L. plantarum B2028 (Lp) treated porcine
fermentation systems.
The numbers of Lactobacillus-Enterococcus detected using the Lab158 FISH
probe over the 24 hour period of incubation were significantly increased with the
inclusion of LAC and Lp + LAC to porcine fermentation systems (P<0.05).
Interestingly, a particularly prominent increase in Lactobacillus-Enterococcus numbers
was observed in the LAC treated porcine batch culture system after 10 hours of
incubation (Figure 5.9). Mean values for Lactobacillus-Enterococcus calculated from
all collected time points were significantly higher for Lp + LAC compared with CTR
(P<0.05). No significant differences in Lactobacillus-Enterococcus were found in
CTR or Lp treated fermentation systems.
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No significant changes in bifidobacteria numbers with the inclusion of LAC, Lp +
LAC or Lp were observed (P=1.00). Similarly, no significant changes were recorded
in total numbers of bacteria numbers detected with DAPI stain (P=0.619).
Figure 5.8 Bacterial numbers (Log10 cells/ml) enumerated using a Sal303 FISH probe
over a 24 hour incubation period within porcine batch culture system inoculated with
STm SL1344nalr and treated with LAC, L. plantarum B2028 (Lp), L. plantarum
B2028 + LAC (Lp + LAC), respectively. CTR was inoculated only with 10% (v/v)
faecal slurry and STm SL1344nalr. Bacterial numbers are showed at specific time
points: 0 hour (hatched bar), 5 hours (white bar), 10 hours (black bar), 24 hours (grey
bar). The assay was performed in duplicate on two separate occasions and the SEM is
shown. Values significantly different from the CTR at the specific time point are
indicated by * P<0.05 and * P<0.05; values significantly different from the 0 hour at
24 hours are indicated cP<0.05.
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Figure 5.9 Bacterial numbers (Log10 cells/ml) enumerated using a Lab158 FISH probe
over a 24 hour incubation period within porcine batch culture system inoculated with
STm SL1344nalr and treated with LAC, L. plantarum B2028 (Lp), L. plantarum
B2028 + LAC (Lp + LAC), respectively. CTR was inoculated with only with 10%
(v/v) faecal slurry and STm SL1344nalr. Bacterial numbers are showed at specific time
points: 0 hour (hatched bar), 5 hours (white bar), 10 hours (black bar), 24 hours (grey
bar). The assay was performed in duplicate on two separate occasions and the SEM is
shown. Values significantly different from the CTR at the 24 hours are indicated by *
P<0.05; values significantly different from the 0 hour at 24 hours are indicated by
aP<0.001 and cP<0.05.
5.2.4.2 Short chain fatty acids analysis
The production of short chain fatty acids (SCFA) in the porcine batch culture
fermentation system (section 5.2.4.1) upon inclusion of the various treatment regimes
was analysed by HPLC (section 2.4.1).
The addition of the prospective pre, pro or synbiotic was not correlated with the
detectable changes in lactic acid concentrations (Figure 5.10). The CTR samples had
reducing amounts of lactic acid so that by 24 hours the concentration was at the limits
of detection. As predicted, by 24 hours, increases in SCFA concentrations (sum of
acetic, propionic and butyric acids) were observed in all treatment groups and the
control (P<0.001 and P<0.05 respectively) (Figure 5.11).
Delving deeper into the specific changes seen in the four treatments, after 5 hour
incubation the total SCFA produced had risen in each of the four treatments about
three-fold. However, there were no significant differences in SCFA concentration
between treatments. After 10 hours, the general trend for increased accumulation of
SCFA in all treatments continued to be observed but inclusion of LAC with or without
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L. plantarum resulted in the significantly higher concentrations of total SCFA
(P<0.01). After 24 hours, the increase in concentrations of total SCFA in all treatments
was again observed. However, the amounts for treatments containing LAC (LAC and
Lp + LAC) and for Lp alone were all significantly higher than CTR (P<0.001,
P<0.001 and P<0.05, respectively).
Whilst Figure 5.11 shows the total SCFA data, more detailed analysis of the
individual components of the SCFA was also undertaken and these data are shown in
Figure 5.12. A general trend for the ratios of four SCFAs was shown across all
treatment groups with concentrations of each being in the order of acetic > propionic >
butyric > lactic acid. After 5 hour incubation there were no significant differences
between treatments. However, after 10 hours for the Lp and CTR propionate
concentrations were significantly less than all other treatments (P<0.05 and P<0.001).
At the same time point acetate concentrations were significantly higher than butyrate.
After 24 hour incubation, the concentrations of all acids in all treatments were higher
than CTR. Also at this time point, acetic acid was higher versus those of butyrate for
LAC and Lp (P<0.01 and P<0.05 respectively). In both LAC and Lp + LAC
treatments butyrate concentrations were significantly higher than CTR (P<0.001).
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Figure 5.10 Concentrations (mM) of lactic acid at 0, 5, 10 and 24 hours of
fermentation period, in a porcine batch culture system inoculated with STm
SL1344nalr and treated with LAC (hatched bar), L. plantarum B2028 (Lp) (white bar),
L. plantarum B2028 + LAC (Lp + LAC) (black bar). CTR (grey bar) was included and
inoculated with with 10% (v/v) faecal slurry and STm SL1344nalr. The assay was
performed in duplicate on two separate occasions and the SEM is shown.
Figure 5.11 Concentrations (mM) of SCFA (sum of acetic, propionic and butyric acid)
at 0, 5, 10 and 24 hours of fermentation period, in a porcine batch culture system
inoculated with STm SL1344nalr and treated with with LAC (hatched bar), L.
plantarum B2028 (Lp) (white bar), L. plantarum B2028 + LAC (Lp + LAC) (black
bar). CTR (grey bar) was inoculated only with 10% (v/v) faecal slurry and STm
SL1344nalr. The assay was performed in duplicate on two separate occasions and the
SEM is shown. Values significantly different from the CTR at the specific time point
are indicated by * P<0.05 and *** P<0.001; values significantly different from the 0
hour at 24 hours are indicated by aP<0.01, bP<0.01 and cP<0.05.
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Figure 5.12 Concentrations (mM) of lactic (hatched bar), acetic (white bar), propionic (black bar) and butyric (grey bar) acid at times 0 hour (A),
5 hours (B), 10 hours (C), 24 hours (D) hours in a porcine batch cultures inoculated with STm SL1344nalr and treated with LAC, L. plantarum
B2028 (Lp), L. plantarum B2028 + LAC (Lp + LAC). CTR was inoculated only with 10% faecal slurry and STm SL1344nalr only. The assay
was performed in duplicate on two separate occasions and the SEM is shown. Values significantly different from the CTR at 24 hours are
indicated by * P<0.05, ** P<0.01 and *** P<0.001.
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5.3 Discussion
Studies presented in this chapter aimed to evaluate the anti-Salmonella activity
of the synbiotic containing L. plantarum B2028 and LAC. The mechanisms of the
antibacterial activity of probiotics are not yet fully defined, however, they seem to be
multi-factorial as discussed earlier in this thesis (Servin, 2004). Therefore, a range of
porcine in vitro models was employed to investigate the impact of the synbiotic and
its constituent components upon the biology of STm SL1344 nalr. Specifically, the
various models assessed growth, adhesion/invasion to epithelial cells and survival in
dynamic and complex batch culture system. Moreover, the studies in this section
were performed with the view that use of adequate in vitro models is a precondition
for a successful animal studies and essential from animal welfare perspective (Boyen
et al., 2009; Russell and Burch, 1992).
Following from the previous findings where the growth of STm SL1344 nalr was
significantly inhibited by L. plantarum B2028 CFS, a pH-dependent antibacterial
effect against the growth of STm SL1344 nalr was demonstrated here. The growth of
STm SL1344 nalr with L. plantarum B2028 supernatants either non-buffered (pH3.8)
or adjusted (pH 4.5) was significantly reduced compared with the growth in LB-G
medium. Neutralisation of the L. plantarum B2028 cell free supernatants to pH 7.2
completely eliminated their antimicrobial effect on STm SL1344 nalr. The pH-
dependent mechanism of the antagonistic activity of L. casei GG on Salmonella was
previously reported (Hudault et al., 1997), and this is in agreement with our findings.
Nevertheless, it is important to remember that in the studies presented in this thesis
supernatants were included at the 10% (v/v) dilution factor. So, whilst pH seems to
be the primary effector, it may be argued that pH in combination with specific
metabolites are important in inhibition of STm SL1344 nalr growth. This concept is
partially borne out by the findings in which we observed that lactic acid control
(MRS-LA) at pH 3.8, had a similar inhibitory activity to the supernatants of L.
plantarum B2028. Adjusting to pH 4.5, in contrast to L. plantarum B2028
supernatants (CFS, CFSL) the pH controls (MRS, MRSL) and one of the lactic acid
controls (MRS-LA) resulted in loss of that activity against STm SL1344 nalr.
In the later study where the STm SL1344 nalr was pre-incubated with the L.
plantarum B2028 supernatants or respective pH/lactic acid controls it was also
observed that only CFS/CFSL had the significant inhibitory effect on STm SL1344
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nalr invasion when compared to the pH controls. These sets of data illustrate the
importance of lactic acid in the anti-Salmonella activity of L. plantarum B2028
supernatant; yet it also shows that it is not exclusive factor of. Those results also fit
previously published findings of both lactic acid and low pH playing an important
role in the antibacterial activity of probiotics (De Keersmaecker et al., 2006; Makras
et al., 2006; Servin, 2004). The organic acids and pH can affect microbes
independently, yet as the pH determines the ratio of dissociated and non-dissociated
forms of an acid near its pKa it influence the effect of it (Eklund, 1983). This could
explain gradual decrease in the effect of L. plantarum B2028 supernatant and lactic
acid control on STm SL1344 nalr growth. Although, both dissociated and non-
dissociated forms of acids have been assigned for inhibitory effect towards various
pathogens, nevertheless the latter was found to be more profound (Eklund, 1983,
1985). As the porcine luminal colonic content batch culture models showed, acetate
was the most abundant organic produced in all of the treatments. Whilst the studies
here focused on lactate, perhaps further studies with acetate and for that matter
propionate and butyrate need to be performed to assess the relative contributions
each SCFA makes to the inhibition of STm SL1344 nalr. Certainly, acetate has been
shown to be more inhibitory than lactate in auxanography experiments performed
with E. coli (Woodward, personal communication). The data suggest that L.
plantarum B2028 is heterofermentative producing equimolar amounts of lactic and
acetic acids. It is not unreasonable to assume both lactic and acetic acids are
inhibitory at the lower pHs tested here. Following on from this, inhibitory
compounds other than lactic acid in lactobacilli supernatants have been reported
(Fayol-Messaoudi et al., 2005; Silva et al., 1987). Interestingly Niku-Paavola et al.
(1999) showed the presence of a low molecular mass compound in the supernatant of
L. plantarum that was inhibitory towards the Gram-negative bacterium P.
agglomerans in co-operation with lactic acid. Indeed, Alakomi et al. (2000)
demonstrated the role of lactic acid as a permeabiliser of the Gram-negative bacteria
outer membrane (OM), which could facilitate effective penetration of the numerous
antimicrobial metabolites produced by the LAB that are normally unable to penetrate
the OM or sensitize the gram negative bacteria to bacteriocins. It could possibly be
hypothesised that the antimicrobial mechanism of L. plantarum B2028 supernatants
against STm SL1344 nalr is due to an as yet unknown metabolite that works
synergistically with the lactic acid. In addition, and as suggested above with regard to
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acetic acid, the presence and/or unique ratio of the various organic acids in the
supernatant in conjunction with the pH may work synergistically to inhibit STm
SL1344 nalr. Further in depth studies targeting the presence of other compounds are
necessary.
In order to initiate the infection process pathogenic bacteria must first adhere to
the surface of the epithelial cells (Weinstein et al., 1998). Several studies indicated
that LAB could prevent pathogens adhesion by competing for the same receptor
sites, steric hindrance, co-aggregation or the production of antimicrobial molecules,
thus resulting in reduced colonisation (Bernet-Camard et al., 1997; Bernet et al.,
1994; Gueimonde et al., 2005; Lee et al., 2003; Mappley et al., 2011; Neeser et al.,
2000). In the previous chapter, it was demonstrated that L. plantarum B2028 adhered
to the IPEC-J2 cells in high numbers. In the adhesion and invasion assays using
monolayer and 3D cells, a significant reduction of adhesion and invasion of STm
SL1344 nalr was observed when co-administered with L. plantarum B2028 cells with
the supernatant or the supernatant alone. Neither MRS nor L. plantarum B2028 cells
alone showed any effect upon the adherence or invasion of STm SL1344 nalr. This
suggests that low pH of the supernatant is at least partially responsible for reduction
of Salmonella adherence and invasion into epithelial cells. This does not preclude the
possibility that the inhibitory effects both on the growth and the adhesion/invasion of
STm SL1344 nalr could be partially attributable to a secreted unidentified
antimicrobial substance. The antimicrobial effect of L. acidophilus LB CFS,
attributable to the presence of a non-lactic acid molecule (s) was previously reported
(Coconnier et al., 1997). Authors observed that pre-treatment of S. Typhimurium
SL1344 with L. acidophilus LB CFS for 1 hour resulted in its significant decrease in
association and even greater reduction of pathogen inhibition to Caco-2 cells. Those
findings corroborate the results in this chapter, indicating that the Salmonella
invasive phenotype was affected by the pre-treatment with L. plantarum B2028
supernatant and while lactic acid played important role, CFS/CFSL was even more
potent. Interestingly, recent studies shed more light on more possible mechanisms of
lactobacilli anti-Salmonella activity as it was demonstrated that pre-treatment of S.
Typhimurium SL1344 with the CFS of from L. acidophilus LB caused temporary
loss swimming motility without effecting flagella expression, that in turn resulted in
delayed entry into Caco-2/TC7 cells (Lievin-Le Moal et al., 2011).
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It is possible to exclude a co-aggregative mechanism of action of L. plantarum
B2028 which has been observed for L. reuteri LM1 strain (Mappley et al., 2011)
because washed L. plantarum B2028 cells showed no effect upon reduction of the
adhesion or invasion of STm SL1344 nalr. Interestingly, Bernet et al. (1994)
demonstrated that when the spent culture supernatant of L. acidophilus LA1 was
discarded and replaced with the fresh culture medium a significant loss of adhesion
to intestinal cells of this strain occurred. The Lactobacillus spp. adherence process to
epithelial cells is a complex mechanism which seems to be influenced by multiple
factors like bacterial physiology and physicochemical parameters but also the pH
(Greene and Klaenhammer, 1994; Henriksson et al., 1991; Pelletier et al., 1997).
These findings collectively suggest an explanation why L. plantarum B2028 cells
devoid of the supernatant showed no effect against Salmonella adherence/invasion.
CFSL alone reduced STm SL1344 nalr invasion by 10.0-fold and L. plantarum
with CFSL by 20.6-fold in monolayers and 13.0-fold, 30.2-fold in 3D cells
respectively. Although, this reduction was very significant with both treatments
when the probiotic was administered together with its supernatant this effect was
greatest. It might be, that regardless of pH and lactic acid activity other components
of CFSL enhance L. plantarum B2028 adherence to epithelial cells perhaps
promoting stearic hindrance for the attachment of STm SL1344 nalr. The importance
of lipoteichoic acid (LTA) and expolysaccharide (EPS) molecules in the mechanism
of lactobacilli adhesion to epithelial cells has been demonstrated previously (Granato
et al., 1999; Lebeer et al., 2008; Ruas-Madiedo et al., 2006; Sherman and Savage,
1986). The impact of pH or other metabolites in the supernatant on enhancing the
role of these molecules in adherence and/or stearic hindrance needs to be further
assessed.
Of all the studies performed in this chapter it may be argued that IVOC was the
most physiologically relevant because the system uses entire tissue with an integrated
structure as found in vivo. IVOC model was formerly used to study the adhesive
properties of pathogens and the associated host cellular responses (Girard et al.,
2007; Phillips and Frankel, 2000). Furthermore, Henriksson et al. (1991) employed
the porcine gastric squamous epithelium IVOC model to study the adhesion
characteristics of L. fermentum. However, a limitation of this model in our study was
the inability to differentiate STm SL1344 nalr bacteria that had adhered or invaded;
quantification was, therefore, of the total associated STm SL1344 nalr. Unlike the
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monolayer and 3D cell model data, no significant differences were observed upon
administration of L. plantarum B2028 with CFSL or CFSL alone in the number of
associated STm SL1344 nalr. This result does not rule out the possibility that,
although STm SL1344 nalr associated, invasion has been inhibited. In IVOC the only
significant reduction of association was with the Lp + LAC treatment (P<0.05).
Neither Lp nor LAC alone reduced association indicating that a only the combined
treatment was effective in inhibiting association of STm SL1344 nalr with tissue.
Perhaps a combination of stearic hindrance by bound Lp, co-aggregation with Lp and
blocking of binding sites by the oligosaccharide LAC collectively had the effect.
None of these options are supported by other data from this work, however, although
Searle et al. (2009, 2010) did show that GOS acted as a barrier to adherence in their
in vivo studies. In hind-sight it would have been useful to have undertook cellular
response studies in the IVOC studies as these may have revealed greater detail
relating to host cell interactions.
The studies described in section 3.2.5 of Chapter 3 demonstrated significant
increases of Lactobacillus-Enterococcus and SCFA concentrations with the inclusion
of LAC, FOS and their synbiotic combination with L. plantarum B2028 into a
porcine batch culture fermentation system. The enhancement of LAB numbers and
SCFA concentrations have been previously linked with the reduction of Salmonella
(Meynell, 1963; Prohaszka et al., 1990). Therefore, the effect of the synbiotic
combination of L. plantarum B2028 and LAC upon Salmonella, bifidobacteria and
Lactobacillus-Enterococcus numbers and the end product metabolites was evaluated
using a porcine colonic luminal content batch culture model. As demonstrated, the
inclusion of LAC alone significantly increased STm SL1344nalr numbers at 24 hours
as compared with CTR (P<0.05). This is perhaps a surprising result as the
expectation might have been that LAC would be metabolised by bifidobacteria and
lactobacilli to produce inhibitory substances. Interestingly, there was a significant
increase in the numbers of organisms binding the Lab158 probe, which was observed
after 10 and 24 hours compared with the 0 hour time point (P<0.001; P<0.05
respectively). As previously demonstrated, STm SL1344nalr is unable to utilise LAC
as a sole carbon source. Taken collectively, these data suggest that the increase in the
numbers of STm SL1344nalr may reflect its growth on end products or by-products
of the LAC fermentation by other members of porcine colonic microbiota. The data
also suggest that those intermediates were readily bio-available and not in an
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environment which was inhibitory. These finding are similar to those of Petersen et
al. (2009) and support the previous studies of Martin-Pealez et al. (2010), who
demonstrated no reduction in Salmonella numbers in porcines with the
administration of lactulose in their diets.
Interestingly, a significant decrease in STm SL1344nalr numbers was observed
with the prospective synbiotic after 10 and 24 hours of incubation compared with 0
hour (P<0.05). There was a concomitant gradual increase in Lactobacillus-
Enterococcus numbers from 0 to 24 hours (P<0.05). The inclusion of either of pre,
pro or synbiotic was not correlated with increased lactic acid concentrations, which
was previously observed in the first batch culture study. As mentioned previously, it
is most likely that other bacterial species present in the porcine faecal slurry had
utilised the lactate which in turn added to the pool of total SCFAs (Duncan et al.,
2004; Hashizume et al., 2003; Ushida et al., 2002). The significant increase in SCFA
concentrations (sum of acetic, propionic and butyric acids) from 0 to 24 hour time
point was observed for all treated vessels (P<0.001) including CTR (P<0.05). The
fact that fermentation in the control also yielded these acids indicates that there was
fermentable substrate in the control vessel to yield these products. Addition of LAC
and Lp + LAC enhanced yields most significantly compared with CTR (P<0.001).
Moreover where LAC and Lp + LAC were included the concentrations of butyrate
were significantly higher than CTR (P<0.001). The results showed that inclusion of
both LAC alone or the synbiotic containing L. plantarum B2028 and LAC resulted in
the increased numbers of those bacteria that bound the Lab158 probe and SCFA
concentrations. Importantly, it was only with the synbiotic that the numbers of
bacteria that bound the Sal303 probe decreased. This might indicate that active
metabolites other than SCFA could have played role in reducing STm SL1344nalr
survival. Further to described above studies, it was demonstrated by Coconnier-
Polter et al. (2005) that L. acidophilus LB CFS exerted remarkable S. Typhimurium
SL1344 killing activity after 4 hour exposure to CFS, attributable to non-lactic acid
molecule(s), more precisely CFS promoted depletion of intracellular ATP,
lipopolysaccharide release, sensitizes Salmonella membrane and increases its
permeabilization. It could possibly be hypothesised that this could also be true in
case of this complex microbial environment.
Moreover, by additionally introducing the L. plantarum B2028 we might have
created an unfavorable niche for STm SL1344nalr. Due to the character of this model
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(static closed fermentation system) it is not possible to observe other effects which
this complex environment may play on STm SL1344nalr colonisation. For instance,
various studies showed that different SCFA can regulate the invasive phenotype of
Salmonella by up or down-regulating virulence gene expression (Lawhon et al.,
2002; Van Immerseel et al., 2004a; Van Immerseel et al., 2004b). Butyrate and
propionate in particular have been reported to reduce the expression of the invasion
genes (Gantois et al., 2006; Lawhon et al., 2002; Van Immerseel et al., 2004b). In
both batch culture studies inclusion of LAC and L. plantarum B2028 + LAC resulted
in higher butyrate concentrations than CTR, which has been demonstrated to be
associated with reduced faecal shedding and intestinal colonisation in pigs (Boyen et
al., 2008). In addition, organic acids might play a positive role in digestion,
absorption and contribute to epithelial cell proliferation in pigs (Mroz et al., 2005).
Collectively, the findings presented here show complexity of the L. plantarum
B2028 activity against STm SL1344nalr, and unquestionably further investigation is
required to evaluate further mechanisms underlying that activity. However, those
results encourage further assessment of L. plantarum B2028 and LAC in an animal
model as the next step of the selection for a successful synbiotic combination, which
could be incorporated into a feed to control zoonotic pathogens like S. Typhimurium.
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Chapter 6
Evaluation of an in feed administration of L. plantarum
B2028 and lactulose to pigs experimentally challenged with
S. Typhimurium – an in vivo pilot study
6.1 Introduction
Despite the continuing decline in the number of laboratory-confirmed human
salmonellosis cases in the UK, a total of 10,071 cases were confirmed in 2009 and
9,685 cases in 2010 (DEFRA, 2009, 2010). S. Typhimurium remained the second
most commonly reported serovar in those cases during this time frame and over those
two years increased by 4.6% (DEFRA, 2010).
Pig infections caused by S. Typhimurium result in significant economic losses
and pose an important human health issue (Boyen et al., 2008; Meyerholz et al.,
2002) with pork and pork products considered as one of the major sources of human
salmonellosis (Lo Fo Wong et al., 2002). In pigs, non-typhoidal salmonellosis is
clinically manifested by onset of diarrhoea, pyrexia, in-appetence and lethargy. As
disease is generally characterised by low mortality, but high morbidity rates, the
majority of the pigs recover from infection and often become asymptomatic carriers
(Wilcock and Olander, 1977). Those carrier pigs act as a reservoir and result in long
term persistence of Salmonella in herds and thereby sustain risk of food chain
contamination (Boyen et al., 2008).
For many years antimicrobial growth promoters have been used in livestock feed
due to their beneficial effects on feed conversion rates and reduced disease incidence
(Delsol et al., 2004; McEwen and Fedorka-Cray, 2002). Nevertheless, prolonged use
of antimicrobial agents in veterinary medicine and animal husbandry ultimately
resulted in the development of resistance in pathogenic bacteria (Aarestrup and
Carstensen, 1998; Boerlin et al., 2001; Taylor, 1997). Subsequently, due to the
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human health concerns and follow-on consequences manifested by increased
frequency of treatment failures and increased severity of infections (FAO, WHO
2004), the EU banned the use of antimicrobial growth promoters in livestock as from
2006 (Castanon, 2007). Following termination of the prophylactic use of in-feed
antibiotics, there resulted an increased need for research towards growth
improvement and alternative control strategies (Castillo et al., 2008; McEwen and
Fedorka-Cray, 2002) (FAO, WHO 2004), which would offer comparable beneficial
effects and stimulate production.
Various alternative in-feed approaches have been studied to date and some are
used commercially with, for example, organic acids, herbal extracts, probiotics,
prebiotics and synbiotics as feed additives (Collado et al., 2007; Collins et al., 2009;
Mappley et al., 2011; Partanen et al., 2006; Searle et al., 2009; Szabo et al., 2009),
which were discussed in detail in Chapter 1 of this thesis. Supplementation of pig
diet with various competitive exclusion cultures has been reported to reduce the
severity of clinical signs and lower the numbers of Salmonella in the faeces
(Fedorka-Cray et al., 1999; Genovese et al., 2003). In addition, Casey et al. (2007)
concluded that mixtures of probiotic strains improved both clinical and
microbiological outcome of salmonellosis.
The results presented in the previous chapters of this thesis demonstrated that
exposure of STm SL1344nalr to L. plantarum B2028 + LAC supernatant
significantly reduced growth and also invasion of STm SL1344nalr into IPEC-J2
cells. Furthermore, addition of LAC and L. plantarum B2028 + LAC to porcine
faecal batch cultures, resulted in increases in lactobacilli and decreases in STm
SL1344nalr within the system. In vitro studies are advantageous in that they generate
data that, in this set of studies, indicate this synbiotic combination may be an
effective control of S. Typhimurium infection in the pig before and without recourse
to in vivo studies. However, in vitro studies cannot replace the in vivo model in its
complexity (Boyen et al., 2009). Therefore, this last chapter describes a use of a
porcine in vivo model to test the efficacy of LAC and L. plantarum B2028 alone and
as a synbiotic combination to control infection caused by STm SL1344nalr.
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6.2 Results
6.2.1 Experimental design summary
To study the individual and combined impact of L. plantarum B2028 and
lactulose (LAC) in a pig model of Salmonella infection, the following study design
was implemented (Figure 6.1, further details in sections 2.6.3 & 2.6.4). Briefly,
twenty four 4-week-old commercial piglets were separated into four experimental
groups and allowed 1 week to acclimatise (day -14 to -7) to the environment and
diet. At 5 weeks of age (day -7 onwards), the diets for each of three test groups were
supplemented with 1% (w/v) LAC (LAC group), L. plantarum B2028 (1010
cfu/animal/day) (Lp group), and combination of both (Lp + LAC group), and the
treatments were provided until the end of the study (day -14 to 10). Piglets from
control group (CTR group) continued to receive the original diet without
supplements. Subsequently, 7 days after in-feed treatment inclusion, piglets were
challenged with S. Typhimurium SL1344nalr (STm SL1344 nalr) (5 × 108 cfu) (day
0). The presence of Salmonella was evaluated before the challenge on four occasions
(days -11, -7, -3, -1) and afterwards daily from day 0 to 10. The numbers of
Lactobacillus spp. and E. coli in faecal samples from each of the piglets in all study
groups were evaluated before and after Salmonella challenge, on days: -7, -1, 4, 7
and 10.
Figure 6.1 Graphic summary of an in vivo study design.
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6.2.2 Physiological and zootechnical performance
Piglets in their respective experimental groups responded well to the
incorporation of L. plantarum B2028 alone, LAC alone and L. plantarum B2028 +
LAC together into a feed. As anticipated no signs of diarrhoea or decline in
physiological performance were observed following inclusion of the feed additives
before the challenge with STm SL1344nalr (days -7 to 0).
Experimental challenge with STm SL1344nalr resulted in the development of
mild clinical signs of salmonellosis in all groups. Those, were limited to slight
pyrexia, with the temperature 40°C or above in two piglets during the first 3 days in
each experimental group and in further 2/6 piglets in the group treated with LAC and
the un-treated control group from day 3 onwards. Figure 6.2, shows the mean rectal
temperatures in each study group. There were no statistically significant differences
between groups.
Figure 6.2 Rectal body temperature (˚ C) of piglets experimentally challenged with
STm SL1344nalr and treated with LAC (green circles), L. plantarum B2028 (blue
circles), L. plantarum B2028 + LAC (red circles) and fed un-treated diet (black
circle). Animals were monitored daily until day 9 after challenge. Presented values
are means of six animals in each of the experimental group and the SEM is shown.
Soft faeces were observed in the majority of piglets during the first four days
after STm SL1344nalr challenge and intermittently throughout the study, with no
observable differences between the treatment groups.
The body weights of piglets, monitored weekly before and after Salmonella
challenge (days -7 to 7), increased regularly and showed values comparable to those
of normal development of body weight in piglets at that age. This increase in weight
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from the beginning of the feeding trial was significant in animals from all four
treatment groups (P<0.001) with no significant difference between them (Table 6.1).
Administration of LAC, L. plantarum B2028 and L. plantarum B2028 together
with LAC had no significant effect on the average feed intake or the gain to feed
ratio during the pre and post infection period as compared with un-treated control
group (Table 6.1). However, it was interesting to note that the Lp + LAC group
showed the greatest ADG during the Salmonella challenge compared with any other
group at any other time.
Table 6.1 Pig growth performance parameters (weight, average daily gain, average
daily feed intake and gain to feed ratio).
Parameter Experimental group
LAC L .plantarum
B2028
L. plantarum
B2028 + LAC
Control
Weight (kg)
Day -7 11.10 ± 0.58 10.90 ± 0.31 10.73 ± 0.57 10.83 ± 0.63
Day 0 13.50 ± 0.64 13.70 ± 0.45 13.23 ± 0.73 13.43 ± 0.63
Day 7 16.23 ± 0.64 16.10 ± 0.46 16.40 ± 0.74 16.20 ± 0.62
Average daily gain
(ADG) (g)
Day -7 to 0 343 ± 35.3 400 ± 23.3 357 ± 43.4 371 ± 23.3
Day 0 to 7 390 ± 48.1 342 ± 51.1 452 ± 22.6 395 ± 20.0
Day -7 to 7 366 ± 27.0 371 ± 21.5 404 ± 25.7 383 ± 11.3
Average daily feed
intake (ADFI) (g)
Day -7 to 0 976 ± 39.4 930 ± 46.4 914 ± 42.4 954  ± 38.4
Day 0 to 7 1083 ± 0 1026 ± 37.6 1083 ± 0 1096 ± 9.91
Day -7 to 7 1029 ± 34.0 978 ± 44.7 998 ± 43.9 1011 ± 35.0
Gain to feed ratio
(G:F)
Day -7 to 0 0.35 0.43 0.39 0.38
Day 0 to 7 0.36 0.34 0.41 0.36
Day -7 to 7 0.35 0.37 0.40 0.37
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6.2.3 Effect of feeding L plantarum B2028 and lactulose on S. Typhimurium
faecal shedding
Isolation of STm SL1344nalr from faeces was carried out by direct plating onto
BGA supplemented with 15 µg/ml nalidixic acid and further enrichment as described
previously in section 2.6.5. Throughout the post-infection period isolation of
pathogen via direct plating was limited and only achieved for some of the animals
within each experimental group and sporadically, which was most likely a result of
the low numbers shed by some of animals rather than low sensitivity of the isolation
method, especially as enrichment was used. Due to intermittent Salmonella shedding
a scoring system was applied giving score values to each animal accordingly: (0)
faeces negative for Salmonella on direct culture and following enrichment; (1)
negative on direct culture but positive after enrichment; (2) positive on direct culture
(and enrichment) with Salmonella counts up to 3.5 Log cfu/g faeces; (3) positive on
direct culture (and enrichment) with counts from 3.5 Log cfu/g to 5 Log cfu/g faeces
and (4) positive on direct culture (and enrichment) with counts above 5 Log cfu/g
faeces.
Five of the six piglets in each experimental group were confirmed positive by
enrichment at day 1 after challenge (Table 6.2). Only in the LAC group 6/6 animals
were found Salmonella positive, this was at days 3 and 10 after challenge.
Throughout the entire post-infection period 5/6 pigs from un-treated control group
were Salmonella positive on five days after challenge, on four days from L.
plantarum B2028 group, whereas only once from the synbiotic group. Moreover,
only 3/6 animals treated with L. plantarum B2028 + LAC were found to be
Salmonella positive over six days. The mean number of Salmonella shedding piglets
throughout the entire 10 days in the group treated with L. plantarum B2028 + LAC
was significantly reduced in comparison to the number of piglets in the group treated
with L. plantarum B2028 alone (P<0.05) and a trend toward significance was
observed in comparison to un-treated control and LAC treated groups (P=0.06).
Moreover, on average the shedding, as evaluated by score values and calculated
for entire post challenge period for each experimental group, showed lower values
for L. plantarum B2028 + LAC that were significantly different in comparison to un-
treated control (P<0.05). The highest Salmonella score was detected on day 1 and 3
post challenge with the mean values of 2.6, 2.3, 2.1 and 2.8 for LAC, L. plantarum
B2028, L. plantarum B2028 + LAC and un-treated group, respectively on day 1 post
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challenge. STm SL1344nalr was isolated from faeces by direct plating from 5/6
piglets in LAC and un-treated control group and from 4/6 piglets in groups treated
with L. plantarum B2028 and L. plantarum B2028 + LAC. On day 3, the Salmonella
score values were 2, 1.5, 1.33 and 2.1 for LAC, L. plantarum B2028, L. plantarum
B2028 + LAC and control group respectively with 4/6 piglets (LAC and un-treated
group) and 3/6 piglets (L. plantarum B2028, L. plantarum B2028 + LAC group)
were positive on direct culture. A gradual decrease in the number of Salmonella
positive faecal samples detected by direct culture and lower Salmonella score was
observed after that point with mean score values no higher than 1.5 for all
experimental groups except for day 7 for un-treated and day 10 for LAC group with
1.8 and 2 mean values, respectively (Figure 6.3). During the 10 days post infection
the overall trend for Salmonella shedding calculated as the sum of score values was
Lp + LAC (8.83) < Lp (11.0) < LAC (11.6) < CTR (12.8).
Table 6.2 The number of Salmonella positive faecal samples collected from piglets
(n=6) in each experimental group during post-infection period (10 days).
Days Experimental group
LAC L. plantarum B2028 L. plantarum B2028
+ LAC
Control
1 5/6 5/6 5/6 5/6
2 2/6 3/6 2/6 3/6
3 6/6 4/6 3/6 5/6
4 2/6 5/6 2/6 4/6
5 3/6 3/6 3/6 3/6
6 2/6 5/6 3/6 3/6
7 4/6 5/6 3/6 5/6
8 4/6 4/6 3/6 4/6
9 5/6 4/6 4/6 5/6
10 6/6 4/6 3/6 5/6
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Figure 6.3 Salmonella faecal shedding results from the feeding trial evaluated during
10 days post STm SL1344nalr challenge. Respective experimental groups consisted of six
piglets and each was treated with LAC (hatched bar), L. plantarum B2028 (white bar),
L. plantarum B2028 + LAC (black bar) and fed un-treated diet (grey bar). The
scoring system was used for the data analysis, indicating the individual piglets with
the lowest score value 0 were negative and with the highest value 4 shed more than 5
Log cfu/g faeces. Presented values (scores) are means of six animals in each of the
experimental group and the SEM is shown.
6.2.4 S. Typhimurium dissemination in tissues collected at post-mortem
Animals shedding Salmonella throughout the study were selected and examined
at post-mortem as described in section 2.6.6. Salmonella was isolated from jejunum,
ileum, colon, caecum and mesenteric lymph nodes in all experimental groups. From
jejunum, Salmonella was only isolated from animals in LAC and un-treated group.
No Salmonella was recovered from liver and spleen of all animals subjected to post-
mortem examination.
To compare the colonisation level between experimental groups the scoring
system was applied as described in previous section and presented in Figure 6.4. No
differences were found among the treatments.
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Figure 6.4 Salmonella colonisation in porcine tissues sampled at post-mortem at day
10 post STm SL1344nalr challenge. Piglets within respective experimental group
were treated with LAC (hatched bar), L. plantarum B2028 (white bar), L. plantarum
B2028 + LAC (black bar) and fed un-treated diet (grey bar). Presented values
(scores) are means of three animals in each of the experimental group and the SEM is
shown.
6.2.5 Effect of feeding L. plantarum B2028 and lactulose on pig faecal microbiota
Lactobacilli and E. coli numbers from faecal samples were determined as
described previously in section 2.6.5. To evaluate the outcome of the respective diets
on those bacterial groups, faecal samples were collected and enumerated twice (days
-7 and -1) before STm SL1344nalr challenge and also on days 4, 7 and 10 after STm
SL1344nalr challenge (Figure 6.5 & 6.6).
6.2.5.1 Lactobacillus spp. changes
The inclusion of either LAC, L. plantarum B2028 or L. plantarum B2028 +
LAC in the diet had no significant effect on the numbers of lactobacilli during the
first week of diet administration (days -7 to -1). Following STm SL1344nalr
challenge (day 4), decreases in the numbers of lactobacilli in comparison to the pre-
challenge values were observed in L. plantarum B2028 + LAC group (P=0.055).
However, on day 7 after challenge the number of lactobacilli isolated from that group
was again higher and significantly higher than in the un-treated control group
(P<0.05). No significant differences in the numbers of lactobacilli in piglets treated
with LAC, L. plantarum B2028, L. plantarum B2028 + LAC or un-treated control
group were found on the last day of the study (day 10 after challenge). However the
tendency to an increase in the number of lactobacilli in comparison to the control
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group (P=0.059) was observed in the group treated with L. plantarum B2028 + LAC.
Colonies from each plate taken for quantification were randomly selected for oxidase
and catalase testing. All tested isolates were confirmed to be oxidase and catalase
negative and therefore believed that all bacteria isolated on MRS medium were of
Lactobacillus genus.
In addition, the presence of L. plantarum spp. in the faeces was examined prior
to and after STm SL1344nalr challenge using the previously described PCR (Kwon
et al., 2004). Faeces of all piglets were negative for L. plantarum by PCR prior to
feeding the experimental diet (day -7). Following diet inclusion (day -1), L.
plantarum could be detected in animals from each of the experimental groups,
however in those groups not receiving L. plantarum B2028 only one of six animals
tested positive. The percentage of animals positive for L. plantarum by PCR was
equal to or greater than 50% in the two groups receiving prospective probiotic or the
synbiotic combination. Similar findings were made at day 4 and 10 after SL1344nalr
challenge (Table 6.4).
Figure 6.5 Counts of Lactobacillus spp. (Log cfu/g) recovered from faeces of piglets
treated with LAC (hatched bar), L. plantarum B2028 (white bar), L. plantarum
B2028 + LAC (black bar) and un-treated control group (grey bar) before and after
STm SL1344nalr challenge. Dotted line indicates STm SL1344nalr challenge and day
0 of post-infection period. Presented values are means of six animals in each of the
experimental group and the SEM is shown. Values significantly different from the
control at the specific time point are indicated by * P<0.05.
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Table 6.3 The number of positive samples for L. plantarum spp. tested by PCR
(Kwon et al., 2004).
Daya Experimental group
LAC L. plantarum B2028 L. plantarum B2028
+ LAC
Control
-7 0/6 0/6 0/6 0/6
-1 1/6 4/6 3/6 1/6
4 2/6 3/6 4/6 0/6
10 1/6 4/6 4/6 1/6
a Tested throughout the entire feeding trial, during pre challenge week (twice) and post STm
SL1344nalr challenge (twice).
6.2.5.2 E. coli spp. changes
As observed for lactobacilli, the inclusion of LAC, L. plantarum B2028 or L.
plantarum B2028 + LAC in the diet had no significant effect on E. coli numbers
during the first week. On day 4 after challenge E. coli numbers in the L. plantarum
B2028 + LAC treated group were significantly decreased when compared to values
in LAC and un-treated control group (P<0.05). With the exception of this one time
point, no significant differences were observed for E. coli numbers at any other time
after STm SL1344nalr challenge. However, there appeared to be lower number of E.
coli after STm SL1344nalr challenge across the treatment groups with the exception
of the LAC treatment where E. coli numbers remained consistently higher than the
other groups. These differences were not significant.
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Fig 6.6 Counts of E. coli (Log cfu/g) recovered from the faeces of piglets treated
with LAC (hatched bar), L. plantarum B2028 (white bar), L. plantarum B2028 +
LAC (black bar) and un-treated control group (grey bar) before and after STm
SL1344nalr challenge. Dotted line indicates STm SL1344nalr challenge and day 0 of
post-infection period. Presented values are means of six animals in each of the
experimental group and the SEM is shown. Values significantly different from the
control at the specific time point are indicated by * P<0.05.
The ratio of lactobacilli to coliforms has been used previously as an indicator of
animal gut health and growth performance (Muralidhara et al., 1977; Pollmann et al.,
1980). It is considered that the higher the ratio, the better the health of the animal gut.
The lactobacilli to E. coli ratio (L:E) was determined (Figure 6.7) to assess whether
treatment with either LAC, L. plantarum B2028 or L. plantarum B2028 + LAC
helped to maintain a favourable L:E relationship. In general, treatments with L.
plantarum B2028 and L. plantarum B2028 + LAC resulted in higher L:E ratio in
comparison to un-treated control group and on day 4 after STm SL1344nalr
challenge the difference in L:E for the Lp + LAC compared with all other groups was
significantly greater (p<0.05). Furthermore, at 10 days after challenge the highers
L:E ratio was observed in animals treated with L. plantarum B2028 + LAC.
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Fig 6.7 Ratio of lactobacilli to E. coli recovered from the faeces of piglets treated
with LAC (green circles), L. plantarum B2028 (blue circles), L. plantarum B2028 +
LAC (red circles), un-treated control group (black circles) and calculated before and
after STm SL1344nalr challenge throughout the study. The arrow indicates STm
SL1344nalr challenge and day 0 of post-infection period. Presented values are means
of six animals in each of the experimental group and the SEM is shown. Values
significantly different from the control at the specific time point are indicated by *
P<0.05.
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6.3 Discussion
Results described in previous chapters demonstrated that L. plantarum B2028 or
its supernatant reduced the growth, adhesion and invasion into porcine epithelial
cells of STm SL1344nalr. Moreover, Collins et al. (2010) reported that this strain
modified mucosal barrier function of porcine tissues and promoted host cytoskeletal
rearrangements. Probiotics including genera of Lactobacillus, Lactococcus, Bacillus,
Bifidobacterium, Enterococcus are live microbial feed supplements and when
administered have been reported to confer multiple beneficial effects on pig health,
for example improving intestinal microbial balance (Nemcova et al., 1999) and
reducing the incidence of diarrhoea (Huang et al., 2004; Shu and Gill, 2001). One of
the ways of enhancing the efficacy of probiotics could be their administration with
synergistically acting components (Bomba et al., 2002). It was demonstrated in
Chapter 3, that LAC supported the growth of L. plantarum B2028 and stimulated
endogenous lactobacilli within the porcine faecal batch culture system. So the aim of
this study was to evaluate the administration effect of LAC, L. plantarum B2028
alone or in combination with LAC on S. Typhimurium shedding and colonisation,
but also to determine associated growth performance parameters of piglets and
bacterial population changes including L:E ratio of the bacterial faecal population.
The treatment regimes were incorporated into a diet from one week prior to STm
SL1344nalr challenge until the end of the study. The treatments had no effect on
piglet daily weight gain, and physiological performance was not disrupted by any
treatment pre-challenge. Throughout the entire study the gain of weight was gradual
and increased significantly (P<0.001) in all experimental groups after 2 weeks.
Despite STm SL1344nalr infection it was noticed that in piglets treated with L.
plantarum B2028 + LAC the ADG showed trend to increase during that second week
(P=0.088). It was previously demonstrated by Pollmann et al. (1980) that
improvement in ADG following inclusion of L. acidophilus in ‘starter’ pig diet was
dependent upon lactose administration at the same time.
Challenge with 5 x 108 cfu/pig of STm SL1344nalr resulted in the onset of mild
clinical infection in all four experimental groups. During the entire post-infection
period the body temperature equal to or above 40°C was recorded more frequently in
piglets in the un-treated control and LAC group than piglets in L. plantarum B2028
and L. plantarum B2028 + LAC treated groups, without significance. Animals in all
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experimental groups developed mild diarrhea, especially during the first four days,
however this parameter did not seem to be significantly affected by any of the
treatments. With that in mind, reports in the literature differ in findings and between
experimental approaches. For example, previous studies by Szabo et al. (2009)
demonstrated that administration of E. faecium NCIMB 10415 to the diet of weaned
pigs and challenged with S. Typhimurium increased the incidence of diarrhoea and
elevated body temperature in comparison to un-treated group, whereas the contrary
was reported by Casey et al. (2007).
Colonisation of the piglets by STm SL1344nalr, as assessed by selective culture
of faeces, indicated that the majority of piglets in all experimental groups on day 1
after challenge were colonised. Shedding thereafter was intermittent and sporadic
and on average only one treatment group, that with L. plantrarum B2028 + LAC
supplementation, showed statistically significant differences from the control group
comparing over entire post infection period. The difficulty with such animal
experiments is establishing the correct inoculum to induce sufficient colonisation and
clinical symptoms to evaluate any mitigating effects of the various treatments. The
strain and inoculum size have been used in these laboratories before successfully in
antibiotic treatment studies (Delsol et al., 2003). However, the challenge dose may
have been too high and thereby overcome any ameliorating effects of the treatments.
This would be the case if it assumed that any protective effects of the treatments are
modest. Perhaps low dose exposure by in-contact transmission studies may have
been a more appropriate challenge model. The limitation on the number of animals
for use in this study precluded any investigation of alternative models. In retrospect,
it may have been sensible to have studied larger numbers of animals in just two study
groups, namely un-treated and L. plantarum B2028 + LAC which from the in vitro
studies seemed most promising. This would have limited teasing out the
contributions of LAC but especially L. plantarum B2028 alone. Also, whilst every
effort was made to ensure the source of the piglets was from a non-vaccinated
Salmonella free herd, it is possible that some maternal or even induced immunity
was in the study group. In retrospect, an assessment of the immune status prior to
challenge and during the infection model, even if only by ELISA for humoral
circulating antibody, may have enlightening.
Because of restrictions on facility and time, at the end of the study only three
pigs from each treatment group were examined post mortem. Those which were
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shedding Salmonella throughout the study were selected for the analysis. Liver,
spleen, jejunum, colon, caecum and mesenteric lymph nodes were collected to
evaluate STm SL1344nalr colonisation level. In retrospect, the selection criteria may
have introduced bias and perhaps all six animals from the control and from the Lp +
LAC treated group may have been more appropriate. The sites of colonisation were
very much as expected although evidence for deep tissue colonisation was not
gained. The observed colonisation of the digestive track samples and dissemination
to mesenteric lymph node samples of STm SL1344nalr corresponds with the classic
and reported sites affected by S. Typhimurium (Fedorka-Cray et al., 1995; Vieira-
Pinto et al., 2006). The differences in gut colonisation between treatment groups
were again modest. In general, the colonisation differences observed were site
dependent; interestingly the lower colonisation level for L. plantarum + LAC was
seen in the colon and the highest in mesenteric lymph node samples, without
significance. Moreover, LAC treatment seemed to be associated with higher
colonisation level in those positive animals. These appear somewhat contradictory
results but as it was observed in terms of L:E ratios perhaps LAC is metabolised to
stimulate the inhibitory effects of Lp and other resident bifidobacteia and lactobacilli.
Treatment with L. plantarum B2028 + LAC reduced Salmonella shedding
(P<0.05) in weaned piglets, which was further linked with increased numbers of
Lactobacillus spp. As for LAC, increased numbers of lactobacilli were observed,
without significance. Administration of both LAC and L. plantarum B2028 together
modulated the L:E ratio and reduced the numbers of E coli. It could be postulated
that the L. plantarum + LAC did not affect the numbers of E. coli whereas the
presence of STm SL1344nalr did, perhaps by some competitive mechanism.
However, this seems unlikely given that all the data indicate this treatment
suppressed STm SL1344nalr and therefore reduced numbers of STm SL1344nalr, are
less likely to impact on E. coli. It seems more likely that as E. coli and STm
SL1344nalr share similar physiologies that the symbiotic or LAC alone may
influence colonisation of both as suggested by Guenther et al. (2010).
Interestingly, faecal samples subjected to PCR showed the same prevalence of L.
plantarum positive piglets in groups treated with L. plantarum B2028 and L.
plantarum B2028 + LAC, which is not surprising given the added load of the
organisms in the diet. It should however be borne in mind that the PCR is not
specific for strain B2028. Clearly, an addition of strain B2028 resulted in enhanced
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numbers of L. plantarum spp. These data are supported by the findings of Pollmann
et al. (1980) who observed that in pigs receiving probiotic supplement together with
lactose counts of lactobacilli were increased whereas no such effect was observed
with administration of the probiotic supplement alone. Letellier et al. (2000) also
reported increases in Gram-positive rod and coccoid bacteria after probiotic, FOS,
and their symbiotic combination during S. Typhimurium experimental infection.
Their studies showed no changes of pathogen shedding in the faeces, however. L.
plantarum was present in the pigs prior to the challenge as these organisms were
detected in the CTR and LAC groups but in much lower abundance than Lp treated
groups. It is possible that LAC stimulated L. plantarum growth as the LAC group
developed more PCR positive samples than the CTR group.
The reports of in vivo efficacy of probiotics and prebiotics in the control of S.
Typhimurium in pigs are contradictory; this could be strain, dose dependant and diet
composition dependant; for example supplementation of single probiotics showed no
beneficial effect or greater pathogen excretion and enhanced organ colonisation in
pigs challenged with S. Typhimurium (Kreuzer et al., 2012; Szabo et al., 2009). On
the other hand using a combination of five probiotic strains observed reductions in
Salmonella shedding and alleviation of clinical disease outcome (Casey et al., 2007).
A trend to reduce the frequency of Salmonella excretion in this study was
observed, which possibly could be attributable to enhancement of lactobacilli
numbers via synergistic effects of L. plantarum B2028 and LAC. This could indicate
that administration of L. plantarum B2028 and LAC together, might prove to be
effective in the field as an alternative control measure to control zoonotic Salmonella
infections in pigs due to gut microbiota modulation and improvement of general
animal health especially after weaning. Daily handling of animals for sampling in the
studies reported here is an additional stress factor for the piglets which could have
enhanced colonisation. Furthermore, the permanent contact of individual animals that
were negative and positive for STm SL1344nalr piglets within any one study group
and their contact with the contaminated environment could have increased
recrudescence of Salmonella during this study (Callaway et al., 2006; Verbrugghe et
al., 2011). This would contribute to reducing any significance in tissue colonisation
observed among the animals examined. Nevertheless, from the data obtained here we
can conclude that LAC is essential to potentiate the probiotic effect of L. plantarum
B2028 during outcome of S. Typhimurium experimental infection and that
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longitudinal studies of this synbiotic should be carried out to evaluate further its full
potential. Certainly, there is a need to study the immunomodulatory effects of L.
plantarum B2028 and LAC as these are as yet unknown.
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Chapter 7
General discussion
Human infections due to Salmonella spp. continuously represent major public
health and economic burden (Adams and Moss, 2008; EFSA, 2012; Voetsch et al.,
2004). Moreover as discussed beforehand (Chapter 1), pork and pork products are
important reservoirs of S. Typhimurium. Thus, the control of S. Typhimurium
colonisation in pigs is essential in order to reduce the occurrence of salmonellosis in
humans, primarily those attributed to serovar Typhimurium. One of the formerly
implemented on-farm approaches to control gastrointestinal pathogens and improve
zootechnical performance of animals was the use of AGPs (Dibner and Richards,
2005). It has been postulated that the mechanisms by which AGPs improved the
growth promotion was associated with their influence on the balance of GIT
microflora, inhibition of pathogens (Dibner and Richards, 2005) and consequences of
those changes on immune stimulation (Costa et al., 2011; Niewold, 2007). Following
the ban on in-feed antimicrobials in the EU (Castanon, 2007) there has been anecdotal
evidence for increases in endemic disease and statutory pathogens such as S.
Typhimurium remain a recognised human health risk factor in the food production
chain. Thus improvement of the host’s resistance to pathogens by alternative on-farm
control strategies has become essential. Hence, the development of pre-, pro- and syn-
biotics are clearly understandable approaches, as these represent opportunities to
modulate the gut microflora, an already recognised complex and dynamic ecosystem
(Xu and Gordon, 2003), to contribute to animal health and performance (Konstantinov
et al., 2006a). Lactobacillus spp. are regarded as one of the major groups of bacteria
present in the pig gut (Castillo et al., 2006; Konstantinov et al., 2004) and are of
particular interest due to the growing evidence of the protective and health benefits that
they confer in pigs (Bomba et al., 1998; Bomba et al., 2002; Castillo et al., 2011;
Konstantinov et al., 2006a; Servin, 2004). However, much of this work is empirical
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and there remains a need to delve deeper into the mechanisms of protection and health
promotion.
Roberfroid (1998) suggested that synbiotics may exert greater beneficial effect to
that of individual pre- or probiotics. He argued that prebiotics will stimulate the growth
of those organisms capable of metabolising these complex oligosaccharides.
Subsequently, fortifying the flora with additional bacterial species that benefit from
that metabolism will have greater health and protective impacts than either alone.
Thus, one of the aims of these studies was the construction of an effective synbiotic
that can successfully be employed to control Salmonella colonisation in pigs. Three
out of the sixteen probiotic candidates tested in this thesis (Chapter 3), showed strong
antimicrobial effect on S. Typhimurium growth. However, ultimately, the porcine
isolate L. plantarum B2028 (Collins et al., 2010) was chosen for further studies to
comply with the range of selection criteria for new probiotics (Klaenhammer and
Kullen, 1999). In addition, a porcine source could imply better survival and ability to
colonise the pig GIT. The ubiquitous L. plantarum spp. is found in many ecological
niches (Lee et al., 2011; Plumed-Ferrer et al., 2004; Siezen et al., 2010) as well as the
gastrointestinal tract of human (Ahrne et al., 1998; Molin et al., 1993) and animals
(Collins et al., 2010; De Angelis et al., 2006; Rodriguez-Palacios et al., 2009).
Previous studies demonstrated production of bacteriocin by L. plantarum spp.
(Todorov et al., 2010) as well as antimicrobial activity against Salmonella (Fayol-
Messaoudi et al., 2007; Kaushik et al., 2009; Makras et al., 2006) suggesting that L.
plantarum isolates were suitable potential probiotic strains for the specific task of
impacting on S. Typhimurium. Interestingly, because the assay for these studies was
control of Salmonella, and that alone, it is highly likely that these studies were not
fully exploited to assay other potential benefits of the various pro- and pre-biotic
combinations assessed.
Having selected L. plantarum for use in an in vivo model it was necessary to fulfill
further selection criteria (Klaenhammer and Kullen, 1999; Saarela et al., 2000) such as
the ability to resist low pH and bile: these studies were described in Chapter 4. Despite
showing sensitivity to the lowest tested pH ranges in the in vitro environment, it could
still be argued that the presence of feed in the stomach might to some degree confer
protection of the probiotic (Conway et al., 1987; Desmond et al., 2002). Thus,
enabling appropriate numbers of viable cells to reach the lower gut and exert their
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beneficial properties. Corcoran et al. (2005) demonstrated enhanced survival of
lactobacilli strains in the presence of metabolisable carbohydrates and hence it could
be hypothesized that lactulose might contribute to L. plantarum better survival. The
ability of lactobacilli to form a biofilm structures on the epithelial surfaces of the
oesophagus and the pars oesophagea of the pig stomach (Tannock, 1992), could also
be advantageous for the survival in the harsh acidic environment. It remains unclear
what numbers need to pass through to the lower gut to exert beneficial effects and the
numbers required will depend on their mode action against S. Typhimurium. Again,
until we have a greater understanding of the mechanisms of action, formulating
delivery regimes will be potentially inaccurate estimates. Irrespective of that,
protection from acid and bile will enhance the survival of the strain and so approaches
such as microencapsulation could be employed (Rokka and Rantamäki, 2010) and
which have been demonstrated to improve gastrointestinal resistance of probiotic
strains (Del Piano et al., 2010). Due to growing awareness of antibiotic resistance, and
to conform to the EU legislative framework (discussed in Chapter 1) the L. plantarum
B2028 resistance profile was assessed showing that L. plantarum B2028 is susceptible
to seven out of eight tested antibiotics. Nevertheless, prior to any commercial
application, the assessment of resistance to quinupristin/dalfopristin and further
screening for the presence of resistance genes is required. This was an area of research
that for time reasons was not pursued. It is known that prior to commercialisation
many probiotic strains are treated to remove resistance genes, especially those that are
plasmid mediated that can be lost by simple chemical treatments.
As part of synbiotic to be used in these studies, the prebiotic LAC was selected
(Chapter 3). Enhancement of the beneficial gut microbiota with prebiotics and in turn
contribution to improved health status and resistance to pathogens is known (Gaggia et
al., 2010). The ability of LAC to selectively promote intestinal microbiota including
bifidobacteria and lactobacilli has been reported extensively in human studies
(Ballongue et al., 1997; Kontula et al., 2002; Tuohy et al., 2002). In this study, LAC
promoted growth of L. plantarum in the pure culture and in fermentations with the
complex porcine microflora in which significant increases of Lactobacillus-
Enterococcus bacteria was observed, which corroborate with the findings of Martin-
Pelaez et al. (2008). Additionally, S. Typhimurium failed to utilise LAC as a sole
carbon source (Chapter 3) indicating the combination of L. plantarum and LAC would
Chapter 7
163
be the most effective combination in impacting on S. Typhimurium. It would be of
interest to know whether the breakdown products of LAC from the porcine microflora
fermentations would support the growth of S. Typhimurium. Simple monosaccharides
are likely to be produced but these are likely to be lactose a substrate that salmonellas
cannot use, making the selection of LAC logical.
Before the L. plantarum B2028 and LAC was evaluated as an intervention against
S. Typhimurium colonisation in the pig model, it was essential to demonstrate its
efficacy using range of the in vitro models and to determine the possible mode of
action. To test the synbiotic concept for the studies where cell free supernatant was
used, LAC was also included in the growth medium as a main carbon source.
Numerous studies have reported antagonistic activities of lactobacilli against
Salmonella due to production of antimicrobial substances, both lactic acid and other
compounds (Bernet-Camard et al., 1997; Coconnier-Polter et al., 2005; Coconnier et
al., 1997; Coconnier et al., 2000; Makras et al., 2006; Tejero-Sarinena et al., 2012). It
was demonstrated (Chapter 3), that the growth inhibition of S. Typhimurium by
lactobacilli strains was directly correlated to the amount of lactic acid in cell free
supernatants and, as mentioned above, the porcine derived L. plantarum isolate was
one of three lactobacilli that showed strong inhibition of Salmonella growth. This
inhibitory effect of L. plantarum supernatant was confirmed to be pH dependant and
could mostly be assigned to the presence of lactic acid (Chapter 5). Nevertheless, this
anti-Salmonella activity was not solely lactic acid, and so the presence of non lactic
acid compound(s) is probable and need further assessment. It is most likely, especially
in an in vivo environment that various factors, including production of organic acids,
non-lactic acid molecules, competition for receptor sites or inhibition by co-
aggregation all synergistically contribute towards inhibition of S. Typhimurium. It was
demonstrated (Chapter 5), that a short pre-exposure of Salmonella to L. plantarum
supernatants reduced the pathogen’s ability to invade IPEC-J2 cells but without
compromising viability of the Salmonella. In fact, it was previously reported that
exposure of S. Typhimurium to the CFS of L. acidophilus LB resulted in temporary
impairment of motility of the pathogen, hence it reduced the invasion to human
enterocyte-like cells (Lievin-Le Moal et al., 2011). Certainly, flagella have been shown
to play an important role in the adhesion and invasion of Salmonella (Allen-Vercoe
and Woodward, 1999; La Ragione et al., 2003). It would have been of considerable
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interest to explore any impact of L. plantarum and/or its CFS upon the motility of
Salmonella. Low pH will disrupt proton motive force and deplete energy from the
motor of the flagella. Also, low pH may cause disaggregation of the protein monomers
of flagella changing amplitude or even organelle integrity, thus compromising motility.
Simultaneous co-incubation of S. Typhimurium with L. plantarum and its cell free
supernatant dramatically reduced its ability to invade monolayers and 3D IPEC-J2
cells (Chapter 5). The presence of probiotic supernatant was essential in generating this
effect but, interestingly, L. plantarum cells together with the supernatant had an even
greater inhibitory effect on Salmonella invasion. This perhaps suggests a synergistic
effect whereby, in addition to inhibitory compounds present in supernatant that effects
the invasive phenotype of Salmonella, the L. plantarum bacterial cells may themselves
compete or interfere with the pathogen during the initial attachment. Mappley et al.
(2011) demonstrated a physical interaction between a lactic acid probiotic and
Brachyspira pilosicoli that interfered and reduced attachment of the pathogen to host
cells. Perhaps physical association between organisms is an important generic control
mechanism. This warrants further investigation. However, in this study LAC or
washed probiotic cells alone failed to reduce the adherence or invasion S.
Typhimurium. This suggests that the cell free supernatant plays a primary crucial role
in the inhibition and that bacterial cells of L. plantarum enhanced the inhibition but
only in the appropriate environment, possibly pH or presence of certain metabolites.
The importance of the CFS of L. acidophilus LA1 for its adhesion was previously
demonstrated (Bernet et al., 1994). The role of a L. acidophilus derived proteinaceous
compound present in the supernatant for its adherence was highlighted by the authors.
However, the ability of L. plantarum to adhere to epithelial cells was demonstrated
(Chapter 4), it was not in this instance determined if the adherence is affected by the
presence of its own CFS. Thus the exact mechanism of adherence such as mediation by
the presence of proteinaceous molecules, mannose adhesins (Adlerberth et al., 1996;
Bernet et al., 1994; Coconnier et al., 1992; Greene and Klaenhammer, 1994) or other
adhesive structures (Granato et al., 1999; Sherman and Savage, 1986) is unclear and
would be worth further investigation. However, no protective effect of L. plantarum
and CFSL against the association of S. Typhimurium using porcine IVOC was
observed (Chapter 5). Due to the complex nature of this model the effect of the pre and
probiotic candidate on the Salmonella invasion was not studied more fully, even
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though it may be argued that IVOC is a more realistic model system to use. The IPEC-
J2 cells that were used for the adhesion and invasion studies were only shown to have
the glycocalyx layer on the surface (Schierack et al., 2006) as opposed to the porcine
jejunal or colonic mucosal tissues used in the IVOC model, which had a mature mucus
layer. The key components of the mucus are secreted mucins, but also defensins,
lysozyme and secretory IgA (Clamp and Creeth, 1984; Hollingsworth and Swanson,
2004). In studies using human gut mucosal tissues (Haque et al., 2004) Salmonella was
observed in the large numbers in the mucus, but the interaction of the pathogen with
the epithelial cells was greatly delayed, suggesting protective role of the mucus layer.
Collins et al. (2010) in his study, showed however that L. plantarum B2028 did not
reduce association or cellular pathology induced in the porcine mucosal tissues by S.
Typhimurium, which was in agreement with the results presented in this study.
Nevertheless, the ability to modulate jejunal and colonic mucin levels was
demonstrated for this strain. Using human intestinal glycoproteins, Tuomola et al.
(1999) demonstrated that the ability of lactobacilli to protect against the adherence of
Salmonella was strain dependent. More in depth studies are therefore needed to
evaluate L. plantarum interaction with the porcine mucus. It would also be interesting
to evaluate production of exopolysaccharides (EPS), that was shown in L. plantarum
spp. (Tallon et al., 2003) and, interestingly, as it was concluded elsewhere that present
in the gut EPS could decrease probiotic and increase Salmonella adhesion to  mucus
(Ruas-Madiedo et al., 2006).
Inclusion of the of LAC and synbiotics containing LAC in the porcine batch
culture system, in part representing the complex conditions of porcine colonic
environment, resulted in significant increases of the Lactobacillus-Enteroccocus
bacterial group. This correlated with the increases in SCFA (Chapter 3). It was then
hypothesized that administration of the L. plantarum B2028 combined with the ability
of LAC to enhance endogenous lactobacilli will impact on pathogen survival. Indeed,
further work (Chapter 5) showed that the L. plantarum B2028 and LAC synbiotic
resulted in decrease in Salmonella cell numbers over time. The fermentation of
prebiotic was additionally correlated with the gradual increase in SCFA
concentrations. In vivo, the majority of the SCFA are swiftly absorbed in the colon to
be metabolized at various body sites (Cook and Sellin, 1998). Butyrate especially is a
key energy source for colonocytes, also important for apoptosis and cell proliferation
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(Topping and Clifton, 2001). Interestingly, fermentation of LAC resulted in higher
butyric concentration than the other prebiotic tested (Chapter 3) and Martin-Pelaez et
al. (2008) One limitation of this study was the assessment of bacterial populations by
FISH, restricting the information regarding which other members of the pig gut
microflora might have been stimulated by administration of the L. plantarum and
LAC. The synbiotic containing L. plantarum and LAC inhibited S. Typhimurium
survival in the batch culture system but there is scant information on the role of other
organisms or other metabolites. Metagenomic approaches may have shed further light
on changes in the bacterial population on fermentation of the synbiotic in the
fermentation system. Detailed chemical analysis, a metabonomic approach, would
have given clues as to shifts in metabolites. These in-depth approaches may have
yielded new lines of investigation regarding inhibition of Salmonella. Further studies
investigating the Salmonella membrane damage following time course exposure to L.
plantarum B2028 supernatant or supernatant collected from the batch culture system
might also be helpful. S. Typhimurium membrane permeabilization was induced by the
CFS of L. acidophilus (Coconnier-Polter et al., 2005).
The in vitro studies/models provided a useful platform to study the anti-Salmonella
efficacy and the mode of action of probiotics and synbiotics, minimizing animal use.
Nevertheless, the in vitro systems use do not account for multiple physiological
parameters that are going to modulate that effect in vivo. It was always the aim of these
studies, if financially achievable, to evaluate the prospective probiotic L. plantarum
B2028 alone or as a synbiotic in a pig infection model. The results generated from the
pig study (Chapter 6) corroborated in vitro data presented in this thesis and confirmed
the superior effect of the probiotic candidate in combination with lactulose in
comparison to probiotic or prebiotic alone. Precisely, the higher lactobacilli counts
were observed in the group feed the synbiotic and this correlated with the reduced
frequency of Salmonella shedding. Incidentally, or perhaps more likely as a direct
consequence of the symbiotic in the pig diet, the numbers of E. coli were also reduced.
This is probably unsurprising given the similarities in metabolic capabilities between
Salmonella and E. coli (AbuOun et al., 2009). Detection of L. plantarum by PCR
mainly in those groups receiving pro- and synbiotic might indicate that L. plantarum
B2028 did colonise the porcine gut, with LAC acting synergistically, possibly
enhancing the growth and colonisation of the administered probiotic and possibly
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similar strains that were already resident in the gut flora. It is to be presumed the
beneficial effects which, in this study was primarily the reduction of intestinal carriage
of S. Typhimurium, were mediated by lactobacilli. However, as discussed above,
without a full analysis of the entire gut population and its metabonome it is not
possible to say this authoritatively. However, the addition of fermentable
carbohydrates supported growth specific lactobacilli in the gut of weaning piglets
(Konstantinov et al., 2004) and, similar to the findings of the study reported here. The
administration of L. paracasei in combination with maltodextrins, FOS or
polyunsaturated fatty acids enhanced pathogen reduction in the pig (Bomba et al.,
2002).
The porcine intestinal microbial community represents a very complex and
balanced ecosystem (Leser et al., 2002) that under stress conditions, such as during
weaning or infection, might get considerably disturbed (Pieper et al., 2008). Feed
additives that mitigate against such gut disturbances may also protect against the worst
effects of change or infections. Indeed, it has been reported that probiotics are most
effective in the young pigs, particularly when the gut microlora is disturbed at weaning
(Stavric and Kornegay, 1995). Even a single oral administration at the time of weaning
was shown to modify the intestinal microbiota that benefitted the health status of the
pig (Pieper et al., 2009).
The protective effects of pro- and prebiotics may be exerted against pathogens in
many ways; competition for nutrients and receptors, production of antimicrobial
compounds, including organic acids that create unfavorable niche (Servin, 2004). In
the future it would be interesting to evaluate the effect of those treatments and
correlation on complex bacterial populations, the SCFA concentrations in the gut
contents and metabolites changes in the gut contents, body fluids and various tissues.
Perhaps to further enhance the effect of synbiotic combinations used in this study,
future studies should concentrate on isolation of other potential porcine probiotic
strains that could be used in conjunction with these synbiotics. The findings of Casey
et al. (2007) could indicate that multiple species are required to confer best protective
effect against Salmonella infection. Recent studies reported isolation of L. sobrius a
common commensal present in the gastrointestinal tract of piglets (Konstantinov et al.,
2006b) that was shown to exert protective effect against E. coli in vitro (Roselli et al.,
2007) and in vivo (Konstantinov et al., 2008). It may be attractive to include additional
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prebiotics, such as MOS that acts as a receptor analog, so the pathogen inhibition and
host health improvement at the gut level can be mediated via various mechanisms.
Previous studies seems to support the idea of supplementation of probiotics to pregnant
sow and neonatal piglets (Genovese et al., 2000; Taras et al., 2005) and perhaps future
studies should evaluate inclusion of L. plantarum and LAC to sows and their litters.
Collectively, the in vitro and in vivo studies presented in this thesis, indicated that
the synbiotic that comprised a porcine isolate of L. plantarum and lactulose was more
effective to modulate the selected bacterial populations in comparison to L. plantarum
or lactulose alone. Furthermore, an in vitro anti-Salmonella activity and the ability to
reduce the frequency of S. Typhimurium shedding in the trial study was demonstrated.
The evidence gained suggests that this synbiotic approach could be applied to improve
gut health and as a control strategy for S. Typhimurium in pigs. Nevertheless,
longitudinal studies in the field are required that should also focus on the effect of L.
plantarum and lactulose administration on the immune response in pigs treated with
this synbiotic.
169
References
Aarestrup, F.M., and Carstensen, B. (1998). Effect of tylosin used as a growth promoter on the
occurrence of macrolide-resistant enterococci and staphylococci in pigs. Microb Drug Resist 4, 307-312.
AbuOun, M., Suthers, P.F., Jones, G.I., Carter, B.R., Saunders, M.P., Maranas, C.D., Woodward, M.J.,
and Anjum, M.F. (2009). Genome scale reconstruction of a Salmonella metabolic model: comparison of
similarity and differences with a commensal Escherichia coli strain. J Biol Chem 284, 29480-29488.
Adams, M.R., and Hall, C.J. (1988). Growth inhibition of food-borne pathogens by lactic and acetic
acids and their mixtures. Int J Food Sci Technol 23, 287-292.
Adams, M.R., and Moss, M.O. (2008). Salmonella. In: Food Microbiology. Adams, M.R. and Moss, M.
O. (eds.). 3rd Edn., RSC Publishing, Guildford, UK., ISBN: 978-0-85404-284-5, pp: 235-249.
Adlerberth, I., Ahrne, S., Johansson, M.L., Molin, G., Hanson, L.A., and Wold, A.E. (1996). A
mannose-specific adherence mechanism in Lactobacillus plantarum conferring binding to the human
colonic cell line HT-29. Appl Environ Microbiol 62, 2244-2251.
Agunos, A., Ibuki, M., Yokomizo, F., and Mine, Y. (2007). Effect of dietary beta1-4 mannobiose in the
prevention of Salmonella enteritidis infection in broilers. Br Poult Sci 48, 331-341.
Ahrne, S., Nobaek, S., Jeppsson, B., Adlerberth, I., Wold, A.E., and Molin, G. (1998). The normal
Lactobacillus flora of healthy human rectal and oral mucosa. J Appl Microbiol 85, 88-94.
Alakomi, H.L., Skytta, E., Saarela, M., Mattila-Sandholm, T., Latva-Kala, K., and Helander, I.M.
(2000). Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane. Appl
Environ Microbiol 66, 2001-2005.
Alam, J., Singh, B.R., Hansda, D., Singh, V.P., and Verma, J.C. (2009). Evaluation of aroA deletion
mutant of Salmonella enterica subspecies enterica serovar Abortusequi for its vaccine candidate
potential. Indian J Exp Biol 47, 871-879.
Alexopoulos, C., Georgoulakis, I.E., Tzivara, A., Kyriakis, C.S., Govaris, A., and Kyriakis, S.C. (2004).
Field evaluation of the effect of a probiotic-containing Bacillus licheniformis and Bacillus subtilis
spores on the health status, performance, and carcass quality of grower and finisher pigs. J Vet Med A
Physiol Pathol Clin Med 51, 306-312.
Allen-Vercoe, E., and Woodward, M.J. (1999). The role of flagella, but not fimbriae, in the adherence of
Salmonella enterica serotype Enteritidis to chick gut explant. J Med Microbiol 48, 771-780.
Altenhoefer, A., Oswald, S., Sonnenborn, U., Enders, C., Schulze, J., Hacker, J., and Oelschlaeger, T.A.
(2004). The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal
epithelial cells by different enteroinvasive bacterial pathogens. FEMS Immunol Med Microbiol 40, 223-
229.
Altschul, S.F., Gish, W., Miller, W., Myers, E.W., and Lipman, D.J. (1990). Basic local alignment
search tool. J Mol Biol 215, 403-410.
Anadon, A., Martinez-Larranaga, M.R., and Aranzazu Martinez, M. (2006). Probiotics for animal
nutrition in the European Union. Regulation and safety assessment. Regul Toxicol Pharmacol 45, 91-95.
Angelakis, E., Million, M., Henry, M., and Raoult, D. (2011). Rapid and accurate bacterial identification
in probiotics and yoghurts by MALDI-TOF mass spectrometry. J Food Sci 76, M568-572.
170
Anonymous (2003). Regulation (EC) No 2160/2003 of the European Parliament and of the Council of
17 November 2003 on the control of Salmonella and other specified food-borne zoonotic agents.
Official Journal of European Union, L325, pp: 1-15.
Anonymous (2010). FCC Consortium: Analysis of the costs and benefits of setting a target for the
reduction of Salmonella in slaughter pigs for European Commission Health and Consumers Directorate-
General.SANCO/2008/E2/0362010.
http://ec.europa.eu/food/food/biosafety/salmonella/docs/fattening_pigs_analysis_costs.pdf.
Antonio, M.A., Rabe, L.K., and Hillier, S.L. (2005). Colonization of the rectum by Lactobacillus species
and decreased risk of bacterial vaginosis. J Infect Dis 192, 394-398.
Aspinall, S.T., Hindle, M.A., and Hutchinson, D.N. (1992). Improved isolation of salmonellae from
faeces using a semisolid Rappaport-Vassiliadis medium. Eur J Clin Microbiol Infect Dis 11, 936-939.
Axelsson, L.T., Chung, T.C., Dobrogosz, W.J., and Lindgren, S.E. (1989). Production of a Broad
Spectrum Antimicrobial Substance by Lactobacillus reuteri. Microb Ecol in Health and Disease 2, 131-
136.
Baggesen, D.L., Sorensen, G., Nielsen, E.M., and Wegener, H.C. (2010). Phage typing of Salmonella
Typhimurium - is it still a useful tool for surveillance and outbreak investigation? Euro Surveill 15,
19471.
Ballongue, J., Schumann, C., and Quignon, P. (1997). Effects of lactulose and lactitol on colonic
microflora and enzymatic activity. Scand J Gastroenterol Suppl 222, 41-44.
Baloda, S.B., Christensen, L., and Trajcevska, S. (2001). Persistence of a Salmonella enterica serovar
typhimurium DT12 clone in a piggery and in agricultural soil amended with Salmonella-contaminated
slurry. Appl Environ Microbiol 67, 2859-2862.
Barbosa, T.M., Serra, C.R., La Ragione, R.M., Woodward, M.J., and Henriques, A.O. (2005). Screening
for bacillus isolates in the broiler gastrointestinal tract. Appl Environ Microbiol 71, 968-978.
Barrow, P.A. (2000). Diagnosis of Salmonella by ELISA and Other Tests. In: Wray, C., Wray, A. (eds.),
Salmonella in Domestic Animals. CABI Publishing, New York, pp. 407-428
Barrow, P.A., Page, K., and Lovell, M.A. (2001). The virulence for gnotobiotic pigs of live attenuated
vaccine strains of Salmonella enterica serovars Typhimurium and Enteritidis. Vaccine 19, 3432-3436.
Barrow, P.A., and Wallis, T.S. (2000). Vaccination against Salmonella infections in food animals:
rationale theoretical basis and practical application. In: Wray, C., Wray, A. (Eds.), Salmonella in
Domestic Animals. CABI Publishing, New York, pp. 323-339.
Bauer, E., Williams, B.A., Voigt, C., Mosenthin, R., and Verstegen, M.W. (2001). Microbial activities
of faeces from unweaned and adult pigs, in relation to selected fermentable carbohydrates. Animal
Science 73, 313-322.
Baumler, A.J., and Heffron, F. (1995). Identification and sequence analysis of lpfABCDE, a putative
fimbrial operon of Salmonella typhimurium. J Bacteriol 177, 2087-2097.
Baumler, A.J., Tsolis, R.M., Bowe, F.A., Kusters, J.G., Hoffmann, S., and Heffron, F. (1996a). The pef
fimbrial operon of Salmonella typhimurium mediates adhesion to murine small intestine and is
necessary for fluid accumulation in the infant mouse. Infect Immun 64, 61-68.
Baumler, A.J., Tsolis, R.M., and Heffron, F. (1996b). Contribution of fimbrial operons to attachment to
and invasion of epithelial cell lines by Salmonella typhimurium. Infect Immun 64, 1862-1865.
Bearson, B.L., and Bearson, S.M. (2008). The role of the QseC quorum-sensing sensor kinase in
colonization and norepinephrine-enhanced motility of Salmonella enterica serovar Typhimurium.
171
Microb Pathog 44, 271-278.
Bearson, B.L., Bearson, S.M., Uthe, J.J., Dowd, S.E., Houghton, J.O., Lee, I., Toscano, M.J., and Lay,
D.C., Jr. (2008). Iron regulated genes of Salmonella enterica serovar Typhimurium in response to
norepinephrine and the requirement of fepDGC for norepinephrine-enhanced growth. Microbes Infect
10, 807-816.
Bearson, B.L., Wilson, L., and Foster, J.W. (1998). A low pH-inducible, PhoPQ-dependent acid
tolerance response protects Salmonella typhimurium against inorganic acid stress. J Bacteriol 180, 2409-
2417.
Belenguer, A., Duncan, S.H., Calder, A.G., Holtrop, G., Louis, P., Lobley, G.E., and Flint, H.J. (2006).
Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing
anaerobes from the human gut. Appl Environ Microbiol 72, 3593-3599.
Beloeil, P.A., Chauvin, C., Proux, K., Fablet, C., Madec, F., and Alioum, A. (2007). Risk factors for
Salmonella seroconversion of fattening pigs in farrow-to-finish herds. Vet Res 38, 835-848.
Belsue, J.B., Alujas, A.M., and Porter, R. (2011). Detection of high serological prevalence and
comparison of different tests for Salmonella in pigs in Northern Ireland. Vet Rec 169, 153.
Bergman, E.N. (1990). Energy contributions of volatile fatty acids from the gastrointestinal tract in
various species. Physiol Rev 70, 567-590.
Bernet-Camard, M.F., Lievin, V., Brassart, D., Neeser, J.R., Servin, A.L., and Hudault, S. (1997). The
human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active
in vitro and in vivo. Appl Environ Microbiol 63, 2747-2753.
Bernet, M.F., Brassart, D., Neeser, J.R., and Servin, A.L. (1994). Lactobacillus acidophilus LA 1 binds
to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent
bacteria. Gut 35, 483-489.
Bertani, G. (1951). Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia
coli. J Bacteriol 62, 293-300.
Bertani, G. (2004). Lysogeny at mid-twentieth century: P1, P2, and other experimental systems. J
Bacteriol 186, 595-600.
Beshkova, D., and Frengova, G. (2012). Bacteriocins from lactic acid bacteria: Microorganisms of
potential biotechnological importance for the dairy industry. Engineering in Life Sciences 12, 419-432.
Bezkorovainy, A. (2001). Probiotics: determinants of survival and growth in the gut. Am J Clin Nutr 73,
399S-405S.
Bielecka, M., Biedrzycka, E., and Majkowska, A. (2002). Selection of probiotics and prebiotics for
synbiotics and conﬁrmation of their in vivo effectiveness. Food Research International 3, 125-131.
Boerlin, P., and Reid-Smith, R.J. (2008). Antimicrobial resistance: its emergence and transmission.
Anim Health Res Rev 9, 115-126.
Boerlin, P., Wissing, A., Aarestrup, F.M., Frey, J., and Nicolet, J. (2001). Antimicrobial growth
promoter ban and resistance to macrolides and vancomycin in enterococci from pigs. J Clin Microbiol
39, 4193-4195.
Bohlander, S.K., Espinosa, R., 3rd, Le Beau, M.M., Rowley, J.D., and Diaz, M.O. (1992). A method for
the rapid sequence-independent amplification of microdissected chromosomal material. Genomics 13,
1322-1324.
Bolton, A.J., Osborne, M.P., Wallis, T.S., and Stephen, J. (1999). Interaction of Salmonella
choleraesuis, Salmonella dublin and Salmonella typhimurium with porcine and bovine terminal ileum in
172
vivo. Microbiology 145 ( Pt 9), 2431-2441.
Bomba, A., Gancarcikova, S., Nemcova, R., Herich, R., Kastel, R., Depta, A., Demeterova, M., Ledeck,
V., and Zitnan, R. (1998). The effect of lactic acid bacteria on intestinal metabolism and metabolic
profile in gnotobiotic pigs. Dtsch Tierarztl Wochenschr 105, 384-389.
Bomba, A., Nemcova, R., Gancarcikova, S., Herich, R., Guba, P., and Mudronova, D. (2002).
Improvement of the probiotic effect of micro-organisms by their combination with maltodextrins,
fructo-oligosaccharides and polyunsaturated fatty acids. Br J Nutr 88 Suppl 1, S95-99.
Bottazzi, V. (1983). Food and feed production with microorganisms. Biotechnology, 5: 315-63. .
Botteldoorn, N., Heyndrickx, M., Rijpens, N., Grijspeerdt, K., and Herman, L. (2003). Salmonella on
pig carcasses: positive pigs and cross contamination in the slaughterhouse. J Appl Microbiol 95, 891-
903.
Bouhnik, Y., Attar, A., Joly, F.A., Riottot, M., Dyard, F., and Flourie, B. (2004a). Lactulose ingestion
increases faecal bifidobacterial counts: a randomised double-blind study in healthy humans. Eur J Clin
Nutr 58, 462-466.
Bouhnik, Y., Raskine, L., Simoneau, G., Vicaut, E., Neut, C., Flourie, B., Brouns, F., and Bornet, F.R.
(2004b). The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy
humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study.
Am J Clin Nutr 80, 1658-1664.
Bourriaud, C., Robins, R.J., Martin, L., Kozlowski, F., Tenailleau, E., Cherbut, C., and Michel, C.
(2005). Lactate is mainly fermented to butyrate by human intestinal microfloras but inter-individual
variation is evident. J Appl Microbiol 99, 201-212.
Bovee-Oudenhoven, I., and Van der Meer, R. (1997). Protective effects of dietary lactulose and calcium
phosphate against Salmonella infection. Scand J Gastroenterol Suppl 222, 112-114.
Boyen, F., Haesebrouck, F., Maes, D., Van Immerseel, F., Ducatelle, R., and Pasmans, F. (2008a). Non-
typhoidal Salmonella infections in pigs: a closer look at epidemiology, pathogenesis and control. Vet
Microbiol 130, 1-19.
Boyen, F., Haesebrouck, F., Vanparys, A., Volf, J., Mahu, M., Van Immerseel, F., Rychlik, I., Dewulf,
J., Ducatelle, R., and Pasmans, F. (2008b). Coated fatty acids alter virulence properties of Salmonella
Typhimurium and decrease intestinal colonization of pigs. Vet Microbiol 132, 319-327.
Boyen, F., Pasmans, F., Van Immerseel, F., Donne, E., Morgan, E., Ducatelle, R., and Haesebrouck, F.
(2009). Porcine in vitro and in vivo models to assess the virulence of Salmonella enterica serovar
Typhimurium for pigs. Lab Anim 43, 46-52.
Brashears, M.M., Galyean, M.L., Loneragan, G.H., Mann, J.E., and Killinger-Mann, K. (2003).
Prevalence of Escherichia coli O157:H7 and performance by beef feedlot cattle given Lactobacillus
direct-fed microbials. J Food Prot 66, 748-754.
Brenner, F.W., Villar, R.G., Angulo, F.J., Tauxe, R., and Swaminathan, B. (2000). Salmonella
nomenclature. J Clin Microbiol 38, 2465-2467.
Bron, P.A., Marco, M., Hoffer, S.M., Van Mullekom, E., de Vos, W.M., and Kleerebezem, M. (2004).
Genetic characterization of the bile salt response in Lactobacillus plantarum and analysis of responsive
promoters in vitro and in situ in the gastrointestinal tract. J Bacteriol 186, 7829-7835.
Brown, N.F., Vallance, B.A., Coombes, B.K., Valdez, Y., Coburn, B.A., and Finlay, B.B. (2005).
Salmonella pathogenicity island 2 is expressed prior to penetrating the intestine. PLoS Pathog 1, e32.
Callaway, T.R., Edrington, T.S., Anderson, R.C., Byrd, J.A., and Nisbet, D.J. (2008a). Gastrointestinal
microbial ecology and the safety of our food supply as related to Salmonella. J Anim Sci 86, E163-172.
173
Callaway, T.R., Edrington, T.S., Anderson, R.C., Harvey, R.B., Genovese, K.J., Kennedy, C.N., Venn,
D.W., and Nisbet, D.J. (2008b). Probiotics, prebiotics and competitive exclusion for prophylaxis against
bacterial disease. Anim Health Res Rev 9, 217-225.
Callaway, T.R., Morrow, J.L., Edrington, T.S., Genovese, K.J., Dowd, S., Carroll, J., Dailey, J.W.,
Harvey, R.B., Poole, T.L., Anderson, R.C., et al. (2006). Social stress increases fecal shedding of
Salmonella typhimurium by early weaned piglets. Curr Issues Intest Microbiol 7, 65-71.
Callaway, T.R., Morrow, J.L., Johnson, A.K., Dailey, J.W., Wallace, F.M., Wagstrom, E.A., McGlone,
J.J., Lewis, A.R., Dowd, S.E., Poole, T.L., et al. (2005). Environmental prevalence and persistence of
Salmonella spp. in outdoor swine wallows. Foodborne Pathog Dis 2, 263-273.
Cannon, J.P., Lee, T.A., Bolanos, J.T., and Danziger, L.H. (2005). Pathogenic relevance of
Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis 24, 31-40.
Carrique-Mas, J.J., and Davies, R.H. (2008). Sampling and bacteriological detection of Salmonella in
poultry and poultry premises: a review. Rev Sci Tech 27, 665-677.
Cartman, S.T., La Ragione, R.M., and Woodward, M.J. (2008). Bacterial spore formers as probiotics for
poultry. In: Food Science and Technology Bulletin: Functional Foods. IFIS Publishing, UK. 4, 21-30.
Casey, P.G., Gardiner, G.E., Casey, G., Bradshaw, B., Lawlor, P.G., Lynch, P.B., Leonard, F.C.,
Stanton, C., Ross, R.P., Fitzgerald, G.F., et al. (2007). A five-strain probiotic combination reduces
pathogen shedding and alleviates disease signs in pigs challenged with Salmonella enterica Serovar
Typhimurium. Appl Environ Microbiol 73, 1858-1863.
Castanon, J.I. (2007). History of the use of antibiotic as growth promoters in European poultry feeds.
Poult Sci 86, 2466-2471.
Castillo, M., Martin-Orue, S.M., Manzanilla, E.G., Badiola, I., Martin, M., and Gasa, J. (2006).
Quantification of total bacteria, enterobacteria and lactobacilli populations in pig digesta by real-time
PCR. Vet Microbiol 114, 165-170.
Castillo, M., Martin-Orue, S.M., Taylor-Pickard, J.A., Perez, J.F., and Gasa, J. (2008). Use of
mannanoligosaccharides and zinc chelate as growth promoters and diarrhea preventative in weaning
pigs: Effects on microbiota and gut function. J Anim Sci 86, 94-101.
Castillo, N.A., Perdigon, G., and de Moreno de Leblanc, A. (2011). Oral administration of a probiotic
Lactobacillus modulates cytokine production and TLR expression improving the immune response
against Salmonella enterica serovar Typhimurium infection in mice. BMC Microbiol 11, 177.
Chateau, N., Deschamps, A.M., and Hadj Sassi, A. (1994). Heterogeneity of bile salts resistance in the
Lactobacillus isolates of a probiotic consortium. Lett Appl Microbiol 18, 42-44.
Chichlowski, M., Croom, J., Havenstein, G.B., and Koci, M.D. (2007). Metabolic and Physiological
Impact of Probiotics or Direct-Fed-Microbials on Poultry: A Brief Review of Current Knowledge.
International Journal of Poultry Science 6, 694-704.
Chiu, C.H., Su, L.H., and Chu, C. (2004). Salmonella enterica serotype Choleraesuis: epidemiology,
pathogenesis, clinical disease, and treatment. Clin Microbiol Rev 17, 311-322.
Cho, J.H., Zhao, P.Y., and Kim, I.H. (2011). Probiotics as a Dietary Additive for Pigs: A Review.
Journal of Animal and Veterinary Advances 10, 2127-2134.
Clamp, J.R., and Creeth, J.M. (1984). Some non-mucin components of mucus and their possible
biological roles. Ciba Found Symp 109, 121-136.
Clough, H.E., Fenton, S.E., French, N.P., Miller, A.J., and Cook, A.J. (2009). Evidence from the UK
Zoonoses Action Plan in favour of localised anomalies of Salmonella infection on United Kingdom pig
farms. Prev Vet Med 89, 67-74.
174
Coconnier-Polter, M.H., Lievin-Le Moal, V., and Servin, A.L. (2005). A Lactobacillus acidophilus
strain of human gastrointestinal microbiota origin elicits killing of enterovirulent Salmonella enterica
Serovar Typhimurium by triggering lethal bacterial membrane damage. Appl Environ Microbiol 71,
6115-6120.
Coconnier, M.H., Klaenhammer, T.R., Kerneis, S., Bernet, M.F., and Servin, A.L. (1992). Protein-
mediated adhesion of Lactobacillus acidophilus BG2FO4 on human enterocyte and mucus-secreting cell
lines in culture. Appl Environ Microbiol 58, 2034-2039.
Coconnier, M.H., Lievin, V., Bernet-Camard, M.F., Hudault, S., and Servin, A.L. (1997). Antibacterial
effect of the adhering human Lactobacillus acidophilus strain LB. Antimicrob Agents Chemother 41,
1046-1052.
Coconnier, M.H., Lievin, V., Lorrot, M., and Servin, A.L. (2000). Antagonistic activity of Lactobacillus
acidophilus LB against intracellular Salmonella enterica serovar Typhimurium infecting human
enterocyte-like Caco-2/TC-7 cells. Appl Environ Microbiol 66, 1152-1157.
Cogliani, C., Goossens, H., and Greko, C. (2011). Restricting Antimicrobial Use in Food Animals:
Lessons from Europe. Banning nonessential antibiotic uses in food animals is intended to reduce pools
of resistance genes. Microbe 6, 274-279.
Coleman, R., Iqbal, S., Godfrey, P.P., and Billington, D. (1979). Membranes and bile formation.
Composition of several mammalian biles and their membrane-damaging properties. Biochem J 178,
201-208.
Collado, M.C., Grzeskowiak, L., and Salminen, S. (2007). Probiotic strains and their combination
inhibit in vitro adhesion of pathogens to pig intestinal mucosa. Curr Microbiol 55, 260-265.
Collard, J.M., Bertrand, S., Dierick, K., Godard, C., Wildemauwe, C., Vermeersch, K., Duculot, J., Van
Immerseel, F., Pasmans, F., Imberechts, H., et al. (2008). Drastic decrease of Salmonella Enteritidis
isolated from humans in Belgium in 2005, shift in phage types and influence on foodborne outbreaks.
Epidemiol Infect 136, 771-781.
Collins, J.W. (2010). Evaluation of Lactobacillus plantarum as a control strategy for Salmonella
typhimurium using porcine in vitro models of infection (Thesis).
Collins, J.W., Coldham, N.G., Salguero, F.J., Cooley, W.A., Newell, W.R., Rastall, R.A., Gibson, G.R.,
Woodward, M.J., and La Ragione, R.M. (2010). Response of porcine intestinal in vitro organ culture
tissues following exposure to Lactobacillus plantarum JC1 and Salmonella enterica serovar
Typhimurium SL1344. Appl Environ Microbiol 76, 6645-6657.
Collins, J.W., La Ragione, R.M., Woodward, M.J., and Searle, L.E. (2009). Application of prebiotics
and probiotics in livestock, pp. 1123-1192. In: D. Charalampopoulos and  R. A. Rastall (eds.), Prebiotics
and Probiotics Science and Technology (New York, Springer).
Collins, M.D., and Gibson, G.R. (1999). Probiotics, prebiotics, and synbiotics: approaches for
modulating the microbial ecology of the gut. Am J Clin Nutr 69, 1052S-1057S.
Conway, P.L. (1997). Development of intestinal microbiota. Gastrointestinal microbes and host
interactions. In: Mackie, R. I., Whyte, B. A. and Isaacson, R. E., (Eds.), Gastrointestinal
Microbiol., Chapman and Hall, London. 2, 3-38.
Conway, P.L., Gorbach, S.L., and Goldin, B.R. (1987). Survival of lactic acid bacteria in the human
stomach and adhesion to intestinal cells. J Dairy Sci 70, 1-12.
Cook, S.I., and Sellin, J.H. (1998). Review article: short chain fatty acids in health and disease. Aliment
Pharmacol Ther 12, 499-507.
Corcionivoschi, N., Drinceanu, D., Stef, L., Luca, I., Julean, C., and Mingyart, O. (2010). Probiotics-
indentification and ways of action. Innov Romanian Food Biotechnology 6, 1-11.
175
Corcoran, B.M., Stanton, C., Fitzgerald, G.F., and Ross, R.P. (2005). Survival of probiotic lactobacilli in
acidic environments is enhanced in the presence of metabolizable sugars. Appl Environ Microbiol 71,
3060-3067.
Costa, E., Uwiera, R.R., Kastelic, J.P., Selinger, L.B., and Inglis, G.D. (2011). Non-therapeutic
administration of a model antimicrobial growth promoter modulates intestinal immune responses. Gut
Pathog 3, 14.
Cotter, P.D., Hill, C., and Ross, R.P. (2005). Bacteriocins: developing innate immunity for food. Nat
Rev Microbiol 3, 777-788.
Counotte, G.H., and Prins, R.A. (1981). Regulation of lactate metabolism in the rumen. Vet Res
Commun 5, 101-115.
Counotte, G.H., Prins, R.A., Janssen, R.H., and Debie, M.J. (1981). Role of Megasphaera elsdenii in the
Fermentation of dl-[2-C]lactate in the Rumen of Dairy Cattle. Appl Environ Microbiol 42, 649-655.
Cummings, J.H. (1981). Short chain fatty acids in the human colon. Gut 22, 763-779.
Curtiss, R., 3rd, and Kelly, S.M. (1987). Salmonella typhimurium deletion mutants lacking adenylate
cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect Immun 55, 3035-3043.
Dahiya, R.S., and Speck, M.L. (1968). Hydrogen peroxide formation by lactobacilli and its effect on
Staphylococcus aureus. J Dairy Sci 51, 1568-1572.
Daims, H., Stoecker, K., and Wagner, M. (2005). Fluorescence in situ hybridization for the detection of
procaryotes. In: Osborn, A. M., Smith, C. J. (eds.). Advanced Methods in Molecular Microbial Ecology.
Bios-Garland, Abingdon, UK. pp. 213-239.
Danielsen, M., and Wind, A. (2003). Susceptibility of Lactobacillus spp. to antimicrobial agents. Int J
Food Microbiol 82, 1-11.
Darwin, K.H., and Miller, V.L. (1999). Molecular basis of the interaction of Salmonella with the
intestinal mucosa. Clin Microbiol Rev 12, 405-428.
Davies, J.E. (1997). Origins, acquisition and dissemination of antibiotic resistance determinants. Ciba
Found Symp 207, 15-27; discussion 27-35.
Davies, P.R., Morrow, W.E., Jones, F.T., Deen, J., Fedorka-Cray, P.J., and Gray, J.T. (1997a). Risk of
shedding Salmonella organisms by market-age hogs in a barn with open-flush gutters. J Am Vet Med
Assoc 210, 386-389.
Davies, P.R., Morrow, W.E., Jones, F.T., Deen, J., Fedorka-Cray, P.J., and Harris, I.T. (1997b).
Prevalence of Salmonella in finishing swine raised in different production systems in North Carolina,
USA. Epidemiol Infect 119, 237-244.
Davies, P.R., Scott Hurd, H., Funk, J.A., Fedorka-Cray, P.J., and Jones, F.T. (2004). The role of
contaminated feed in the epidemiology and control of Salmonella enterica in pork production.
Foodborne Pathog Dis 1, 202-215.
Davies, P.R., Turkson, P.K., Funk, J.A., Nichols, M.A., Ladely, S.R., and Fedorka-Cray, P.J. (2000).
Comparison of methods for isolating Salmonella bacteria from faeces of naturally infected pigs. J Appl
Microbiol 89, 169-177.
Davies, R.H., and Wray, C. (1995). Mice as carriers of Salmonella enteritidis on persistently infected
poultry units. Vet Rec 137, 337-341.
Davies, R.H., and Wray, C. (1997). Distribution of Salmonella contamination in ten animal feedmills.
Vet Microbiol 57, 159-169.
176
Davis, M.E., Maxwell, C.V., Erf, G.F., Brown, D.C., and Wistuba, T.J. (2004). Dietary supplementation
with phosphorylated mannans improves growth response and modulates immune function of weanling
pigs. J Anim Sci 82, 1882-1891.
De Angelis, M., Siragusa, S., Berloco, M., Caputo, L., Settanni, L., Alfonsi, G., Amerio, M., Grandi, A.,
Ragni, A., and Gobbetti, M. (2006). Selection of potential probiotic lactobacilli from pig feces to be
used as additives in pelleted feeding. Res Microbiol 157, 792-801.
De Keersmaecker, S.C., Verhoeven, T.L., Desair, J., Marchal, K., Vanderleyden, J., and Nagy, I. (2006).
Strong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella typhimurium is due to
accumulation of lactic acid. FEMS Microbiol Lett 259, 89-96.
De Man, J.C., Rogosa, M., and Sharpe, M.E. (1960). A Medium for the cultivation of lactobacilli. J
Appl Bacteriol 23, 130-135.
De Smedt, J.M., and Bolderdijk, R.F. (1987). Dynamics of Salmonella isolation with modiﬁed semi-
solid Rappaport–Vassiliadis medium. Journal of Food Protection 50, 658–661.
De Smedt, J.M., Bolderdijk, R.F., Rappold, H., and Lautenschlaeger, D. (1986). Rapid Salmonella
detection in foods by motility enrichment on a modified semi-solid Rappaport-Vassiliadis medium. J
Food Prot 49, 510-514.
DEFRA (2009). Zoonoses Report United Kingdom 2009, pp. 79-86, London: Department for
Environment, Food and Rural Affairs (http://www.defra.gov.uk/publications/2011/2006/2021/pb13571-
zoonoses-report-uk-12009/).
DEFRA (2010). Zoonoses Report United Kingdom 2010, pp. 45-49, London: Department for
Environment, Food and Rural Affairs (http://www.defra.gov.uk/publications/2011/2009/2009/pb13627-
zoonoses-report-uk-12010/).
Del Piano, M., Carmagnola, S., Andorno, S., Pagliarulo, M., Tari, R., Mogna, L., Strozzi, G.P., Sforza,
F., and Capurso, L. (2010). Evaluation of the intestinal colonization by microencapsulated probiotic
bacteria in comparison with the same uncoated strains. J Clin Gastroenterol 44 Suppl 1, S42-46.
Delcenserie, V., Martel, D., Lamoureux, M., Amiot, J., Boutin, Y., and Roy, D. (2008).
Immunomodulatory effects of probiotics in the intestinal tract. Curr Issues Mol Biol 10, 37-54.
Delsol, A.A., Anjum, M., Woodward, M.J., Sunderland, J., and Roe, J.M. (2003). The effect of
chlortetracycline treatment and its subsequent withdrawal on multi-resistant Salmonella enterica serovar
Typhimurium DT104 and commensal Escherichia coli in the pig. J Appl Microbiol 95, 1226-1234.
Delsol, A.A., Woodward, M.J., and Roe, J.M. (2004). Effect of a 5 day enrofloxacin treatment on
Salmonella enterica serotype Typhimurium DT104 in the pig. J Antimicrob Chemother 53, 396-398.
Denagamage, T.N., O'Connor, A.M., Sargeant, J.M., Rajic, A., and McKean, J.D. (2007). Efficacy of
vaccination to reduce Salmonella prevalence in live and slaughtered swine: a systematic review of
literature from 1979 to 2007. Foodborne Pathog Dis 4, 539-549.
Deplancke, B., and Gaskins, H.R. (2001). Microbial modulation of innate defense: goblet cells and the
intestinal mucus layer. Am J Clin Nutr 73, 1131S-1141S.
Desmond, C., Ross, R.P., O'Callaghan, E., Fitzgerald, G., and Stanton, C. (2002). Improved survival of
Lactobacillus paracasei NFBC 338 in spray-dried powders containing gum acacia. J Appl Microbiol 93,
1003-1011.
Dibb-Fuller, M.P., Allen-Vercoe, E., Thorns, C.J., and Woodward, M.J. (1999). Fimbriae- and flagella-
mediated association with and invasion of cultured epithelial cells by Salmonella enteritidis.
Microbiology 145 ( Pt 5), 1023-1031.
Dibb-Fuller, M.P., Best, A., Stagg, D.A., Cooley, W.A., and Woodward, M.J. (2001). An in-vitro model
177
for studying the interaction of Escherichia coli O157:H7 and other enteropathogens with bovine primary
cell cultures. J Med Microbiol 50, 759-769.
Dibner, J.J., and Richards, J.D. (2005). Antibiotic growth promoters in agriculture: history and mode of
action. Poult Sci 84, 634-643.
Dibner, J.J., Richards, J.D., and Knight, C.D. (2008). Microbial Imprinting in Gut Development and
Health. J Appl Poult Res 17, 174-188
Doyle, M.E. (2001). Alternatives to Antibiotic Use for Growth Promotion in Animal Husbandry. Food
Research Institute. http:/fri.wisc.edu/docs/pdf/antibiot.pdf.
Doyle, M.P., and Erickson, M.C. (2006). Reducing the carriage of foodborne pathogens in livestock and
poultry. Poult Sci 85, 960-973.
Doyle, M.P., and Erickson, M.C. (2012). Opportunities for mitigating pathogen contamination during
on-farm food production. Int J Food Microbiol 152, 54-74.
du Toit, M., Franz, C.M., Dicks, L.M., Schillinger, U., Haberer, P., Warlies, B., Ahrens, F., and
Holzapfel, W.H. (1998). Characterisation and selection of probiotic lactobacilli for a preliminary
minipig feeding trial and their effect on serum cholesterol levels, faeces pH and faeces moisture content.
Int J Food Microbiol 40, 93-104.
Duguid, J.P., Anderson, E.S., and Campbell, I. (1966). Fimbriae and adhesive properties in Salmonellae.
J Pathol Bacteriol 92, 107-138.
Dumas, M.E., Barton, R.H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., Fearnside, J., Tatoud, R.,
Blanc, V., Lindon, J.C., et al. (2006). Metabolic profiling reveals a contribution of gut microbiota to
fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci U S A 103, 12511-12516.
Duncan, S.H., Louis, P., and Flint, H.J. (2004). Lactate-utilizing bacteria, isolated from human feces,
that produce butyrate as a major fermentation product. Appl Environ Microbiol 70, 5810-5817.
Dunne, C., O'Mahony, L., Murphy, L., Thornton, G., Morrissey, D., O'Halloran, S., Feeney, M., Flynn,
S., Fitzgerald, G., Daly, C., et al. (2001). In vitro selection criteria for probiotic bacteria of human
origin: correlation with in vivo findings. Am J Clin Nutr 73, 386S-392S.
Edel, W., and Kampelmacher, E.H. (1973). Comparative studies on the isolation of "sublethally injured"
salmonellae in nine European laboratories. Bull World Health Organ 48, 167-174.
Edwards, R.A., Schifferli, D.M., and Maloy, S.R. (2000). A role for Salmonella fimbriae in
intraperitoneal infections. Proc Natl Acad Sci U S A 97, 1258-1262.
EFSA (2005). Opinion of the Scientific Panel on Additives and Products or Substances used in Animal
Feed on the updating of the criteria used in the assessment of bacteria for resistance to antibiotics of
human or veterinary importance. EFSA Journal 223, 1-12.
EFSA (2008a). European Food Safety Authority. Report of the Task Force on Zoonoses Data Collection
on the analysis of the baseline survey on the prevalence of Salmonella in slaughter pigs, Part A. EFSA
Journal 135, 1-111.
EFSA (2008b). Technical guidance prepared by the Panel on Additives and Products or Substances used
in Animal Feed (FEEDAP) on the update on the criteria used in the assessment of bacterial resistance to
antibiotics of human or veterinary importance (efsa.europa.eu/en/efsajournal/doc/732.pdf). EFSA
Journal 732, 1-15.
EFSA (2009). European Food Safety Authority. Analysis of the baseline survey on the prevalence of
Salmonella in holdings with breeding pigs, in the EU, 2008, Part A: Salmonella prevalence estimates.
EFSA Journal 7(12):1377. www.efsa.europa.eu.
178
EFSA (2010). European Food Safety Authority, European Centre for Disease Prevention and Control;
The Community Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-
borne Outbreaks in the European Union in 2008. EFSA Journal 8(1):1496.
www.efsa.europa.eu/efsajournal.
EFSA (2012). European Food Safety Authority, European Centre for Disease Prevention and Control;
The European UnionSummary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-
borne Outbreaks in 2010. EFSA Journal 10(3):2597.www.efsa.europa.eu/efsajournal.
Eklund, T. (1983). The antimicrobial effect of dissociated and undissociated sorbic acid at different pH
levels. J Appl Bacteriol 54, 383-389.
Eklund, T. (1985). The effect of sorbic acid and esters of p-hydroxybenzoic acid on the protonmotive
force in Escherichia coli membrane vesicles. J Gen Microbiol 131, 73-76.
Elisha, B.G., and Courvalin, P. (1995). Analysis of genes encoding D-alanine:D-alanine ligase-related
enzymes in Leuconostoc mesenteroides and Lactobacillus spp. Gene 152, 79-83.
Eschenbach, D.A., Davick, P.R., Williams, B.L., Klebanoff, S.J., Young-Smith, K., Critchlow, C.M.,
and Holmes, K.K. (1989). Prevalence of hydrogen peroxide-producing Lactobacillus species in normal
women and women with bacterial vaginosis. J Clin Microbiol 27, 251-256.
Estrada, A., Drew, M.D., and Van Kessel, A. ( 2001). Effect of the dietary supplemention of
fructooligosaccharides and Bifidobacterium longum to early-weaned pigs on performance and fecal
bacterial populations Can J Anim Sci 81, 141-148.
Eswarappa, S.M., Janice, J., Nagarajan, A.G., Balasundaram, S.V., Karnam, G., Dixit, N.M., and
Chakravortty, D. (2008). Differentially evolved genes of Salmonella pathogenicity islands: insights into
the mechanism of host specificity in Salmonella. PLoS One 3, e3829.
Euzeby, J.P. (1999). Revised Salmonella nomenclature: designation of Salmonella enterica (ex
Kauffmann and Edwards 1952) Le Minor and Popoff 1987 sp. nov., nom. rev. as the neotype species of
the genus Salmonella Lignieres 1900 (approved lists 1980), rejection of the name Salmonella
choleraesuis (Smith 1894) Weldin 1927 (approved lists 1980), and conservation of the name Salmonella
typhi (Schroeter 1886) Warren and Scott 1930 (approved lists 1980). Request for an opinion. Int J Syst
Bacteriol 49 Pt 2, 927-930.
Ewen, S.W., Naughton, P.J., Grant, G., Sojka, M., Allen-Vercoe, E., Bardocz, S., Thorns, C.J., and
Pusztai, A. (1997). Salmonella enterica var Typhimurium and Salmonella enterica var Enteritidis
express type 1 fimbriae in the rat in vivo. FEMS Immunol Med Microbiol 18, 185-192.
Ezaki, T., Amano, M., Kawamura, Y., and Yabuuchi, E. (2000a). Proposal of Salmonella paratyphi sp.
nov., nom. rev. and request for an opinion to conserve the specific epithet paratyphi in the binary
combination Salmonella paratyphi as nomen epitheton conservandum. Int J Syst Evol Microbiol 50 Pt 2,
941-944.
Ezaki, T., Kawamura, Y., and Yabuuchi, E. (2000b). Recognition of nomenclatural standing of
Salmonella typhi (Approved Lists 1980), Salmonella enteritidis (Approved Lists 1980) and Salmonella
typhimurium (Approved Lists 1980), and conservation of the specific epithets enteritidis and
typhimurium. Request for an opinion. Int J Syst Evol Microbiol 50 Pt 2, 945-947.
Fayol-Messaoudi, D., Berger, C.N., Coconnier-Polter, M.H., Lievin-Le Moal, V., and Servin, A.L.
(2005). pH-, Lactic acid-, and non-lactic acid-dependent activities of probiotic Lactobacilli against
Salmonella enterica Serovar Typhimurium. Appl Environ Microbiol 71, 6008-6013.
Fayol-Messaoudi, D., Coconnier-Polter, M.H., Moal, V.L., Atassi, F., Berger, C.N., and Servin, A.L.
(2007). The Lactobacillus plantarum strain ACA-DC287 isolated from a Greek cheese demonstrates
antagonistic activity in vitro and in vivo against Salmonella enterica serovar Typhimurium. J Appl
Microbiol 103, 657-665.
179
Fedorka-Cray, P., Bush, E., Thomas, L.A., Gray, J.G., McKean, J., and Harris, D.L. (1997a). Salmonella
Infection in Herds of Swine. Swine Research Report, 1996. Paper 59.
http://lib.dr.iastate.edu/swinereports_1996/59.
Fedorka-Cray, P.J., Bailey, J.S., Stern, N.J., Cox, N.A., Ladely, S.R., and Musgrove, M. (1999).
Mucosal competitive exclusion to reduce Salmonella in swine. J Food Prot 62, 1376-1380.
Fedorka-Cray, P.J., Gray, J.T., and Wray, C. (2000). Salmonella infections in Pigs. In: Wray, C., Wray,
A. (eds.), Salmonella in Domestic Animals. CABI Publishing, New York, pp. 191-207.
Fedorka-Cray, P.J., Hogg, A., Gray, J.T., Lorenzen, K., Velasquez, J., and Von Behren, P. (1997b).
Feed and feed trucks as sources of Salmonella contamination in swine. Swine Health and Production 5,
198-193.
Fedorka-Cray, P.J., Kelley, L.C., Stabel, T.J., Gray, J.T., and Laufer, J.A. (1995). Alternate routes of
invasion may affect pathogenesis of Salmonella typhimurium in swine. Infect Immun 63, 2658-2664.
Fedorka-Cray, P.J., Whipp, S.C., Isaacson, R.E., Nord, N., and Lager, K. (1994). Transmission of
Salmonella typhimurium to swine. Vet Microbiol 41, 333-344.
Felten, A., Barreau, C., Bizet, C., Lagrange, P.H., and Philippon, A. (1999). Lactobacillus species
identification, H2O2 production, and antibiotic resistance and correlation with human clinical status. J
Clin Microbiol 37, 729-733.
Fleige, S., Preissinger, W., Meyer, H.H., and Pfaffl, M.W. (2007). Effect of lactulose on growth
performance and intestinal morphology of pre-ruminant calves using a milk replacer containing
Enterococcus faecium. Animal 1, 367-373.
Fleige, S., Preissinger, W., Meyer, H.H., and Pfaffl, M.W. (2009). The immunomodulatory effect of
lactulose on Enterococcus faecium fed preruminant calves. J Anim Sci 87, 1731-1738.
Foegeding, P.M., and Busta, F.F. (1991). Chemical food preservatives. In: Disinfection, Sterilization
and Preservation.  (Eds.), Block, S. S., Philadelphia, Lea & Febiger. pp: 802-832.
Foster, J.W. (1991). Salmonella acid shock proteins are required for the adaptive acid tolerance
response. J Bacteriol 173, 6896-6902.
Foster, J.W. (2001). Acid Stress Responses of Salmonella and E. coli:Survival Mechanisms, Regulation,
and Implications for Pathogenesis. The Journal of Microbiol 39, 89-94.
Foster, J.W., and Hall, H.K. (1990). Adaptive acidification tolerance response of Salmonella
typhimurium. J Bacteriol 172, 771-778.
Fu, Y., and Galan, J.E. (1999). A salmonella protein antagonizes Rac-1 and Cdc42 to mediate host-cell
recovery after bacterial invasion. Nature 401, 293-297.
Fuller, R. (1989). Probiotics in man and animals. J Appl Bacteriol 66, 365-378.
Fuller, R. (1992). Probiotics. The Scientific Basis. Chapman & Hall, London.
Fuller, R. (2004). What is a Probiotic? Biologist 51, 232.
Fuller, R., Barrow, P.A., and Brooker, B.E. (1978). Bacteria associated with the gastric epithelium of
neonatal pigs. Appl Environ Microbiol 35, 582-591.
Funk, J.A., Davies, P.R., and Nichols, M.A. (2000). The effect of fecal sample weight on detection of
Salmonella enterica in swine feces. J Vet Diagn Invest 12, 412-418.
Gaggia, F., Mattarelli, P., and Biavati, B. (2010). Probiotics and prebiotics in animal feeding for safe
food production. Int J Food Microbiol 141 Suppl 1, S15-28.
180
Galan, J.E. (2001). Salmonella interactions with host cells: type III secretion at work. Annu Rev Cell
Dev Biol 17, 53-86.
Galan, J.E., and Collmer, A. (1999). Type III secretion machines: bacterial devices for protein delivery
into host cells. Science 284, 1322-1328.
Galan, J.E., and Wolf-Watz, H. (2006). Protein delivery into eukaryotic cells by type III secretion
machines. Nature 444, 567-573.
Galan, J.E., and Zhou, D. (2000). Striking a balance: modulation of the actin cytoskeleton by
Salmonella. Proc Natl Acad Sci U S A 97, 8754-8761.
Galyov, E.E., Wood, M.W., Rosqvist, R., Mullan, P.B., Watson, P.R., Hedges, S., and Wallis, T.S.
(1997). A secreted effector protein of Salmonella dublin is translocated into eukaryotic cells and
mediates inflammation and fluid secretion in infected ileal mucosa. Mol Microbiol 25, 903-912.
Gantois, I., Ducatelle, R., Pasmans, F., Haesebrouck, F., Hautefort, I., Thompson, A., Hinton, J.C., and
Van Immerseel, F. (2006). Butyrate specifically down-regulates salmonella pathogenicity island 1 gene
expression. Appl Environ Microbiol 72, 946-949.
Ganzle, M.G. (2004). Reutericyclin: biological activity, mode of action, and potential applications. Appl
Microbiol Biotechnol 64, 326-332.
Ganzle, M.G., Holtzel, A., Walter, J., Jung, G., and Hammes, W.P. (2000). Characterization of
reutericyclin produced by Lactobacillus reuteri LTH2584. Appl Environ Microbiol 66, 4325-4333.
Genovese, K.J., Anderson, R.C., Harvey, R.B., Callaway, T.R., Poole, T.L., Edrington, T.S., Fedorka-
Cray, P.J., and Nisbet, D.J. (2003). Competitive exclusion of Salmonella from the gut of neonatal and
weaned pigs. J Food Prot 66, 1353-1359.
Genovese, K.J., Anderson, R.C., Harvey, R.B., and Nisbet, D.J. (2000). Competitive exclusion treatment
reduces the mortality and fecal shedding associated with enterotoxigenic Escherichia coli infection in
nursery-raised neonatal pigs. Can J Vet Res 64, 204-207.
Giang, H.H., Viet, T.Q., Ogle, B., and Lindberg, J.E. (2010). Growth performance, digestibility, gut
environment and health status in weaned piglets fed a diet supplemented with potentially probiotic
complexes of lactic acid bacteria. Livestock Science 129, 95-103.
Gibson, G.R. (1999). Dietary modulation of the human gut microflora using the prebiotics oligofructose
and inulin. J Nutr 129, 1438S-1441S.
Gibson, G.R., Probert, H.M., Loo, J.V., Rastall, R.A., and Roberfroid, M.B. (2004). Dietary modulation
of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 17, 259-275.
Gibson, G.R., and Roberfroid, M.B. (1995). Dietary modulation of the human colonic microbiota:
introducing the concept of prebiotics. J Nutr 125, 1401-1412.
Gibson, G.R., Willems, A., Reading, S., and Collins, M.D. (1996). Fermentation of non-digestible
oligosaccharides by human colonic bacteria. Proc Nutr Soc 55, 899-912.
Gill, H.S. (2003). Probiotics to enhance anti-infective defences in the gastrointestinal tract. Best Pract
Res Clin Gastroenterol 17, 755-773.
Gilliland, S.E., Staley, T.E., and Bush, L.J. (1984). Importance of bile tolerance of Lactobacillus
acidophilus used as a dietary adjunct. J Dairy Sci 67, 3045-3051.
Girard, F., Batisson, I., Frankel, G.M., Harel, J., and Fairbrother, J.M. (2005). Interaction of
enteropathogenic and Shiga toxin-producing Escherichia coli and porcine intestinal mucosa: role of
intimin and Tir in adherence. Infect Immun 73, 6005-6016.
181
Girard, F., Dziva, F., van Diemen, P., Phillips, A.D., Stevens, M.P., and Frankel, G. (2007). Adherence
of enterohemorrhagic Escherichia coli O157, O26, and O111 strains to bovine intestinal explants ex
vivo. Appl Environ Microbiol 73, 3084-3090.
Goodwin, T.J., Schroeder, W.F., Wolf, D.A., and Moyer, M.P. (1993). Rotating-wall vessel coculture of
small intestine as a prelude to tissue modeling: aspects of simulated microgravity. Proc Soc Exp Biol
Med 202, 181-192.
Granato, D., Perotti, F., Masserey, I., Rouvet, M., Golliard, M., Servin, A., and Brassart, D. (1999). Cell
surface-associated lipoteichoic acid acts as an adhesion factor for attachment of Lactobacillus johnsonii
La1 to human enterocyte-like Caco-2 cells. Appl Environ Microbiol 65, 1071-1077.
Gray, J.T., Fedorka-Cray, P.J., Stabel, T.J., and Ackermann, M.R. (1995). Influence of inoculation route
on the carrier state of Salmonella choleraesuis in swine. Vet Microbiol 47, 43-59.
Greene, J.D., and Klaenhammer, T.R. (1994). Factors involved in adherence of lactobacilli to human
Caco-2 cells. Appl Environ Microbiol 60, 4487-4494.
Gregory, P.C., McFadyen, M., and Rayner, D.V. (1990). Pattern of gastric emptying in the pig: relation
to feeding. Br J Nutr 64, 45-58.
Grimont, P.A.D., Grimont, F., and Bouvet, P. (2000). Taxonomy of the Genus Salmonella. In: Wray, C.,
Wray, A. (eds.), Salmonella in Domestic Animals. CABI Publishing, New York, pp. 1-18.
Grimont, P.A.D., and Weill, F.-X. (2007). Antigenic Formulae of the Salmonella serovars. 9th ed. WHO
Collaborating Centre for Reference and Research on Salmonella. Pasteur Institute, Paris, France.
http://www.pasteur.fr/ip/portal/action/WebdriveActionEvent/oid/01s-000036-089.
Gueimonde, M., Jalonen, L., He, F., Hiramatsu, M., and Salminen, S. (2005). Adhesion and competitive
inhibition and displacement of human enteropathogens by selected lactobacilli. Food Research
International 39, 467-471.
Gueimonde, M., and Salminen, S. (2006). New methods for selecting and evaluating probiotics. Dig
Liver Dis 38 Suppl 2, S242-247.
Hacker, J., and Kaper, J.B. (2000). Pathogenicity islands and the evolution of microbes. Annu Rev
Microbiol 54, 641-679.
Haesebrouck, F., Pasmans, F., Chiers, K., Maes, D., Ducatelle, R., and Decostere, A. (2004). Efficacy of
vaccines against bacterial diseases in swine: what can we expect? Vet Microbiol 100, 255-268.
Hakkinen, M., and Schneitz, C. (1996). Efficacy of a commercial competitive exclusion product against
a chicken pathogenic Escherichia coli and E coli O157:H7. Vet Rec 139, 139-141.
Hakkinen, M., and Schneitz, C. (1999). Efficacy of a commercial competitive exclusion product against
Campylobacter jejuni. Br Poult Sci 40, 619-621.
Hanisch, J., Ehinger, J., Ladwein, M., Rohde, M., Derivery, E., Bosse, T., Steffen, A., Bumann, D.,
Misselwitz, B., Hardt, W.D., et al. (2010). Molecular dissection of Salmonella-induced membrane
ruffling versus invasion. Cell Microbiol 12, 84-98.
Hansen, C.F., Hernandez, A., Mansfield, J., Hidalgo, A., La, T., Phillips, N.D., Hampson, D.J., and
Pluske, J.R. (2011). A high dietary concentration of inulin is necessary to reduce the incidence of swine
dysentery in pigs experimentally challenged with Brachyspira hyodysenteriae. Br J Nutr 106, 1506-
1513.
Hansen, C.F., Phillips, N.D., La, T., Hernandez, A., Mansfield, J., Kim, J.C., Mullan, B.P., Hampson,
D.J., and Pluske, J.R. (2010). Diets containing inulin but not lupins help to prevent swine dysentery in
experimentally challenged pigs. J Anim Sci 88, 3327-3336.
182
Haque, A., Bowe, F., Fitzhenry, R.J., Frankel, G., Thomson, M., Heuschkel, R., Murch, S., Stevens,
M.P., Wallis, T.S., Phillips, A.D., et al. (2004). Early interactions of Salmonella enterica serovar
typhimurium with human small intestinal epithelial explants. Gut 53, 1424-1430.
Hardt, W.D., Chen, L.M., Schuebel, K.E., Bustelo, X.R., and Galan, J.E. (1998). S. typhimurium
encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host
cells. Cell 93, 815-826.
Harmsen, H.J.M., Elfferich, P., Schut, F., and Welling, G.W. (1999). A 16S rRNA-targeted probe for
detection of lactobacilli and enterococci in fecal samples by fluorescent in situ hybridization. Microb
Ecol Health Dis 11, 3-12.
Hashizume, K., Tsukahara, T., Yamada, K., Koyama, H., and Ushida, K. (2003). Megasphaera elsdenii
JCM1772T normalizes hyperlactate production in the large intestine of fructooligosaccharide-fed rats by
stimulating butyrate production. J Nutr 133, 3187-3190.
Haslewood, G.A. (1971). Bile salts of germ-free domestic fowl and pigs. Biochem J 123, 15-18.
Hayward, R.D., and Koronakis, V. (2002). Direct modulation of the host cell cytoskeleton by
Salmonella actin-binding proteins. Trends Cell Biol 12, 15-20.
Henics, T., and Wheatley, D.N. (1999). Cytoplasmic vacuolation, adaptation and cell death: a view on
new perspectives and features. Biol Cell 91, 485-498.
Henriksson, A., Szewzyk, R., and Conway, P.L. (1991). Characteristics of the adhesive determinants of
Lactobacillus fermentum 104. Appl Environ Microbiol 57, 499-502.
Hensel, M. (2000). Salmonella pathogenicity island 2. Mol Microbiol 36, 1015-1023.
Higgins, J.P., Higgins, S.E., Wolfenden, A.D., Henderson, S.N., Torres-Rodriguez, A., Vicente, J.L.,
Hargis, B.M., and Tellez, G. (2010). Effect of lactic acid bacteria probiotic culture treatment timing on
Salmonella Enteritidis in neonatal broilers. Poult Sci 89, 243-247.
Hill, A.A., Snary, E.L., Arnold, M.E., Alban, L., and Cook, A.J. (2008). Dynamics of Salmonella
transmission on a British pig grower-finisher farm: a stochastic model. Epidemiol Infect 136, 320-333.
Hollingsworth, M.A., and Swanson, B.J. (2004). Mucins in cancer: protection and control of the cell
surface. Nat Rev Cancer 4, 45-60.
Holzapfel, W.H., Haberer, P., Geisen, R., Bjorkroth, J., and Schillinger, U. (2001). Taxonomy and
important features of probiotic microorganisms in food and nutrition. Am J Clin Nutr 73, 365S-373S.
Hossain, M., Abramowitz, W., Watrous, B.J., Szpunar, G.J., and Ayres, J.W. (1990). Gastrointestinal
transit of nondisintegrating, nonerodible oral dosage forms in pigs. Pharm Res 7, 1163-1166.
Houdijk, J.G., Hartemink, R., Verstegen, M.W., and Bosch, M.W. (2002). Effects of dietary non-
digestible oligosaccharides on microbial characteristics of ileal chyme and faeces in weaner pigs. Arch
Tierernahr 56, 297-307.
Huang, C., Qiao, S., Li, D., Piao, X., and Ren, J. (2004). Effect of Lactobacilli on the performance,
diarrhea incidence, VFA concentration and gastrointestinal microbial flora of weaning pigs. Asian-Aust
J Anim Sci 17, 401-409.
Hudault, S., Lievin, V., Bernet-Camard, M.F., and Servin, A.L. (1997). Antagonistic activity exerted in
vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl
Environ Microbiol 63, 513-518.
Huff, W.E., Huff, G.R., Rath, N.C., Balog, J.M., and Donoghue, A.M. (2002a). Prevention of
Escherichia coli infection in broiler chickens with a bacteriophage aerosol spray. Poult Sci 81, 1486-
1491.
183
Huff, W.E., Huff, G.R., Rath, N.C., Balog, J.M., Xie, H., Moore, P.A., Jr., and Donoghue, A.M.
(2002b). Prevention of Escherichia coli respiratory infection in broiler chickens with bacteriophage
(SPR02). Poult Sci 81, 437-441.
Hume, M.E., Byrd, J.A., Stanker, L.H., and Ziprin, R.L. (1998). Reduction of caecal Listeria
monocytogenes in Leghorn chicks following treatment with a competitive exclusion culture
(PREEMPT). Lett Appl Microbiol 26, 432-436.
Hyronimus, B., Le Marrec, C., Sassi, A.H., and Deschamps, A. (2000). Acid and bile tolerance of spore-
forming lactic acid bacteria. Int J Food Microbiol 61, 193-197.
ISO (2002). International Organization for Standardization (ISO). ISO 6579:2002/Amd 1:2007. Annex
D: Detection of Salmonella spp. in animal faeces and in samples of the primary production stage.
Geneva.
Isolauri, E. (2001). Probiotics in human disease. Am J Clin Nutr 73, 1142S-1146S.
Isolauri, E., Kirjavainen, P.V., and Salminen, S. (2002). Probiotics: a role in the treatment of intestinal
infection and inflammation? Gut 50 Suppl 3, III54-59.
Isolauri, E., Sutas, Y., Kankaanpaa, P., Arvilommi, H., and Salminen, S. (2001). Probiotics: effects on
immunity. Am J Clin Nutr 73, 444S-450S.
Ivanek, R., Osterberg, J., Gautam, R., and Sternberg Lewerin, S. (2012). Salmonella fecal shedding and
immune responses are dose- and serotype- dependent in pigs. PLoS One 7, e34660.
Janardhana, V., Broadway, M.M., Bruce, M.P., Lowenthal, J.W., Geier, M.S., Hughes, R.J., and Bean,
A.G. (2009). Prebiotics modulate immune responses in the gut-associated lymphoid tissue of chickens. J
Nutr 139, 1404-1409.
Jankowska, A., Laubitz, D., Antushevich, H., Zabielski, R., and Grzesiuk, E. (2008). Competition of
Lactobacillus paracasei with Salmonella enterica for adhesion to Caco-2 cells. J Biomed Biotechnol
2008, 357964.
Jensen, A.N., Hansen, L.L., Baggesen, D.L., and Molbak, L. (2012). Effects of feeding finisher pigs
with chicory or lupine feed for one week or two weeks before slaughter with respect to levels of
Bifidobacteria and Campylobacter. Animal, 1-9.
Jones, B.D., Lee, C.A., and Falkow, S. (1992). Invasion by Salmonella typhimurium is affected by the
direction of flagellar rotation. Infect Immun 60, 2475-2480.
Jung, K., Ha, Y., Ha, S.K., Han, D.U., Kim, D.W., Moon, W.K., and Chae, C. (2004). Antiviral effect of
Saccharomyces cerevisiae beta-glucan to swine influenza virus by increased production of interferon-
gamma and nitric oxide. J Vet Med B Infect Dis Vet Public Health 51, 72-76.
Kaplan, H., and Hutkins, R.W. (2003). Metabolism of fructooligosaccharides by Lactobacillus paracasei
1195. Appl Environ Microbiol 69, 2217-2222.
Kararli, T.T. (1995). Comparison of the gastrointestinal anatomy, physiology, and biochemistry of
humans and commonly used laboratory animals. Biopharm Drug Dispos 16, 351-380.
Kass, M.L., Van Soest, P.J., Pond, W.G., Lewis, B., and McDowell, R.E. (1980). Utilization of Dietary
Fiber from Alfalfa by Growing Swine. I. Apparent Digestibility of Diet Components in Specific
Segments of the Gastrointestinal Tract. J Anim Sci 50, 175-191.
Kauffmann, F. (1935). Weitere erfahrungen mit den Kombinierten Anreichurungsverfahren für
Salmonellabazillus. Z Hyg Infektionskr 117, 26-32.
Kaushik, J.K., Kumar, A., Duary, R.K., Mohanty, A.K., Grover, S., and Batish, V.K. (2009). Functional
and probiotic attributes of an indigenous isolate of Lactobacillus plantarum. PLoS One 4, e8099.
184
Kingsley, R.A., and Baumler, A.J. (2000). Host adaptation and the emergence of infectious disease: the
Salmonella paradigm. Mol Microbiol 36, 1006-1014.
Klaenhammer, T.R., and Kullen, M.J. (1999). Selection and design of probiotics. Int J Food Microbiol
50, 45-57.
Klare, I., Konstabel, C., Muller-Bertling, S., Reissbrodt, R., Huys, G., Vancanneyt, M., Swings, J.,
Goossens, H., and Witte, W. (2005). Evaluation of new broth media for microdilution antibiotic
susceptibility testing of Lactobacilli, Pediococci, Lactococci, and Bifidobacteria. Appl Environ
Microbiol 71, 8982-8986.
Klare, I., Konstabel, C., Werner, G., Huys, G., Vankerckhoven, V., Kahlmeter, G., Hildebrandt, B.,
Muller-Bertling, S., Witte, W., and Goossens, H. (2007). Antimicrobial susceptibilities of Lactobacillus,
Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use. J
Antimicrob Chemother 59, 900-912.
Klebanoff, S.J., Hillier, S.L., Eschenbach, D.A., and Waltersdorph, A.M. (1991). Control of the
microbial flora of the vagina by H2O2-generating lactobacilli. J Infect Dis 164, 94-100.
Klein, G., Pack, A., Bonaparte, C., and Reuter, G. (1998). Taxonomy and physiology of probiotic lactic
acid bacteria. Int J Food Microbiol 41, 103-125.
Kneifel, W., Rajal, A., and Kulbe, K.D. (2000). In vitro growth behaviour of probiotic bacteria in
culture media with carbohydrates of prebiotic importance. Microb Ecol in Health and Disease 12, 27-34.
Kolida, S., and Gibson, G.R. (2007). Prebiotic capacity of inulin-type fructans. J Nutr 137, 2503S-
2506S.
Kolida, S., Tuohy, K., and Gibson, G.R. (2002). Prebiotic effects of inulin and oligofructose. Br J Nutr
87 Suppl 2, S193-197.
Koll, P., Mandar, R., Marcotte, H., Leibur, E., Mikelsaar, M., and Hammarstrom, L. (2008).
Characterization of oral lactobacilli as potential probiotics for oral health. Oral Microbiol Immunol 23,
139-147.
Konstantinov, S.R., Awati, A., Smidt, H., Williams, B.A., Akkermans, A.D., and de Vos, W.M. (2004).
Specific response of a novel and abundant Lactobacillus amylovorus-like phylotype to dietary prebiotics
in the guts of weaning piglets. Appl Environ Microbiol 70, 3821-3830.
Konstantinov, S.R., Awati, A.A., Williams, B.A., Miller, B.G., Jones, P., Stokes, C.R., Akkermans,
A.D., Smidt, H., and de Vos, W.M. (2006a). Post-natal development of the porcine microbiota
composition and activities. Environ Microbiol 8, 1191-1199.
Konstantinov, S.R., Poznanski, E., Fuentes, S., Akkermans, A.D., Smidt, H., and de Vos, W.M. (2006b).
Lactobacillus sobrius sp. nov., abundant in the intestine of weaning piglets. Int J Syst Evol Microbiol
56, 29-32.
Konstantinov, S.R., Smidt, H., Akkermans, A.D., Casini, L., Trevisi, P., Mazzoni, M., De Filippi, S.,
Bosi, P., and de Vos, W.M. (2008). Feeding of Lactobacillus sobrius reduces Escherichia coli F4 levels
in the gut and promotes growth of infected piglets. FEMS Microbiol Ecol 66, 599-607.
Kontula, P., Nollet, L., Saarela, M., Vilpponen-Salmela, T., Verstraete, W., Mattila-Sandholm, T., and
von Wright, A. (2002). The Effect of Lactulose on the Survival of Lactobacillus rhamnosus in the
Simulator of the Human Intestinal Microbial Ecosystem (SHIME) and in vivo. Microb Ecol in Health
and Disease 14, 90-96.
Kranker, S., Alban, L., Boes, J., and Dahl, J. (2003). Longitudinal study of Salmonella enterica aerotype
Typhimurium infection in three Danish farrow-to-finish swine herds. J Clin Microbiol 41, 2282-2288.
Krause, D.O., Bhandari, S.K., House, J.D., and Nyachoti, C.M. (2010). Response of nursery pigs to a
185
synbiotic preparation of starch and an anti-Escherichia coli K88 probiotic. Appl Environ Microbiol 76,
8192-8200.
Kreuzer, S., Janczyk, P., Assmus, J., Schmidt, M.F., Brockmann, G.A., and Nockler, K. (2012). No
beneficial effects evident for Enterococcus faecium NCIMB 10415 in weaned pigs infected with
Salmonella enterica serovar Typhimurium DT104. Appl Environ Microbiol 78, 4816-4825.
Kubori, T., Matsushima, Y., Nakamura, D., Uralil, J., Lara-Tejero, M., Sukhan, A., Galan, J.E., and
Aizawa, S.I. (1998). Supramolecular structure of the Salmonella typhimurium type III protein secretion
system. Science 280, 602-605.
Kubori, T., Sukhan, A., Aizawa, S.I., and Galan, J.E. (2000). Molecular characterization and assembly
of the needle complex of the Salmonella typhimurium type III protein secretion system. Proc Natl Acad
Sci U S A 97, 10225-10230.
Kudoh, K., Shimizu, J., Ishiyama, A., Wada, M., Takita, T., Kanke, Y., and Innami, S. (1999). Secretion
and excretion of immunoglobulin A to cecum and feces differ with type of indigestible saccharides. J
Nutr Sci Vitaminol (Tokyo) 45, 173-181.
Kuhle, V., Jackel, D., and Hensel, M. (2004). Effector proteins encoded by Salmonella pathogenicity
island 2 interfere with the microtubule cytoskeleton after translocation into host cells. Traffic 5, 356-
370.
Kuhn, H., Wonde, B., Rabsch, W., and Reissbrodt, R. (1994). Evaluation of Rambach agar for detection
of Salmonella subspecies I to VI. Appl Environ Microbiol 60, 749-751.
Kunz, C., Rudloff, S., Baier, W., Klein, N., and Strobel, S. (2000). Oligosaccharides in human milk:
structural, functional, and metabolic aspects. Annu Rev Nutr 20, 699-722.
Kwon, H.S., Yang, E.H., Yeon, S.W., Kang, B.H., and Kim, T.Y. (2004). Rapid identification of
probiotic Lactobacillus species by multiplex PCR using species-specific primers based on the region
extending from 16S rRNA through 23S rRNA. FEMS Microbiol Lett 239, 267-275.
La Ragione, R.M., Casula, G., Cutting, S.M., and Woodward, M.J. (2001). Bacillus subtilis spores
competitively exclude Escherichia coli O78:K80 in poultry. Vet Microbiol 79, 133-142.
La Ragione, R.M., Cooley, W.A., Velge, P., Jepson, M.A., and Woodward, M.J. (2003). Membrane
ruffling and invasion of human and avian cell lines is reduced for aflagellate mutants of Salmonella
enterica serotype Enteritidis. Int J Med Microbiol 293, 261-272.
La Ragione, R.M., Narbad, A., Gasson, M.J., and Woodward, M.J. (2004). In vivo characterization of
Lactobacillus johnsonii FI9785 for use as a defined competitive exclusion agent against bacterial
pathogens in poultry. Lett Appl Microbiol 38, 197-205.
La Ragione, R.M., and Woodward, M.J. (2003). Competitive exclusion by Bacillus subtilis spores of
Salmonella enterica serotype Enteritidis and Clostridium perfringens in young chickens. Vet Microbiol
94, 245-256.
Laerke, H.N., Jensen, B.B., and Hojsgaard, S. (2000). In vitro fermentation pattern of D-tagatose is
affected by adaptation of the microbiota from the gastrointestinal tract of pigs. J Nutr 130, 1772-1779.
Langendijk, P.S., Schut, F., Jansen, G.J., Raangs, G.C., Kamphuis, G.R., Wilkinson, M.H., and Welling,
G.W. (1995). Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-
specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 61,
3069-3075.
Lawhon, S.D., Maurer, R., Suyemoto, M., and Altier, C. (2002). Intestinal short-chain fatty acids alter
Salmonella typhimurium invasion gene expression and virulence through BarA/SirA. Mol Microbiol 46,
1451-1464.
186
Lawley, T.D., and Walker, A.W. (2013). Intestinal colonization resistance. Immunology 138, 1-11.
Le Minor, L. (1994). The genus Salmonella. In: Ballows, A., Trüper, H.G., Dworkin, M., Harber, W.
and Scheiffer,
K.-H. (eds) The Prokaryotes. Springer, New York, pp. 2760–2774.
Le Minor, L., and Popoff, M.Y. (1987). Request for an Opinion. Designation of Salmonella enterica sp.
nov., nom. rev., as the type and only species of the genus Salmonella. Int J Syst Bacteriol 37, 465–468.
Lebeer, S., Vanderleyden, J., and De Keersmaecker, S.C. (2008). Genes and molecules of lactobacilli
supporting probiotic action. Microbiol Mol Biol Rev 72, 728-764, Table of Contents.
Lee, H., Yoon, H., Ji, Y., Kim, H., Park, H., Lee, J., Shin, H., and Holzapfel, W. (2011). Functional
properties of Lactobacillus strains isolated from kimchi. Int J Food Microbiol 145, 155-161.
Lee, Y.K., Puong, K.Y., Ouwehand, A.C., and Salminen, S. (2003). Displacement of bacterial pathogens
from mucus and Caco-2 cell surface by lactobacilli. J Med Microbiol 52, 925-930.
Leser, T.D., Amenuvor, J.Z., Jensen, T.K., Lindecrona, R.H., Boye, M., and Moller, K. (2002). Culture-
independent analysis of gut bacteria: the pig gastrointestinal tract microbiota revisited. Appl Environ
Microbiol 68, 673-690.
Lessard, M., Dupuis, M., Gagnon, N., Nadeau, E., Matte, J.J., Goulet, J., and Fairbrother, J.M. (2009).
Administration of Pediococcus acidilactici or Saccharomyces cerevisiae boulardii modulates
development of porcine mucosal immunity and reduces intestinal bacterial translocation after
Escherichia coli challenge. J Anim Sci 87, 922-934.
Letellier, A., Messier, S., Lessard, L., and Quessy, S. (2000). Assesment of various treatments to reduce
carriage of Salmonella in swine. Can J Vet Res 64, 27-31.
Letellier, A., Messier, S., Pare, J., Menard, J., and Quessy, S. (1999). Distribution of Salmonella in
swine herds in Quebec. Vet Microbiol 67, 299-306.
Liebana, E., Garcia-Migura, L., Clouting, C., Clifton-Hadley, F.A., Breslin, M., and Davies, R.H.
(2003). Molecular fingerprinting evidence of the contribution of wildlife vectors in the maintenance of
Salmonella Enteritidis infection in layer farms. J Appl Microbiol 94, 1024-1029.
Lievin-Le Moal, V., Amsellem, R., and Servin, A.L. (2011). Impairment of swimming motility by
antidiarrheic Lactobacillus acidophilus strain LB retards internalization of Salmonella enterica serovar
Typhimurium within human enterocyte-like cells. Antimicrob Agents Chemother 55, 4810-4820.
Lilly, D.M., and Stillwell, R.H. (1965). Probiotics: Growth-Promoting Factors Produced by
Microorganisms. Science 147, 747-748.
Lin, C.K., Tsai, H.C., Lin, P.P., Tsen, H.Y., and Tsai, C.C. (2008). Lactobacillus acidophilus LAP5 able
to inhibit the Salmonella choleraesuis invasion to the human Caco-2 epithelial cell. Anaerobe 14, 251-
255.
Linde, K., Hahn, I., and Vielitz, E. (1996). Entwicklung von optimal für das Huhn attenuierten
Salmonella-Lebendimpfstoffen. Tierärztl Umschau 51, 23-31.
Linton, A.H., Jennett, N.E., and Heard, T.W. (1970). Multiplication of Salmonella in liquid feed and its
influence on the duration of excretion in pigs. Res Vet Sci 11, 452-457.
Ljungh, A., and Wadstrom, T. (2006). Lactic acid bacteria as probiotics. Curr Issues Intest Microbiol 7,
73-89.
Lo Fo Wong, D.M.A., Dahlc, J., Stegea, H., van der Wolfd, P.J., Leontidese, L., von Altrockf, A., and
Thorbergg, B.M. (2004). Herd-level risk factors for subclinical Salmonella infection in European
finishing-pig herds. Prev Vet Med 62, 253-266.
187
Lo Fo Wong, D.M.A., Hald, T., van der Wolf, P.J., and Swanenburg, M. (2002). Epidemiology and
control measures for Salmonella in pigs and pork. Livest Prod Sci 76, 215-222.
Lowry, V.K., Farnell, M.B., Ferro, P.J., Swaggerty, C.L., Bahl, A., and Kogut, M.H. (2005). Purified
beta-glucan as an abiotic feed additive up-regulates the innate immune response in immature chickens
against Salmonella enterica serovar Enteritidis. Int J Food Microbiol 98, 309-318.
Macfarlane, G.T., Gibson, G.R., and Cummings, J.H. (1992). Comparison of fermentation reactions in
different regions of the human colon. J Appl Bacteriol 72, 57-64.
Macfarlane, G.T., and Macfarlane, S. (2007a). Models for intestinal fermentation: association between
food components, delivery systems, bioavailability and functional interactions in the gut. Current
Opinion in Biotechnlogy 18:, 156- 162.
Macfarlane, G.T., and Macfarlane, S. (2007b). Models for intestinal fermentation: association between
food components, delivery systems, bioavailability and functional interactions in the gut. Curr Opin
Biotechnol 18, 156-162.
Macfarlane, G.T., Macfarlane, S., and Gibson, G.R. (1998). Validation of a Three-Stage Compound
Continuous Culture System for Investigating the Effect of Retention Time on the Ecology and
Metabolism of Bacteria in the Human Colon. Microb Ecol 35, 180-187.
Macfarlane, G.T., Steed, H., and Macfarlane, S. (2008). Bacterial metabolism and health-related effects
of galacto-oligosaccharides and other prebiotics. J Appl Microbiol 104, 305-344.
Mackie, R.I., Sghir, A., and Gaskins, H.R. (1999). Developmental microbial ecology of the neonatal
gastrointestinal tract. Am J Clin Nutr 69, 1035S-1045S.
Main-Hester, K.L., Colpitts, K.M., Thomas, G.A., Fang, F.C., and Libby, S.J. (2008). Coordinate
regulation of Salmonella pathogenicity island 1 (SPI1) and SPI4 in Salmonella enterica serovar
Typhimurium. Infect Immun 76, 1024-1035.
Majowicz, S.E., Musto, J., Scallan, E., Angulo, F.J., Kirk, M., O'Brien, S.J., Jones, T.F., Fazil, A., and
Hoekstra, R.M. (2010). The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis
50, 882-889.
Makras, L., Triantafyllou, V., Fayol-Messaoudi, D., Adriany, T., Zoumpopoulou, G., Tsakalidou, E.,
Servin, A., and De Vuyst, L. (2006). Kinetic analysis of the antibacterial activity of probiotic lactobacilli
towards Salmonella enterica serovar Typhimurium reveals a role for lactic acid and other inhibitory
compounds. Res Microbiol 157, 241-247.
Mappley, L.J., Tchorzewska, M.A., Cooley, W.A., Woodward, M.J., and La Ragione, R.M. (2011).
Lactobacilli antagonize the growth, motility, and adherence of Brachyspira pilosicoli: a potential
intervention against avian intestinal spirochetosis. Appl Environ Microbiol 77, 5402-5411.
Marchesi, J.R., Sato, T., Weightman, A.J., Martin, T.A., Fry, J.C., Hiom, S.J., Dymock, D., and Wade,
W.G. (1998). Design and evaluation of useful bacterium-specific PCR primers that amplify genes
coding for bacterial 16S rRNA. Appl Environ Microbiol 64, 795-799.
Marteau, P., Pochart, P., Bouhnik, Y., and Rambaud, J.C. (1993). The fate and effects of transiting,
nonpathogenic microorganisms in the human intestine. World Rev Nutr Diet 74, 1-21.
Martin-Pelaez, S., Costabile, A., Hoyles, L., Rastall, R.A., Gibson, G.R., La Ragione, R.M., Woodward,
M.J., Mateu, E., and Martin-Orue, S.M. (2010). Evaluation of the inclusion of a mixture of organic acids
or lactulose into the feed of pigs experimentally challenged with Salmonella Typhimurium. Vet
Microbiol 142, 337-345.
Martin-Pelaez, S., Gibson, G.R., Martin-Orue, S.M., Klinder, A., Rastall, R.A., La Ragione, R.M.,
Woodward, M.J., and Costabile, A. (2008). In vitro fermentation of carbohydrates by porcine faecal
inocula and their influence on Salmonella Typhimurium growth in batch culture systems. FEMS
188
Microbiol Ecol 66, 608-619.
Martin, F.P., Dumas, M.E., Wang, Y., Legido-Quigley, C., Yap, I.K., Tang, H., Zirah, S., Murphy,
G.M., Cloarec, O., Lindon, J.C., et al. (2007). A top-down systems biology view of microbiome-
mammalian metabolic interactions in a mouse model. Mol Syst Biol 3, 112.
Martin, R., Soberon, N., Vaneechoutte, M., Florez, A.B., Vazquez, F., and Suarez, J.E. (2008).
Characterization of indigenous vaginal lactobacilli from healthy women as probiotic candidates. Int
Microbiol 11, 261-266.
Mathur, S., and Singh, R. (2005). Antibiotic resistance in food lactic acid bacteria--a review. Int J Food
Microbiol 105, 281-295.
Matsuzaki, S., Rashel, M., Uchiyama, J., Sakurai, S., Ujihara, T., Kuroda, M., Ikeuchi, M., Tani, T.,
Fujieda, M., Wakiguchi, H., et al. (2005). Bacteriophage therapy: a revitalized therapy against bacterial
infectious diseases. J Infect Chemother 11, 211-219.
McBain, A.J., and Macfarlane, G.T. (1997). Investigations of bifidobacterial ecology and
oligosaccharide metabolism in a three-stage compound continuous culture system. Scand J
Gastroenterol Suppl 222, 32-40.
McClelland, M., Sanderson, K.E., Clifton, S.W., Latreille, P., Porwollik, S., Sabo, A., Meyer, R., Bieri,
T., Ozersky, P., McLellan, M., et al. (2004). Comparison of genome degradation in Paratyphi A and
Typhi, human-restricted serovars of Salmonella enterica that cause typhoid. Nat Genet 36, 1268-1274.
McEwen, S.A., and Fedorka-Cray, P.J. (2002). Antimicrobial use and resistance in animals. Clin Infect
Dis 34 Suppl 3, S93-S106.
McGhie, E.J., Brawn, L.C., Hume, P.J., Humphreys, D., and Koronakis, V. (2009). Salmonella takes
control: effector-driven manipulation of the host. Curr Opin Microbiol 12, 117-124.
McHan, F., and Shotts, E.B. (1993). Effect of short-chain fatty acids on the growth of Salmonella
typhimurium in an in vitro system. Avian Dis 37, 396-398.
Mead, G.C. (2000). Prospects for 'competitive exclusion' treatment to control salmonellas and other
foodborne pathogens in poultry. Vet J 159, 111-123.
Meeusen, E.N., Walker, J., Peters, A., Pastoret, P.P., and Jungersen, G. (2007). Current status of
veterinary vaccines. Clin Microbiol Rev 20, 489-510, table of contents.
Mellmann, A., Cloud, J., Maier, T., Keckevoet, U., Ramminger, I., Iwen, P., Dunn, J., Hall, G., Wilson,
D., Lasala, P., et al. (2008). Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass
spectrometry in comparison to 16S rRNA gene sequencing for species identification of nonfermenting
bacteria. J Clin Microbiol 46, 1946-1954.
Metchnikoff, E. (1907). The Prolongation of Life. Optimistic studies. London: Butterworth-Heinemann.
Meyerholz, D.K., Stabel, T.J., Ackermann, M.R., Carlson, S.A., Jones, B.D., and Pohlenz, J. (2002).
Early epithelial invasion by Salmonella enterica serovar Typhimurium DT104 in the swine ileum. Vet
Pathol 39, 712-720.
Meynell, G.G. (1963). Antibacterial mechanisms of the mouse gut. II. The role of Eh and volatile fatty
acids in the normal gut. Br J Exp Pathol 44, 209-219.
Miao, E.A., Brittnacher, M., Haraga, A., Jeng, R.L., Welch, M.D., and Miller, S.I. (2003). Salmonella
effectors translocated across the vacuolar membrane interact with the actin cytoskeleton. Mol Microbiol
48, 401-415.
Mikkelsen, L.L., Naughton, P.J., Hedemann, M.S., and Jensen, B.B. (2004). Effects of physical
properties of feed on microbial ecology and survival of Salmonella enterica serovar Typhimurium in the
189
pig gastrointestinal tract. Appl Environ Microbiol 70, 3485-3492.
Miles, A.A., Misra, S.S., and Irwin, J.O. (1983). The estimation of the bactericidal power of the blood. J
Hyg (Lond) 38, 732-749.
Milner, K.C., and Shaffer, M.F. (1952). Bacteriologic studies of experimental Salmonella infections in
chicks. J Infect Dis 90, 81-96.
Mitsuoka, T., Hidaka, H., and Eida, T. (1987). Effect of fructo-oligosaccharides on intestinal microflora.
Nahrung 31, 427-436.
Molin, G., Jeppsson, B., Johansson, M.L., Ahrne, S., Nobaek, S., Stahl, M., and Bengmark, S. (1993).
Numerical taxonomy of Lactobacillus spp. associated with healthy and diseased mucosa of the human
intestines. J Appl Bacteriol 74, 314-323.
Moon, S.Y., and Zheng, Y. (2003). Rho GTPase-activating proteins in cell regulation. Trends Cell Biol
13, 13-22.
Morelli, L. (2000). In vitro selection of probiotic lactobacilli: a critical appraisal. Curr Issues Intest
Microbiol 1, 59-67.
Morgan, E. (2007). Salmonella Pathogenicity Islands. In: Rhen, M., Maskell, D., Mastroeni, P., and
Threlfall, J. (eds.), Salmonella Molecular Biology and Pathogenesis. Horizon bioscience, Norfolk, UK.
pp: 67-88.
Moser, S.A., and Savage, D.C. (2001). Bile salt hydrolase activity and resistance to toxicity of
conjugated bile salts are unrelated properties in lactobacilli. Appl Environ Microbiol 67, 3476-3480.
Mountzouris, K.C., Balaskas, C., Fava, F., Tuohy, K.M., Gibson, G.R., and Fegeros, K. (2006).
Profiling of composition and metabolic activities of the colonic microflora of growing pigs fed diets
supplemented with prebiotic oligosaccharides. Anaerobe 12, 178-185.
Mroz, Z. (2005). Organic acids as potential alternatives to antibiotic growth promoters for pigs.
Advances in Pork Production 16, 169-182.
Muralidhara, K.S., Sheggeby, G.G., Elliker, P.R., England, D.C., and Sandine, W.E. (1977). Effect of
feeding Lactobacilli on the coliform and Lactobacillus flora of intestinal tissue and feces from pigs. J
Food Prot 40, 288-295.
Nagura, T., Hachimura, S., Hashiguchi, M., Ueda, Y., Kanno, T., Kikuchi, H., Sayama, K., and
Kaminogawa, S. (2002). Suppressive effect of dietary raffinose on T-helper 2 cell-mediated immunity.
Br J Nutr 88, 421-426.
Neeser, J.R., Granato, D., Rouvet, M., Servin, A., Teneberg, S., and Karlsson, K.A. (2000).
Lactobacillus johnsonii La1 shares carbohydrate-binding specificities with several enteropathogenic
bacteria. Glycobiology 10, 1193-1199.
Nemcova, R., Bomba, A., Gancarcikova, S., Herich, R., and Guba, P. (1999). Study of the effect of
Lactobacillus paracasei and fructooligosaccharides on the faecal microflora in weanling piglets. Berl
Munch Tierarztl Wochenschr 112, 225-228.
Nemcova, R., Bomba, A., Gancarcikova, S., Reiffova, K., Guba, P., Koscova, J., Jonecova, Z.,
Scirankova, L., and Bugarsky, A. (2007). Effects of the administration of lactobacilli, maltodextrins and
fructooligosaccharides upon the adhesion of E. coli O8:K88 to the intestinal mucosa and organic acid
levels in the gut contents of piglets. Vet Res Commun 31, 791-800.
Nickerson, C.A., Goodwin, T.J., Terlonge, J., Ott, C.M., Buchanan, K.L., Uicker, W.C., Emami, K.,
LeBlanc, C.L., Ramamurthy, R., Clarke, M.S., et al. (2001). Three-dimensional tissue assemblies: novel
models for the study of Salmonella enterica serovar Typhimurium pathogenesis. Infect Immun 69, 7106-
7120.
190
Nielsen, B., Baggesen, D., Bager, F., Haugegaard, J., and Lind, P. (1995). The serological response to
Salmonella serovars typhimurium and infantis in experimentally infected pigs. The time course followed
with an indirect anti-LPS ELISA and bacteriological examinations. Vet Microbiol 47, 205-218.
Nielsen, B., Ekeroth, L., Bager, F., and Lind, P. (1998). Use of muscle fluid as a source of antibodies for
serologic detection of Salmonella infection in slaughter pig herds. J Vet Diagn Invest 10, 158-163.
Niewold, T.A. (2007). The nonantibiotic anti-inflammatory effect of antimicrobial growth promoters,
the real mode of action? A hypothesis. Poult Sci 86, 605-609.
Niku-Paavola, M.L., Laitila, A., Mattila-Sandholm, T., and Haikara, A. (1999). New types of
antimicrobial compounds produced by Lactobacillus plantarum. J Appl Microbiol 86, 29-35.
Nisbet, D. (2002). Defined competitive exclusion cultures in the prevention of enteropathogen
colonisation in poultry and swine. Antonie Van Leeuwenhoek 81, 481-486.
Nissle, A. (1916). Ueber die Grundlagen einer neuen ursaechlichen Bekaempfung der pathologischen
Darmflora. Deutsche Medizinische Wochenschrift 42, 1181–1184.
Nordentoft, S., Christensen, H., and Wegener, H.C. (1997). Evaluation of a fluorescence-labelled
oligonucleotide probe targeting 23S rRNA for in situ detection of Salmonella serovars in paraffin-
embedded tissue sections and their rapid identification in bacterial smears. J Clin Microbiol 35, 2642-
2648.
Nousiainen, J., Javanainen, P., and Setälä, J. (2004). Lactic Acid Bacteria as Animal Probiotics. In:
Salminen, S., von Wright, A., Arthur Ouwehand, A. (eds.) Lactic acid bacteria. Microbiological and
Functional Aspects. Thrird edition. New York. Marcel Dekker, Inc. pp. 437-473.
Nurmi, E., and Rantala, M. (1973). New aspects of Salmonella infection in broiler production. Nature
241, 210-211.
Oelschlaeger, T.A. (2010). Mechanisms of probiotic actions - A review. Int J Med Microbiol 300, 57-
62.
Ohashi, Y., Tokunaga, M., Taketomo, N., and Ushida, K. (2007). Stimulation of indigenous lactobacilli
by fermented milk prepared with probiotic bacterium, Lactobacillus delbrueckii subsp. bulgaricus strain
2038, in the pigs. J Nutr Sci Vitaminol (Tokyo) 53, 82-86.
Ohl, M.E., and Miller, S.I. (2001). Salmonella: a model for bacterial pathogenesis. Annu Rev Med 52,
259-274.
Olsson, M., Syk, A., and Wollin, R. (1991). Identification of Salmonellae with the 4-methylumbelliferyl
caprilate fluorescence test. J Clin Microbiol 29, 2631-2632.
Ouwehand, A.C., Salminen, S., and Isolauri, E. (2002). Probiotics: an overview of beneficial effects.
Antonie Van Leeuwenhoek 82, 279-289.
Ouwehand, A.C., and Vesterlund, S. (2004). Antimicrobial components from lactic acid bacteria. In:
Salminen, S., von Wright, A., Ouwehand, A. (Eds.), Lactic acid bacteria: microbiology and functional
aspects. Marcel Dekker, Inc., New York, pp.375-395. .
Page, S.W. (2006). Current use of antimicrobial growth promoters in food animals: the benefits. In:
Barug. D., de Jong. J., Kies. A. K., Verstegen, M. W. A. (eds.), Antimicrobial growth promoters. Where
do we go from here? Wageningen Academic Publishers. The Netherlands. pp. 19-51
Pan, X., Chenc, F., Wu, T., Tanga, H., and Zhao, Z. (2008). The acid, biletolerance and
antimicrobialproperty of Lactobacillusacidophilus NIT. Food Control 20, 598-602.
Pan, X.D., Chen, F.Q., Wu, T.X., Tang, H.G., and Zhao, Z.Y. (2009). Prebiotic oligosaccharides change
the concentrations of short-chain fatty acids and the microbial population of mouse bowel. J Zhejiang
191
Univ Sci B 10, 258-263.
Papatsiros, V.G., Christodoulopoulos, G., and Filippopoulos, L.C. (2012). The use of organic acids in
monogastric animals (swine and rabbits). Journal of Cell and Animal Biology 6, 154-159.
Pardon, P., Sanchis, R., Marly, J., Lantier, F., Pepin, M., and Popoff, M. (1988). [Ovine salmonellosis
caused by Salmonella abortus ovis]. Ann Rech Vet 19, 221-235.
Parker, R.B. (1974). Probiotics, the other half of the antibiotic story. Anim Nutr Health 29, 4-8.
Parry, C.M. ( 2006). Epidemiological and clinical aspects of human typhoid fever. In. Matroeni, P. and
Maskell, D. (eds.), Salmonella infections: Clinical, immunological and molecular aspects. Cambridge
University Press, New York, pp. 1-24.
Partanen, K., Karhapaa, M., and Siljander-Rasi, H. (2006). Performance, carcass quality, and gastric
alterations in fattening pigs fed additives containing formic acid either coated with sorbate or mixed
with lactic acid. Agricultural and Food Science 15, 324-339.
Pascual, L.M., Daniele, M.B., Pajaro, C., and Barberis, L. (2006). Lactobacillus species isolated from
the vagina: identification, hydrogen peroxide production and nonoxynol-9 resistance. Contraception 73,
78-81.
Patel, J.C., and Galan, J.E. (2005). Manipulation of the host actin cytoskeleton by Salmonella--all in the
name of entry. Curr Opin Microbiol 8, 10-15.
Patterson, J.A., and Burkholder, K.M. (2003). Application of prebiotics and probiotics in poultry
production. Poult Sci 82, 627-631.
Pelletier, C., Bouley, C., Cayuela, C., Bouttier, S., Bourlioux, P., and Bellon-Fontaine, M.N. (1997).
Cell surface characteristics of Lactobacillus casei subsp. casei, Lactobacillus paracasei subsp. paracasei,
and Lactobacillus rhamnosus strains. Appl Environ Microbiol 63, 1725-1731.
Perreten, V., Vorlet-Fawer, L., Slickers, P., Ehricht, R., Kuhnert, P., and Frey, J. (2005). Microarray-
based detection of 90 antibiotic resistance genes of gram-positive bacteria. J Clin Microbiol 43, 2291-
2302.
Phillips, A.D., and Frankel, G. (2000). Intimin-mediated tissue specificity in enteropathogenic
Escherichia coli interaction with human intestinal organ cultures. J Infect Dis 181, 1496-1500.
Pie, S., Awati, A., Vida, S., Falluel, I., Williams, B.A., and Oswald, I.P. (2007). Effects of added
fermentable carbohydrates in the diet on intestinal proinflammatory cytokine-specific mRNA content in
weaning piglets. J Anim Sci 85, 673-683.
Pieper, R., Janczyk, P., Schumann, R., and Souffrant, W.B. (2006). The intestinal microflora of piglets
around weaning - with emphasis on lactobacilli. Archiva Zootechnica 9, 28-40.
Pieper, R., Janczyk, P., Urubschurov, V., Korn, U., Pieper, B., and Souffrant, W.B. (2009). Effect of a
single oral administration of Lactobacillus plantarum DSMZ 8862/8866 before and at the time point of
weaning on intestinal microbial communities in piglets. Int J Food Microbiol 130, 227-232.
Pieper, R., Janczyk, P., Zeyner, A., Smidt, H., Guiard, V., and Souffrant, W.B. (2008). Ecophysiology
of the developing total bacterial and lactobacillus communities in the terminal small intestine of
weaning piglets. Microb Ecol 56, 474-483.
Pierce, K.M., Callan, J.J., McCarthy, P., and O’Doherty, J.V. (2005). Performance of weanling pigs
offered low or high lactose diets supplemented with avilamycin or inulin. British Society of Animal
Science 80, 313-318.
Plumed-Ferrer, C., Llopis, M., Hyvönen, P., and von Wright, A. (2004). Characterization of the
microbial community and its changes in liquid piglet feed formulations. J Sci Food Agric 84, 1315-
192
1318.
Pollmann, D.S., Danielson, D.M., and Peo, E.R., Jr. (1980). Effect of Lactobacillus acidophilus on
starter pigs fed a diet supplemented with lactose. J Anim Sci 51, 638-644.
Popoff, M.Y., Bockemuhl, J., Brenner, F.W., and Gheesling, L.L. (2001). Supplement 2000 (no. 44) to
the Kauffmann-White scheme. Res Microbiol 152, 907-909.
Popoff, M.Y., Bockemuhl, J., and Gheesling, L.L. (2004). Supplement 2002 (no. 46) to the Kauffmann-
White scheme. Res Microbiol 155, 568-570.
Pridmore, R.D., Pittet, A.C., Praplan, F., and Cavadini, C. (2008). Hydrogen peroxide production by
Lactobacillus johnsonii NCC 533 and its role in anti-Salmonella activity. FEMS Microbiol Lett 283,
210-215.
Prohaszka, L., Jayarao, B.M., Fabian, A., and Kovacs, S. (1990). The role of intestinal volatile fatty
acids in the Salmonella shedding of pigs. Zentralbl Veterinarmed B 37, 570-574.
Pullinger, G.D., van Diemen, P.M., Carnell, S.C., Davies, H., Lyte, M., and Stevens, M.P. (2010). 6-
hydroxydopamine-mediated release of norepinephrine increases faecal excretion of Salmonella enterica
serovar Typhimurium in pigs. Vet Res 41, 68.
Quintero, M., Maldonado, M., Perez-Munoz, M., Jimenez, R., Fangman, T., Rupnow, J., Wittke, A.,
Russell, M., and Hutkins, R. (2011). Adherence inhibition of Cronobacter sakazakii to intestinal
epithelial cells by prebiotic oligosaccharides. Curr Microbiol 62, 1448-1454.
Rabsch, W., Andrews, H.L., Kingsley, R.A., Prager, R., Tschape, H., Adams, L.G., and Baumler, A.J.
(2002). Salmonella enterica serotype Typhimurium and its host-adapted variants. Infect Immun 70,
2249-2255.
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., and Medzhitov, R. (2004).
Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell
118, 229-241.
Rambach, A. (1990). New plate medium for facilitated differentiation of Salmonella spp. from Proteus
spp. and other enteric bacteria. Appl Environ Microbiol 56, 301-303.
Randall, L.P., Cooles, S.W., Coldham, N.G., Penuela, E.G., Mott, A.C., Woodward, M.J., Piddock, L.J.,
and Webber, M.A. (2007). Commonly used farm disinfectants can select for mutant Salmonella enterica
serovar Typhimurium with decreased susceptibility to biocides and antibiotics without compromising
virulence. J Antimicrob Chemother 60, 1273-1280.
Randall, L.P., Cooles, S.W., Piddock, L.J., and Woodward, M.J. (2004). Effect of triclosan or a phenolic
farm disinfectant on the selection of antibiotic-resistant Salmonella enterica. J Antimicrob Chemother
54, 621-627.
Randall, L.P., Kirchner, M., Teale, C.J., Coldham, N.G., Liebana, E., and Clifton-Hadley, F. (2009).
Evaluation of CHROMagar CTX, a novel medium for isolating CTX-M-ESBL-positive
Enterobacteriaceae while inhibiting AmpC-producing strains. J Antimicrob Chemother 63, 302-308.
Raya, R.R., Oot, R.A., Moore-Maley, B., Wieland, S., Callaway, T.R., Kutter, E.M., and Brabban, A.D.
(2011). Naturally resident and exogenously applied T4-like and T5-like bacteriophages can reduce
Escherichia coli O157:H7 levels in sheep guts. Bacteriophage 1, 15-24.
Reeves, M.W., Evins, G.M., Heiba, A.A., Plikaytis, B.D., and Farmer, J.J., 3rd (1989). Clonal nature of
Salmonella typhi and its genetic relatedness to other salmonellae as shown by multilocus enzyme
electrophoresis, and proposal of Salmonella bongori comb. nov. J Clin Microbiol 27, 313-320.
Rettger, L.F., Levy, W.N., Weinstein, L., and Weiss, J.E. (1935). Lactobacillus acidophilus and its
therapeutic application. Yale University Press, New Haven.
193
Ridlon, J.M., Kang, D.J., and Hylemon, P.B. (2006). Bile salt biotransformations by human intestinal
bacteria. J Lipid Res 47, 241-259.
Roberfroid, M., Gibson, G.R., Hoyles, L., McCartney, A.L., Rastall, R., Rowland, I., Wolvers, D.,
Watzl, B., Szajewska, H., Stahl, B., et al. (2010). Prebiotic effects: metabolic and health benefits. Br J
Nutr 104 Suppl 2, S1-63.
Roberfroid, M.B. (1998). Prebiotics and synbiotics: concepts and nutritional properties. Br J Nutr 80,
S197-202.
Roberfroid, M.B. (2000a). Chicory fructooligosaccharides and the gastrointestinal tract. Nutrition 16,
677-679.
Roberfroid, M.B. (2000b). Prebiotics and probiotics: are they functional foods? Am J Clin Nutr 71,
1682S-1687S; discussion 1688S-1690S.
Roberfroid, M.B. (2008). Prebiotics: Concept, Definition, Criteria, Methodologies, and Products. In:
Handbook of Prebiotics. Gibson, G. R and Roberfroid, M. B. (eds.), CRC Press, Taylor & Francis
Group. pp. 39-68.
Rodriguez-Palacios, A., Staempfli, H.R., Duffield, T., and Weese, J.S. (2009). Isolation of bovine
intestinal Lactobacillus plantarum and Pediococcus acidilactici with inhibitory activity against
Escherichia coli O157 and F5. J Appl Microbiol 106, 393-401.
Rodriguez, E., Arques, J.L., Rodriguez, R., Nunez, M., and Medina, M. (2003). Reuterin production by
lactobacilli isolated from pig faeces and evaluation of probiotic traits. Lett Appl Microbiol 37, 259-263.
Roesler, U., Heller, P., Waldmann, K.H., Truyen, U., and Hensel, A. (2006). Immunization of sows in
an integrated pig-breeding herd using a homologous inactivated Salmonella vaccine decreases the
prevalence of Salmonella typhimurium infection in the offspring. J Vet Med B Infect Dis Vet Public
Health 53, 224-228.
Roesler, U., Marg, H., Schroder, I., Mauer, S., Arnold, T., Lehmann, J., Truyen, U., and Hensel, A.
(2004). Oral vaccination of pigs with an invasive gyrA-cpxA-rpoB Salmonella Typhimurium mutant.
Vaccine 23, 595-603.
Rokka, S., and Rantamäki, P. (2010). Protecting probiotic bacteria by microencapsulation: challenges
for industrial applications. Eur Food Res Technol 231, 1-12.
Roselli, M., Finamore, A., Britti, M.S., Konstantinov, S.R., Smidt, H., de Vos, W.M., and Mengheri, E.
(2007). The novel porcine Lactobacillus sobrius strain protects intestinal cells from enterotoxigenic
Escherichia coli K88 infection and prevents membrane barrier damage. J Nutr 137, 2709-2716.
Rosochacki, S.J., Piekarzewska, A.B., Poloszynowicz, J., and Sakowski, T. (2000). The influence of
restraint immobilization stress on the concentration qf bioamines and cortisol in plasma of Pietrain and
Duroc pigs. J Vet Med A Physiol Pathol Clin Med 47, 231-242.
Round, J.L., and Mazmanian, S.K. (2009). The gut microbiota shapes intestinal immune responses
during health and disease. Nat Rev Immunol 9, 313-323.
Rowland, I., Capurso, L., Collins, K., Cummings, J., Delzenne, N., Goulet, O., Guarner, F., Marteau, P.,
and Meier, R. (2010). Current level of consensus on probiotic science--report of an expert meeting--
London, 23 November 2009. Gut Microbes 1, 436-439.
Ruas-Madiedo, P., Gueimonde, M., Margolles, A., de los Reyes-Gavilan, C.G., and Salminen, S. (2006).
Exopolysaccharides produced by probiotic strains modify the adhesion of probiotics and
enteropathogens to human intestinal mucus. J Food Prot 69, 2011-2015.
Russell, W.M.S., and Burch, R.L. (1992). The Principles of Humane Experimental Technique, Special
Edition edn (Potters Bar: Universities Federation for Animal Welfare).
194
Rychlik, I., and Barrow, P.A. (2005). Salmonella stress management and its relevance to behaviour
during intestinal colonisation and infection. FEMS Microbiol Rev 29, 1021-1040.
Rycroft, C.E., Jones, M.R., Gibson, G.R., and Rastall, R.A. (2001). A comparative in vitro evaluation of
the fermentation properties of prebiotic oligosaccharides. J Appl Microbiol 91, 878-887.
Saarela, M., Hallamaa, K., Mattila-Sandholm, T., and Mättö, J. (2003). The effect of lactose derivatives
lactulose, lactitol and lactobionic acid on the functional and technological properties of potentially
probiotic Lactobacillus strains. International Dairy Journal 13, 291-302.
Saarela, M., Mogensen, G., Fonden, R., Matto, J., and Mattila-Sandholm, T. (2000). Probiotic bacteria:
safety, functional and technological properties. J Biotechnol 84, 197-215.
Sabater-Molina, M., Larque, E., Torrella, F., and Zamora, S. (2009). Dietary fructooligosaccharides and
potential benefits on health. J Physiol Biochem 65, 315-328.
Saiki, R.K., Gelfand, D.H., Stoffel, S., Scharf, S.J., Higuchi, R., Horn, G.T., Mullis, K.B., and Erlich,
H.A. (1988). Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.
Science 239, 487-491.
Sakata, T., Kojima, T., Fujieda, M., Takahashi, M., and Michibata, T. (2003). Influences of probiotic
bacteria on organic acid production by pig caecal bacteria in vitro. Proc Nutr Soc 62, 73-80.
Sako, T., Matsumoto, K., and Tanaka, R. (1999). Recent progress on research and applications of non-
digestible galacto-oligosaccharides International Dairy Journal 9, 69-80.
Salminen, S., von Wright, A., Morelli, L., Marteau, P., Brassart, D., de Vos, W.M., Fonden, R., Saxelin,
M., Collins, K., Mogensen, G., et al. (1998). Demonstration of safety of probiotics -- a review. Int J
Food Microbiol 44, 93-106.
Salmon, D.E., and Smith, T. (1886). The bacterium of swine plague. American Monthly Microbiology
Journal 7, 24.
Salvana, E.M., and Frank, M. (2006). Lactobacillus endocarditis: case report and review of cases
reported since 1992. J Infect 53, e5-e10.
Saminathan, M., Sieo, C.C., Kalavathy, R., Abdullah, N., and Ho, Y.W. (2011). Effect prebiotic
oligosaccharides on growth of Lactobacillus strains used as a probiotic for chickens African Journal of
Microbiology Research 5, 57-64.
Sanders, M.E., Akkermans, L.M., Haller, D., Hammerman, C., Heimbach, J., Hormannsperger, G.,
Huys, G., Levy, D.D., Lutgendorff, F., Mack, D., et al. (2010). Safety assessment of probiotics for
human use. Gut Microbes 1, 164-185.
Santander, J., and Curtiss, R., 3rd (2010). Salmonella enterica Serovars Typhi and Paratyphi A are
avirulent in newborn and infant mice even when expressing virulence plasmid genes of Salmonella
Typhimurium. J Infect Dev Ctries 4, 723-731.
Santos, A.C., Roberts, J.A., Cook, A.J., Simons, R., Sheehan, R., Lane, C., Adak, G.K., Clifton-Hadley,
F.A., and Rodrigues, L.C. (2011). Salmonella Typhimurium and Salmonella Enteritidis in England:
costs to patients, their families, and primary and community health services of the NHS. Epidemiol
Infect 139, 742-753.
Santos, R.L., Tsolis, R.M., Baumler, A.J., and Adams, L.G. (2003). Pathogenesis of Salmonella-induced
enteritis. Braz J Med Biol Res 36, 3-12.
Santos, R.L., Zhang, S., Tsolis, R.M., Kingsley, R.A., Adams, L.G., and Baumler, A.J. (2001). Animal
models of Salmonella infections: enteritis versus typhoid fever. Microbes Infect 3, 1335-1344.
Sarbini, S.R., Kolida, S., Naeye, T., Einerhand, A., Brison, Y., Remaud-Simeon, M., Monsan, P.,
195
Gibson, G.R., and Rastall, R.A. (2011). In vitro fermentation of linear and alpha-1,2-branched dextrans
by the human fecal microbiota. Appl Environ Microbiol 77, 5307-5315.
Saulnier, D.M., Gibson, G.R., and Kolida, S. (2008). In vitro effects of selected synbiotics on the human
faecal microbiota composition. FEMS Microbiol Ecol 66, 516-527.
Saulnier, D.M., Kolida, S., and Gibson, G.R. (2009a). Microbiology of the human intestinal tract and
approaches for its dietary modulation. Curr Pharm Des 15, 1403-1414.
Saulnier, D.M., Spinler, J.K., Gibson, G.R., and Versalovic, J. (2009b). Mechanisms of probiosis and
prebiosis: considerations for enhanced functional foods. Curr Opin Biotechnol 20, 135-141.
SCAN (2001). Guidelines for the assessment of additives in feedingstuffs. Part II: Enzymes and
microorganisms. European Commission, Health and Consumer Protection Directorate-General. (SCAN)
Scientific Committee on Animal Nutrition. Available from: ec.europa.eu/food/fs/sc/scan/out68_en.pdf
Scharek, L., Altherr, B.J., Tolke, C., and Schmidt, M.F. (2007a). Influence of the probiotic Bacillus
cereus var. toyoi on the intestinal immunity of piglets. Vet Immunol Immunopathol 120, 136-147.
Scharek, L., Guth, J., Filter, M., and Schmidt, M.F. (2007b). Impact of the probiotic bacteria
Enterococcus faecium NCIMB 10415 (SF68) and Bacillus cereus var. toyoi NCIMB 40112 on the
development of serum IgG and faecal IgA of sows and their piglets. Arch Anim Nutr 61, 223-234.
Schierack, P., Kleta, S., Tedin, K., Babila, J.T., Oswald, S., Oelschlaeger, T.A., Hiemann, R., Paetzold,
S., and Wieler, L.H. (2011). E. coli Nissle 1917 Affects Salmonella adhesion to porcine intestinal
epithelial cells. PLoS One 6, e14712.
Schierack, P., Nordhoff, M., Pollmann, M., Weyrauch, K.D., Amasheh, S., Lodemann, U., Jores, J.,
Tachu, B., Kleta, S., Blikslager, A., et al. (2006). Characterization of a porcine intestinal epithelial cell
line for in vitro studies of microbial pathogenesis in swine. Histochem Cell Biol 125, 293-305.
Schierack, P., Wieler, L.H., Taras, D., Herwig, V., Tachu, B., Hlinak, A., Schmidt, M.F., and Scharek,
L. (2007). Bacillus cereus var. toyoi enhanced systemic immune response in piglets. Vet Immunol
Immunopathol 118, 1-11.
Schneitz, C. (2005). Competitive exclusion in poultry-30 years of research. Food Control 16, 657-667.
Schoeni, J.L., and Wong, A.C. (1994). Inhibition of Campylobacter jejuni colonization in chicks by
defined competitive exclusion bacteria. Appl Environ Microbiol 60, 1191-1197.
Schrezenmeir, J., and de Vrese, M. (2001). Probiotics, prebiotics, and synbiotics--approaching a
definition. Am J Clin Nutr 73, 361S-364S.
Searle, L.E., Best, A., Nunez, A., Salguero, F.J., Johnson, L., Weyer, U., Dugdale, A.H., Cooley, W.A.,
Carter, B., Jones, G., et al. (2009). A mixture containing galactooligosaccharide, produced by the
enzymic activity of Bifidobacterium bifidum, reduces Salmonella enterica serovar Typhimurium
infection in mice. J Med Microbiol 58, 37-48.
Searle, L.E., Cooley, W.A., Jones, G., Nunez, A., Crudgington, B., Weyer, U., Dugdale, A.H., Tzortzis,
G., Collins, J.W., Woodward, M.J., et al. (2010). Purified galactooligosaccharide, derived from a
mixture produced by the enzymic activity of Bifidobacterium bifidum, reduces Salmonella enterica
serovar Typhimurium adhesion and invasion in vitro and in vivo. J Med Microbiol 59, 1428-1439.
Seifert, S., and Watzl, B. (2008). Prebiotics and the Immune System: Review of Experimental and
Human Data. In: Handbook of Prebiotics. Gibson, G. R and Roberfroid, M. B. (eds.), CRC Press, Taylor
& Francis Group. pp. 143-162.
Selke, M., Meens, J., Springer, S., Frank, R., and Gerlach, G.F. (2007). Immunization of pigs to prevent
disease in humans: construction and protective efficacy of a Salmonella enterica serovar Typhimurium
live negative-marker vaccine. Infect Immun 75, 2476-2483.
196
Semenov, A.V., van Overbeek, L., and van Bruggen, A.H. (2009). Percolation and survival of
Escherichia coli O157:H7 and Salmonella enterica serovar Typhimurium in soil amended with
contaminated dairy manure or slurry. Appl Environ Microbiol 75, 3206-3215.
Servin, A.L. (2004). Antagonistic activities of lactobacilli and bifidobacteria against microbial
pathogens. FEMS Microbiol Rev 28, 405-440.
Sherman, L.A., and Savage, D.C. (1986). Lipoteichoic acids in Lactobacillus strains that colonize the
mouse gastric epithelium. Appl Environ Microbiol 52, 302-304.
Shivaprasad, H.L. (2000). Fowl typhoid and pullorum disease. Rev Sci Tech 19, 405-424.
Shoaf-Sweeney, K.D., and Hutkins, R.W. (2008). Chapter 2 Adherence, Anti-Adherence, and
Oligosaccharides: Preventing Pathogens from Sticking to the Host. Adv Food Nutr Res 55, 101-161.
Shu, Q., and Gill, H.S. (2001). A dietary probiotic (Bifidobacterium lactis HN019) reduces the severity
of Escherichia coli O157:H7 infection in mice. Med Microbiol Immunol 189, 147-152.
Siezen, R.J., Tzeneva, V.A., Castioni, A., Wels, M., Phan, H.T., Rademaker, J.L., Starrenburg, M.J.,
Kleerebezem, M., Molenaar, D., and van Hylckama Vlieg, J.E. (2010). Phenotypic and genomic
diversity of Lactobacillus plantarum strains isolated from various environmental niches. Environ
Microbiol 12, 758-773.
Silva, M., Jacobus, N.V., Deneke, C., and Gorbach, S.L. (1987). Antimicrobial substance from a human
Lactobacillus strain. Antimicrob Agents Chemother 31, 1231-1233.
Simpson, J.M., McCracken, V.J., Gaskins, H.R., and Mackie, R.I. (2000). Denaturing gradient gel
electrophoresis analysis of 16S ribosomal DNA amplicons to monitor changes in fecal bacterial
populations of weaning pigs after introduction of Lactobacillus reuteri strain MM53. Appl Environ
Microbiol 66, 4705-4714.
Sims, M.D., Dawson, K.A., Newman, K.E., Spring, P., and Hoogell, D.M. (2004). Effects of dietary
mannan oligosaccharide, bacitracin methylene disalicylate, or both on the live performance and
intestinal microbiology of turkeys. Poult Sci 83, 1148-1154.
Skrivanova, E., and Marounek, M. (2007). Influence of pH on antimicrobial activity of organic acids
against rabbit enteropathogenic strain of Escherichia coli. Folia Microbiol (Praha) 52, 70-72.
Smiricky-Tjardes, M.R., Grieshop, C.M., Flickinger, E.A., Bauer, L.L., and Fahey, G.C., Jr. (2003).
Dietary galactooligosaccharides affect ileal and total-tract nutrient digestibility, ileal and fecal bacterial
concentrations, and ileal fermentative characteristics of growing pigs. J Anim Sci 81, 2535-2545.
Smith, H.W. (1965). Observations on the Flora of the Alimentary Tract of Animals and Factors
Affecting Its Composition. J Pathol Bacteriol 89, 95-122.
Smith, H.W., and Huggins, M.B. (1983). Effectiveness of phages in treating experimental Escherichia
coli diarrhoea in calves, piglets and lambs. J Gen Microbiol 129, 2659-2675.
Song, Y.L., Kato, N., Matsumiya, Y., Liu, C.X., Kato, H., and Watanabe, K. (1999). Identification of
and hydrogen peroxide production by fecal and vaginal lactobacilli isolated from Japanese women and
newborn infants. J Clin Microbiol 37, 3062-3064.
Spinler, J.K., Taweechotipatr, M., Rognerud, C.L., Ou, C.N., Tumwasorn, S., and Versalovic, J. (2008).
Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse
enteric bacterial pathogens. Anaerobe 14, 166-171.
Stark, K.D., Regula, G., Hernandez, J., Knopf, L., Fuchs, K., Morris, R.S., and Davies, P. (2006).
Concepts for risk-based surveillance in the field of veterinary medicine and veterinary public health:
review of current approaches. BMC Health Serv Res 6, 20.
197
Stavric, S., and d’Aoust, J.Y. (1993). Undefined and defined bacterial preparations for the competitive
exclusion of Salmonella in poultry – a review. J Food Prot 56, 173–180.
Stavric, S., and Kornegay, E.T. (1995). Microbial probiotic for pigs and poultry. In: RJ Wallace, R. J.,
Chesson, A. (eds.), Biotechnology in Animal Feeds and Animal Feeding. VCH Verlagsgesellschaft
mbH, Weinheim, pp. 205–231.
Stecher, B., Hapfelmeier, S., Muller, C., Kremer, M., Stallmach, T., and Hardt, W.D. (2004). Flagella
and chemotaxis are required for efficient induction of Salmonella enterica serovar Typhimurium colitis
in streptomycin-pretreated mice. Infect Immun 72, 4138-4150.
Steele-Mortimer, O. (2008). The Salmonella-containing vacuole: moving with the times. Curr Opin
Microbiol 11, 38-45.
Stern, N.J., Cox, N.A., Bailey, J.S., Berrang, M.E., and Musgrove, M.T. (2001). Comparison of mucosal
competitive exclusion and competitive exclusion treatment to reduce Salmonella and Campylobacter
spp. colonization in broiler chickens. Poult Sci 80, 156-160.
Stokes, J.L., and Bayne, H.G. (1958). Growth-factor-dependent strains of Salmonellae. J Bacteriol 76,
417-421.
Strus, M., Janczyk, A., Gonet-Surowka, A., Brzychczy-Wloch, M., Stochel, G., Kochan, P., and
Heczko, P.B. (2009). Effect of hydrogen peroxide of bacterial origin on apoptosis and necrosis of gut
mucosa epithelial cells as a possible pathomechanism of inflammatory bowel disease and cancer. J
Physiol Pharmacol 60 Suppl 6, 55-60.
Sukhan, A., Kubori, T., and Galan, J.E. (2003). Synthesis and localization of the Salmonella SPI-1 type
III secretion needle complex proteins PrgI and PrgJ. J Bacteriol 185, 3480-3483.
Sulakvelidze, A., Alavidze, Z., and Morris, J.G., Jr. (2001). Bacteriophage therapy. Antimicrob Agents
Chemother 45, 649-659.
Suo, C., Yin, Y., Wang, X., Lou, X., Song, D., Wang, X., and Gu, Q. (2012). Effects of lactobacillus
plantarum ZJ316 on pig growth and pork quality. BMC Vet Ress 8.
Swanenburg, M., Urlings, H.A., Keuzenkamp, D.A., and Snijders, J.M. (2001a). Salmonella in the
lairage of pig slaughterhouses. J Food Prot 64, 12-16.
Swanenburg, M., van der Wolf, P.J., Urlings, H.A., Snijders, J.M., and van Knapen, F. (2001b).
Salmonella in slaughter pigs: the effect of logistic slaughter procedures of pigs on the prevalence of
Salmonella in pork. Int J Food Microbiol 70, 231-242.
Switt, A.I., Soyer, Y., Warnick, L.D., and Wiedmann, M. (2009). Emergence, distribution, and
molecular and phenotypic characteristics of Salmonella enterica serotype 4,5,12:i. Foodborne Pathog
Dis 6, 407-415.
Swords, W.E., Wu, C.C., Champlin, F.R., and Buddington, R.K. (1993). Postnatal changes in selected
bacterial groups of the pig colonic microflora. Biol Neonate 63, 191-200.
Szabo, I., Wieler, L.H., Tedin, K., Scharek-Tedin, L., Taras, D., Hensel, A., Appel, B., and Nockler, K.
(2009). Influence of a probiotic strain of Enterococcus faecium on Salmonella enterica serovar
Typhimurium DT104 infection in a porcine animal infection model. Appl Environ Microbiol 75, 2621-
2628.
Takahashi, S., Egawa, Y., Simojo, N., Tsukahara, T., and Ushida, K. (2007). Oral administration of
Lactobacillus plantarum strain Lq80 to weaning piglets stimulates the growth of indigenous lactobacilli
to modify the lactobacillal population. J Gen Appl Microbiol 53, 325-332.
Tallon, R., Bressollier, P., and Urdaci, M.C. (2003). Isolation and characterization of two
exopolysaccharides produced by Lactobacillus plantarum EP56. Res Microbiol 154, 705-712.
198
Tanigawa, K., Kawabata, H., and Watanabe, K. (2010). Identification and typing of Lactococcus lactis
by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Appl Environ Microbiol
76, 4055-4062.
Tannock, G.W. (1992). The lactic microflora of pigs, mice and rats. In: Wood, B. J. B. (eds.), The Lactic
Acid Bacteria, vol. 1, The Lactic Acid Bacteria in Health and Disease. London: Chapman & Hall, pp.
21-48.
Tannock, G.W. (2003). Probiotics: time for a dose of realism. Curr Issues Intest Microbiol 4, 33-42.
Taras, D., Vahjen, W., Macha, M., and Simon, O. (2005). Response of performance characteristics and
fecal consistency to long-lasting dietary supplementation with the probiotic strain Bacillus cereus var.
toyoi to sows and piglets. Arch Anim Nutr 59, 405-417.
Taylor, D.J. (1997). A Realistic Assessment of the Risks of Antimicrobial Use in Animals and its
Effects on Food Safety. Pig J 40, 46-59.
Tejero-Sarinena, S., Barlow, J., Costabile, A., Gibson, G.R., and Rowland, I. (2012). In vitro evaluation
of the antimicrobial activity of a range of probiotics against pathogens: Evidence for the effects of
organic acids. Anaerobe 18, 530-538.
Temmerman, R. (2004). Probiotics--consensus of analysis. S Afr Med J 94, 314-316.
Teramoto, K., Sato, H., Sun, L., Torimura, M., and Tao, H. (2007). A simple intact protein analysis by
MALDI-MS for characterization of ribosomal proteins of two genome-sequenced lactic acid bacteria
and verification of their amino acid sequences. J Proteome Res 6, 3899-3907.
Teuber, M. (1999). Spread of antibiotic resistance with food-borne pathogens. Cell Mol Life Sci 56,
755-763.
Teuber, M., Meile, L., and Schwarz, F. (1999). Acquired antibiotic resistance in lactic acid bacteria from
food. Antonie Van Leeuwenhoek 76, 115-137.
Thomsen, L.E., Knudsen, K.E., Jensen, T.K., Christensen, A.S., Moller, K., and Roepstorff, A. (2007).
The effect of fermentable carbohydrates on experimental swine dysentery and whip worm infections in
pigs. Vet Microbiol 119, 152-163.
Threlfall, E.J. (2000). Epidemic salmonella typhimurium DT 104--a truly international multiresistant
clone. J Antimicrob Chemother 46, 7-10.
Threlfall, E.J., and Frost, J.A. (1990). The identification, typing and fingerprinting of Salmonella:
laboratory aspects and epidemiological applications. J Appl Bacteriol 68, 5-16.
Threlfall, E.J., Frost, J.A., Ward, L.R., and Rowe, B. (1994). Epidemic in cattle and humans of
Salmonella typhimurium DT 104 with chromosomally integrated multiple drug resistance. Vet Rec 134,
577.
Timmerman, H.M., Koning, C.J., Mulder, L., Rombouts, F.M., and Beynen, A.C. (2004). Monostrain,
multistrain and multispecies probiotics--A comparison of functionality and efficacy. Int J Food
Microbiol 96, 219-233.
Tindall, B.J., Grimont, P.A., Garrity, G.M., and Euzeby, J.P. (2005). Nomenclature and taxonomy of the
genus Salmonella. Int J Syst Evol Microbiol 55, 521-524.
Tissier, H. (1906). Traitement des infections intestinales par la méthode de la flore bactérienne de
l'intestin. C R Soc Biol 60, 359-361.
Todorov, S.D., Ho, P., Vaz-Velho, M., and Dicks, L.M. (2010). Characterization of bacteriocins
produced by two strains of Lactobacillus plantarum isolated from Beloura and Chourico, traditional pork
products from Portugal. Meat Sci 84, 334-343.
199
Topping, D.L., and Clifton, P.M. (2001). Short-chain fatty acids and human colonic function: roles of
resistant starch and nonstarch polysaccharides. Physiol Rev 81, 1031-1064.
Trebichavsky, I., Splichalova, A., Rychlik, I., Hojna, H., Muneta, Y., Mori, Y., and Splichal, I. (2006).
Attenuated aroA Salmonella enterica serovar Typhimurium does not induce inflammatory response and
early protection of gnotobiotic pigs against parental virulent LT2 strain. Vaccine 24, 4285-4289.
Tsiloyiannis, V.K., Kyriakis, S.C., Vlemmas, J., and Sarris, K. (2001). The effect of organic acids on the
control of porcine post-weaning diarrhoea. Res Vet Sci 70, 287-293.
Tsukahara, T., Hashizume, K., Koyama, H., and Ushida, K. (2006). Stimulation of butyrate production
through the metabolic interaction among lactic acid bacteria, Lactobacillus acidophilus, and lactic acid-
utilizing bacteria, Megasphaera elsdenii, in porcine cecal digesta. Anim Sci J 77, 454-461.
Tsukahara, T., Iwasaki, Y., Nakayama, K., and Ushida, K. (2003). Stimulation of butyrate production in
the large intestine of weaning piglets by dietary fructooligosaccharides and its influence on the
histological variables of the large intestinal mucosa. J Nutr Sci Vitaminol (Tokyo) 49, 414-421.
Tuohy, K.M., Probert, H.M., Smejkal, C.W., and Gibson, G.R. (2003). Using probiotics and prebiotics
to improve gut health. Drug Discov Today 8, 692-700.
Tuohy, K.M., Rouzaud, G.C., Bruck, W.M., and Gibson, G.R. (2005). Modulation of the human gut
microflora towards improved health using prebiotics--assessment of efficacy. Curr Pharm Des 11, 75-
90.
Tuohy, K.M., Ziemer, C.J., Klinder, A., Knobel, Y., Pool-Zobel, B.L., and Gibson, G.R. (2002). A
Human Volunteer Study to Determine the Prebiotic Effects of Lactulose Powder on Human Colonic
Microbiota. Microb Ecol in Health and Disease 14, 165-173.
Tuomola, E.M., Ouwehand, A.C., and Salminen, S.J. (1999). The effect of probiotic bacteria on the
adhesion of pathogens to human intestinal mucus. FEMS Immunol Med Microbiol 26, 137-142.
Tynkkynen, S., Singh, K.V., and Varmanen, P. (1998). Vancomycin resistance factor of Lactobacillus
rhamnosus GG in relation to enterococcal vancomycin resistance (van) genes. Int J Food Microbiol 41,
195-204.
Tzortzis, G., Goulas, A.K., Gee, J.M., and Gibson, G.R. (2005). A novel galactooligosaccharide mixture
increases the bifidobacterial population numbers in a continuous in vitro fermentation system and in the
proximal colonic contents of pigs in vivo. J Nutr 135, 1726-1731.
Uchiya, K., Barbieri, M.A., Funato, K., Shah, A.H., Stahl, P.D., and Groisman, E.A. (1999). A
Salmonella virulence protein that inhibits cellular trafficking. EMBO J 18, 3924-3933.
Ushida, K., Hoshi, S., and Ajisaka, K. (2002). 13C-NMR Studies on Lactate Metabolism in a Porcine
Gut Microbial Ecosystem. Microbial Ecology in Health and Disease 14, 241-246.
Uzzau, S., Brown, D.J., Wallis, T., Rubino, S., Leori, G., Bernard, S., Casadesus, J., Platt, D.J., and
Olsen, J.E. (2000). Host adapted serotypes of Salmonella enterica. Epidemiol Infect 125, 229-255.
Van Immerseel, F., Boyen, F., Gantois, I., Timbermont, L., Bohez, L., Pasmans, F., Haesebrouck, F.,
and Ducatelle, R. (2005). Supplementation of coated butyric acid in the feed reduces colonization and
shedding of Salmonella in poultry. Poult Sci 84, 1851-1856.
Van Immerseel, F., De Buck, J., De Smet, I., Pasmans, F., Haesebrouck, F., and Ducatelle, R. (2004a).
Interactions of butyric acid- and acetic acid-treated Salmonella with chicken primary cecal epithelial
cells in vitro. Avian Dis 48, 384-391.
Van Immerseel, F., Fievez, V., de Buck, J., Pasmans, F., Martel, A., Haesebrouck, F., and Ducatelle, R.
(2004b). Microencapsulated short-chain fatty acids in feed modify colonization and invasion early after
infection with Salmonella enteritidis in young chickens. Poult Sci 83, 69-74.
200
Van Immerseel, F., Russell, J.B., Flythe, M.D., Gantois, I., Timbermont, L., Pasmans, F., Haesebrouck,
F., and Ducatelle, R. (2006). The use of organic acids to combat Salmonella in poultry: a mechanistic
explanation of the efficacy. Avian Pathol 35, 182-188.
Vandenbergh, P.A. (1993). Lactic acid bacteria, their metabolic products and interference with
microbial growth. FEMS Microbiol Rev 12, 221-237.
Vassiliadis, P. (1983). The Rappaport-Vassiliadis (RV) enrichment medium for the isolation of
salmonellas: an overview. J Appl Bacteriol 54, 69-76.
Verbrugghe, E., Boyen, F., Van Parys, A., Van Deun, K., Croubels, S., Thompson, A., Shearer, N.,
Leyman, B., Haesebrouck, F., and Pasmans, F. (2011). Stress induced Salmonella Typhimurium
recrudescence in pigs coincides with cortisol induced increased intracellular proliferation in
macrophages. Vet Res 42, 118.
Verdonk, J.M., Shim, S.B., van Leeuwen, P., and Verstegen, M.W. (2005). Application of inulin-type
fructans in animal feed and pet food. Br J Nutr 93 Suppl 1, S125-138.
Verstegen, M.W., and Williams, B.A. (2002). Alternatives to the use of antibiotics as growth promoters
for monogastric animals. Anim Biotechnol 13, 113-127.
Vico, J.P., and Mainar-Jaime, R.C. (2011). The use of meat juice or blood serum for the diagnosis of
Salmonella infection in pigs and its possible implications on Salmonella control programs. J Vet Diagn
Invest 23, 528-531.
Vieira-Pinto, M., Tenreiro, R., and Martins, C. (2006). Unveiling contamination sources and
dissemination routes of Salmonella sp. in pigs at a Portuguese slaughterhouse through macrorestriction
profiling by pulsed-field gel electrophoresis. Int J Food Microbiol 110, 77-84.
Voetsch, A.C., Van Gilder, T.J., Angulo, F.J., Farley, M.M., Shallow, S., Marcus, R., Cieslak, P.R.,
Deneen, V.C., and Tauxe, R.V. (2004). FoodNet estimate of the burden of illness caused by
nontyphoidal Salmonella infections in the United States. Clin Infect Dis 38 Suppl 3, S127-134.
von Wright, A. (2005). Regulating the safety of probiotics-the European approach. Curr Pharm Des 11,
17-23.
Vondruskova, H., Slamova, R., Trckova, M., Zraly, Z., and Pavlik, I. (2010). Alternatives to antibiotic
growth promoters in prevention of diarrhoea in weaned piglets: a review. Veterinarni Medicina 55, 199-
224.
Vos, A.P., M'Rabet, L., Stahl, B., Boehm, G., and Garssen, J. (2007). Immune-modulatory effects and
potential working mechanisms of orally applied nondigestible carbohydrates. Crit Rev Immunol 27, 97-
140.
Vulevic, J., Drakoularakou, A., Yaqoob, P., Tzortzis, G., and Gibson, G.R. (2008). Modulation of the
fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS)
in healthy elderly volunteers. Am J Clin Nutr 88, 1438-1446.
Vyvoda, O.S., Coleman, R., and Holdsworth, G. (1977). Effects of different bile salts upon the
composition and morphology of a liver plasma membrane preparation. Deoxycholate is more membrane
damaging than cholate and its conjugates. Biochim Biophys Acta 465, 68-76.
Walker, W.A. (2008). Mechanisms of action of probiotics. Clin Infect Dis 46 Suppl 2, S87-91;
discussion S144-151.
Wall, S.K., Zhang, J., Rostagno, M.H., and Ebner, P.D. (2010). Phage therapy to reduce preprocessing
Salmonella infections in market-weight swine. Appl Environ Microbiol 76, 48-53.
Wallis, T.S., and Galyov, E.E. (2000). Molecular basis of Salmonella-induced enteritis. Mol Microbiol
36, 997-1005.
201
Wang, X., and Gibson, G.R. (1993). Effects of the in vitro fermentation of oligofructose and inulin by
bacteria growing in the human large intestine. J Appl Bacteriol 75, 373-380.
Wang, Y.C., Chang, Y.C., Chuang, H.L., Chiu, C.C., Yeh, K.S., Chang, C.C., Hsuan, S.L., Lin, W.H.,
and Chen, T.H. (2011). Transmission of Salmonella between swine farms by the housefly (Musca
domestica). J Food Prot 74, 1012-1016.
Waterman, S.R., and Holden, D.W. (2003). Functions and effectors of the Salmonella pathogenicity
island 2 type III secretion system. Cell Microbiol 5, 501-511.
Watson, J.A., and Schubert, J. (1969). Action of hydrogen peroxide on growth inhibition of Salmonella
typhimurium. J Gen Microbiol 57, 25-34.
Weinstein, D.L., O'Neill, B.L., Hone, D.M., and Metcalf, E.S. (1998). Differential early interactions
between Salmonella enterica serovar Typhi and two other pathogenic Salmonella serovars with
intestinal epithelial cells. Infect Immun 66, 2310-2318.
Wilcock, B.P. (1979). Experimental Klebsiella and Salmonella infection in neonatal swine. Can J Comp
Med 43, 200-206.
Wilcock, B.P., Armstrong, C.H., and Olander, H.J. (1976). The significance of the serotype in the
clinical and pathological features of naturally occurring porcine salmonellosis. Can J Comp Med 40, 80-
88.
Wilcock, B.P., and Olander, H.J. (1977). The pathogenesis of porcine rectal stricture. I. The naturally
occurring disease and its association with salmonellosis. Vet Pathol 14, 36-42.
Wilcock, B.P., and Schwartz, K. (1992). Salmonellosis. In: Leman, A. D., Straw, B. E., Mengeling, W.
E., D'Allaire, S., Taylor, D. J. (Eds.), Diseases of Swine. 7th ed. Iowa State University Press, pp.570-
583.
Wilmes-Riesenberg, M.R., Bearson, B., Foster, J.W., and Curtiss III, R. (1996). Role of the Acid
Tolerance Response in Virulence of Salmonella typhimurium. Infect Immun 64, 1085-1092.
Winfield, M.D., and Groisman, E.A. (2003). Role of nonhost environments in the lifestyles of
Salmonella and Escherichia coli. Appl Environ Microbiol 69, 3687-3694.
Wong, J.M., and Jenkins, D.J. (2007). Carbohydrate digestibility and metabolic effects. J Nutr 137,
2539S-2546S.
Xu, J., and Gordon, J.I. (2003). Honor thy symbionts. Proc Natl Acad Sci U S A 100, 10452-10459.
Yanahira, S., Morita, M., Aoe, S., Suguri, T., Takada, Y., Miura, S., and Nakajima, I. (1997). Effects of
lactitol-oligosaccharides on calcium and magnesium absorption in rats. J Nutr Sci Vitaminol (Tokyo)
43, 123-132.
Yap, P.S., and Gilliland, S.E. (2000). Comparison of newly isolated strains of Lactobacillus delbrueckii
subsp. lactis for hydrogen peroxide production at 5 degrees C. J Dairy Sci 83, 628-632.
Yazawa, K., Imai, K., and Tamura, Z. (1978). Oligosaccharides and polysaccharides specifically
utilizable by bifidobacteria. Chem Pharm Bull (Tokyo) 26, 3306-3311.
Yin, Q., and Zheng, Q. (2005). Isolation and identification of the dominant Lactobacillus in gut and
faeces of pigs using carbohydrate fermentation and 16S rDNA analysis. J Biosci Bioeng 99, 68-71.
Yusrizal, T., and Chen, C. (2003). Effect of Adding Chicory Fructans in Feed on Fecal and Intestinal
Microflora and Excreta Volatile Ammonia. International Journal of Poultry Science 3, 188-194.
Zentek, J., Marquart, B., and Pietrzak, T. (2002). Intestinal effects of mannanoligosaccharides,
transgalactooligosaccharides, lactose and lactulose in dogs. J Nutr 132, 1682S-1684S.
202
Zhang, G., Ma, L., and Doyle, M.P. (2007a). Potential competitive exclusion bacteria from poultry
inhibitory to Campylobacter jejuni and Salmonella. J Food Prot 70, 867-873.
Zhang, G., Ma, L., and Doyle, M.P. (2007b). Salmonellae reduction in poultry by competitive exclusion
bacteria Lactobacillus salivarius and Streptococcus cristatus. J Food Prot 70, 874-878.
Zhang, S., Kingsley, R.A., Santos, R.L., Andrews-Polymenis, H., Raffatellu, M., Figueiredo, J., Nunes,
J., Tsolis, R.M., Adams, L.G., and Baumler, A.J. (2003). Molecular pathogenesis of Salmonella enterica
serotype typhimurium-induced diarrhea. Infect Immun 71, 1-12.
Zhou, D., Chen, L.M., Hernandez, L., Shears, S.B., and Galan, J.E. (2001). A Salmonella inositol
polyphosphatase acts in conjunction with other bacterial effectors to promote host cell actin
cytoskeleton rearrangements and bacterial internalization. Mol Microbiol 39, 248-259.
Zhou, D., Mooseker, M.S., and Galan, J.E. (1999). Role of the S. typhimurium actin-binding protein
SipA in bacterial internalization. Science 283, 2092-2095.
